*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 37.97 47.82 5.46 38.65 48.02 7.40 22.90 30.21 5.13 24.67 29.05 5.02 coo 41.02 51.33 13.36 40.18 47.06 9.99 17.29 28.50 12.14 22.41 28.51 15.17 coo 39.17 42.30 8.54 40.94 44.26 7.78 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 37.97 47.82 5.46 38.65 48.02 7.40 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 41.02 51.33 13.36 40.18 47.06 9.99 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 39.17 42.30 8.54 40.94 44.26 7.78 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 129 ASP.? 12.18 O ACT A 134 M 206 SER A 121 SER^? 16.65 CH3 ACT A 134 M 210 ARG B 81 ARG^? 17.71 OXT ACT B 134 M 214 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 4.86 1.75 6.36 4.91 0.13 7.65 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 21.93 21.60 5.62 22.92 20.74 3.60 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP B 129 ASP.? 12.08 OXT ACT B 134 M 206 SER B 121 SER^? 16.88 CH3 ACT B 134 M 210 ARG A 81 ARG^? 17.75 O ACT A 134 M 214 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 23.88 0.36 5.26 23.01 -2.52 5.93 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 31.66 3.78 4.83 30.09 2.36 4.90 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 2 hits 1c17_c11 naa= 4 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 1 4 # 1 A 149 PHE A 42 PHE^? 12.32 OXT ACT A 134 A 215 SER A 121 SER^? 16.65 CH3 ACT A 134 A 218 THR A 41 THR^? 18.02 CH3 ACT A 134 A 255 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 44.60 28.41 9.39 42.46 29.45 10.83 14.89 21.94 7.67 12.75 23.35 8.74 coo 38.32 30.82 8.35 40.14 29.77 7.21 21.93 21.60 5.62 22.92 20.74 3.60 coo 39.65 24.77 7.41 41.19 24.89 8.93 18.34 24.70 5.20 19.06 25.00 3.19 coo 36.63 36.86 14.86 40.52 38.40 10.14 28.94 23.42 11.82 28.39 29.21 14.30 1d3g_c01 source 1d3g DIHYDROOROTATE DEHYDROGENASE : 1 hits 1d3g_c01 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 278 ARG A 58 ARG~? 15.97 OXT ACT A 134 A 298 GLU A 61 GLU~? 18.11 OXT ACT A 134 A 348 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 19.67 16.84 1.03 22.28 17.57 2.36 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 9.78 27.17 8.97 7.03 26.14 8.06 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 9.19 27.65 13.99 8.36 28.92 12.52 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 A 170 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 278 ARG B 58 ARG~? 15.94 O ACT B 134 A 298 GLU B 61 GLU~? 17.99 O ACT B 134 A 348 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 9.78 -10.54 -4.22 7.03 -9.65 -3.15 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 9.01 -11.16 -9.07 8.40 -12.39 -7.45 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 22.87 -13.88 -0.47 24.63 -12.69 -0.32 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 2 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG A 58 ARG~? 15.97 OXT ACT A 134 B 278 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 298 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 348 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo -8.10 23.98 3.08 -8.58 21.04 2.27 9.78 27.17 8.97 7.03 26.14 8.06 coo -19.09 15.00 16.26 -16.38 15.21 14.84 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -19.42 16.58 21.15 -18.01 16.20 19.59 21.22 11.60 -0.72 21.76 13.12 0.60 coo -3.61 14.95 13.27 -5.31 15.62 12.23 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 B 170 ARG A 81 ARG^? 17.75 O ACT A 134 B 278 ARG B 58 ARG~? 15.94 O ACT B 134 B 298 GLU B 61 GLU~? 17.99 O ACT B 134 B 348 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo -8.10 23.98 3.08 -8.58 21.04 2.27 23.88 0.36 5.26 23.01 -2.52 5.93 coo -19.09 15.00 16.26 -16.38 15.21 14.84 9.78 -10.54 -4.22 7.03 -9.65 -3.15 coo -19.42 16.58 21.15 -18.01 16.20 19.59 9.01 -11.16 -9.07 8.40 -12.39 -7.45 coo -3.61 14.95 13.27 -5.31 15.62 12.23 22.87 -13.88 -0.47 24.63 -12.69 -0.32 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 B 170 ARG B 58 ARG~? 15.94 O ACT B 134 B 278 ARG A 81 ARG^? 17.75 O ACT A 134 B 298 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 348 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo -8.10 23.98 3.08 -8.58 21.04 2.27 9.78 -10.54 -4.22 7.03 -9.65 -3.15 coo -19.09 15.00 16.26 -16.38 15.21 14.84 23.88 0.36 5.26 23.01 -2.52 5.93 coo -19.42 16.58 21.15 -18.01 16.20 19.59 21.29 4.79 5.54 21.77 3.26 4.19 coo -3.61 14.95 13.27 -5.31 15.62 12.23 22.87 -13.88 -0.47 24.63 -12.69 -0.32 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 4 4 # 4 B 170 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 278 ARG A 58 ARG~? 15.97 OXT ACT A 134 B 298 GLU A 61 GLU~? 18.11 OXT ACT A 134 B 348 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo -8.10 23.98 3.08 -8.58 21.04 2.27 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -19.09 15.00 16.26 -16.38 15.21 14.84 9.78 27.17 8.97 7.03 26.14 8.06 coo -19.42 16.58 21.15 -18.01 16.20 19.59 9.19 27.65 13.99 8.36 28.92 12.52 coo -3.61 14.95 13.27 -5.31 15.62 12.23 22.90 30.21 5.13 24.67 29.05 5.02 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 4 hits 1i8t_c03 naa= 4 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 60 ASP A 95 ASP^? -2.87 O ACT A 134s A 175 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.29 4.79 5.54 21.77 3.26 4.19 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.92 6.03 15.16 12.65 6.91 13.72 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 60 ASP A 95 ASP^? -2.87 O ACT A 134s A 175 TYR B 125 TYR^? 11.31 O ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.29 4.79 5.54 21.77 3.26 4.19 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.92 6.03 15.16 12.65 6.91 13.72 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 60 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 175 TYR B 125 TYR^? 11.31 O ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.29 4.79 5.54 21.77 3.26 4.19 coo 56.42 28.06 12.93 55.01 27.92 14.50 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 60 ASP A 95 ASP^? -2.87 O ACT A 134s A 175 TYR A 122 TYR^? 8.33 CH3 ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.89 12.66 7.54 12.94 12.92 9.40 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.92 6.03 15.16 12.65 6.91 13.72 coo 45.02 22.04 15.38 46.16 24.00 13.76 18.19 17.99 8.45 16.46 16.26 9.80 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 60 ASP A 95 ASP^? -2.87 O ACT A 134s A 175 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.89 12.66 7.54 12.94 12.92 9.40 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.92 6.03 15.16 12.65 6.91 13.72 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 60 ASP A 95 ASP^? -2.87 O ACT A 134s A 175 TYR B 125 TYR^? 11.31 O ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.89 12.66 7.54 12.94 12.92 9.40 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.92 6.03 15.16 12.65 6.91 13.72 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 60 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 175 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.89 12.66 7.54 12.94 12.92 9.40 coo 56.42 28.06 12.93 55.01 27.92 14.50 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 60 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 175 TYR B 125 TYR^? 11.31 O ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.89 12.66 7.54 12.94 12.92 9.40 coo 56.42 28.06 12.93 55.01 27.92 14.50 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 9 3 # 9 A 49 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 60 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 175 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.22 11.60 -0.72 21.76 13.12 0.60 coo 56.42 28.06 12.93 55.01 27.92 14.50 26.00 19.90 3.85 25.60 19.04 1.99 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 10 3 # 10 A 49 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 60 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 175 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.22 11.60 -0.72 21.76 13.12 0.60 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 11 3 # 11 A 49 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 60 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 175 TYR B 125 TYR^? 11.31 O ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.22 11.60 -0.72 21.76 13.12 0.60 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 12 3 # 12 A 49 GLU B 124 GLU^? -3.39 O ACT B 134s A 60 ASP A 129 ASP.? 12.18 O ACT A 134 A 175 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 56.42 28.06 12.93 55.01 27.92 14.50 4.86 1.75 6.36 4.91 0.13 7.65 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 13 3 # 13 A 49 GLU B 124 GLU^? -3.39 O ACT B 134s A 60 ASP A 129 ASP.? 12.18 O ACT A 134 A 175 TYR B 125 TYR^? 11.31 O ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 56.42 28.06 12.93 55.01 27.92 14.50 4.86 1.75 6.36 4.91 0.13 7.65 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 14 3 # 14 A 49 GLU B 124 GLU^? -3.39 O ACT B 134s A 60 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 175 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 15 3 # 15 A 49 GLU B 124 GLU^? -3.39 O ACT B 134s A 60 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 175 TYR B 122 TYR^? 8.37 CH3 ACT B 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 45.02 22.04 15.38 46.16 24.00 13.76 18.14 -1.53 -3.61 16.39 0.20 -4.99 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 16 3 # 16 A 49 GLU B 124 GLU^? -3.39 O ACT B 134s A 60 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 175 TYR B 125 TYR^? 11.31 O ACT A 134 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 56.42 28.06 12.93 55.01 27.92 14.50 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.01 5.62 2.81 17.58 3.86 4.41 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 16 hits 1a50_c03 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 43 TRP^? 14.25 OXT ACT B 134 223 ASP B 80 ASP^? 13.20 OXT ACT B 134 258 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 127.19 33.46 26.14 126.78 36.79 28.15 15.04 20.31 0.01 11.76 18.61 -1.33 coo 126.95 41.66 23.38 128.48 40.72 24.51 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 138.83 37.95 25.17 133.50 36.37 26.52 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP B 43 TRP^? 14.30 O ACT A 134 223 ASP A 80 ASP^? 13.33 O ACT A 134 258 LYS A 105 LYS^? 12.80 O ACT A 134 coo 127.19 33.46 26.14 126.78 36.79 28.15 15.09 -3.95 4.83 11.80 -2.25 6.20 coo 126.95 41.66 23.38 128.48 40.72 24.51 21.99 0.20 10.14 20.59 -0.43 11.58 coo 138.83 37.95 25.17 133.50 36.37 26.52 8.54 2.73 14.15 9.40 -2.89 16.14 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 2 hits 1aam_c01 naa= 3 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 A 457 SER A 111 SER^? 14.00 CH3 ACT A 134 A 630 CYH A 120 CYH^? 19.90 CH3 ACT A 134 A 675 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 2.70 -0.05 22.31 2.42 1.39 24.24 21.88 13.56 5.40 22.76 13.90 3.16 coo 0.87 7.55 27.28 1.82 5.91 25.24 24.68 23.88 6.89 26.52 23.27 4.81 coo 0.10 3.62 28.03 1.23 2.44 26.67 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 A 457 SER B 111 SER^? 14.22 CH3 ACT B 134 A 630 CYH B 120 CYH^? 20.05 CH3 ACT B 134 A 675 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 2.70 -0.05 22.31 2.42 1.39 24.24 21.84 2.81 -0.55 22.81 2.45 1.66 coo 0.87 7.55 27.28 1.82 5.91 25.24 24.60 -7.54 -2.15 26.44 -7.04 -0.09 coo 0.10 3.62 28.03 1.23 2.44 26.67 25.97 -3.50 0.94 25.56 -2.60 2.79 1amo_c00 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 2 hits 1amo_c00 naa= 3 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 B 457 SER A 111 SER^? 14.00 CH3 ACT A 134 B 630 CYH A 120 CYH^? 19.90 CH3 ACT A 134 B 675 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 48.68 26.05 22.04 49.09 24.42 23.79 21.88 13.56 5.40 22.76 13.90 3.16 coo 50.83 17.98 26.05 49.75 19.82 24.27 24.68 23.88 6.89 26.52 23.27 4.81 coo 51.67 21.81 27.15 50.44 23.13 26.00 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 B 457 SER B 111 SER^? 14.22 CH3 ACT B 134 B 630 CYH B 120 CYH^? 20.05 CH3 ACT B 134 B 675 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 48.68 26.05 22.04 49.09 24.42 23.79 21.84 2.81 -0.55 22.81 2.45 1.66 coo 50.83 17.98 26.05 49.75 19.82 24.27 24.60 -7.54 -2.15 26.44 -7.04 -0.09 coo 51.67 21.81 27.15 50.44 23.13 26.00 25.97 -3.50 0.94 25.56 -2.60 2.79 1amo_c01 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 2 hits 1amo_c01 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 39 ASP^? 22.84 CH3 ACT A 134 214 ASP B 113 ASP^? 18.51 CH3 ACT B 134 289 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.90 30.21 5.13 24.67 29.05 5.02 coo 26.86 59.76 46.36 25.42 58.23 45.92 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 95 ASP^? -2.87 O ACT A 134s 214 ASP B 117 ASP.? 24.72 CH3 ACT B 134 289 ASP A 80 ASP^? 13.33 O ACT A 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.92 6.03 15.16 12.65 6.91 13.72 coo 26.86 59.76 46.36 25.42 58.23 45.92 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 113 ASP^? 18.42 CH3 ACT A 134 214 ASP B 34 ASP~? 20.32 CH3 ACT B 134 289 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.00 19.90 3.85 25.60 19.04 1.99 coo 26.86 59.76 46.36 25.42 58.23 45.92 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 113 ASP^? 18.42 CH3 ACT A 134 214 ASP B 117 ASP.? 24.72 CH3 ACT B 134 289 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.00 19.90 3.85 25.60 19.04 1.99 coo 26.86 59.76 46.36 25.42 58.23 45.92 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 34 ASP~? 20.32 CH3 ACT B 134 214 ASP A 7 ASP~? 23.80 CH3 ACT A 134 289 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 37.70 12.40 8.53 36.14 12.23 7.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 39 ASP^? 22.90 CH3 ACT B 134 214 ASP A 113 ASP^? 18.42 CH3 ACT A 134 289 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 26.86 59.76 46.36 25.42 58.23 45.92 26.00 19.90 3.85 25.60 19.04 1.99 coo 9.42 68.07 30.27 7.35 68.27 30.10 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 95 ASP^? -2.82 OXT ACT B 134s 214 ASP A 117 ASP.? 24.68 CH3 ACT A 134 289 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 26.86 59.76 46.36 25.42 58.23 45.92 33.24 23.97 14.06 32.62 25.96 14.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 113 ASP^? 18.51 CH3 ACT B 134 214 ASP A 117 ASP.? 24.68 CH3 ACT A 134 289 ASP A 80 ASP^? 13.33 O ACT A 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 26.86 59.76 46.36 25.42 58.23 45.92 33.24 23.97 14.06 32.62 25.96 14.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.99 0.20 10.14 20.59 -0.43 11.58 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 8 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 80 ASP^? 13.33 O ACT A 134 227 GLU B 92 GLU^? 14.52 OXT ACT B 134 289 ASP A 95 ASP^? -2.87 O ACT A 134s coo -0.62 65.95 29.97 0.31 67.47 31.05 21.99 0.20 10.14 20.59 -0.43 11.58 coo 3.96 55.76 41.24 4.83 57.69 41.17 21.22 11.60 -0.72 21.76 13.12 0.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 80 ASP^? 13.33 O ACT A 134 227 GLU B 92 GLU^? 14.52 OXT ACT B 134 289 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.99 0.20 10.14 20.59 -0.43 11.58 coo 3.96 55.76 41.24 4.83 57.69 41.17 21.22 11.60 -0.72 21.76 13.12 0.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 80 ASP^? 13.33 O ACT A 134 227 GLU B 124 GLU^? -3.39 O ACT B 134s 289 ASP A 95 ASP^? -2.87 O ACT A 134s coo -0.62 65.95 29.97 0.31 67.47 31.05 21.99 0.20 10.14 20.59 -0.43 11.58 coo 3.96 55.76 41.24 4.83 57.69 41.17 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 95 ASP^? -2.87 O ACT A 134s 227 GLU A 18 GLU~? 15.74 CH3 ACT A 134 289 ASP A 80 ASP^? 13.33 O ACT A 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.92 6.03 15.16 12.65 6.91 13.72 coo 3.96 55.76 41.24 4.83 57.69 41.17 26.95 12.09 19.56 26.58 10.45 20.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 113 ASP^? 18.42 CH3 ACT A 134 227 GLU A 92 GLU^? 14.49 CH3 ACT A 134 289 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.00 19.90 3.85 25.60 19.04 1.99 coo 3.96 55.76 41.24 4.83 57.69 41.17 21.29 4.79 5.54 21.77 3.26 4.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 113 ASP^? 18.42 CH3 ACT A 134 227 GLU A 124 GLU^? -3.29 OXT ACT A 134s 289 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.00 19.90 3.85 25.60 19.04 1.99 coo 3.96 55.76 41.24 4.83 57.69 41.17 13.89 12.66 7.54 12.94 12.92 9.40 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 80 ASP^? 13.20 OXT ACT B 134 227 GLU A 92 GLU^? 14.49 CH3 ACT A 134 289 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 21.29 4.79 5.54 21.77 3.26 4.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 80 ASP^? 13.20 OXT ACT B 134 227 GLU A 92 GLU^? 14.49 CH3 ACT A 134 289 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo -0.62 65.95 29.97 0.31 67.47 31.05 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 21.29 4.79 5.54 21.77 3.26 4.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP B 80 ASP^? 13.20 OXT ACT B 134 227 GLU A 124 GLU^? -3.29 OXT ACT A 134s 289 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo -0.62 65.95 29.97 0.31 67.47 31.05 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 13.89 12.66 7.54 12.94 12.92 9.40 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 95 ASP^? -2.82 OXT ACT B 134s 227 GLU B 18 GLU~? 15.73 CH3 ACT B 134 289 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 3.96 55.76 41.24 4.83 57.69 41.17 26.90 4.34 -14.80 26.44 5.99 -16.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 113 ASP^? 18.51 CH3 ACT B 134 227 GLU B 92 GLU^? 14.52 OXT ACT B 134 289 ASP A 80 ASP^? 13.33 O ACT A 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 21.22 11.60 -0.72 21.76 13.12 0.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 113 ASP^? 18.51 CH3 ACT B 134 227 GLU B 124 GLU^? -3.39 O ACT B 134s 289 ASP A 80 ASP^? 13.33 O ACT A 134 coo -0.62 65.95 29.97 0.31 67.47 31.05 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.99 0.20 10.14 20.59 -0.43 11.58 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 12 hits 1amy_c06 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 84 SER^? 20.86 CH3 ACT A 134 A 292 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 322 HIS B 14 HIS~? 17.16 CH3 ACT B 134 coo 36.34 32.23 39.60 36.43 34.62 39.93 30.40 10.24 3.82 32.46 10.17 5.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 24.17 25.65 19.58 23.03 26.79 20.97 coo 41.69 45.14 46.60 41.78 47.19 46.18 30.01 5.88 -9.10 29.93 7.73 -8.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 84 SER^? 20.86 CH3 ACT A 134 A 292 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 322 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 36.34 32.23 39.60 36.43 34.62 39.93 30.40 10.24 3.82 32.46 10.17 5.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 22.90 30.21 5.13 24.67 29.05 5.02 coo 41.69 45.14 46.60 41.78 47.19 46.18 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 84 SER^? 20.86 CH3 ACT A 134 A 292 ASP A 95 ASP^? -2.87 O ACT A 134s A 322 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 36.34 32.23 39.60 36.43 34.62 39.93 30.40 10.24 3.82 32.46 10.17 5.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 13.92 6.03 15.16 12.65 6.91 13.72 coo 41.69 45.14 46.60 41.78 47.19 46.18 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 84 SER^? 20.86 CH3 ACT A 134 A 292 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 322 HIS A 4 HIS.? -31.85 CH3 ACT A 134s coo 36.34 32.23 39.60 36.43 34.62 39.93 30.40 10.24 3.82 32.46 10.17 5.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 41.69 45.14 46.60 41.78 47.19 46.18 43.87 10.57 9.16 45.61 11.32 10.07 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER A 111 SER^? 14.00 CH3 ACT A 134 A 292 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 322 HIS A 50 HIS.? 14.57 OXT ACT B 134 coo 36.34 32.23 39.60 36.43 34.62 39.93 21.88 13.56 5.40 22.76 13.90 3.16 coo 19.73 19.18 41.39 21.50 18.65 40.34 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.53 19.16 0.69 7.13 18.70 -1.26 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 84 SER^? 21.05 CH3 ACT B 134 A 292 ASP A 95 ASP^? -2.87 O ACT A 134s A 322 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 36.34 32.23 39.60 36.43 34.62 39.93 30.37 6.08 1.00 32.42 6.12 -0.34 coo 19.73 19.18 41.39 21.50 18.65 40.34 13.92 6.03 15.16 12.65 6.91 13.72 coo 41.69 45.14 46.60 41.78 47.19 46.18 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 84 SER^? 21.05 CH3 ACT B 134 A 292 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 322 HIS A 4 HIS.? -31.85 CH3 ACT A 134s coo 36.34 32.23 39.60 36.43 34.62 39.93 30.37 6.08 1.00 32.42 6.12 -0.34 coo 19.73 19.18 41.39 21.50 18.65 40.34 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 41.69 45.14 46.60 41.78 47.19 46.18 43.87 10.57 9.16 45.61 11.32 10.07 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER B 84 SER^? 21.05 CH3 ACT B 134 A 292 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 322 HIS A 4 HIS.? -31.85 CH3 ACT A 134s coo 36.34 32.23 39.60 36.43 34.62 39.93 30.37 6.08 1.00 32.42 6.12 -0.34 coo 19.73 19.18 41.39 21.50 18.65 40.34 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 41.69 45.14 46.60 41.78 47.19 46.18 43.87 10.57 9.16 45.61 11.32 10.07 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER B 111 SER^? 14.22 CH3 ACT B 134 A 292 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 322 HIS B 50 HIS.? 14.60 O ACT A 134 coo 36.34 32.23 39.60 36.43 34.62 39.93 21.84 2.81 -0.55 22.81 2.45 1.66 coo 19.73 19.18 41.39 21.50 18.65 40.34 37.70 12.40 8.53 36.14 12.23 7.15 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.58 -2.80 4.18 7.21 -2.33 6.13 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 9 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 84 SER^? 20.86 CH3 ACT A 134 B 292 ASP A 34 ASP~? 20.39 CH3 ACT A 134 B 322 HIS B 14 HIS~? 17.16 CH3 ACT B 134 coo 35.42 71.28 22.94 36.24 69.06 22.37 30.40 10.24 3.82 32.46 10.17 5.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 24.17 25.65 19.58 23.03 26.79 20.97 coo 48.81 64.16 26.34 49.30 62.16 26.73 30.01 5.88 -9.10 29.93 7.73 -8.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 84 SER^? 20.86 CH3 ACT A 134 B 292 ASP A 39 ASP^? 22.84 CH3 ACT A 134 B 322 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 35.42 71.28 22.94 36.24 69.06 22.37 30.40 10.24 3.82 32.46 10.17 5.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 22.90 30.21 5.13 24.67 29.05 5.02 coo 48.81 64.16 26.34 49.30 62.16 26.73 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 84 SER^? 20.86 CH3 ACT A 134 B 292 ASP A 95 ASP^? -2.87 O ACT A 134s B 322 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 35.42 71.28 22.94 36.24 69.06 22.37 30.40 10.24 3.82 32.46 10.17 5.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 13.92 6.03 15.16 12.65 6.91 13.72 coo 48.81 64.16 26.34 49.30 62.16 26.73 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 84 SER^? 20.86 CH3 ACT A 134 B 292 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 322 HIS A 4 HIS.? -31.85 CH3 ACT A 134s coo 35.42 71.28 22.94 36.24 69.06 22.37 30.40 10.24 3.82 32.46 10.17 5.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 48.81 64.16 26.34 49.30 62.16 26.73 43.87 10.57 9.16 45.61 11.32 10.07 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER A 111 SER^? 14.00 CH3 ACT A 134 B 292 ASP B 7 ASP~? 23.98 CH3 ACT B 134 B 322 HIS A 50 HIS.? 14.57 OXT ACT B 134 coo 35.42 71.28 22.94 36.24 69.06 22.37 21.88 13.56 5.40 22.76 13.90 3.16 coo 24.74 78.07 5.59 24.32 79.03 7.46 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.53 19.16 0.69 7.13 18.70 -1.26 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER B 84 SER^? 21.05 CH3 ACT B 134 B 292 ASP A 95 ASP^? -2.87 O ACT A 134s B 322 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 35.42 71.28 22.94 36.24 69.06 22.37 30.37 6.08 1.00 32.42 6.12 -0.34 coo 24.74 78.07 5.59 24.32 79.03 7.46 13.92 6.03 15.16 12.65 6.91 13.72 coo 48.81 64.16 26.34 49.30 62.16 26.73 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER B 84 SER^? 21.05 CH3 ACT B 134 B 292 ASP B 34 ASP~? 20.32 CH3 ACT B 134 B 322 HIS A 14 HIS~? 17.04 CH3 ACT A 134 coo 35.42 71.28 22.94 36.24 69.06 22.37 30.37 6.08 1.00 32.42 6.12 -0.34 coo 24.74 78.07 5.59 24.32 79.03 7.46 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 48.81 64.16 26.34 49.30 62.16 26.73 30.04 10.42 13.88 29.99 8.58 12.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER B 84 SER^? 21.05 CH3 ACT B 134 B 292 ASP B 39 ASP^? 22.90 CH3 ACT B 134 B 322 HIS A 4 HIS.? -31.85 CH3 ACT A 134s coo 35.42 71.28 22.94 36.24 69.06 22.37 30.37 6.08 1.00 32.42 6.12 -0.34 coo 24.74 78.07 5.59 24.32 79.03 7.46 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 48.81 64.16 26.34 49.30 62.16 26.73 43.87 10.57 9.16 45.61 11.32 10.07 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER B 84 SER^? 21.05 CH3 ACT B 134 B 292 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 322 HIS A 4 HIS.? -31.85 CH3 ACT A 134s coo 35.42 71.28 22.94 36.24 69.06 22.37 30.37 6.08 1.00 32.42 6.12 -0.34 coo 24.74 78.07 5.59 24.32 79.03 7.46 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 48.81 64.16 26.34 49.30 62.16 26.73 43.87 10.57 9.16 45.61 11.32 10.07 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER B 111 SER^? 14.22 CH3 ACT B 134 B 292 ASP A 7 ASP~? 23.80 CH3 ACT A 134 B 322 HIS B 50 HIS.? 14.60 O ACT A 134 coo 35.42 71.28 22.94 36.24 69.06 22.37 21.84 2.81 -0.55 22.81 2.45 1.66 coo 24.74 78.07 5.59 24.32 79.03 7.46 37.70 12.40 8.53 36.14 12.23 7.15 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.58 -2.80 4.18 7.21 -2.33 6.13 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 10 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 107 ARG^? 13.51 O ACT A 134 B 342 ASP A 95 ASP^? -2.87 O ACT A 134s B 531 ARG A 81 ARG^? 17.75 O ACT A 134 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 13.92 6.03 15.16 12.65 6.91 13.72 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 23.88 0.36 5.26 23.01 -2.52 5.93 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 107 ARG^? 13.48 OXT ACT B 134 B 342 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 531 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 23.90 15.91 -0.43 22.97 18.81 -0.95 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c00 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 223 ASP A 95 ASP^? -2.87 O ACT A 134s A 265 LYS A 102 LYS^? 18.24 O ACT A 134 coo 39.74 52.86 65.74 41.15 55.14 66.52 19.15 14.12 14.90 17.05 13.12 13.34 coo 30.70 47.50 67.53 29.83 49.47 67.39 13.92 6.03 15.16 12.65 6.91 13.72 coo 19.99 54.53 64.11 20.55 58.78 68.33 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 42 PHE^? 12.32 OXT ACT A 134 A 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 265 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 39.74 52.86 65.74 41.15 55.14 66.52 14.89 21.94 7.67 12.75 23.35 8.74 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.00 19.90 3.85 25.60 19.04 1.99 coo 19.99 54.53 64.11 20.55 58.78 68.33 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 91 PHE^? 12.26 CH3 ACT A 134 A 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 265 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 39.74 52.86 65.74 41.15 55.14 66.52 24.03 9.83 10.49 26.27 11.25 11.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.00 19.90 3.85 25.60 19.04 1.99 coo 19.99 54.53 64.11 20.55 58.78 68.33 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 20 PHE~? 5.94 CH3 ACT B 134 A 223 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 265 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo 39.74 52.86 65.74 41.15 55.14 66.52 19.13 2.31 -10.10 17.00 3.15 -8.48 coo 30.70 47.50 67.53 29.83 49.47 67.39 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 19.99 54.53 64.11 20.55 58.78 68.33 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 42 PHE^? 12.28 O ACT B 134 A 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 265 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 39.74 52.86 65.74 41.15 55.14 66.52 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo 30.70 47.50 67.53 29.83 49.47 67.39 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 91 PHE^? 12.41 CH3 ACT B 134 A 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 265 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 39.74 52.86 65.74 41.15 55.14 66.52 24.01 6.53 -5.66 26.22 5.03 -6.49 coo 30.70 47.50 67.53 29.83 49.47 67.39 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1ax4_c04 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 20 PHE~? 5.83 CH3 ACT A 134 B 223 ASP A 95 ASP^? -2.87 O ACT A 134s B 265 LYS A 102 LYS^? 18.24 O ACT A 134 coo 7.48 54.94 99.62 7.67 52.27 100.42 19.15 14.12 14.90 17.05 13.12 13.34 coo 10.43 61.66 91.81 9.80 60.04 90.61 13.92 6.03 15.16 12.65 6.91 13.72 coo 5.43 58.06 80.08 8.57 53.00 79.37 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 42 PHE^? 12.32 OXT ACT A 134 B 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 265 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 7.48 54.94 99.62 7.67 52.27 100.42 14.89 21.94 7.67 12.75 23.35 8.74 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.00 19.90 3.85 25.60 19.04 1.99 coo 5.43 58.06 80.08 8.57 53.00 79.37 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 91 PHE^? 12.26 CH3 ACT A 134 B 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 265 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 7.48 54.94 99.62 7.67 52.27 100.42 24.03 9.83 10.49 26.27 11.25 11.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.00 19.90 3.85 25.60 19.04 1.99 coo 5.43 58.06 80.08 8.57 53.00 79.37 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 20 PHE~? 5.94 CH3 ACT B 134 B 223 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 265 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo 7.48 54.94 99.62 7.67 52.27 100.42 19.13 2.31 -10.10 17.00 3.15 -8.48 coo 10.43 61.66 91.81 9.80 60.04 90.61 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 5.43 58.06 80.08 8.57 53.00 79.37 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 42 PHE^? 12.28 O ACT B 134 B 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 265 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 7.48 54.94 99.62 7.67 52.27 100.42 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo 10.43 61.66 91.81 9.80 60.04 90.61 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 91 PHE^? 12.41 CH3 ACT B 134 B 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 265 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 7.48 54.94 99.62 7.67 52.27 100.42 24.01 6.53 -5.66 26.22 5.03 -6.49 coo 10.43 61.66 91.81 9.80 60.04 90.61 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1ax4_c05 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 20 PHE~? 5.83 CH3 ACT A 134 C 223 ASP A 95 ASP^? -2.87 O ACT A 134s C 265 LYS A 102 LYS^? 18.24 O ACT A 134 coo -6.55 73.45 23.60 -6.77 71.48 21.66 19.15 14.12 14.90 17.05 13.12 13.34 coo -9.52 75.74 33.62 -8.85 73.74 33.93 13.92 6.03 15.16 12.65 6.91 13.72 coo -4.44 67.20 42.32 -7.50 62.41 40.49 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 42 PHE^? 12.32 OXT ACT A 134 C 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 C 265 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -6.55 73.45 23.60 -6.77 71.48 21.66 14.89 21.94 7.67 12.75 23.35 8.74 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.00 19.90 3.85 25.60 19.04 1.99 coo -4.44 67.20 42.32 -7.50 62.41 40.49 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 91 PHE^? 12.26 CH3 ACT A 134 C 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 C 265 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo -6.55 73.45 23.60 -6.77 71.48 21.66 24.03 9.83 10.49 26.27 11.25 11.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.00 19.90 3.85 25.60 19.04 1.99 coo -4.44 67.20 42.32 -7.50 62.41 40.49 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 20 PHE~? 5.94 CH3 ACT B 134 C 223 ASP B 95 ASP^? -2.82 OXT ACT B 134s C 265 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -6.55 73.45 23.60 -6.77 71.48 21.66 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -9.52 75.74 33.62 -8.85 73.74 33.93 13.83 10.37 -10.37 12.59 9.49 -8.86 coo -4.44 67.20 42.32 -7.50 62.41 40.49 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 42 PHE^? 12.28 O ACT B 134 C 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 C 265 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -6.55 73.45 23.60 -6.77 71.48 21.66 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -9.52 75.74 33.62 -8.85 73.74 33.93 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 91 PHE^? 12.41 CH3 ACT B 134 C 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 C 265 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo -6.55 73.45 23.60 -6.77 71.48 21.66 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -9.52 75.74 33.62 -8.85 73.74 33.93 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1ax4_c06 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 20 PHE~? 5.83 CH3 ACT A 134 D 223 ASP A 95 ASP^? -2.87 O ACT A 134s D 265 LYS A 102 LYS^? 18.24 O ACT A 134 coo -38.60 55.38 52.70 -40.06 57.72 53.04 19.15 14.12 14.90 17.05 13.12 13.34 coo -29.46 51.67 48.51 -28.63 53.31 49.56 13.92 6.03 15.16 12.65 6.91 13.72 coo -18.87 56.53 54.79 -19.47 62.22 53.03 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 42 PHE^? 12.32 OXT ACT A 134 D 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 D 265 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -38.60 55.38 52.70 -40.06 57.72 53.04 14.89 21.94 7.67 12.75 23.35 8.74 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.00 19.90 3.85 25.60 19.04 1.99 coo -18.87 56.53 54.79 -19.47 62.22 53.03 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 91 PHE^? 12.26 CH3 ACT A 134 D 223 ASP A 113 ASP^? 18.42 CH3 ACT A 134 D 265 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo -38.60 55.38 52.70 -40.06 57.72 53.04 24.03 9.83 10.49 26.27 11.25 11.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.00 19.90 3.85 25.60 19.04 1.99 coo -18.87 56.53 54.79 -19.47 62.22 53.03 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 20 PHE~? 5.94 CH3 ACT B 134 D 223 ASP B 95 ASP^? -2.82 OXT ACT B 134s D 265 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -38.60 55.38 52.70 -40.06 57.72 53.04 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -29.46 51.67 48.51 -28.63 53.31 49.56 13.83 10.37 -10.37 12.59 9.49 -8.86 coo -18.87 56.53 54.79 -19.47 62.22 53.03 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 42 PHE^? 12.28 O ACT B 134 D 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 D 265 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -38.60 55.38 52.70 -40.06 57.72 53.04 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -29.46 51.67 48.51 -28.63 53.31 49.56 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 91 PHE^? 12.41 CH3 ACT B 134 D 223 ASP B 113 ASP^? 18.51 CH3 ACT B 134 D 265 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo -38.60 55.38 52.70 -40.06 57.72 53.04 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -29.46 51.67 48.51 -28.63 53.31 49.56 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1ax4_c07 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 43 TRP^? 14.25 OXT ACT B 134 A 222 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 258 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 89.83 15.40 0.01 90.61 18.86 1.71 15.04 20.31 0.01 11.76 18.61 -1.33 coo 82.92 20.43 2.47 84.82 20.45 1.55 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP B 43 TRP^? 14.30 O ACT A 134 A 222 ASP A 80 ASP^? 13.33 O ACT A 134 A 258 LYS A 105 LYS^? 12.80 O ACT A 134 coo 89.83 15.40 0.01 90.61 18.86 1.71 15.09 -3.95 4.83 11.80 -2.25 6.20 coo 82.92 20.43 2.47 84.82 20.45 1.55 21.99 0.20 10.14 20.59 -0.43 11.58 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 8.54 2.73 14.15 9.40 -2.89 16.14 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 43 TRP^? 14.25 OXT ACT B 134 B 222 ASP B 80 ASP^? 13.20 OXT ACT B 134 B 258 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 103.45 44.39 16.20 102.66 41.02 14.32 15.04 20.31 0.01 11.76 18.61 -1.33 coo 110.10 38.66 15.58 108.40 39.41 14.53 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 107.51 45.54 4.76 105.41 44.51 10.25 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP B 43 TRP^? 14.30 O ACT A 134 B 222 ASP A 80 ASP^? 13.33 O ACT A 134 B 258 LYS A 105 LYS^? 12.80 O ACT A 134 coo 103.45 44.39 16.20 102.66 41.02 14.32 15.09 -3.95 4.83 11.80 -2.25 6.20 coo 110.10 38.66 15.58 108.40 39.41 14.53 21.99 0.20 10.14 20.59 -0.43 11.58 coo 107.51 45.54 4.76 105.41 44.51 10.25 8.54 2.73 14.15 9.40 -2.89 16.14 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c03 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 182 GLU A 86 GLU.? 27.53 CH3 ACT B 134 A 286 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo 26.03 44.66 108.90 25.67 42.61 108.82 37.70 12.40 8.53 36.14 12.23 7.15 coo 18.06 44.02 105.38 18.08 45.37 107.03 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 25.47 38.28 112.06 27.26 39.30 111.54 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 95 ASP^? -2.87 O ACT A 134s A 182 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 286 ASN A 133 ASN.? 9.96 O ACT A 134 coo 26.03 44.66 108.90 25.67 42.61 108.82 13.92 6.03 15.16 12.65 6.91 13.72 coo 18.06 44.02 105.38 18.08 45.37 107.03 13.89 12.66 7.54 12.94 12.92 9.40 coo 25.47 38.28 112.06 27.26 39.30 111.54 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 182 GLU B 86 GLU.? 27.22 CH3 ACT A 134 A 286 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo 26.03 44.66 108.90 25.67 42.61 108.82 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 18.06 44.02 105.38 18.08 45.37 107.03 35.82 0.62 5.15 36.84 -0.64 6.51 coo 25.47 38.28 112.06 27.26 39.30 111.54 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 182 GLU B 124 GLU^? -3.39 O ACT B 134s A 286 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 26.03 44.66 108.90 25.67 42.61 108.82 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 18.06 44.02 105.38 18.08 45.37 107.03 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 25.47 38.28 112.06 27.26 39.30 111.54 12.00 16.42 -6.80 12.35 17.03 -8.83 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 4 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 7 ASP~? 23.80 CH3 ACT A 134 B 182 GLU A 86 GLU.? 27.53 CH3 ACT B 134 B 286 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo 13.82 69.26 132.27 11.87 70.14 132.51 37.70 12.40 8.53 36.14 12.23 7.15 coo 8.74 63.05 136.42 9.87 62.19 134.79 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 8.26 72.60 129.22 10.14 73.45 129.80 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 95 ASP^? -2.87 O ACT A 134s B 182 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 286 ASN A 133 ASN.? 9.96 O ACT A 134 coo 13.82 69.26 132.27 11.87 70.14 132.51 13.92 6.03 15.16 12.65 6.91 13.72 coo 8.74 63.05 136.42 9.87 62.19 134.79 13.89 12.66 7.54 12.94 12.92 9.40 coo 8.26 72.60 129.22 10.14 73.45 129.80 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP B 7 ASP~? 23.98 CH3 ACT B 134 B 182 GLU B 86 GLU.? 27.22 CH3 ACT A 134 B 286 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo 13.82 69.26 132.27 11.87 70.14 132.51 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 8.74 63.05 136.42 9.87 62.19 134.79 35.82 0.62 5.15 36.84 -0.64 6.51 coo 8.26 72.60 129.22 10.14 73.45 129.80 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 182 GLU B 124 GLU^? -3.39 O ACT B 134s B 286 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 13.82 69.26 132.27 11.87 70.14 132.51 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 8.74 63.05 136.42 9.87 62.19 134.79 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 8.26 72.60 129.22 10.14 73.45 129.80 12.00 16.42 -6.80 12.35 17.03 -8.83 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 4 hits 1b57_c01 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 50 HIS.? 14.57 OXT ACT B 134 A 91 ARG B 107 ARG^? 13.48 OXT ACT B 134 A 129 SER B 132 SER.? 12.23 OXT ACT B 134 coo 24.39 47.01 49.70 26.42 47.04 49.21 6.53 19.16 0.69 7.13 18.70 -1.26 coo 25.98 44.20 42.23 28.53 42.98 43.43 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 30.00 49.76 45.68 28.73 48.72 47.47 7.68 17.54 -6.39 7.22 18.14 -4.05 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS B 50 HIS.? 14.60 O ACT A 134 A 91 ARG A 107 ARG^? 13.51 O ACT A 134 A 129 SER A 132 SER.? 12.20 O ACT A 134 coo 24.39 47.01 49.70 26.42 47.04 49.21 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 25.98 44.20 42.23 28.53 42.98 43.43 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 30.00 49.76 45.68 28.73 48.72 47.47 7.72 -1.19 11.22 7.31 -1.68 8.88 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 50 HIS.? 14.57 OXT ACT B 134 B 91 ARG B 107 ARG^? 13.48 OXT ACT B 134 B 129 SER B 132 SER.? 12.23 OXT ACT B 134 coo 18.19 17.03 40.71 18.55 17.18 38.64 6.53 19.16 0.69 7.13 18.70 -1.26 coo 25.60 21.10 38.54 23.57 20.93 36.25 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 21.33 14.29 34.62 19.25 14.88 35.71 7.68 17.54 -6.39 7.22 18.14 -4.05 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS B 50 HIS.? 14.60 O ACT A 134 B 91 ARG A 107 ARG^? 13.51 O ACT A 134 B 129 SER A 132 SER.? 12.20 O ACT A 134 coo 18.19 17.03 40.71 18.55 17.18 38.64 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 25.60 21.10 38.54 23.57 20.93 36.25 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 21.33 14.29 34.62 19.25 14.88 35.71 7.72 -1.19 11.22 7.31 -1.68 8.88 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 32 PHE~? 11.19 CH3 ACT A 134 A 159 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 188 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 13.91 34.58 14.67 12.95 36.00 12.47 20.55 19.39 16.02 20.64 18.71 13.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 24.17 25.65 19.58 23.03 26.79 20.97 coo 22.55 41.65 15.60 18.92 37.20 14.63 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 40 PHE^? 14.40 CH3 ACT A 134 A 159 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 188 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 13.91 34.58 14.67 12.95 36.00 12.47 20.14 24.61 9.13 19.21 21.98 9.50 coo 20.97 28.40 16.26 20.19 30.15 15.34 24.17 25.65 19.58 23.03 26.79 20.97 coo 22.55 41.65 15.60 18.92 37.20 14.63 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 93 PHE^? 5.64 CH3 ACT A 134 A 159 ASP A 80 ASP^? 13.33 O ACT A 134 A 188 LYS A 105 LYS^? 12.80 O ACT A 134 coo 13.91 34.58 14.67 12.95 36.00 12.47 18.45 6.69 12.19 16.89 8.99 12.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 21.99 0.20 10.14 20.59 -0.43 11.58 coo 22.55 41.65 15.60 18.92 37.20 14.63 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE B 32 PHE~? 11.23 CH3 ACT B 134 A 159 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 188 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 13.91 34.58 14.67 12.95 36.00 12.47 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo 20.97 28.40 16.26 20.19 30.15 15.34 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE B 40 PHE^? 14.44 CH3 ACT B 134 A 159 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 188 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 13.91 34.58 14.67 12.95 36.00 12.47 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo 20.97 28.40 16.26 20.19 30.15 15.34 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 93 PHE^? 5.85 CH3 ACT B 134 A 159 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 188 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 13.91 34.58 14.67 12.95 36.00 12.47 18.48 9.68 -7.33 16.94 7.39 -7.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 22.55 41.65 15.60 18.92 37.20 14.63 8.51 13.68 -9.31 9.43 19.36 -11.32 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 6 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 81 ARG^? 17.75 O ACT A 134 A 141 THR A 83 THR^? 17.54 CH3 ACT A 134 A 235 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo 6.21 93.81 36.58 4.58 96.33 37.17 23.88 0.36 5.26 23.01 -2.52 5.93 coo 6.80 92.87 28.33 4.91 92.74 27.40 28.55 7.09 4.80 27.08 6.14 3.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 22.87 -13.88 -0.47 24.63 -12.69 -0.32 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 115 ARG^? 23.19 CH3 ACT A 134 A 141 THR A 87 THR.? 22.88 CH3 ACT A 134 A 235 ASP A 34 ASP~? 20.39 CH3 ACT A 134 coo 6.21 93.81 36.58 4.58 96.33 37.17 29.95 27.15 5.66 27.05 27.70 4.87 coo 6.80 92.87 28.33 4.91 92.74 27.40 31.21 17.48 2.82 31.09 18.74 1.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 24.17 25.65 19.58 23.03 26.79 20.97 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 141 THR A 41 THR^? 18.02 CH3 ACT A 134 A 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 6.21 93.81 36.58 4.58 96.33 37.17 19.67 16.84 1.03 22.28 17.57 2.36 coo 6.80 92.87 28.33 4.91 92.74 27.40 18.34 24.70 5.20 19.06 25.00 3.19 coo 12.98 90.36 47.57 11.26 89.62 46.62 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 141 THR A 88 THR^? 17.94 CH3 ACT A 134 A 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 6.21 93.81 36.58 4.58 96.33 37.17 19.67 16.84 1.03 22.28 17.57 2.36 coo 6.80 92.87 28.33 4.91 92.74 27.40 28.18 15.22 3.40 26.60 15.27 1.86 coo 12.98 90.36 47.57 11.26 89.62 46.62 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 141 THR B 83 THR^? 17.78 CH3 ACT B 134 A 235 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo 6.21 93.81 36.58 4.58 96.33 37.17 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 6.80 92.87 28.33 4.91 92.74 27.40 28.55 9.24 0.02 27.11 10.23 1.39 coo 12.98 90.36 47.57 11.26 89.62 46.62 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 115 ARG^? 23.47 CH3 ACT B 134 A 141 THR B 87 THR.? 23.05 CH3 ACT B 134 A 235 ASP B 34 ASP~? 20.32 CH3 ACT B 134 coo 6.21 93.81 36.58 4.58 96.33 37.17 29.96 -10.90 -1.02 27.10 -11.56 -0.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 31.16 -1.20 2.01 31.03 -2.27 3.89 coo 12.98 90.36 47.57 11.26 89.62 46.62 24.12 -9.16 -14.81 22.98 -10.29 -16.20 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 141 THR B 41 THR^? 18.20 CH3 ACT B 134 A 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo 6.21 93.81 36.58 4.58 96.33 37.17 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 6.80 92.87 28.33 4.91 92.74 27.40 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 12.98 90.36 47.57 11.26 89.62 46.62 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 141 THR B 88 THR^? 18.11 CH3 ACT B 134 A 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo 6.21 93.81 36.58 4.58 96.33 37.17 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 6.80 92.87 28.33 4.91 92.74 27.40 28.17 1.09 1.44 26.55 0.98 2.93 coo 12.98 90.36 47.57 11.26 89.62 46.62 13.92 6.03 15.16 12.65 6.91 13.72 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 8 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 115 ARG^? 23.19 CH3 ACT A 134 D 141 THR A 87 THR.? 22.88 CH3 ACT A 134 D 235 ASP A 34 ASP~? 20.39 CH3 ACT A 134 coo -8.33 92.80 100.06 -7.71 95.33 98.44 29.95 27.15 5.66 27.05 27.70 4.87 coo -9.24 93.49 108.77 -7.37 94.21 109.61 31.21 17.48 2.82 31.09 18.74 1.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 24.17 25.65 19.58 23.03 26.79 20.97 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 D 141 THR A 41 THR^? 18.02 CH3 ACT A 134 D 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo -8.33 92.80 100.06 -7.71 95.33 98.44 19.67 16.84 1.03 22.28 17.57 2.36 coo -9.24 93.49 108.77 -7.37 94.21 109.61 18.34 24.70 5.20 19.06 25.00 3.19 coo -14.64 87.74 89.51 -12.89 87.43 90.65 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 D 141 THR A 88 THR^? 17.94 CH3 ACT A 134 D 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo -8.33 92.80 100.06 -7.71 95.33 98.44 19.67 16.84 1.03 22.28 17.57 2.36 coo -9.24 93.49 108.77 -7.37 94.21 109.61 28.18 15.22 3.40 26.60 15.27 1.86 coo -14.64 87.74 89.51 -12.89 87.43 90.65 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 115 ARG^? 23.47 CH3 ACT B 134 D 141 THR B 87 THR.? 23.05 CH3 ACT B 134 D 235 ASP B 34 ASP~? 20.32 CH3 ACT B 134 coo -8.33 92.80 100.06 -7.71 95.33 98.44 29.96 -10.90 -1.02 27.10 -11.56 -0.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 31.16 -1.20 2.01 31.03 -2.27 3.89 coo -14.64 87.74 89.51 -12.89 87.43 90.65 24.12 -9.16 -14.81 22.98 -10.29 -16.20 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 D 141 THR B 41 THR^? 18.20 CH3 ACT B 134 D 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo -8.33 92.80 100.06 -7.71 95.33 98.44 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -9.24 93.49 108.77 -7.37 94.21 109.61 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo -14.64 87.74 89.51 -12.89 87.43 90.65 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 D 141 THR B 88 THR^? 18.11 CH3 ACT B 134 D 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo -8.33 92.80 100.06 -7.71 95.33 98.44 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -9.24 93.49 108.77 -7.37 94.21 109.61 28.17 1.09 1.44 26.55 0.98 2.93 coo -14.64 87.74 89.51 -12.89 87.43 90.65 13.92 6.03 15.16 12.65 6.91 13.72 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 81 ARG^? 17.75 O ACT A 134 C 141 THR A 83 THR^? 17.54 CH3 ACT A 134 C 235 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo -5.79 67.26 36.83 -4.57 64.58 37.74 23.88 0.36 5.26 23.01 -2.52 5.93 coo -6.81 68.31 28.28 -4.82 68.47 27.57 28.55 7.09 4.80 27.08 6.14 3.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 22.87 -13.88 -0.47 24.63 -12.69 -0.32 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 115 ARG^? 23.19 CH3 ACT A 134 C 141 THR A 87 THR.? 22.88 CH3 ACT A 134 C 235 ASP A 34 ASP~? 20.39 CH3 ACT A 134 coo -5.79 67.26 36.83 -4.57 64.58 37.74 29.95 27.15 5.66 27.05 27.70 4.87 coo -6.81 68.31 28.28 -4.82 68.47 27.57 31.21 17.48 2.82 31.09 18.74 1.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 24.17 25.65 19.58 23.03 26.79 20.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 C 141 THR A 41 THR^? 18.02 CH3 ACT A 134 C 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo -5.79 67.26 36.83 -4.57 64.58 37.74 19.67 16.84 1.03 22.28 17.57 2.36 coo -6.81 68.31 28.28 -4.82 68.47 27.57 18.34 24.70 5.20 19.06 25.00 3.19 coo -13.01 70.96 47.58 -11.44 71.65 46.34 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 C 141 THR A 88 THR^? 17.94 CH3 ACT A 134 C 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo -5.79 67.26 36.83 -4.57 64.58 37.74 19.67 16.84 1.03 22.28 17.57 2.36 coo -6.81 68.31 28.28 -4.82 68.47 27.57 28.18 15.22 3.40 26.60 15.27 1.86 coo -13.01 70.96 47.58 -11.44 71.65 46.34 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 81 ARG^? 17.71 OXT ACT B 134 C 141 THR B 83 THR^? 17.78 CH3 ACT B 134 C 235 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo -5.79 67.26 36.83 -4.57 64.58 37.74 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -6.81 68.31 28.28 -4.82 68.47 27.57 28.55 9.24 0.02 27.11 10.23 1.39 coo -13.01 70.96 47.58 -11.44 71.65 46.34 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 115 ARG^? 23.47 CH3 ACT B 134 C 141 THR B 87 THR.? 23.05 CH3 ACT B 134 C 235 ASP B 34 ASP~? 20.32 CH3 ACT B 134 coo -5.79 67.26 36.83 -4.57 64.58 37.74 29.96 -10.90 -1.02 27.10 -11.56 -0.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 31.16 -1.20 2.01 31.03 -2.27 3.89 coo -13.01 70.96 47.58 -11.44 71.65 46.34 24.12 -9.16 -14.81 22.98 -10.29 -16.20 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 C 141 THR B 41 THR^? 18.20 CH3 ACT B 134 C 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo -5.79 67.26 36.83 -4.57 64.58 37.74 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -6.81 68.31 28.28 -4.82 68.47 27.57 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo -13.01 70.96 47.58 -11.44 71.65 46.34 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 C 141 THR B 88 THR^? 18.11 CH3 ACT B 134 C 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo -5.79 67.26 36.83 -4.57 64.58 37.74 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -6.81 68.31 28.28 -4.82 68.47 27.57 28.17 1.09 1.44 26.55 0.98 2.93 coo -13.01 70.96 47.58 -11.44 71.65 46.34 13.92 6.03 15.16 12.65 6.91 13.72 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 8 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 81 ARG^? 17.75 O ACT A 134 B 141 THR A 83 THR^? 17.54 CH3 ACT A 134 B 235 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo 8.13 67.41 100.27 7.18 68.35 97.45 23.88 0.36 5.26 23.01 -2.52 5.93 coo 8.28 67.78 108.81 6.22 67.65 109.43 28.55 7.09 4.80 27.08 6.14 3.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 22.87 -13.88 -0.47 24.63 -12.69 -0.32 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 81 ARG^? 17.75 O ACT A 134 B 141 THR B 87 THR.? 23.05 CH3 ACT B 134 B 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo 8.13 67.41 100.27 7.18 68.35 97.45 23.88 0.36 5.26 23.01 -2.52 5.93 coo 8.28 67.78 108.81 6.22 67.65 109.43 31.16 -1.20 2.01 31.03 -2.27 3.89 coo 14.55 73.52 89.47 12.81 73.95 90.56 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 115 ARG^? 23.19 CH3 ACT A 134 B 141 THR A 87 THR.? 22.88 CH3 ACT A 134 B 235 ASP A 34 ASP~? 20.39 CH3 ACT A 134 coo 8.13 67.41 100.27 7.18 68.35 97.45 29.95 27.15 5.66 27.05 27.70 4.87 coo 8.28 67.78 108.81 6.22 67.65 109.43 31.21 17.48 2.82 31.09 18.74 1.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 24.17 25.65 19.58 23.03 26.79 20.97 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 141 THR A 41 THR^? 18.02 CH3 ACT A 134 B 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 8.13 67.41 100.27 7.18 68.35 97.45 19.67 16.84 1.03 22.28 17.57 2.36 coo 8.28 67.78 108.81 6.22 67.65 109.43 18.34 24.70 5.20 19.06 25.00 3.19 coo 14.55 73.52 89.47 12.81 73.95 90.56 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 141 THR A 88 THR^? 17.94 CH3 ACT A 134 B 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 8.13 67.41 100.27 7.18 68.35 97.45 19.67 16.84 1.03 22.28 17.57 2.36 coo 8.28 67.78 108.81 6.22 67.65 109.43 28.18 15.22 3.40 26.60 15.27 1.86 coo 14.55 73.52 89.47 12.81 73.95 90.56 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 141 THR A 87 THR.? 22.88 CH3 ACT A 134 B 235 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 8.13 67.41 100.27 7.18 68.35 97.45 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 8.28 67.78 108.81 6.22 67.65 109.43 31.21 17.48 2.82 31.09 18.74 1.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 141 THR B 83 THR^? 17.78 CH3 ACT B 134 B 235 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo 8.13 67.41 100.27 7.18 68.35 97.45 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 8.28 67.78 108.81 6.22 67.65 109.43 28.55 9.24 0.02 27.11 10.23 1.39 coo 14.55 73.52 89.47 12.81 73.95 90.56 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG B 115 ARG^? 23.47 CH3 ACT B 134 B 141 THR B 87 THR.? 23.05 CH3 ACT B 134 B 235 ASP B 34 ASP~? 20.32 CH3 ACT B 134 coo 8.13 67.41 100.27 7.18 68.35 97.45 29.96 -10.90 -1.02 27.10 -11.56 -0.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 31.16 -1.20 2.01 31.03 -2.27 3.89 coo 14.55 73.52 89.47 12.81 73.95 90.56 24.12 -9.16 -14.81 22.98 -10.29 -16.20 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 141 THR B 41 THR^? 18.20 CH3 ACT B 134 B 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo 8.13 67.41 100.27 7.18 68.35 97.45 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 8.28 67.78 108.81 6.22 67.65 109.43 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 14.55 73.52 89.47 12.81 73.95 90.56 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 141 THR B 88 THR^? 18.11 CH3 ACT B 134 B 235 ASP A 95 ASP^? -2.87 O ACT A 134s coo 8.13 67.41 100.27 7.18 68.35 97.45 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 8.28 67.78 108.81 6.22 67.65 109.43 28.17 1.09 1.44 26.55 0.98 2.93 coo 14.55 73.52 89.47 12.81 73.95 90.56 13.92 6.03 15.16 12.65 6.91 13.72 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 10 hits 1bd3_c03 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 61 GLU~? 18.11 OXT ACT A 134 A 503 TYR A 65 TYR~? 10.42 OXT ACT A 134 A 537 GLU A 48 GLU.? 14.70 OXT ACT A 134 coo 24.06 146.21 11.09 22.89 146.18 9.36 9.19 27.65 13.99 8.36 28.92 12.52 coo 15.91 140.69 8.32 15.71 143.39 9.13 5.70 19.83 13.85 3.74 18.38 12.48 coo 16.65 144.44 13.24 18.34 145.22 12.33 3.89 23.33 8.60 3.75 23.77 10.68 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 503 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 537 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 24.06 146.21 11.09 22.89 146.18 9.36 21.29 4.79 5.54 21.77 3.26 4.19 coo 15.91 140.69 8.32 15.71 143.39 9.13 16.00 10.76 2.04 17.57 12.50 0.46 coo 16.65 144.44 13.24 18.34 145.22 12.33 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU B 61 GLU~? 17.99 O ACT B 134 A 503 TYR B 65 TYR~? 10.45 O ACT B 134 A 537 GLU B 48 GLU.? 15.07 O ACT B 134 coo 24.06 146.21 11.09 22.89 146.18 9.36 9.01 -11.16 -9.07 8.40 -12.39 -7.45 coo 15.91 140.69 8.32 15.71 143.39 9.13 5.53 -3.38 -9.18 3.64 -1.85 -7.81 coo 16.65 144.44 13.24 18.34 145.22 12.33 3.87 -7.04 -3.75 3.32 -7.55 -5.74 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 503 TYR B 125 TYR^? 11.31 O ACT A 134 A 537 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo 24.06 146.21 11.09 22.89 146.18 9.36 21.22 11.60 -0.72 21.76 13.12 0.60 coo 15.91 140.69 8.32 15.71 143.39 9.13 16.01 5.62 2.81 17.58 3.86 4.41 coo 16.65 144.44 13.24 18.34 145.22 12.33 21.29 4.79 5.54 21.77 3.26 4.19 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 4 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 61 GLU~? 18.11 OXT ACT A 134 A 504 TYR A 65 TYR~? 10.42 OXT ACT A 134 A 540 GLU A 48 GLU.? 14.70 OXT ACT A 134 coo 81.34 87.29 87.22 82.36 86.09 88.61 9.19 27.65 13.99 8.36 28.92 12.52 coo 80.85 81.34 94.77 81.70 80.16 92.41 5.70 19.83 13.85 3.74 18.38 12.48 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.89 23.33 8.60 3.75 23.77 10.68 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 61 GLU~? 17.99 O ACT B 134 A 504 TYR B 65 TYR~? 10.45 O ACT B 134 A 540 GLU B 48 GLU.? 15.07 O ACT B 134 coo 81.34 87.29 87.22 82.36 86.09 88.61 9.01 -11.16 -9.07 8.40 -12.39 -7.45 coo 80.85 81.34 94.77 81.70 80.16 92.41 5.53 -3.38 -9.18 3.64 -1.85 -7.81 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.87 -7.04 -3.75 3.32 -7.55 -5.74 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU B 61 GLU~? 17.99 O ACT B 134 B 504 TYR B 65 TYR~? 10.45 O ACT B 134 B 540 GLU B 48 GLU.? 15.07 O ACT B 134 coo 86.52 35.28 112.74 87.08 36.38 110.99 9.01 -11.16 -9.07 8.40 -12.39 -7.45 coo 84.93 40.21 105.31 85.72 41.45 107.72 5.53 -3.38 -9.18 3.64 -1.85 -7.81 coo 83.38 41.19 112.55 85.47 40.59 112.72 3.87 -7.04 -3.75 3.32 -7.55 -5.74 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c03 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 128 SER.? 10.42 O ACT A 134 A 54 PRO B 45 PRO.? 8.65 O ACT B 134 A 96 ASP A 129 ASP.? 12.18 O ACT A 134 coo -9.03 45.15 44.45 -7.51 43.26 44.28 9.47 2.37 6.00 8.93 0.44 7.47 coo -12.82 46.62 43.11 -11.69 44.75 42.79 10.34 3.28 1.15 9.54 1.23 1.66 coo -5.86 47.39 44.34 -4.55 46.60 42.83 4.86 1.75 6.36 4.91 0.13 7.65 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 2 3 # 2 A 53 SER B 128 SER.? 10.40 OXT ACT B 134 A 54 PRO A 45 PRO.? 8.62 OXT ACT A 134 A 96 ASP B 129 ASP.? 12.08 OXT ACT B 134 coo -9.03 45.15 44.45 -7.51 43.26 44.28 9.49 14.01 -1.20 8.95 15.98 -2.61 coo -12.82 46.62 43.11 -11.69 44.75 42.79 10.40 13.18 3.72 9.54 15.17 3.18 coo -5.86 47.39 44.34 -4.55 46.60 42.83 4.87 14.63 -1.58 4.99 16.28 -2.86 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 2 hits 1boo_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 17 PHE~? 9.37 CH3 ACT A 134 A 205 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 236 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.39 11.02 14.17 21.27 9.32 13.60 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.17 25.65 19.58 23.03 26.79 20.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 17 PHE~? 9.37 CH3 ACT A 134 A 205 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 236 LYS A 31 LYS~? 20.89 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.39 11.02 14.17 21.27 9.32 13.60 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 33.24 23.97 14.06 32.62 25.96 14.31 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 22.53 21.87 21.40 25.12 21.84 25.97 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 205 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 236 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 19.15 14.12 14.90 17.05 13.12 13.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.17 25.65 19.58 23.03 26.79 20.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 205 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 236 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 19.15 14.12 14.90 17.05 13.12 13.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.17 25.65 19.58 23.03 26.79 20.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 205 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 236 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 19.15 14.12 14.90 17.05 13.12 13.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.17 25.65 19.58 23.03 26.79 20.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE A 32 PHE~? 11.19 CH3 ACT A 134 A 205 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 236 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 20.55 19.39 16.02 20.64 18.71 13.32 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 33.24 23.97 14.06 32.62 25.96 14.31 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE A 40 PHE^? 14.40 CH3 ACT A 134 A 205 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 236 LYS A 31 LYS~? 20.89 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 20.14 24.61 9.13 19.21 21.98 9.50 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 33.24 23.97 14.06 32.62 25.96 14.31 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 22.53 21.87 21.40 25.12 21.84 25.97 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE A 42 PHE^? 12.32 OXT ACT A 134 A 205 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 236 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 14.89 21.94 7.67 12.75 23.35 8.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.17 25.65 19.58 23.03 26.79 20.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE A 63 PHE~? 9.05 CH3 ACT A 134 A 205 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 236 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 14.60 20.08 14.87 16.25 19.26 12.77 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 22.90 30.21 5.13 24.67 29.05 5.02 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE A 112 PHE^? 11.25 CH3 ACT A 134 A 205 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 236 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.79 16.00 9.29 22.27 15.23 11.49 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.17 25.65 19.58 23.03 26.79 20.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE A 112 PHE^? 11.25 CH3 ACT A 134 A 205 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 236 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.79 16.00 9.29 22.27 15.23 11.49 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.17 25.65 19.58 23.03 26.79 20.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE A 112 PHE^? 11.25 CH3 ACT A 134 A 205 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 236 LYS A 31 LYS~? 20.89 CH3 ACT A 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.79 16.00 9.29 22.27 15.23 11.49 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 33.24 23.97 14.06 32.62 25.96 14.31 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 22.53 21.87 21.40 25.12 21.84 25.97 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE B 17 PHE~? 9.52 CH3 ACT B 134 A 205 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 236 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.32 5.37 -9.36 21.26 7.18 -8.91 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE B 17 PHE~? 9.52 CH3 ACT B 134 A 205 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 236 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.32 5.37 -9.36 21.26 7.18 -8.91 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE B 20 PHE~? 5.94 CH3 ACT B 134 A 205 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 236 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 19.13 2.31 -10.10 17.00 3.15 -8.48 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE B 20 PHE~? 5.94 CH3 ACT B 134 A 205 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 236 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 19.13 2.31 -10.10 17.00 3.15 -8.48 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 17 3 # 17 A 109 PHE B 20 PHE~? 5.94 CH3 ACT B 134 A 205 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 236 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 19.13 2.31 -10.10 17.00 3.15 -8.48 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 18 3 # 18 A 109 PHE B 20 PHE~? 5.94 CH3 ACT B 134 A 205 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 236 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 19.13 2.31 -10.10 17.00 3.15 -8.48 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 19 3 # 19 A 109 PHE B 32 PHE~? 11.23 CH3 ACT B 134 A 205 ASP B 117 ASP.? 24.72 CH3 ACT B 134 A 236 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 20 3 # 20 A 109 PHE B 42 PHE^? 12.28 O ACT B 134 A 205 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 236 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 21 3 # 21 A 109 PHE B 63 PHE~? 8.97 CH3 ACT B 134 A 205 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 236 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 22 3 # 22 A 109 PHE B 63 PHE~? 8.97 CH3 ACT B 134 A 205 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 236 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 23 3 # 23 A 109 PHE B 112 PHE^? 11.41 CH3 ACT B 134 A 205 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 236 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.76 0.41 -4.47 22.23 1.06 -6.71 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 24 3 # 24 A 109 PHE B 112 PHE^? 11.41 CH3 ACT B 134 A 205 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 236 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 4.14 2.10 36.34 6.69 3.08 36.92 23.76 0.41 -4.47 22.23 1.06 -6.71 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 24 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 22 GLN~? 15.94 CH3 ACT A 134 A 91 LEU A 24 LEU~? 5.31 CH3 ACT A 134 A 133 GLU A 18 GLU~? 15.74 CH3 ACT A 134 coo 43.58 43.67 66.73 42.32 42.78 68.15 20.14 15.38 24.13 21.73 16.51 24.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.13 11.98 18.72 14.77 12.01 16.62 coo 44.05 36.87 70.65 43.15 38.64 69.97 26.95 12.09 19.56 26.58 10.45 20.84 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 22 GLN~? 15.94 CH3 ACT A 134 A 91 LEU A 24 LEU~? 5.31 CH3 ACT A 134 A 133 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 43.58 43.67 66.73 42.32 42.78 68.15 20.14 15.38 24.13 21.73 16.51 24.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.13 11.98 18.72 14.77 12.01 16.62 coo 44.05 36.87 70.65 43.15 38.64 69.97 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 30 GLN~? 19.00 CH3 ACT A 134 A 91 LEU A 33 LEU~? 15.46 CH3 ACT A 134 A 133 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 43.58 43.67 66.73 42.32 42.78 68.15 19.86 25.98 22.72 18.81 27.05 21.20 coo 38.58 45.09 70.44 38.28 45.21 72.59 19.33 24.92 17.48 17.22 24.79 17.00 coo 44.05 36.87 70.65 43.15 38.64 69.97 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 22 GLN~? 15.85 CH3 ACT B 134 A 91 LEU B 24 LEU~? 5.21 CH3 ACT B 134 A 133 GLU B 18 GLU~? 15.73 CH3 ACT B 134 coo 43.58 43.67 66.73 42.32 42.78 68.15 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 44.05 36.87 70.65 43.15 38.64 69.97 26.90 4.34 -14.80 26.44 5.99 -16.02 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 22 GLN~? 15.85 CH3 ACT B 134 A 91 LEU B 24 LEU~? 5.21 CH3 ACT B 134 A 133 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 43.58 43.67 66.73 42.32 42.78 68.15 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 44.05 36.87 70.65 43.15 38.64 69.97 15.52 -2.78 -21.66 14.62 -4.61 -22.18 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 30 GLN~? 18.92 CH3 ACT B 134 A 91 LEU B 33 LEU~? 15.42 CH3 ACT B 134 A 133 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 43.58 43.67 66.73 42.32 42.78 68.15 19.65 -9.51 -17.96 18.67 -10.61 -16.42 coo 38.58 45.09 70.44 38.28 45.21 72.59 19.26 -8.50 -12.67 17.08 -8.37 -12.30 coo 44.05 36.87 70.65 43.15 38.64 69.97 15.52 -2.78 -21.66 14.62 -4.61 -22.18 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 22 GLN~? 15.94 CH3 ACT A 134 B 591 LEU A 24 LEU~? 5.31 CH3 ACT A 134 B 633 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 88.06 44.34 57.19 89.06 45.53 55.74 20.14 15.38 24.13 21.73 16.51 24.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 15.13 11.98 18.72 14.77 12.01 16.62 coo 95.42 44.52 54.43 93.46 45.31 54.70 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 30 GLN~? 19.00 CH3 ACT A 134 B 591 LEU A 33 LEU~? 15.46 CH3 ACT A 134 B 633 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 88.06 44.34 57.19 89.06 45.53 55.74 19.86 25.98 22.72 18.81 27.05 21.20 coo 86.70 48.66 52.61 87.15 48.69 50.51 19.33 24.92 17.48 17.22 24.79 17.00 coo 95.42 44.52 54.43 93.46 45.31 54.70 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 22 GLN~? 15.85 CH3 ACT B 134 B 591 LEU B 24 LEU~? 5.21 CH3 ACT B 134 B 633 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 88.06 44.34 57.19 89.06 45.53 55.74 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 86.70 48.66 52.61 87.15 48.69 50.51 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 95.42 44.52 54.43 93.46 45.31 54.70 15.52 -2.78 -21.66 14.62 -4.61 -22.18 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 30 GLN~? 18.92 CH3 ACT B 134 B 591 LEU B 33 LEU~? 15.42 CH3 ACT B 134 B 633 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 88.06 44.34 57.19 89.06 45.53 55.74 19.65 -9.51 -17.96 18.67 -10.61 -16.42 coo 86.70 48.66 52.61 87.15 48.69 50.51 19.26 -8.50 -12.67 17.08 -8.37 -12.30 coo 95.42 44.52 54.43 93.46 45.31 54.70 15.52 -2.78 -21.66 14.62 -4.61 -22.18 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 22 GLN~? 15.94 CH3 ACT A 134 C1091 LEU A 24 LEU~? 5.31 CH3 ACT A 134 C1133 GLU A 18 GLU~? 15.74 CH3 ACT A 134 coo 68.29 34.44 43.03 66.67 34.74 44.37 20.14 15.38 24.13 21.73 16.51 24.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.13 11.98 18.72 14.77 12.01 16.62 coo 63.14 29.39 46.25 63.84 31.31 45.74 26.95 12.09 19.56 26.58 10.45 20.84 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 22 GLN~? 15.94 CH3 ACT A 134 C1091 LEU A 24 LEU~? 5.31 CH3 ACT A 134 C1133 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 68.29 34.44 43.03 66.67 34.74 44.37 20.14 15.38 24.13 21.73 16.51 24.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.13 11.98 18.72 14.77 12.01 16.62 coo 63.14 29.39 46.25 63.84 31.31 45.74 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 30 GLN~? 19.00 CH3 ACT A 134 C1091 LEU A 33 LEU~? 15.46 CH3 ACT A 134 C1133 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 68.29 34.44 43.03 66.67 34.74 44.37 19.86 25.98 22.72 18.81 27.05 21.20 coo 65.83 38.95 47.05 65.46 38.90 49.20 19.33 24.92 17.48 17.22 24.79 17.00 coo 63.14 29.39 46.25 63.84 31.31 45.74 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 22 GLN~? 15.85 CH3 ACT B 134 C1091 LEU B 24 LEU~? 5.21 CH3 ACT B 134 C1133 GLU B 18 GLU~? 15.73 CH3 ACT B 134 coo 68.29 34.44 43.03 66.67 34.74 44.37 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 63.14 29.39 46.25 63.84 31.31 45.74 26.90 4.34 -14.80 26.44 5.99 -16.02 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 22 GLN~? 15.85 CH3 ACT B 134 C1091 LEU B 24 LEU~? 5.21 CH3 ACT B 134 C1133 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 68.29 34.44 43.03 66.67 34.74 44.37 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 63.14 29.39 46.25 63.84 31.31 45.74 15.52 -2.78 -21.66 14.62 -4.61 -22.18 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 30 GLN~? 18.92 CH3 ACT B 134 C1091 LEU B 33 LEU~? 15.42 CH3 ACT B 134 C1133 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 68.29 34.44 43.03 66.67 34.74 44.37 19.65 -9.51 -17.96 18.67 -10.61 -16.42 coo 65.83 38.95 47.05 65.46 38.90 49.20 19.26 -8.50 -12.67 17.08 -8.37 -12.30 coo 63.14 29.39 46.25 63.84 31.31 45.74 15.52 -2.78 -21.66 14.62 -4.61 -22.18 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 22 GLN~? 15.94 CH3 ACT A 134 A 91 LEU A 24 LEU~? 5.31 CH3 ACT A 134 A 133 GLU A 18 GLU~? 15.74 CH3 ACT A 134 coo 38.23 53.34 67.59 38.84 53.87 69.56 20.14 15.38 24.13 21.73 16.51 24.99 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.13 11.98 18.72 14.77 12.01 16.62 coo 45.08 56.04 70.60 43.15 55.19 70.77 26.95 12.09 19.56 26.58 10.45 20.84 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 22 GLN~? 15.94 CH3 ACT A 134 A 91 LEU A 24 LEU~? 5.31 CH3 ACT A 134 A 133 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 38.23 53.34 67.59 38.84 53.87 69.56 20.14 15.38 24.13 21.73 16.51 24.99 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.13 11.98 18.72 14.77 12.01 16.62 coo 45.08 56.04 70.60 43.15 55.19 70.77 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 30 GLN~? 19.00 CH3 ACT A 134 A 91 LEU A 33 LEU~? 15.46 CH3 ACT A 134 A 133 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 38.23 53.34 67.59 38.84 53.87 69.56 19.86 25.98 22.72 18.81 27.05 21.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 19.33 24.92 17.48 17.22 24.79 17.00 coo 45.08 56.04 70.60 43.15 55.19 70.77 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 22 GLN~? 15.85 CH3 ACT B 134 A 91 LEU B 24 LEU~? 5.21 CH3 ACT B 134 A 133 GLU B 18 GLU~? 15.73 CH3 ACT B 134 coo 38.23 53.34 67.59 38.84 53.87 69.56 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 45.08 56.04 70.60 43.15 55.19 70.77 26.90 4.34 -14.80 26.44 5.99 -16.02 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 22 GLN~? 15.85 CH3 ACT B 134 A 91 LEU B 24 LEU~? 5.21 CH3 ACT B 134 A 133 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 38.23 53.34 67.59 38.84 53.87 69.56 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 45.08 56.04 70.60 43.15 55.19 70.77 15.52 -2.78 -21.66 14.62 -4.61 -22.18 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 30 GLN~? 18.92 CH3 ACT B 134 A 91 LEU B 33 LEU~? 15.42 CH3 ACT B 134 A 133 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 38.23 53.34 67.59 38.84 53.87 69.56 19.65 -9.51 -17.96 18.67 -10.61 -16.42 coo 35.40 53.22 73.30 35.37 54.87 74.74 19.26 -8.50 -12.67 17.08 -8.37 -12.30 coo 45.08 56.04 70.60 43.15 55.19 70.77 15.52 -2.78 -21.66 14.62 -4.61 -22.18 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 6 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 80 ASP^? 13.33 O ACT A 134 A 354 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 421 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 31.05 49.37 64.51 31.97 51.11 63.85 21.99 0.20 10.14 20.59 -0.43 11.58 coo 29.07 50.42 58.36 29.02 52.18 59.49 21.29 4.79 5.54 21.77 3.26 4.19 coo 30.82 59.76 58.47 31.12 59.02 60.40 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 354 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 421 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 31.05 49.37 64.51 31.97 51.11 63.85 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 29.07 50.42 58.36 29.02 52.18 59.49 21.22 11.60 -0.72 21.76 13.12 0.60 coo 30.82 59.76 58.47 31.12 59.02 60.40 26.00 19.90 3.85 25.60 19.04 1.99 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 80 ASP^? 13.33 O ACT A 134 B 354 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 421 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 25.90 8.19 53.87 25.36 6.97 52.29 21.99 0.20 10.14 20.59 -0.43 11.58 coo 27.87 10.66 47.95 27.82 8.60 48.27 21.29 4.79 5.54 21.77 3.26 4.19 coo 26.02 1.87 43.38 25.90 1.97 45.49 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP B 80 ASP^? 13.20 OXT ACT B 134 B 354 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 421 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 25.90 8.19 53.87 25.36 6.97 52.29 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 27.87 10.66 47.95 27.82 8.60 48.27 21.22 11.60 -0.72 21.76 13.12 0.60 coo 26.02 1.87 43.38 25.90 1.97 45.49 26.00 19.90 3.85 25.60 19.04 1.99 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 53 ASN^? 13.62 OXT ACT A 134 192 ASP B 129 ASP.? 12.08 OXT ACT B 134 195 HIS A 50 HIS.? 14.57 OXT ACT B 134 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 12.53 24.41 5.81 10.72 23.33 5.51 coo 56.18 0.19 32.76 56.16 -1.23 31.19 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 6.53 19.16 0.69 7.13 18.70 -1.26 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 53 ASN^? 13.51 O ACT B 134 192 ASP A 129 ASP.? 12.18 O ACT A 134 195 HIS B 50 HIS.? 14.60 O ACT A 134 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 12.53 -7.97 -0.98 10.78 -6.78 -0.73 coo 56.18 0.19 32.76 56.16 -1.23 31.19 4.86 1.75 6.36 4.91 0.13 7.65 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 6.58 -2.80 4.18 7.21 -2.33 6.13 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 2 hits 1bwp_c01 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 65 ARG B 107 ARG^? 13.48 OXT ACT B 134 A 85 HIS A 50 HIS.? 14.57 OXT ACT B 134 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 13.89 12.66 7.54 12.94 12.92 9.40 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 14.41 16.45 -2.54 16.63 18.58 -2.64 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 6.53 19.16 0.69 7.13 18.70 -1.26 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU B 124 GLU^? -3.39 O ACT B 134s A 65 ARG A 107 ARG^? 13.51 O ACT A 134 A 85 HIS B 50 HIS.? 14.60 O ACT A 134 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 13.91 3.81 -2.65 12.88 3.52 -4.44 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 14.42 -0.01 7.43 16.47 -2.30 7.52 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 6.58 -2.80 4.18 7.21 -2.33 6.13 1c54_c00 source 1c54 RIBONUCLEASE SA : 2 hits 1c54_c00 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 16 HIS A 4 HIS.? -31.85 CH3 ACT A 134s A 67 GLY A 0 GLY.? 23.91 CH3 ACT B 134 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 37.70 12.40 8.53 36.14 12.23 7.15 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 43.87 10.57 9.16 45.61 11.32 10.07 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 35.16 7.61 0.26 34.64 7.43 0.87 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 16 HIS A 4 HIS.? -31.85 CH3 ACT A 134s A 67 GLY B 0 GLY.? 23.71 CH3 ACT A 134 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 37.70 12.40 8.53 36.14 12.23 7.15 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 43.87 10.57 9.16 45.61 11.32 10.07 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 35.16 8.68 4.55 34.62 8.93 3.96 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 16 HIS B 4 HIS.? -31.93 CH3 ACT B 134s A 67 GLY A 0 GLY.? 23.91 CH3 ACT B 134 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 43.77 5.80 -4.34 45.50 5.09 -5.28 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 35.16 7.61 0.26 34.64 7.43 0.87 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 16 HIS B 4 HIS.? -31.93 CH3 ACT B 134s A 67 GLY B 0 GLY.? 23.71 CH3 ACT A 134 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 43.77 5.80 -4.34 45.50 5.09 -5.28 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 35.16 8.68 4.55 34.62 8.93 3.96 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 4 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 7 ASP~? 23.80 CH3 ACT A 134 C 16 HIS A 4 HIS.? -31.85 CH3 ACT A 134s C 67 GLY B 0 GLY.? 23.71 CH3 ACT A 134 coo 10.04 44.27 88.44 9.47 42.32 89.03 37.70 12.40 8.53 36.14 12.23 7.15 coo 6.38 39.80 88.71 6.88 38.89 86.87 43.87 10.57 9.16 45.61 11.32 10.07 coo 17.63 42.50 89.25 18.11 42.29 88.64 35.16 8.68 4.55 34.62 8.93 3.96 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP B 7 ASP~? 23.98 CH3 ACT B 134 C 16 HIS B 4 HIS.? -31.93 CH3 ACT B 134s C 67 GLY A 0 GLY.? 23.91 CH3 ACT B 134 coo 10.04 44.27 88.44 9.47 42.32 89.03 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 43.77 5.80 -4.34 45.50 5.09 -5.28 coo 17.63 42.50 89.25 18.11 42.29 88.64 35.16 7.61 0.26 34.64 7.43 0.87 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c07 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 81 ARG^? 17.75 O ACT A 134 127 ARG B 123 ARG^? 15.62 CH3 ACT B 134 270 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -0.83 25.63 1.57 0.97 28.05 0.90 23.88 0.36 5.26 23.01 -2.52 5.93 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 94 ARG^? 12.39 O ACT A 134 127 ARG A 107 ARG^? 13.51 O ACT A 134 270 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -0.83 25.63 1.57 0.97 28.05 0.90 16.69 -1.11 11.91 15.79 -2.18 14.67 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 14.42 -0.01 7.43 16.47 -2.30 7.52 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 123 ARG^? 15.41 CH3 ACT A 134 127 ARG B 81 ARG^? 17.71 OXT ACT B 134 270 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -0.83 25.63 1.57 0.97 28.05 0.90 19.67 16.84 1.03 22.28 17.57 2.36 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 123 ARG^? 15.41 CH3 ACT A 134 127 ARG B 107 ARG^? 13.48 OXT ACT B 134 270 GLU B 124 GLU^? -3.39 O ACT B 134s coo -0.83 25.63 1.57 0.97 28.05 0.90 19.67 16.84 1.03 22.28 17.57 2.36 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 14.41 16.45 -2.54 16.63 18.58 -2.64 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG B 81 ARG^? 17.71 OXT ACT B 134 127 ARG A 123 ARG^? 15.41 CH3 ACT A 134 270 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -0.83 25.63 1.57 0.97 28.05 0.90 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 19.67 16.84 1.03 22.28 17.57 2.36 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG B 94 ARG^? 12.34 OXT ACT B 134 127 ARG B 107 ARG^? 13.48 OXT ACT B 134 270 GLU B 124 GLU^? -3.39 O ACT B 134s coo -0.83 25.63 1.57 0.97 28.05 0.90 16.67 17.44 -7.09 15.78 18.56 -9.82 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 14.41 16.45 -2.54 16.63 18.58 -2.64 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG B 123 ARG^? 15.62 CH3 ACT B 134 127 ARG A 81 ARG^? 17.75 O ACT A 134 270 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -0.83 25.63 1.57 0.97 28.05 0.90 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 23.88 0.36 5.26 23.01 -2.52 5.93 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG B 123 ARG^? 15.62 CH3 ACT B 134 127 ARG A 107 ARG^? 13.51 O ACT A 134 270 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -0.83 25.63 1.57 0.97 28.05 0.90 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 14.42 -0.01 7.43 16.47 -2.30 7.52 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 13.89 12.66 7.54 12.94 12.92 9.40 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 8 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 39 ASP^? 22.84 CH3 ACT A 134 264 GLU A 124 GLU^? -3.29 OXT ACT A 134s 328 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.90 30.21 5.13 24.67 29.05 5.02 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.89 12.66 7.54 12.94 12.92 9.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 95 ASP^? -2.87 O ACT A 134s 264 GLU B 92 GLU^? 14.52 OXT ACT B 134 328 ASP A 80 ASP^? 13.33 O ACT A 134 coo 45.62 80.42 43.69 45.65 82.01 45.07 13.92 6.03 15.16 12.65 6.91 13.72 coo 59.69 92.71 39.85 58.53 92.03 41.47 21.22 11.60 -0.72 21.76 13.12 0.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 95 ASP^? -2.87 O ACT A 134s 264 GLU B 124 GLU^? -3.39 O ACT B 134s 328 ASP A 80 ASP^? 13.33 O ACT A 134 coo 45.62 80.42 43.69 45.65 82.01 45.07 13.92 6.03 15.16 12.65 6.91 13.72 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 45.39 90.72 40.63 45.07 89.14 41.90 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 39 ASP^? 22.90 CH3 ACT B 134 264 GLU B 124 GLU^? -3.39 O ACT B 134s 328 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 45.39 90.72 40.63 45.07 89.14 41.90 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 95 ASP^? -2.82 OXT ACT B 134s 264 GLU A 92 GLU^? 14.49 CH3 ACT A 134 328 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 45.62 80.42 43.69 45.65 82.01 45.07 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 59.69 92.71 39.85 58.53 92.03 41.47 21.29 4.79 5.54 21.77 3.26 4.19 coo 45.39 90.72 40.63 45.07 89.14 41.90 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 95 ASP^? -2.82 OXT ACT B 134s 264 GLU A 124 GLU^? -3.29 OXT ACT A 134s 328 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 45.62 80.42 43.69 45.65 82.01 45.07 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.89 12.66 7.54 12.94 12.92 9.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 21.98 16.13 -5.41 20.58 16.67 -6.85 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 51 GLY^? 14.42 OXT ACT A 134 A 228 SER B 128 SER.? 10.40 OXT ACT B 134 A 549 ASP B 129 ASP.? 12.08 OXT ACT B 134 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 10.22 20.76 0.78 10.34 20.77 1.56 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 9.49 14.01 -1.20 8.95 15.98 -2.61 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 4.87 14.63 -1.58 4.99 16.28 -2.86 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 51 GLY^? 14.42 OXT ACT A 134 A 228 SER B 132 SER.? 12.23 OXT ACT B 134 A 549 ASP B 129 ASP.? 12.08 OXT ACT B 134 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 10.22 20.76 0.78 10.34 20.77 1.56 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 7.68 17.54 -6.39 7.22 18.14 -4.05 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 4.87 14.63 -1.58 4.99 16.28 -2.86 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 51 GLY^? 14.43 O ACT B 134 A 228 SER A 128 SER.? 10.42 O ACT A 134 A 549 ASP A 129 ASP.? 12.18 O ACT A 134 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 10.20 -4.27 4.11 10.27 -4.29 3.32 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 9.47 2.37 6.00 8.93 0.44 7.47 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 4.86 1.75 6.36 4.91 0.13 7.65 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 51 GLY^? 14.43 O ACT B 134 A 228 SER A 132 SER.? 12.20 O ACT A 134 A 549 ASP A 129 ASP.? 12.18 O ACT A 134 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 10.20 -4.27 4.11 10.27 -4.29 3.32 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 7.72 -1.19 11.22 7.31 -1.68 8.88 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 4.86 1.75 6.36 4.91 0.13 7.65 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 51 GLY^? 14.42 OXT ACT A 134 B1228 SER B 128 SER.? 10.40 OXT ACT B 134 B1549 ASP B 129 ASP.? 12.08 OXT ACT B 134 coo 126.34 72.75 125.66 125.95 73.27 126.11 10.22 20.76 0.78 10.34 20.77 1.56 coo 131.65 74.68 129.41 130.31 72.73 128.82 9.49 14.01 -1.20 8.95 15.98 -2.61 coo 134.72 69.43 130.42 133.03 70.65 130.08 4.87 14.63 -1.58 4.99 16.28 -2.86 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 51 GLY^? 14.42 OXT ACT A 134 B1228 SER B 132 SER.? 12.23 OXT ACT B 134 B1549 ASP B 129 ASP.? 12.08 OXT ACT B 134 coo 126.34 72.75 125.66 125.95 73.27 126.11 10.22 20.76 0.78 10.34 20.77 1.56 coo 131.65 74.68 129.41 130.31 72.73 128.82 7.68 17.54 -6.39 7.22 18.14 -4.05 coo 134.72 69.43 130.42 133.03 70.65 130.08 4.87 14.63 -1.58 4.99 16.28 -2.86 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 51 GLY^? 14.43 O ACT B 134 B1228 SER A 128 SER.? 10.42 O ACT A 134 B1549 ASP A 129 ASP.? 12.18 O ACT A 134 coo 126.34 72.75 125.66 125.95 73.27 126.11 10.20 -4.27 4.11 10.27 -4.29 3.32 coo 131.65 74.68 129.41 130.31 72.73 128.82 9.47 2.37 6.00 8.93 0.44 7.47 coo 134.72 69.43 130.42 133.03 70.65 130.08 4.86 1.75 6.36 4.91 0.13 7.65 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 51 GLY^? 14.43 O ACT B 134 B1228 SER A 132 SER.? 12.20 O ACT A 134 B1549 ASP A 129 ASP.? 12.18 O ACT A 134 coo 126.34 72.75 125.66 125.95 73.27 126.11 10.20 -4.27 4.11 10.27 -4.29 3.32 coo 131.65 74.68 129.41 130.31 72.73 128.82 7.72 -1.19 11.22 7.31 -1.68 8.88 coo 134.72 69.43 130.42 133.03 70.65 130.08 4.86 1.75 6.36 4.91 0.13 7.65 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 89 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 120 SER A 111 SER^? 14.00 CH3 ACT A 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.29 4.79 5.54 21.77 3.26 4.19 coo -31.18 6.91 75.60 -32.39 8.51 74.91 13.89 12.66 7.54 12.94 12.92 9.40 coo -34.73 8.57 68.21 -33.63 9.08 70.28 21.88 13.56 5.40 22.76 13.90 3.16 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 89 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 120 SER A 84 SER^? 20.86 CH3 ACT A 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.29 4.79 5.54 21.77 3.26 4.19 coo -31.18 6.91 75.60 -32.39 8.51 74.91 21.22 11.60 -0.72 21.76 13.12 0.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 30.40 10.24 3.82 32.46 10.17 5.21 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 89 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 120 SER A 111 SER^? 14.00 CH3 ACT A 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.29 4.79 5.54 21.77 3.26 4.19 coo -31.18 6.91 75.60 -32.39 8.51 74.91 21.22 11.60 -0.72 21.76 13.12 0.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 21.88 13.56 5.40 22.76 13.90 3.16 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 89 GLU B 124 GLU^? -3.39 O ACT B 134s A 120 SER A 128 SER.? 10.42 O ACT A 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.29 4.79 5.54 21.77 3.26 4.19 coo -31.18 6.91 75.60 -32.39 8.51 74.91 13.91 3.81 -2.65 12.88 3.52 -4.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 9.47 2.37 6.00 8.93 0.44 7.47 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 89 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 120 SER B 84 SER^? 21.05 CH3 ACT B 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.22 11.60 -0.72 21.76 13.12 0.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 21.29 4.79 5.54 21.77 3.26 4.19 coo -34.73 8.57 68.21 -33.63 9.08 70.28 30.37 6.08 1.00 32.42 6.12 -0.34 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 89 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 120 SER B 111 SER^? 14.22 CH3 ACT B 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.22 11.60 -0.72 21.76 13.12 0.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 21.29 4.79 5.54 21.77 3.26 4.19 coo -34.73 8.57 68.21 -33.63 9.08 70.28 21.84 2.81 -0.55 22.81 2.45 1.66 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 89 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 120 SER B 128 SER.? 10.40 OXT ACT B 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.22 11.60 -0.72 21.76 13.12 0.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 13.89 12.66 7.54 12.94 12.92 9.40 coo -34.73 8.57 68.21 -33.63 9.08 70.28 9.49 14.01 -1.20 8.95 15.98 -2.61 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 89 GLU B 124 GLU^? -3.39 O ACT B 134s A 120 SER B 111 SER^? 14.22 CH3 ACT B 134 coo -24.35 9.53 67.64 -25.07 11.29 68.60 21.22 11.60 -0.72 21.76 13.12 0.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 13.91 3.81 -2.65 12.88 3.52 -4.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 21.84 2.81 -0.55 22.81 2.45 1.66 1cns_c00 source 1cns CHITINASE : 8 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 89 GLU B 124 GLU^? -3.39 O ACT B 134s B 120 SER A 128 SER.? 10.42 O ACT A 134 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 21.29 4.79 5.54 21.77 3.26 4.19 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 9.47 2.37 6.00 8.93 0.44 7.47 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 89 GLU B 124 GLU^? -3.39 O ACT B 134s B 120 SER A 128 SER.? 10.42 O ACT A 134 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 13.89 12.66 7.54 12.94 12.92 9.40 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 9.47 2.37 6.00 8.93 0.44 7.47 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 89 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 120 SER B 128 SER.? 10.40 OXT ACT B 134 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 21.22 11.60 -0.72 21.76 13.12 0.60 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 13.89 12.66 7.54 12.94 12.92 9.40 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 9.49 14.01 -1.20 8.95 15.98 -2.61 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 124 GLU^? -3.39 O ACT B 134s B 89 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 120 SER B 128 SER.? 10.40 OXT ACT B 134 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 13.89 12.66 7.54 12.94 12.92 9.40 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 9.49 14.01 -1.20 8.95 15.98 -2.61 1cns_c01 source 1cns CHITINASE : 4 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 107 ARG^? 13.51 O ACT A 134 C 101 TYR B 122 TYR^? 8.37 CH3 ACT B 134 C 173 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 32.27 5.62 48.15 31.93 6.48 51.06 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 29.64 3.64 57.39 31.22 5.14 55.65 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 107 ARG^? 13.48 OXT ACT B 134 C 101 TYR A 122 TYR^? 8.33 CH3 ACT A 134 C 173 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 32.27 5.62 48.15 31.93 6.48 51.06 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 29.64 3.64 57.39 31.22 5.14 55.65 18.19 17.99 8.45 16.46 16.26 9.80 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 26.00 19.90 3.85 25.60 19.04 1.99 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 122 TYR^? 8.33 CH3 ACT A 134 B 173 ASP A 113 ASP^? 18.42 CH3 ACT A 134 D 48 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 18.19 17.99 8.45 16.46 16.26 9.80 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 26.00 19.90 3.85 25.60 19.04 1.99 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 14.41 16.45 -2.54 16.63 18.58 -2.64 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 122 TYR^? 8.37 CH3 ACT B 134 B 173 ASP B 113 ASP^? 18.51 CH3 ACT B 134 D 48 ARG A 107 ARG^? 13.51 O ACT A 134 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 14.42 -0.01 7.43 16.47 -2.30 7.52 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 80 ASP^? 13.33 O ACT A 134 A 340 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 395 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 21.99 0.20 10.14 20.59 -0.43 11.58 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 21.29 4.79 5.54 21.77 3.26 4.19 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 340 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 395 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 21.22 11.60 -0.72 21.76 13.12 0.60 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 26.00 19.90 3.85 25.60 19.04 1.99 1cwy_c00 source 1cwy AMYLOMALTASE : 2 hits 1cwy_c00 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 118 LYS^? 23.86 CH3 ACT A 134 A 177 GLU A 38 GLU^? 23.44 CH3 ACT A 134 A 201 LEU A 36 LEU^? 15.44 CH3 ACT A 134 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 28.94 23.42 11.82 28.39 29.21 14.30 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 24.16 32.64 11.25 23.00 32.22 12.98 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 22.11 24.82 12.59 21.08 22.91 12.84 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 118 LYS^? 22.69 CH3 ACT B 134 A 177 GLU B 38 GLU^? 23.46 CH3 ACT B 134 A 201 LEU B 36 LEU^? 15.44 CH3 ACT B 134 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 24.12 -16.18 -6.62 22.89 -15.85 -8.32 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 22.06 -8.36 -7.78 20.99 -6.51 -8.04 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 48 GLU.? 14.70 OXT ACT A 134 A 226 THR A 37 THR^? 20.64 CH3 ACT A 134 A 229 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 9.66 102.78 70.07 9.79 101.18 71.42 3.89 23.33 8.60 3.75 23.77 10.68 coo 7.24 97.46 49.60 8.11 95.69 48.80 24.88 27.66 10.30 25.68 26.74 8.52 coo 10.53 97.56 43.71 9.33 93.71 47.17 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 A 226 THR A 37 THR^? 20.64 CH3 ACT A 134 A 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 9.66 102.78 70.07 9.79 101.18 71.42 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 7.24 97.46 49.60 8.11 95.69 48.80 24.88 27.66 10.30 25.68 26.74 8.52 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 A 226 THR A 41 THR^? 18.02 CH3 ACT A 134 A 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 9.66 102.78 70.07 9.79 101.18 71.42 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 7.24 97.46 49.60 8.11 95.69 48.80 18.34 24.70 5.20 19.06 25.00 3.19 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 226 THR A 41 THR^? 18.02 CH3 ACT A 134 A 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 9.66 102.78 70.07 9.79 101.18 71.42 21.29 4.79 5.54 21.77 3.26 4.19 coo 7.24 97.46 49.60 8.11 95.69 48.80 18.34 24.70 5.20 19.06 25.00 3.19 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 48 GLU.? 15.07 O ACT B 134 A 226 THR B 37 THR^? 20.68 CH3 ACT B 134 A 229 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 9.66 102.78 70.07 9.79 101.18 71.42 3.87 -7.04 -3.75 3.32 -7.55 -5.74 coo 7.24 97.46 49.60 8.11 95.69 48.80 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 A 226 THR B 37 THR^? 20.68 CH3 ACT B 134 A 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 9.66 102.78 70.07 9.79 101.18 71.42 35.82 0.62 5.15 36.84 -0.64 6.51 coo 7.24 97.46 49.60 8.11 95.69 48.80 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 A 226 THR B 41 THR^? 18.20 CH3 ACT B 134 A 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 9.66 102.78 70.07 9.79 101.18 71.42 35.82 0.62 5.15 36.84 -0.64 6.51 coo 7.24 97.46 49.60 8.11 95.69 48.80 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 48 GLU.? 14.70 OXT ACT A 134 B 226 THR A 37 THR^? 20.64 CH3 ACT A 134 B 229 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 15.90 87.61 49.61 13.92 86.96 49.36 3.89 23.33 8.60 3.75 23.77 10.68 coo 20.74 95.78 68.68 19.29 96.84 69.83 24.88 27.66 10.30 25.68 26.74 8.52 coo 22.32 101.61 71.64 17.89 98.63 71.55 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 B 226 THR A 37 THR^? 20.64 CH3 ACT A 134 B 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 15.90 87.61 49.61 13.92 86.96 49.36 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 20.74 95.78 68.68 19.29 96.84 69.83 24.88 27.66 10.30 25.68 26.74 8.52 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 B 226 THR A 41 THR^? 18.02 CH3 ACT A 134 B 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 15.90 87.61 49.61 13.92 86.96 49.36 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 20.74 95.78 68.68 19.29 96.84 69.83 18.34 24.70 5.20 19.06 25.00 3.19 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 226 THR A 41 THR^? 18.02 CH3 ACT A 134 B 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 15.90 87.61 49.61 13.92 86.96 49.36 21.29 4.79 5.54 21.77 3.26 4.19 coo 20.74 95.78 68.68 19.29 96.84 69.83 18.34 24.70 5.20 19.06 25.00 3.19 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 48 GLU.? 15.07 O ACT B 134 B 226 THR B 37 THR^? 20.68 CH3 ACT B 134 B 229 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 15.90 87.61 49.61 13.92 86.96 49.36 3.87 -7.04 -3.75 3.32 -7.55 -5.74 coo 20.74 95.78 68.68 19.29 96.84 69.83 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 B 226 THR B 37 THR^? 20.68 CH3 ACT B 134 B 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 15.90 87.61 49.61 13.92 86.96 49.36 35.82 0.62 5.15 36.84 -0.64 6.51 coo 20.74 95.78 68.68 19.29 96.84 69.83 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 B 226 THR B 41 THR^? 18.20 CH3 ACT B 134 B 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 15.90 87.61 49.61 13.92 86.96 49.36 35.82 0.62 5.15 36.84 -0.64 6.51 coo 20.74 95.78 68.68 19.29 96.84 69.83 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 48 GLU.? 14.70 OXT ACT A 134 C 226 THR A 37 THR^? 20.64 CH3 ACT A 134 C 229 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 5.43 40.40 61.63 4.27 41.99 60.90 3.89 23.33 8.60 3.75 23.77 10.68 coo 22.16 45.88 73.63 23.23 47.70 73.25 24.88 27.66 10.30 25.68 26.74 8.52 coo 28.90 45.91 73.55 25.22 49.72 72.97 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 C 226 THR A 37 THR^? 20.64 CH3 ACT A 134 C 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 5.43 40.40 61.63 4.27 41.99 60.90 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 22.16 45.88 73.63 23.23 47.70 73.25 24.88 27.66 10.30 25.68 26.74 8.52 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 C 226 THR A 41 THR^? 18.02 CH3 ACT A 134 C 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 5.43 40.40 61.63 4.27 41.99 60.90 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 22.16 45.88 73.63 23.23 47.70 73.25 18.34 24.70 5.20 19.06 25.00 3.19 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 226 THR A 41 THR^? 18.02 CH3 ACT A 134 C 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 5.43 40.40 61.63 4.27 41.99 60.90 21.29 4.79 5.54 21.77 3.26 4.19 coo 22.16 45.88 73.63 23.23 47.70 73.25 18.34 24.70 5.20 19.06 25.00 3.19 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 48 GLU.? 15.07 O ACT B 134 C 226 THR B 37 THR^? 20.68 CH3 ACT B 134 C 229 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 5.43 40.40 61.63 4.27 41.99 60.90 3.87 -7.04 -3.75 3.32 -7.55 -5.74 coo 22.16 45.88 73.63 23.23 47.70 73.25 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 C 226 THR B 37 THR^? 20.68 CH3 ACT B 134 C 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 5.43 40.40 61.63 4.27 41.99 60.90 35.82 0.62 5.15 36.84 -0.64 6.51 coo 22.16 45.88 73.63 23.23 47.70 73.25 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 C 226 THR B 41 THR^? 18.20 CH3 ACT B 134 C 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 5.43 40.40 61.63 4.27 41.99 60.90 35.82 0.62 5.15 36.84 -0.64 6.51 coo 22.16 45.88 73.63 23.23 47.70 73.25 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 48 GLU.? 14.70 OXT ACT A 134 D 226 THR A 37 THR^? 20.64 CH3 ACT A 134 D 229 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 26.07 55.89 66.14 25.33 56.50 68.01 3.89 23.33 8.60 3.75 23.77 10.68 coo 11.79 47.62 52.67 10.10 46.51 53.39 24.88 27.66 10.30 25.68 26.74 8.52 coo 10.05 41.79 49.80 7.94 44.71 53.76 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 D 226 THR A 37 THR^? 20.64 CH3 ACT A 134 D 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 26.07 55.89 66.14 25.33 56.50 68.01 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 11.79 47.62 52.67 10.10 46.51 53.39 24.88 27.66 10.30 25.68 26.74 8.52 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 86 GLU.? 27.53 CH3 ACT B 134 D 226 THR A 41 THR^? 18.02 CH3 ACT A 134 D 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 26.07 55.89 66.14 25.33 56.50 68.01 35.97 15.66 -0.32 36.99 16.96 -1.64 coo 11.79 47.62 52.67 10.10 46.51 53.39 18.34 24.70 5.20 19.06 25.00 3.19 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU A 92 GLU^? 14.49 CH3 ACT A 134 D 226 THR A 41 THR^? 18.02 CH3 ACT A 134 D 229 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 26.07 55.89 66.14 25.33 56.50 68.01 21.29 4.79 5.54 21.77 3.26 4.19 coo 11.79 47.62 52.67 10.10 46.51 53.39 18.34 24.70 5.20 19.06 25.00 3.19 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 48 GLU.? 15.07 O ACT B 134 D 226 THR B 37 THR^? 20.68 CH3 ACT B 134 D 229 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 26.07 55.89 66.14 25.33 56.50 68.01 3.87 -7.04 -3.75 3.32 -7.55 -5.74 coo 11.79 47.62 52.67 10.10 46.51 53.39 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 28.80 -7.02 -7.08 28.66 -10.73 -10.74 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 D 226 THR B 37 THR^? 20.68 CH3 ACT B 134 D 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 26.07 55.89 66.14 25.33 56.50 68.01 35.82 0.62 5.15 36.84 -0.64 6.51 coo 11.79 47.62 52.67 10.10 46.51 53.39 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU B 86 GLU.? 27.22 CH3 ACT A 134 D 226 THR B 41 THR^? 18.20 CH3 ACT B 134 D 229 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 26.07 55.89 66.14 25.33 56.50 68.01 35.82 0.62 5.15 36.84 -0.64 6.51 coo 11.79 47.62 52.67 10.10 46.51 53.39 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.26 -12.01 -7.36 22.35 -12.14 -10.46 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 14 HIS~? 17.04 CH3 ACT A 134 A 200 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 229 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 1.13 77.49 40.64 0.62 75.57 39.98 30.04 10.42 13.88 29.99 8.58 12.87 coo 0.84 91.24 49.01 2.91 91.61 49.23 24.17 25.65 19.58 23.03 26.79 20.97 coo 10.53 97.56 43.71 9.33 93.71 47.17 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS B 14 HIS~? 17.16 CH3 ACT B 134 A 200 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 229 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 1.13 77.49 40.64 0.62 75.57 39.98 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 10.53 97.56 43.71 9.33 93.71 47.17 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 14 HIS~? 17.04 CH3 ACT A 134 B 200 ASP A 34 ASP~? 20.39 CH3 ACT A 134 B 229 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 9.24 94.26 88.22 8.02 94.07 89.92 30.04 10.42 13.88 29.99 8.58 12.87 coo 17.54 90.31 75.01 17.17 92.01 73.80 24.17 25.65 19.58 23.03 26.79 20.97 coo 22.32 101.61 71.64 17.89 98.63 71.55 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS B 14 HIS~? 17.16 CH3 ACT B 134 B 200 ASP B 34 ASP~? 20.32 CH3 ACT B 134 B 229 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 9.24 94.26 88.22 8.02 94.07 89.92 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 22.32 101.61 71.64 17.89 98.63 71.55 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 14 HIS~? 17.04 CH3 ACT A 134 C 200 ASP A 34 ASP~? 20.39 CH3 ACT A 134 C 229 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 26.77 65.84 83.49 27.06 67.76 84.27 30.04 10.42 13.88 29.99 8.58 12.87 coo 19.52 52.01 79.59 20.28 51.65 77.65 24.17 25.65 19.58 23.03 26.79 20.97 coo 28.90 45.91 73.55 25.22 49.72 72.97 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS B 14 HIS~? 17.16 CH3 ACT B 134 C 200 ASP B 34 ASP~? 20.32 CH3 ACT B 134 C 229 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 26.77 65.84 83.49 27.06 67.76 84.27 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 28.90 45.91 73.55 25.22 49.72 72.97 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 14 HIS~? 17.04 CH3 ACT A 134 D 200 ASP A 34 ASP~? 20.39 CH3 ACT A 134 D 229 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo -10.90 48.74 53.41 -12.98 48.90 53.67 30.04 10.42 13.88 29.99 8.58 12.87 coo 4.60 52.95 52.50 5.57 51.29 53.40 24.17 25.65 19.58 23.03 26.79 20.97 coo 10.05 41.79 49.80 7.94 44.71 53.76 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS B 14 HIS~? 17.16 CH3 ACT B 134 D 200 ASP B 34 ASP~? 20.32 CH3 ACT B 134 D 229 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo -10.90 48.74 53.41 -12.98 48.90 53.67 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 10.05 41.79 49.80 7.94 44.71 53.76 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 83 THR^? 17.54 CH3 ACT A 134 A 45 THR B 83 THR^? 17.78 CH3 ACT B 134 A 161 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 26.16 88.25 79.16 25.22 89.47 80.71 28.55 7.09 4.80 27.08 6.14 3.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 28.55 9.24 0.02 27.11 10.23 1.39 coo 33.83 91.15 88.62 31.07 91.06 83.02 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR B 83 THR^? 17.78 CH3 ACT B 134 A 45 THR A 83 THR^? 17.54 CH3 ACT A 134 A 161 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 26.16 88.25 79.16 25.22 89.47 80.71 28.55 9.24 0.02 27.11 10.23 1.39 coo 27.73 89.90 76.08 29.24 91.46 75.95 28.55 7.09 4.80 27.08 6.14 3.47 coo 33.83 91.15 88.62 31.07 91.06 83.02 33.61 2.06 -8.46 36.00 -1.11 -11.84 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 83 THR^? 17.54 CH3 ACT A 134 B 45 THR B 83 THR^? 17.78 CH3 ACT B 134 B 161 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 7.39 128.28 94.56 8.34 126.36 94.79 28.55 7.09 4.80 27.08 6.14 3.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 28.55 9.24 0.02 27.11 10.23 1.39 coo -0.17 119.75 99.65 2.51 123.83 95.70 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR B 83 THR^? 17.78 CH3 ACT B 134 B 45 THR A 83 THR^? 17.54 CH3 ACT A 134 B 161 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 7.39 128.28 94.56 8.34 126.36 94.79 28.55 9.24 0.02 27.11 10.23 1.39 coo 5.75 129.25 91.25 4.29 128.16 90.07 28.55 7.09 4.80 27.08 6.14 3.47 coo -0.17 119.75 99.65 2.51 123.83 95.70 33.61 2.06 -8.46 36.00 -1.11 -11.84 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c03 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 26 THR~? 13.82 CH3 ACT A 134 A 159 LYS A 31 LYS~? 20.89 CH3 ACT A 134 A 193 GLU A 18 GLU~? 15.74 CH3 ACT A 134 coo -2.58 16.31 54.79 -4.02 14.93 55.64 14.37 14.46 25.19 16.46 14.87 25.63 coo 2.10 10.68 61.44 -2.14 13.16 60.61 22.53 21.87 21.40 25.12 21.84 25.97 coo -5.33 11.71 69.72 -4.62 11.92 67.73 26.95 12.09 19.56 26.58 10.45 20.84 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 41 THR^? 18.02 CH3 ACT A 134 A 159 LYS A 60 LYS~? 19.22 CH3 ACT A 134 A 193 GLU A 48 GLU.? 14.70 OXT ACT A 134 coo -2.58 16.31 54.79 -4.02 14.93 55.64 18.34 24.70 5.20 19.06 25.00 3.19 coo 2.10 10.68 61.44 -2.14 13.16 60.61 13.42 25.37 15.69 13.26 28.28 21.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 3.89 23.33 8.60 3.75 23.77 10.68 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 88 THR^? 17.94 CH3 ACT A 134 A 159 LYS A 11 LYS~? 24.23 CH3 ACT A 134 A 193 GLU A 18 GLU~? 15.74 CH3 ACT A 134 coo -2.58 16.31 54.79 -4.02 14.93 55.64 28.18 15.22 3.40 26.60 15.27 1.86 coo 2.10 10.68 61.44 -2.14 13.16 60.61 33.70 14.32 13.26 36.02 17.43 17.06 coo -5.33 11.71 69.72 -4.62 11.92 67.73 26.95 12.09 19.56 26.58 10.45 20.84 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 26 THR~? 13.73 CH3 ACT B 134 A 159 LYS B 31 LYS~? 20.62 CH3 ACT B 134 A 193 GLU B 18 GLU~? 15.73 CH3 ACT B 134 coo -2.58 16.31 54.79 -4.02 14.93 55.64 14.26 1.98 -20.43 16.36 1.59 -20.83 coo 2.10 10.68 61.44 -2.14 13.16 60.61 22.46 -5.38 -16.68 25.00 -4.99 -21.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 26.90 4.34 -14.80 26.44 5.99 -16.02 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 41 THR^? 18.20 CH3 ACT B 134 A 159 LYS B 60 LYS~? 18.28 CH3 ACT B 134 A 193 GLU B 48 GLU.? 15.07 O ACT B 134 coo -2.58 16.31 54.79 -4.02 14.93 55.64 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 2.10 10.68 61.44 -2.14 13.16 60.61 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo -5.33 11.71 69.72 -4.62 11.92 67.73 3.87 -7.04 -3.75 3.32 -7.55 -5.74 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 88 THR^? 18.11 CH3 ACT B 134 A 159 LYS B 11 LYS~? 24.30 CH3 ACT B 134 A 193 GLU B 18 GLU~? 15.73 CH3 ACT B 134 coo -2.58 16.31 54.79 -4.02 14.93 55.64 28.17 1.09 1.44 26.55 0.98 2.93 coo 2.10 10.68 61.44 -2.14 13.16 60.61 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo -5.33 11.71 69.72 -4.62 11.92 67.73 26.90 4.34 -14.80 26.44 5.99 -16.02 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 6 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 95 ASP^? -2.87 O ACT A 134s 260 GLU A 92 GLU^? 14.49 CH3 ACT A 134 370 TYR B 125 TYR^? 11.31 O ACT A 134 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 13.92 6.03 15.16 12.65 6.91 13.72 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 21.29 4.79 5.54 21.77 3.26 4.19 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 95 ASP^? -2.87 O ACT A 134s 260 GLU A 124 GLU^? -3.29 OXT ACT A 134s 370 TYR B 125 TYR^? 11.31 O ACT A 134 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 13.92 6.03 15.16 12.65 6.91 13.72 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 13.89 12.66 7.54 12.94 12.92 9.40 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 95 ASP^? -2.82 OXT ACT B 134s 260 GLU B 92 GLU^? 14.52 OXT ACT B 134 370 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 21.22 11.60 -0.72 21.76 13.12 0.60 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP B 95 ASP^? -2.82 OXT ACT B 134s 260 GLU B 124 GLU^? -3.39 O ACT B 134s 370 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 16.00 10.76 2.04 17.57 12.50 0.46 1euu_c00 source 1euu SIALIDASE : 4 hits 1euu_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 14 HIS~? 17.04 CH3 ACT A 134 C 62 LYS A 118 LYS^? 23.86 CH3 ACT A 134 F 35 ASP A 7 ASP~? 23.80 CH3 ACT A 134 coo 15.40 22.79 16.66 13.93 24.10 15.98 30.04 10.42 13.88 29.99 8.58 12.87 coo 19.95 18.98 4.81 18.82 20.94 10.49 28.94 23.42 11.82 28.39 29.21 14.30 coo 16.32 15.30 17.19 17.71 14.73 18.69 37.70 12.40 8.53 36.14 12.23 7.15 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 14 HIS~? 17.16 CH3 ACT B 134 C 62 LYS B 118 LYS^? 22.69 CH3 ACT B 134 F 35 ASP B 7 ASP~? 23.98 CH3 ACT B 134 coo 15.40 22.79 16.66 13.93 24.10 15.98 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 19.95 18.98 4.81 18.82 20.94 10.49 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo 16.32 15.30 17.19 17.71 14.73 18.69 37.67 3.93 -3.68 36.11 4.07 -2.28 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 118 LYS^? 23.86 CH3 ACT A 134 C 105 HIS A 14 HIS~? 17.04 CH3 ACT A 134 D 35 ASP A 7 ASP~? 23.80 CH3 ACT A 134 coo 38.76 28.25 7.87 36.33 26.41 13.58 28.94 23.42 11.82 28.39 29.21 14.30 coo 34.93 19.72 17.37 34.72 18.17 15.98 30.04 10.42 13.88 29.99 8.58 12.87 coo 41.01 23.02 20.83 40.65 24.26 22.55 37.70 12.40 8.53 36.14 12.23 7.15 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 118 LYS^? 22.69 CH3 ACT B 134 C 105 HIS B 14 HIS~? 17.16 CH3 ACT B 134 D 35 ASP B 7 ASP~? 23.98 CH3 ACT B 134 coo 38.76 28.25 7.87 36.33 26.41 13.58 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo 34.93 19.72 17.37 34.72 18.17 15.98 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 41.01 23.02 20.83 40.65 24.26 22.55 37.67 3.93 -3.68 36.11 4.07 -2.28 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 118 LYS^? 23.86 CH3 ACT A 134 B 105 HIS A 14 HIS~? 17.04 CH3 ACT A 134 E 35 ASP A 7 ASP~? 23.80 CH3 ACT A 134 coo 20.51 39.76 8.83 21.23 37.38 14.18 28.94 23.42 11.82 28.39 29.21 14.30 coo 27.18 37.56 20.68 29.07 38.28 20.13 30.04 10.42 13.88 29.99 8.58 12.87 coo 19.97 40.39 22.03 18.53 39.30 23.18 37.70 12.40 8.53 36.14 12.23 7.15 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 118 LYS^? 22.69 CH3 ACT B 134 B 105 HIS B 14 HIS~? 17.16 CH3 ACT B 134 E 35 ASP B 7 ASP~? 23.98 CH3 ACT B 134 coo 20.51 39.76 8.83 21.23 37.38 14.18 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo 27.18 37.56 20.68 29.07 38.28 20.13 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 19.97 40.39 22.03 18.53 39.30 23.18 37.67 3.93 -3.68 36.11 4.07 -2.28 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 42 PHE^? 12.32 OXT ACT A 134 A 210 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 244 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 9.23 46.77 25.11 11.48 48.39 24.76 14.89 21.94 7.67 12.75 23.35 8.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 22.90 30.21 5.13 24.67 29.05 5.02 coo -1.20 42.34 17.67 3.19 45.13 19.06 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 42 PHE^? 12.28 O ACT B 134 A 210 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 244 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 9.23 46.77 25.11 11.48 48.39 24.76 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo 10.51 37.86 19.71 9.07 39.38 20.04 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo -1.20 42.34 17.67 3.19 45.13 19.06 28.80 -7.02 -7.08 28.66 -10.73 -10.74 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 42 PHE^? 12.32 OXT ACT A 134 B 210 ASP A 39 ASP^? 22.84 CH3 ACT A 134 B 244 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 8.76 47.85 34.91 11.08 46.36 35.41 14.89 21.94 7.67 12.75 23.35 8.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 22.90 30.21 5.13 24.67 29.05 5.02 coo -2.38 51.82 41.62 2.07 49.19 40.42 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 42 PHE^? 12.28 O ACT B 134 B 210 ASP B 39 ASP^? 22.90 CH3 ACT B 134 B 244 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 8.76 47.85 34.91 11.08 46.36 35.41 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo 9.06 56.85 40.30 7.71 55.27 39.90 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo -2.38 51.82 41.62 2.07 49.19 40.42 28.80 -7.02 -7.08 28.66 -10.73 -10.74 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 104 TYR^? -4.47 O ACT A 134s A 142 LEU A 24 LEU~? 5.31 CH3 ACT A 134 A 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 6.73 6.71 14.57 8.42 7.72 12.53 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 15.13 11.98 18.72 14.77 12.01 16.62 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 104 TYR^? -4.47 O ACT A 134s A 142 LEU A 100 LEU.? 14.83 O ACT A 134 A 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 6.73 6.71 14.57 8.42 7.72 12.53 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -0.85 10.80 20.55 -0.94 12.90 20.09 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s A 142 LEU B 24 LEU~? 5.21 CH3 ACT B 134 A 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 15.04 4.47 -13.88 14.76 4.50 -11.73 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s A 142 LEU B 100 LEU.? 14.86 OXT ACT B 134 A 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -0.88 5.69 -15.73 -1.00 3.55 -15.38 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.51 13.68 -9.31 9.43 19.36 -11.32 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 104 TYR^? -4.47 O ACT A 134s B 142 LEU A 24 LEU~? 5.31 CH3 ACT A 134 B 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 6.73 6.71 14.57 8.42 7.72 12.53 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 15.13 11.98 18.72 14.77 12.01 16.62 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 104 TYR^? -4.47 O ACT A 134s B 142 LEU A 100 LEU.? 14.83 O ACT A 134 B 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 6.73 6.71 14.57 8.42 7.72 12.53 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -0.85 10.80 20.55 -0.94 12.90 20.09 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s B 142 LEU B 24 LEU~? 5.21 CH3 ACT B 134 B 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 15.04 4.47 -13.88 14.76 4.50 -11.73 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s B 142 LEU B 100 LEU.? 14.86 OXT ACT B 134 B 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -0.88 5.69 -15.73 -1.00 3.55 -15.38 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.51 13.68 -9.31 9.43 19.36 -11.32 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 104 TYR^? -4.47 O ACT A 134s C 142 LEU A 24 LEU~? 5.31 CH3 ACT A 134 C 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 6.73 6.71 14.57 8.42 7.72 12.53 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 15.13 11.98 18.72 14.77 12.01 16.62 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 104 TYR^? -4.47 O ACT A 134s C 142 LEU A 100 LEU.? 14.83 O ACT A 134 C 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 6.73 6.71 14.57 8.42 7.72 12.53 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -0.85 10.80 20.55 -0.94 12.90 20.09 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s C 142 LEU B 24 LEU~? 5.21 CH3 ACT B 134 C 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 15.04 4.47 -13.88 14.76 4.50 -11.73 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s C 142 LEU B 100 LEU.? 14.86 OXT ACT B 134 C 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -0.88 5.69 -15.73 -1.00 3.55 -15.38 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.51 13.68 -9.31 9.43 19.36 -11.32 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 104 TYR^? -4.47 O ACT A 134s D 142 LEU A 24 LEU~? 5.31 CH3 ACT A 134 D 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 6.73 6.71 14.57 8.42 7.72 12.53 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 15.13 11.98 18.72 14.77 12.01 16.62 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 104 TYR^? -4.47 O ACT A 134s D 142 LEU A 100 LEU.? 14.83 O ACT A 134 D 165 LYS A 105 LYS^? 12.80 O ACT A 134 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 6.73 6.71 14.57 8.42 7.72 12.53 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -0.85 10.80 20.55 -0.94 12.90 20.09 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s D 142 LEU B 24 LEU~? 5.21 CH3 ACT B 134 D 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 15.04 4.47 -13.88 14.76 4.50 -11.73 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR B 104 TYR^? -4.53 OXT ACT B 134s D 142 LEU B 100 LEU.? 14.86 OXT ACT B 134 D 165 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -0.88 5.69 -15.73 -1.00 3.55 -15.38 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.51 13.68 -9.31 9.43 19.36 -11.32 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 84 SER^? 20.86 CH3 ACT A 134 A 48 THR A 83 THR^? 17.54 CH3 ACT A 134 A 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 30.40 10.24 3.82 32.46 10.17 5.21 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 28.55 7.09 4.80 27.08 6.14 3.47 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 84 SER^? 20.86 CH3 ACT A 134 A 48 THR B 83 THR^? 17.78 CH3 ACT B 134 A 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 30.40 10.24 3.82 32.46 10.17 5.21 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 28.55 9.24 0.02 27.11 10.23 1.39 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER A 121 SER^? 16.65 CH3 ACT A 134 A 48 THR A 41 THR^? 18.02 CH3 ACT A 134 A 165 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 21.93 21.60 5.62 22.92 20.74 3.60 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 18.34 24.70 5.20 19.06 25.00 3.19 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER B 84 SER^? 21.05 CH3 ACT B 134 A 48 THR A 83 THR^? 17.54 CH3 ACT A 134 A 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 30.37 6.08 1.00 32.42 6.12 -0.34 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 28.55 7.09 4.80 27.08 6.14 3.47 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER B 84 SER^? 21.05 CH3 ACT B 134 A 48 THR B 83 THR^? 17.78 CH3 ACT B 134 A 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 30.37 6.08 1.00 32.42 6.12 -0.34 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 28.55 9.24 0.02 27.11 10.23 1.39 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 47 SER B 121 SER^? 16.88 CH3 ACT B 134 A 48 THR B 41 THR^? 18.20 CH3 ACT B 134 A 165 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 84 SER^? 20.86 CH3 ACT A 134 B 48 THR A 83 THR^? 17.54 CH3 ACT A 134 B 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 30.40 10.24 3.82 32.46 10.17 5.21 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 28.55 7.09 4.80 27.08 6.14 3.47 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER A 84 SER^? 20.86 CH3 ACT A 134 B 48 THR B 83 THR^? 17.78 CH3 ACT B 134 B 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 30.40 10.24 3.82 32.46 10.17 5.21 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 28.55 9.24 0.02 27.11 10.23 1.39 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER A 121 SER^? 16.65 CH3 ACT A 134 B 48 THR A 41 THR^? 18.02 CH3 ACT A 134 B 165 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 21.93 21.60 5.62 22.92 20.74 3.60 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 18.34 24.70 5.20 19.06 25.00 3.19 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER B 84 SER^? 21.05 CH3 ACT B 134 B 48 THR A 83 THR^? 17.54 CH3 ACT A 134 B 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 30.37 6.08 1.00 32.42 6.12 -0.34 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 28.55 7.09 4.80 27.08 6.14 3.47 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER B 84 SER^? 21.05 CH3 ACT B 134 B 48 THR B 83 THR^? 17.78 CH3 ACT B 134 B 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 30.37 6.08 1.00 32.42 6.12 -0.34 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 28.55 9.24 0.02 27.11 10.23 1.39 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 47 SER B 121 SER^? 16.88 CH3 ACT B 134 B 48 THR B 41 THR^? 18.20 CH3 ACT B 134 B 165 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 84 SER^? 20.86 CH3 ACT A 134 C 48 THR A 83 THR^? 17.54 CH3 ACT A 134 C 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 30.40 10.24 3.82 32.46 10.17 5.21 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 28.55 7.09 4.80 27.08 6.14 3.47 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 84 SER^? 20.86 CH3 ACT A 134 C 48 THR B 83 THR^? 17.78 CH3 ACT B 134 C 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 30.40 10.24 3.82 32.46 10.17 5.21 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 28.55 9.24 0.02 27.11 10.23 1.39 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER A 121 SER^? 16.65 CH3 ACT A 134 C 48 THR A 41 THR^? 18.02 CH3 ACT A 134 C 165 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 21.93 21.60 5.62 22.92 20.74 3.60 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 18.34 24.70 5.20 19.06 25.00 3.19 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER B 84 SER^? 21.05 CH3 ACT B 134 C 48 THR A 83 THR^? 17.54 CH3 ACT A 134 C 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 30.37 6.08 1.00 32.42 6.12 -0.34 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 28.55 7.09 4.80 27.08 6.14 3.47 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER B 84 SER^? 21.05 CH3 ACT B 134 C 48 THR B 83 THR^? 17.78 CH3 ACT B 134 C 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 30.37 6.08 1.00 32.42 6.12 -0.34 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 28.55 9.24 0.02 27.11 10.23 1.39 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 47 SER B 121 SER^? 16.88 CH3 ACT B 134 C 48 THR B 41 THR^? 18.20 CH3 ACT B 134 C 165 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 13.39 -8.84 -10.92 12.04 -11.20 -15.77 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 84 SER^? 20.86 CH3 ACT A 134 D 48 THR A 83 THR^? 17.54 CH3 ACT A 134 D 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 30.40 10.24 3.82 32.46 10.17 5.21 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 28.55 7.09 4.80 27.08 6.14 3.47 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER A 84 SER^? 20.86 CH3 ACT A 134 D 48 THR B 83 THR^? 17.78 CH3 ACT B 134 D 165 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 30.40 10.24 3.82 32.46 10.17 5.21 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 28.55 9.24 0.02 27.11 10.23 1.39 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER B 84 SER^? 21.05 CH3 ACT B 134 D 48 THR A 83 THR^? 17.54 CH3 ACT A 134 D 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 30.37 6.08 1.00 32.42 6.12 -0.34 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 28.55 7.09 4.80 27.08 6.14 3.47 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 33.61 2.06 -8.46 36.00 -1.11 -11.84 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 84 SER^? 21.05 CH3 ACT B 134 D 48 THR B 83 THR^? 17.78 CH3 ACT B 134 D 165 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 30.37 6.08 1.00 32.42 6.12 -0.34 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 28.55 9.24 0.02 27.11 10.23 1.39 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 33.61 2.06 -8.46 36.00 -1.11 -11.84 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c07 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 80 ASP^? 13.33 O ACT A 134 A 281 ARG A 81 ARG^? 17.75 O ACT A 134 A 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 54.86 40.00 47.23 55.57 38.60 48.67 21.99 0.20 10.14 20.59 -0.43 11.58 coo 52.08 40.18 50.14 50.83 38.93 47.73 23.88 0.36 5.26 23.01 -2.52 5.93 coo 57.82 31.70 50.73 57.94 34.00 49.17 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP A 80 ASP^? 13.33 O ACT A 134 A 281 ARG A 94 ARG^? 12.39 O ACT A 134 A 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 54.86 40.00 47.23 55.57 38.60 48.67 21.99 0.20 10.14 20.59 -0.43 11.58 coo 52.08 40.18 50.14 50.83 38.93 47.73 16.69 -1.11 11.91 15.79 -2.18 14.67 coo 57.82 31.70 50.73 57.94 34.00 49.17 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 281 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 54.86 40.00 47.23 55.57 38.60 48.67 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 52.08 40.18 50.14 50.83 38.93 47.73 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 57.82 31.70 50.73 57.94 34.00 49.17 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 4 3 # 4 A 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 281 ARG B 94 ARG^? 12.34 OXT ACT B 134 A 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 54.86 40.00 47.23 55.57 38.60 48.67 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 52.08 40.18 50.14 50.83 38.93 47.73 16.67 17.44 -7.09 15.78 18.56 -9.82 coo 57.82 31.70 50.73 57.94 34.00 49.17 16.00 10.76 2.04 17.57 12.50 0.46 1foh_c00 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 80 ASP^? 13.33 O ACT A 134 B 281 ARG A 81 ARG^? 17.75 O ACT A 134 B 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 90.56 80.24 98.04 90.36 81.53 96.34 21.99 0.20 10.14 20.59 -0.43 11.58 coo 86.62 80.67 97.51 87.37 82.00 100.10 23.88 0.36 5.26 23.01 -2.52 5.93 coo 91.83 88.28 92.88 92.60 85.93 94.14 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP A 80 ASP^? 13.33 O ACT A 134 B 281 ARG A 94 ARG^? 12.39 O ACT A 134 B 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 90.56 80.24 98.04 90.36 81.53 96.34 21.99 0.20 10.14 20.59 -0.43 11.58 coo 86.62 80.67 97.51 87.37 82.00 100.10 16.69 -1.11 11.91 15.79 -2.18 14.67 coo 91.83 88.28 92.88 92.60 85.93 94.14 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 B 281 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 90.56 80.24 98.04 90.36 81.53 96.34 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 86.62 80.67 97.51 87.37 82.00 100.10 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 91.83 88.28 92.88 92.60 85.93 94.14 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 B 281 ARG B 94 ARG^? 12.34 OXT ACT B 134 B 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 90.56 80.24 98.04 90.36 81.53 96.34 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 86.62 80.67 97.51 87.37 82.00 100.10 16.67 17.44 -7.09 15.78 18.56 -9.82 coo 91.83 88.28 92.88 92.60 85.93 94.14 16.00 10.76 2.04 17.57 12.50 0.46 1foh_c01 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 80 ASP^? 13.33 O ACT A 134 C 281 ARG A 81 ARG^? 17.75 O ACT A 134 C 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 42.34 76.83 49.10 43.06 78.59 50.01 21.99 0.20 10.14 20.59 -0.43 11.58 coo 46.12 77.15 48.13 44.44 77.61 45.70 23.88 0.36 5.26 23.01 -2.52 5.93 coo 42.69 86.18 51.69 41.59 83.63 51.54 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP A 80 ASP^? 13.33 O ACT A 134 C 281 ARG A 94 ARG^? 12.39 O ACT A 134 C 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 42.34 76.83 49.10 43.06 78.59 50.01 21.99 0.20 10.14 20.59 -0.43 11.58 coo 46.12 77.15 48.13 44.44 77.61 45.70 16.69 -1.11 11.91 15.79 -2.18 14.67 coo 42.69 86.18 51.69 41.59 83.63 51.54 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 C 281 ARG B 81 ARG^? 17.71 OXT ACT B 134 C 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 42.34 76.83 49.10 43.06 78.59 50.01 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 46.12 77.15 48.13 44.44 77.61 45.70 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 42.69 86.18 51.69 41.59 83.63 51.54 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 C 281 ARG B 94 ARG^? 12.34 OXT ACT B 134 C 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 42.34 76.83 49.10 43.06 78.59 50.01 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 46.12 77.15 48.13 44.44 77.61 45.70 16.67 17.44 -7.09 15.78 18.56 -9.82 coo 42.69 86.18 51.69 41.59 83.63 51.54 16.00 10.76 2.04 17.57 12.50 0.46 1foh_c02 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 80 ASP^? 13.33 O ACT A 134 D 281 ARG A 81 ARG^? 17.75 O ACT A 134 D 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 75.05 45.80 106.18 74.73 43.88 105.51 21.99 0.20 10.14 20.59 -0.43 11.58 coo 78.52 44.93 104.78 78.72 44.49 107.76 23.88 0.36 5.26 23.01 -2.52 5.93 coo 72.35 36.51 104.82 72.00 39.20 105.46 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP A 80 ASP^? 13.33 O ACT A 134 D 281 ARG A 94 ARG^? 12.39 O ACT A 134 D 289 TYR B 125 TYR^? 11.31 O ACT A 134 coo 75.05 45.80 106.18 74.73 43.88 105.51 21.99 0.20 10.14 20.59 -0.43 11.58 coo 78.52 44.93 104.78 78.72 44.49 107.76 16.69 -1.11 11.91 15.79 -2.18 14.67 coo 72.35 36.51 104.82 72.00 39.20 105.46 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 D 281 ARG B 81 ARG^? 17.71 OXT ACT B 134 D 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 75.05 45.80 106.18 74.73 43.88 105.51 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 78.52 44.93 104.78 78.72 44.49 107.76 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 72.35 36.51 104.82 72.00 39.20 105.46 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 4 3 # 4 D 54 ASP B 80 ASP^? 13.20 OXT ACT B 134 D 281 ARG B 94 ARG^? 12.34 OXT ACT B 134 D 289 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 75.05 45.80 106.18 74.73 43.88 105.51 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 78.52 44.93 104.78 78.72 44.49 107.76 16.67 17.44 -7.09 15.78 18.56 -9.82 coo 72.35 36.51 104.82 72.00 39.20 105.46 16.00 10.76 2.04 17.57 12.50 0.46 1foh_c03 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c03 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 47 ASP A 95 ASP^? -2.87 O ACT A 134s A 161 TYR B 125 TYR^? 11.31 O ACT A 134 coo 37.12 18.35 73.76 37.09 16.69 72.44 21.29 4.79 5.54 21.77 3.26 4.19 coo 29.81 8.06 73.13 30.21 10.11 72.95 13.92 6.03 15.16 12.65 6.91 13.72 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 47 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 37.12 18.35 73.76 37.09 16.69 72.44 13.89 12.66 7.54 12.94 12.92 9.40 coo 29.81 8.06 73.13 30.21 10.11 72.95 26.00 19.90 3.85 25.60 19.04 1.99 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 47 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 37.12 18.35 73.76 37.09 16.69 72.44 13.89 12.66 7.54 12.94 12.92 9.40 coo 29.81 8.06 73.13 30.21 10.11 72.95 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 47 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 37.12 18.35 73.76 37.09 16.69 72.44 21.22 11.60 -0.72 21.76 13.12 0.60 coo 29.81 8.06 73.13 30.21 10.11 72.95 26.00 19.90 3.85 25.60 19.04 1.99 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 47 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 37.12 18.35 73.76 37.09 16.69 72.44 21.22 11.60 -0.72 21.76 13.12 0.60 coo 29.81 8.06 73.13 30.21 10.11 72.95 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU B 124 GLU^? -3.39 O ACT B 134s A 47 ASP A 129 ASP.? 12.18 O ACT A 134 A 161 TYR B 125 TYR^? 11.31 O ACT A 134 coo 37.12 18.35 73.76 37.09 16.69 72.44 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 29.81 8.06 73.13 30.21 10.11 72.95 4.86 1.75 6.36 4.91 0.13 7.65 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 A 36 GLU B 124 GLU^? -3.39 O ACT B 134s A 47 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 161 TYR B 125 TYR^? 11.31 O ACT A 134 coo 37.12 18.35 73.76 37.09 16.69 72.44 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 29.81 8.06 73.13 30.21 10.11 72.95 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.01 5.62 2.81 17.58 3.86 4.41 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 7 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 47 ASP A 95 ASP^? -2.87 O ACT A 134s B 161 TYR B 125 TYR^? 11.31 O ACT A 134 coo 53.87 35.49 53.22 55.44 35.72 54.61 21.29 4.79 5.54 21.77 3.26 4.19 coo 63.47 43.65 53.95 61.45 43.07 54.06 13.92 6.03 15.16 12.65 6.91 13.72 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 47 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 53.87 35.49 53.22 55.44 35.72 54.61 13.89 12.66 7.54 12.94 12.92 9.40 coo 63.47 43.65 53.95 61.45 43.07 54.06 26.00 19.90 3.85 25.60 19.04 1.99 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 47 ASP B 129 ASP.? 12.08 OXT ACT B 134 B 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 53.87 35.49 53.22 55.44 35.72 54.61 13.89 12.66 7.54 12.94 12.92 9.40 coo 63.47 43.65 53.95 61.45 43.07 54.06 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 47 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 53.87 35.49 53.22 55.44 35.72 54.61 21.22 11.60 -0.72 21.76 13.12 0.60 coo 63.47 43.65 53.95 61.45 43.07 54.06 26.00 19.90 3.85 25.60 19.04 1.99 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 47 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 161 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 53.87 35.49 53.22 55.44 35.72 54.61 21.22 11.60 -0.72 21.76 13.12 0.60 coo 63.47 43.65 53.95 61.45 43.07 54.06 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU B 124 GLU^? -3.39 O ACT B 134s B 47 ASP A 129 ASP.? 12.18 O ACT A 134 B 161 TYR B 125 TYR^? 11.31 O ACT A 134 coo 53.87 35.49 53.22 55.44 35.72 54.61 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 63.47 43.65 53.95 61.45 43.07 54.06 4.86 1.75 6.36 4.91 0.13 7.65 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 B 36 GLU B 124 GLU^? -3.39 O ACT B 134s B 47 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 161 TYR B 125 TYR^? 11.31 O ACT A 134 coo 53.87 35.49 53.22 55.44 35.72 54.61 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 63.47 43.65 53.95 61.45 43.07 54.06 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.01 5.62 2.81 17.58 3.86 4.41 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 7 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 129 ASP.? 12.18 O ACT A 134 A 64 HIS B 50 HIS.? 14.60 O ACT A 134 A 155 ASN B 53 ASN^? 13.51 O ACT B 134 coo 3.12 38.70 24.20 3.24 38.59 26.33 4.86 1.75 6.36 4.91 0.13 7.65 coo 1.90 38.00 29.77 3.91 38.35 29.95 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 9.89 36.55 37.38 9.27 37.99 36.08 12.53 -7.97 -0.98 10.78 -6.78 -0.73 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 64 HIS A 50 HIS.? 14.57 OXT ACT B 134 A 155 ASN A 53 ASN^? 13.62 OXT ACT A 134 coo 3.12 38.70 24.20 3.24 38.59 26.33 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 1.90 38.00 29.77 3.91 38.35 29.95 6.53 19.16 0.69 7.13 18.70 -1.26 coo 9.89 36.55 37.38 9.27 37.99 36.08 12.53 24.41 5.81 10.72 23.33 5.51 1gns_c00 source 1gns SUBTILISIN BPN' : 2 hits 1gns_c00 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 11 LYS~? 24.23 CH3 ACT A 134 210 ARG A 123 ARG^? 15.41 CH3 ACT A 134 225 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 33.70 14.32 13.26 36.02 17.43 17.06 coo 24.74 11.56 73.05 25.29 14.32 71.80 19.67 16.84 1.03 22.28 17.57 2.36 coo 27.81 15.44 77.10 25.66 16.50 75.19 23.90 15.91 -0.43 22.97 18.81 -0.95 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 11 LYS~? 24.23 CH3 ACT A 134 210 ARG B 81 ARG^? 17.71 OXT ACT B 134 225 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 33.70 14.32 13.26 36.02 17.43 17.06 coo 24.74 11.56 73.05 25.29 14.32 71.80 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS A 56 LYS~? 20.00 CH3 ACT A 134 210 ARG B 81 ARG^? 17.71 OXT ACT B 134 225 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.29 28.50 12.14 22.41 28.51 15.17 coo 24.74 11.56 73.05 25.29 14.32 71.80 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS A 56 LYS~? 20.00 CH3 ACT A 134 210 ARG B 107 ARG^? 13.48 OXT ACT B 134 225 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.29 28.50 12.14 22.41 28.51 15.17 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS A 60 LYS~? 19.22 CH3 ACT A 134 210 ARG B 107 ARG^? 13.48 OXT ACT B 134 225 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 13.42 25.37 15.69 13.26 28.28 21.22 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS A 102 LYS^? 18.24 O ACT A 134 210 ARG A 107 ARG^? 13.51 O ACT A 134 225 ARG A 94 ARG^? 12.39 O ACT A 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.63 4.90 19.56 -4.81 6.46 20.35 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS A 105 LYS^? 12.80 O ACT A 134 210 ARG A 81 ARG^? 17.75 O ACT A 134 225 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 8.54 2.73 14.15 9.40 -2.89 16.14 coo 24.74 11.56 73.05 25.29 14.32 71.80 23.88 0.36 5.26 23.01 -2.52 5.93 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS B 11 LYS~? 24.30 CH3 ACT B 134 210 ARG A 81 ARG^? 17.75 O ACT A 134 225 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo 24.74 11.56 73.05 25.29 14.32 71.80 23.88 0.36 5.26 23.01 -2.52 5.93 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS B 11 LYS~? 24.30 CH3 ACT B 134 210 ARG B 123 ARG^? 15.62 CH3 ACT B 134 225 ARG A 81 ARG^? 17.75 O ACT A 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo 24.74 11.56 73.05 25.29 14.32 71.80 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 27.81 15.44 77.10 25.66 16.50 75.19 23.88 0.36 5.26 23.01 -2.52 5.93 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS B 56 LYS~? 20.04 CH3 ACT B 134 210 ARG A 81 ARG^? 17.75 O ACT A 134 225 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 24.74 11.56 73.05 25.29 14.32 71.80 23.88 0.36 5.26 23.01 -2.52 5.93 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS B 56 LYS~? 20.04 CH3 ACT B 134 210 ARG A 107 ARG^? 13.51 O ACT A 134 225 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS B 60 LYS~? 18.28 CH3 ACT B 134 210 ARG A 107 ARG^? 13.51 O ACT A 134 225 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS B 102 LYS^? 18.05 OXT ACT B 134 210 ARG B 107 ARG^? 13.48 OXT ACT B 134 225 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.61 11.65 -14.75 -4.59 9.81 -15.68 coo 24.74 11.56 73.05 25.29 14.32 71.80 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 27.81 15.44 77.10 25.66 16.50 75.19 16.67 17.44 -7.09 15.78 18.56 -9.82 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 14 3 # 14 160 LYS B 105 LYS^? 12.81 OXT ACT B 134 210 ARG B 81 ARG^? 17.71 OXT ACT B 134 225 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 17.51 28.50 73.42 17.24 23.02 75.86 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 24.74 11.56 73.05 25.29 14.32 71.80 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 27.81 15.44 77.10 25.66 16.50 75.19 19.67 16.84 1.03 22.28 17.57 2.36 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 14 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 19 PHE~? 16.57 CH3 ACT A 134 A 298 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 329 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 24.41 18.01 20.14 26.66 18.57 21.69 coo 2.59 0.29 25.55 4.65 0.18 25.07 24.17 25.65 19.58 23.03 26.79 20.97 coo 12.42 6.10 23.27 9.95 1.57 20.16 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 112 PHE^? 11.25 CH3 ACT A 134 A 298 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 329 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 23.79 16.00 9.29 22.27 15.23 11.49 coo 2.59 0.29 25.55 4.65 0.18 25.07 26.00 19.90 3.85 25.60 19.04 1.99 coo 12.42 6.10 23.27 9.95 1.57 20.16 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE B 19 PHE~? 16.60 CH3 ACT B 134 A 298 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 329 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 2.59 0.29 25.55 4.65 0.18 25.07 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 12.42 6.10 23.27 9.95 1.57 20.16 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 112 PHE^? 11.41 CH3 ACT B 134 A 298 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 329 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 23.76 0.41 -4.47 22.23 1.06 -6.71 coo 2.59 0.29 25.55 4.65 0.18 25.07 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 12.42 6.10 23.27 9.95 1.57 20.16 33.61 2.06 -8.46 36.00 -1.11 -11.84 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 19 PHE~? 16.57 CH3 ACT A 134 B 298 ASP A 34 ASP~? 20.39 CH3 ACT A 134 B 329 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 24.41 18.01 20.14 26.66 18.57 21.69 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 24.17 25.65 19.58 23.03 26.79 20.97 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 112 PHE^? 11.25 CH3 ACT A 134 B 298 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 329 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 23.79 16.00 9.29 22.27 15.23 11.49 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 26.00 19.90 3.85 25.60 19.04 1.99 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE B 19 PHE~? 16.60 CH3 ACT B 134 B 298 ASP B 34 ASP~? 20.32 CH3 ACT B 134 B 329 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 112 PHE^? 11.41 CH3 ACT B 134 B 298 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 329 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 23.76 0.41 -4.47 22.23 1.06 -6.71 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 33.61 2.06 -8.46 36.00 -1.11 -11.84 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 19 PHE~? 16.57 CH3 ACT A 134 C 298 ASP A 34 ASP~? 20.39 CH3 ACT A 134 C 329 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 17.41 60.57 64.39 18.40 58.12 65.34 24.41 18.01 20.14 26.66 18.57 21.69 coo 24.10 66.43 63.33 24.18 64.30 63.40 24.17 25.65 19.58 23.03 26.79 20.97 coo 27.64 56.61 58.17 22.18 57.92 60.36 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 112 PHE^? 11.25 CH3 ACT A 134 C 298 ASP A 113 ASP^? 18.42 CH3 ACT A 134 C 329 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 17.41 60.57 64.39 18.40 58.12 65.34 23.79 16.00 9.29 22.27 15.23 11.49 coo 24.10 66.43 63.33 24.18 64.30 63.40 26.00 19.90 3.85 25.60 19.04 1.99 coo 27.64 56.61 58.17 22.18 57.92 60.36 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE B 19 PHE~? 16.60 CH3 ACT B 134 C 298 ASP B 34 ASP~? 20.32 CH3 ACT B 134 C 329 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 17.41 60.57 64.39 18.40 58.12 65.34 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 24.10 66.43 63.33 24.18 64.30 63.40 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 27.64 56.61 58.17 22.18 57.92 60.36 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 112 PHE^? 11.41 CH3 ACT B 134 C 298 ASP B 113 ASP^? 18.51 CH3 ACT B 134 C 329 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 17.41 60.57 64.39 18.40 58.12 65.34 23.76 0.41 -4.47 22.23 1.06 -6.71 coo 24.10 66.43 63.33 24.18 64.30 63.40 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 27.64 56.61 58.17 22.18 57.92 60.36 33.61 2.06 -8.46 36.00 -1.11 -11.84 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 19 PHE~? 16.57 CH3 ACT A 134 D 298 ASP A 34 ASP~? 20.39 CH3 ACT A 134 D 329 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 35.44 53.35 83.81 35.65 54.53 81.28 24.41 18.01 20.14 26.66 18.57 21.69 coo 29.72 46.46 83.60 30.79 47.36 81.99 24.17 25.65 19.58 23.03 26.79 20.97 coo 36.89 44.91 74.55 37.33 48.94 79.01 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 112 PHE^? 11.25 CH3 ACT A 134 D 298 ASP A 113 ASP^? 18.42 CH3 ACT A 134 D 329 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 35.44 53.35 83.81 35.65 54.53 81.28 23.79 16.00 9.29 22.27 15.23 11.49 coo 29.72 46.46 83.60 30.79 47.36 81.99 26.00 19.90 3.85 25.60 19.04 1.99 coo 36.89 44.91 74.55 37.33 48.94 79.01 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE B 19 PHE~? 16.60 CH3 ACT B 134 D 298 ASP B 34 ASP~? 20.32 CH3 ACT B 134 D 329 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 35.44 53.35 83.81 35.65 54.53 81.28 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 29.72 46.46 83.60 30.79 47.36 81.99 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 36.89 44.91 74.55 37.33 48.94 79.01 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 112 PHE^? 11.41 CH3 ACT B 134 D 298 ASP B 113 ASP^? 18.51 CH3 ACT B 134 D 329 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 35.44 53.35 83.81 35.65 54.53 81.28 23.76 0.41 -4.47 22.23 1.06 -6.71 coo 29.72 46.46 83.60 30.79 47.36 81.99 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 36.89 44.91 74.55 37.33 48.94 79.01 33.61 2.06 -8.46 36.00 -1.11 -11.84 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c03 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 369 ARG A 107 ARG^? 13.51 O ACT A 134 A 372 TYR B 125 TYR^? 11.31 O ACT A 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 21.29 4.79 5.54 21.77 3.26 4.19 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 16.01 4.58 27.39 13.82 5.38 28.94 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 2 3 # 2 A 267 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 369 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 372 TYR A 122 TYR^? 8.33 CH3 ACT A 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 13.89 12.66 7.54 12.94 12.92 9.40 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 19.67 16.84 1.03 22.28 17.57 2.36 coo 16.01 4.58 27.39 13.82 5.38 28.94 18.19 17.99 8.45 16.46 16.26 9.80 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 3 3 # 3 A 267 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 369 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 372 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 13.89 12.66 7.54 12.94 12.92 9.40 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 19.67 16.84 1.03 22.28 17.57 2.36 coo 16.01 4.58 27.39 13.82 5.38 28.94 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 4 3 # 4 A 267 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 369 ARG B 107 ARG^? 13.48 OXT ACT B 134 A 372 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 13.89 12.66 7.54 12.94 12.92 9.40 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 16.01 4.58 27.39 13.82 5.38 28.94 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 5 3 # 5 A 267 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 369 ARG B 107 ARG^? 13.48 OXT ACT B 134 A 372 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 21.22 11.60 -0.72 21.76 13.12 0.60 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 16.01 4.58 27.39 13.82 5.38 28.94 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 6 3 # 6 A 267 GLU B 124 GLU^? -3.39 O ACT B 134s A 369 ARG A 107 ARG^? 13.51 O ACT A 134 A 372 TYR B 125 TYR^? 11.31 O ACT A 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 16.01 4.58 27.39 13.82 5.38 28.94 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 7 3 # 7 A 267 GLU B 124 GLU^? -3.39 O ACT B 134s A 369 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 372 TYR B 122 TYR^? 8.37 CH3 ACT B 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 16.01 4.58 27.39 13.82 5.38 28.94 18.14 -1.53 -3.61 16.39 0.20 -4.99 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 8 3 # 8 A 267 GLU B 124 GLU^? -3.39 O ACT B 134s A 369 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 372 TYR B 125 TYR^? 11.31 O ACT A 134 coo 16.47 7.99 31.03 17.36 6.90 32.63 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 16.01 4.58 27.39 13.82 5.38 28.94 16.01 5.62 2.81 17.58 3.86 4.41 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 8 hits 1i1e_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 14 HIS~? 17.04 CH3 ACT A 134 A 200 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 226 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 23.24 46.58 4.39 24.43 46.59 2.66 30.04 10.42 13.88 29.99 8.58 12.87 coo 24.51 43.28 11.18 25.17 44.50 9.58 37.70 12.40 8.53 36.14 12.23 7.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS B 14 HIS~? 17.16 CH3 ACT B 134 A 200 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 226 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 23.24 46.58 4.39 24.43 46.59 2.66 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 28.80 -7.02 -7.08 28.66 -10.73 -10.74 1i29_c01 source 1i29 CSDB : 2 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 12 VAL~? 19.75 CH3 ACT A 134 A 200 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 226 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 31.32 17.27 13.04 31.49 19.34 12.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.17 25.65 19.58 23.03 26.79 20.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 89 VAL^? 16.19 CH3 ACT A 134 A 200 ASP A 80 ASP^? 13.33 O ACT A 134 A 226 LYS A 105 LYS^? 12.80 O ACT A 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 27.38 12.47 5.89 28.64 12.25 7.64 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.99 0.20 10.14 20.59 -0.43 11.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 90 VAL^? 13.41 CH3 ACT A 134 A 200 ASP A 80 ASP^? 13.33 O ACT A 134 A 226 LYS A 105 LYS^? 12.80 O ACT A 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 24.36 10.18 5.78 23.20 9.70 3.91 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.99 0.20 10.14 20.59 -0.43 11.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 90 VAL^? 13.41 CH3 ACT A 134 A 200 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 226 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 24.36 10.18 5.78 23.20 9.70 3.91 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 110 VAL^? 7.57 CH3 ACT A 134 A 200 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 226 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.31 11.75 7.52 18.94 12.80 9.43 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 12 VAL~? 19.90 CH3 ACT B 134 A 200 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 226 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 31.27 -0.94 -8.24 31.47 -3.00 -7.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 89 VAL^? 16.40 CH3 ACT B 134 A 200 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 226 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 27.34 3.88 -1.00 28.63 4.08 -2.77 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 90 VAL^? 13.62 CH3 ACT B 134 A 200 ASP A 80 ASP^? 13.33 O ACT A 134 A 226 LYS A 105 LYS^? 12.80 O ACT A 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 24.36 6.22 -0.91 23.18 6.63 0.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.99 0.20 10.14 20.59 -0.43 11.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 90 VAL^? 13.62 CH3 ACT B 134 A 200 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 226 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 24.36 6.22 -0.91 23.18 6.63 0.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 110 VAL^? 7.71 CH3 ACT B 134 A 200 ASP A 80 ASP^? 13.33 O ACT A 134 A 226 LYS A 105 LYS^? 12.80 O ACT A 134 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.24 4.57 -2.66 18.70 3.49 -4.48 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.99 0.20 10.14 20.59 -0.43 11.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.54 2.73 14.15 9.40 -2.89 16.14 1i29_c03 source 1i29 CSDB : 10 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 A 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.29 28.50 12.14 22.41 28.51 15.17 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.42 25.37 15.69 13.26 28.28 21.22 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 A 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 13.91 3.81 -2.65 12.88 3.52 -4.44 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 2 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 B 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 B 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 17.29 28.50 12.14 22.41 28.51 15.17 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.42 25.37 15.69 13.26 28.28 21.22 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 60 LYS~? 19.22 CH3 ACT A 134 B 74 LYS A 56 LYS~? 20.00 CH3 ACT A 134 B 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.42 25.37 15.69 13.26 28.28 21.22 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 17.29 28.50 12.14 22.41 28.51 15.17 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 B 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 B 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 60 LYS~? 18.28 CH3 ACT B 134 B 74 LYS B 56 LYS~? 20.04 CH3 ACT B 134 B 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 13.91 3.81 -2.65 12.88 3.52 -4.44 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 121 SER^? 16.65 CH3 ACT A 134 A 173 ARG A 58 ARG~? 15.97 OXT ACT A 134 A 211 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 22.72 76.24 0.23 24.60 76.86 -1.25 21.93 21.60 5.62 22.92 20.74 3.60 coo 18.77 77.82 11.69 20.55 80.22 10.73 9.78 27.17 8.97 7.03 26.14 8.06 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 111 SER^? 14.22 CH3 ACT B 134 A 173 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 211 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 22.72 76.24 0.23 24.60 76.86 -1.25 21.84 2.81 -0.55 22.81 2.45 1.66 coo 18.77 77.82 11.69 20.55 80.22 10.73 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER B 121 SER^? 16.88 CH3 ACT B 134 A 173 ARG B 58 ARG~? 15.94 O ACT B 134 A 211 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 22.72 76.24 0.23 24.60 76.86 -1.25 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo 18.77 77.82 11.69 20.55 80.22 10.73 9.78 -10.54 -4.22 7.03 -9.65 -3.15 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 25.97 -3.50 0.94 25.56 -2.60 2.79 1ig8_c00 source 1ig8 HEXOKINASE PII : 3 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 7 ASP~? 23.80 CH3 ACT A 134 158 THR A 87 THR.? 22.88 CH3 ACT A 134 317 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo -2.63 8.40 35.07 -3.66 9.81 36.17 37.70 12.40 8.53 36.14 12.23 7.15 coo -5.30 12.75 41.86 -4.34 13.05 39.99 31.21 17.48 2.82 31.09 18.74 1.05 coo -12.63 17.64 33.66 -10.65 17.90 34.40 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 117 ASP.? 24.68 CH3 ACT A 134 158 THR A 37 THR^? 20.64 CH3 ACT A 134 317 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo -2.63 8.40 35.07 -3.66 9.81 36.17 33.24 23.97 14.06 32.62 25.96 14.31 coo -5.30 12.75 41.86 -4.34 13.05 39.99 24.88 27.66 10.30 25.68 26.74 8.52 coo -12.63 17.64 33.66 -10.65 17.90 34.40 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP B 7 ASP~? 23.98 CH3 ACT B 134 158 THR B 87 THR.? 23.05 CH3 ACT B 134 317 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo -2.63 8.40 35.07 -3.66 9.81 36.17 37.67 3.93 -3.68 36.11 4.07 -2.28 coo -5.30 12.75 41.86 -4.34 13.05 39.99 31.16 -1.20 2.01 31.03 -2.27 3.89 coo -12.63 17.64 33.66 -10.65 17.90 34.40 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 117 ASP.? 24.72 CH3 ACT B 134 158 THR B 37 THR^? 20.68 CH3 ACT B 134 317 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo -2.63 8.40 35.07 -3.66 9.81 36.17 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo -5.30 12.75 41.86 -4.34 13.05 39.99 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo -12.63 17.64 33.66 -10.65 17.90 34.40 25.97 -3.50 0.94 25.56 -2.60 2.79 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 4 hits 1inp_c02 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 22 GLN~? 15.94 CH3 ACT A 134 A 79 PHE A 19 PHE~? 16.57 CH3 ACT A 134 A 80 THR A 21 THR~? 10.25 CH3 ACT A 134 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 20.14 15.38 24.13 21.73 16.51 24.99 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 24.41 18.01 20.14 26.66 18.57 21.69 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 19.72 11.74 19.10 20.90 9.91 19.33 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN B 22 GLN~? 15.85 CH3 ACT B 134 A 79 PHE B 19 PHE~? 16.60 CH3 ACT B 134 A 80 THR B 21 THR~? 10.18 CH3 ACT B 134 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 19.59 4.69 -14.25 20.78 6.50 -14.40 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 2 hits 1j7g_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 38 GLU^? 23.44 CH3 ACT A 134 A 56 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 258 ARG A 115 ARG^? 23.19 CH3 ACT A 134 coo 42.33 1.56 26.99 42.38 2.91 28.66 24.16 32.64 11.25 23.00 32.22 12.98 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.29 28.50 12.14 22.41 28.51 15.17 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 29.95 27.15 5.66 27.05 27.70 4.87 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 38 GLU^? 23.46 CH3 ACT B 134 A 56 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 258 ARG B 115 ARG^? 23.47 CH3 ACT B 134 coo 42.33 1.56 26.99 42.38 2.91 28.66 24.12 -16.18 -6.62 22.89 -15.85 -8.32 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 29.96 -10.90 -1.02 27.10 -11.56 -0.24 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 38 GLU^? 23.44 CH3 ACT A 134 B 56 LYS A 56 LYS~? 20.00 CH3 ACT A 134 B 258 ARG A 115 ARG^? 23.19 CH3 ACT A 134 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 24.16 32.64 11.25 23.00 32.22 12.98 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.29 28.50 12.14 22.41 28.51 15.17 coo 2.64 1.83 34.81 1.56 1.13 32.02 29.95 27.15 5.66 27.05 27.70 4.87 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 38 GLU^? 23.46 CH3 ACT B 134 B 56 LYS B 56 LYS~? 20.04 CH3 ACT B 134 B 258 ARG B 115 ARG^? 23.47 CH3 ACT B 134 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 24.12 -16.18 -6.62 22.89 -15.85 -8.32 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 2.64 1.83 34.81 1.56 1.13 32.02 29.96 -10.90 -1.02 27.10 -11.56 -0.24 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 38 GLU^? 23.44 CH3 ACT A 134 C 56 LYS A 56 LYS~? 20.00 CH3 ACT A 134 C 258 ARG A 115 ARG^? 23.19 CH3 ACT A 134 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 24.16 32.64 11.25 23.00 32.22 12.98 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.29 28.50 12.14 22.41 28.51 15.17 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 29.95 27.15 5.66 27.05 27.70 4.87 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 38 GLU^? 23.46 CH3 ACT B 134 C 56 LYS B 56 LYS~? 20.04 CH3 ACT B 134 C 258 ARG B 115 ARG^? 23.47 CH3 ACT B 134 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 24.12 -16.18 -6.62 22.89 -15.85 -8.32 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 29.96 -10.90 -1.02 27.10 -11.56 -0.24 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 38 GLU^? 23.44 CH3 ACT A 134 D 56 LYS A 56 LYS~? 20.00 CH3 ACT A 134 D 258 ARG A 115 ARG^? 23.19 CH3 ACT A 134 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 24.16 32.64 11.25 23.00 32.22 12.98 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.29 28.50 12.14 22.41 28.51 15.17 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 29.95 27.15 5.66 27.05 27.70 4.87 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 38 GLU^? 23.46 CH3 ACT B 134 D 56 LYS B 56 LYS~? 20.04 CH3 ACT B 134 D 258 ARG B 115 ARG^? 23.47 CH3 ACT B 134 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 24.12 -16.18 -6.62 22.89 -15.85 -8.32 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 29.96 -10.90 -1.02 27.10 -11.56 -0.24 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 A 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 24.97 5.82 58.78 26.79 1.97 55.46 17.29 28.50 12.14 22.41 28.51 15.17 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.42 25.37 15.69 13.26 28.28 21.22 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 A 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo 24.97 5.82 58.78 26.79 1.97 55.46 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 13.91 3.81 -2.65 12.88 3.52 -4.44 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 B 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 B 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 4.84 5.09 23.75 3.30 1.39 27.48 17.29 28.50 12.14 22.41 28.51 15.17 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.42 25.37 15.69 13.26 28.28 21.22 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 B 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 B 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo 4.84 5.09 23.75 3.30 1.39 27.48 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 13.91 3.81 -2.65 12.88 3.52 -4.44 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 C 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 C 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 17.59 37.25 25.80 19.64 34.15 21.60 17.29 28.50 12.14 22.41 28.51 15.17 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.42 25.37 15.69 13.26 28.28 21.22 coo 12.06 27.10 15.56 13.23 27.02 13.80 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 C 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 C 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo 17.59 37.25 25.80 19.64 34.15 21.60 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 12.06 27.10 15.56 13.23 27.02 13.80 13.91 3.81 -2.65 12.88 3.52 -4.44 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 D 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 D 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.29 28.50 12.14 22.41 28.51 15.17 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.42 25.37 15.69 13.26 28.28 21.22 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 D 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 D 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 13.91 3.81 -2.65 12.88 3.52 -4.44 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 39 ASP^? 22.84 CH3 ACT A 134 262 LYS A 56 LYS~? 20.00 CH3 ACT A 134 336 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 61.88 50.78 12.96 63.84 50.60 13.71 22.90 30.21 5.13 24.67 29.05 5.02 coo 63.59 44.40 18.32 63.20 49.74 17.95 17.29 28.50 12.14 22.41 28.51 15.17 coo 72.60 57.42 15.86 71.61 56.68 18.70 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 39 ASP^? 22.90 CH3 ACT B 134 262 LYS B 56 LYS~? 20.04 CH3 ACT B 134 336 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 61.88 50.78 12.96 63.84 50.60 13.71 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 72.60 57.42 15.86 71.61 56.68 18.70 19.60 -0.44 3.82 22.23 -1.26 2.52 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 2 hits 1lam_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 105 LYS^? 12.80 O ACT A 134 A 202 SER A 77 SER^? 10.05 O ACT A 134 A 226 SER A 78 SER^? 12.19 O ACT A 134 coo 1.62 6.10 69.30 3.81 1.25 65.91 8.54 2.73 14.15 9.40 -2.89 16.14 coo 4.43 1.89 61.79 4.31 0.09 63.40 17.06 1.63 18.02 14.62 1.36 17.91 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 202 SER B 77 SER^? 10.03 OXT ACT B 134 A 226 SER B 78 SER^? 12.20 OXT ACT B 134 coo 1.62 6.10 69.30 3.81 1.25 65.91 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 4.43 1.89 61.79 4.31 0.09 63.40 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 20.02 15.26 -10.83 19.07 16.62 -8.98 1m21_c00 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 105 LYS^? 12.80 O ACT A 134 B 202 SER A 77 SER^? 10.05 O ACT A 134 B 226 SER A 78 SER^? 12.19 O ACT A 134 coo 35.67 -0.01 18.11 33.47 4.84 14.73 8.54 2.73 14.15 9.40 -2.89 16.14 coo 32.81 4.27 10.70 32.87 6.07 12.31 17.06 1.63 18.02 14.62 1.36 17.91 coo 28.77 6.36 12.44 30.83 7.25 11.75 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS B 105 LYS^? 12.81 OXT ACT B 134 B 202 SER B 77 SER^? 10.03 OXT ACT B 134 B 226 SER B 78 SER^? 12.20 OXT ACT B 134 coo 35.67 -0.01 18.11 33.47 4.84 14.73 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 32.81 4.27 10.70 32.87 6.07 12.31 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 28.77 6.36 12.44 30.83 7.25 11.75 20.02 15.26 -10.83 19.07 16.62 -8.98 1m21_c01 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 80 ASP^? 13.33 O ACT A 134 A 265 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 369 ASP A 95 ASP^? -2.87 O ACT A 134s coo 11.74 38.14 80.19 10.63 36.40 80.65 21.99 0.20 10.14 20.59 -0.43 11.58 coo 17.36 23.57 72.04 18.68 21.92 71.98 21.22 11.60 -0.72 21.76 13.12 0.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 80 ASP^? 13.33 O ACT A 134 A 265 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 369 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 11.74 38.14 80.19 10.63 36.40 80.65 21.99 0.20 10.14 20.59 -0.43 11.58 coo 17.36 23.57 72.04 18.68 21.92 71.98 21.22 11.60 -0.72 21.76 13.12 0.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 265 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 369 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 11.74 38.14 80.19 10.63 36.40 80.65 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 21.29 4.79 5.54 21.77 3.26 4.19 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 265 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 369 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 11.74 38.14 80.19 10.63 36.40 80.65 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 21.29 4.79 5.54 21.77 3.26 4.19 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 265 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 369 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 11.74 38.14 80.19 10.63 36.40 80.65 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 13.89 12.66 7.54 12.94 12.92 9.40 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.83 10.37 -10.37 12.59 9.49 -8.86 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 5 hits 1m53_c05 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 168 ASN A 8 ASN~? 24.32 CH3 ACT A 134 A 241 HIS A 14 HIS~? 17.04 CH3 ACT A 134 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 33.24 23.97 14.06 32.62 25.96 14.31 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 36.73 18.38 9.71 35.57 19.92 10.59 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 30.04 10.42 13.88 29.99 8.58 12.87 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP B 117 ASP.? 24.72 CH3 ACT B 134 A 168 ASN B 8 ASN~? 24.46 CH3 ACT B 134 A 241 HIS B 14 HIS~? 17.16 CH3 ACT B 134 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 36.75 -2.07 -4.95 35.51 -3.62 -5.82 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 30.01 5.88 -9.10 29.93 7.73 -8.13 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 117 ASP.? 24.68 CH3 ACT A 134 B 168 ASN A 8 ASN~? 24.32 CH3 ACT A 134 B 241 HIS A 14 HIS~? 17.04 CH3 ACT A 134 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 33.24 23.97 14.06 32.62 25.96 14.31 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 36.73 18.38 9.71 35.57 19.92 10.59 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 30.04 10.42 13.88 29.99 8.58 12.87 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP B 117 ASP.? 24.72 CH3 ACT B 134 B 168 ASN B 8 ASN~? 24.46 CH3 ACT B 134 B 241 HIS B 14 HIS~? 17.16 CH3 ACT B 134 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 36.75 -2.07 -4.95 35.51 -3.62 -5.82 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 30.01 5.88 -9.10 29.93 7.73 -8.13 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 81 ARG^? 17.75 O ACT A 134 229 SER B 111 SER^? 14.22 CH3 ACT B 134 325 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo 2.54 15.84 18.57 3.24 17.85 16.30 23.88 0.36 5.26 23.01 -2.52 5.93 coo 10.17 13.48 15.92 9.61 15.76 15.27 21.84 2.81 -0.55 22.81 2.45 1.66 coo 5.42 13.04 19.75 5.74 13.81 17.79 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 81 ARG^? 17.71 OXT ACT B 134 229 SER A 111 SER^? 14.00 CH3 ACT A 134 325 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 2.54 15.84 18.57 3.24 17.85 16.30 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 10.17 13.48 15.92 9.61 15.76 15.27 21.88 13.56 5.40 22.76 13.90 3.16 coo 5.42 13.04 19.75 5.74 13.81 17.79 21.22 11.60 -0.72 21.76 13.12 0.60 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 2 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 56 LYS~? 20.00 CH3 ACT A 134 166 LYS A 60 LYS~? 19.22 CH3 ACT A 134 324 SER A 84 SER^? 20.86 CH3 ACT A 134 coo 25.93 8.11 25.51 26.40 7.80 19.66 17.29 28.50 12.14 22.41 28.51 15.17 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.42 25.37 15.69 13.26 28.28 21.22 coo 46.32 14.55 19.93 45.95 12.72 21.27 30.40 10.24 3.82 32.46 10.17 5.21 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 56 LYS~? 20.00 CH3 ACT A 134 166 LYS A 60 LYS~? 19.22 CH3 ACT A 134 324 SER B 132 SER.? 12.23 OXT ACT B 134 coo 25.93 8.11 25.51 26.40 7.80 19.66 17.29 28.50 12.14 22.41 28.51 15.17 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.42 25.37 15.69 13.26 28.28 21.22 coo 46.32 14.55 19.93 45.95 12.72 21.27 7.68 17.54 -6.39 7.22 18.14 -4.05 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS B 56 LYS~? 20.04 CH3 ACT B 134 166 LYS B 60 LYS~? 18.28 CH3 ACT B 134 324 SER A 132 SER.? 12.20 O ACT A 134 coo 25.93 8.11 25.51 26.40 7.80 19.66 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 46.32 14.55 19.93 45.95 12.72 21.27 7.72 -1.19 11.22 7.31 -1.68 8.88 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS B 56 LYS~? 20.04 CH3 ACT B 134 166 LYS B 60 LYS~? 18.28 CH3 ACT B 134 324 SER B 84 SER^? 21.05 CH3 ACT B 134 coo 25.93 8.11 25.51 26.40 7.80 19.66 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 46.32 14.55 19.93 45.95 12.72 21.27 30.37 6.08 1.00 32.42 6.12 -0.34 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 4 hits 1mdr_c01 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 105 LYS^? 12.80 O ACT A 134 A 217 SER A 77 SER^? 10.05 O ACT A 134 A 241 SER A 78 SER^? 12.19 O ACT A 134 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 8.54 2.73 14.15 9.40 -2.89 16.14 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 17.06 1.63 18.02 14.62 1.36 17.91 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 217 SER B 77 SER^? 10.03 OXT ACT B 134 A 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 105 LYS^? 12.80 O ACT A 134 B 217 SER A 77 SER^? 10.05 O ACT A 134 B 241 SER A 78 SER^? 12.19 O ACT A 134 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 8.54 2.73 14.15 9.40 -2.89 16.14 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 17.06 1.63 18.02 14.62 1.36 17.91 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 B 217 SER B 77 SER^? 10.03 OXT ACT B 134 B 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 17.02 14.81 -13.13 14.60 15.11 -12.99 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 105 LYS^? 12.80 O ACT A 134 C 217 SER A 77 SER^? 10.05 O ACT A 134 C 241 SER A 78 SER^? 12.19 O ACT A 134 coo -12.07 2.83 63.52 -8.95 7.56 61.01 8.54 2.73 14.15 9.40 -2.89 16.14 coo -11.64 10.12 58.62 -9.34 9.31 58.79 17.06 1.63 18.02 14.62 1.36 17.91 coo -9.31 12.91 61.58 -8.56 11.90 59.50 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 C 217 SER B 77 SER^? 10.03 OXT ACT B 134 C 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo -12.07 2.83 63.52 -8.95 7.56 61.01 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -11.64 10.12 58.62 -9.34 9.31 58.79 17.02 14.81 -13.13 14.60 15.11 -12.99 coo -9.31 12.91 61.58 -8.56 11.90 59.50 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 105 LYS^? 12.80 O ACT A 134 D 217 SER A 77 SER^? 10.05 O ACT A 134 D 241 SER A 78 SER^? 12.19 O ACT A 134 coo 32.93 17.78 71.88 30.89 13.50 67.83 8.54 2.73 14.15 9.40 -2.89 16.14 coo 34.38 11.17 66.10 32.18 12.14 65.65 17.06 1.63 18.02 14.62 1.36 17.91 coo 31.34 7.96 67.74 31.44 9.08 65.62 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 D 217 SER B 77 SER^? 10.03 OXT ACT B 134 D 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 32.93 17.78 71.88 30.89 13.50 67.83 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 34.38 11.17 66.10 32.18 12.14 65.65 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 31.34 7.96 67.74 31.44 9.08 65.62 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 105 LYS^? 12.80 O ACT A 134 E 217 SER A 77 SER^? 10.05 O ACT A 134 E 241 SER A 78 SER^? 12.19 O ACT A 134 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 8.54 2.73 14.15 9.40 -2.89 16.14 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 17.06 1.63 18.02 14.62 1.36 17.91 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 E 217 SER B 77 SER^? 10.03 OXT ACT B 134 E 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 105 LYS^? 12.80 O ACT A 134 F 217 SER A 77 SER^? 10.05 O ACT A 134 F 241 SER A 78 SER^? 12.19 O ACT A 134 coo 85.78 13.19 64.96 85.47 13.47 58.63 8.54 2.73 14.15 9.40 -2.89 16.14 coo 87.43 17.13 57.15 85.84 15.39 56.76 17.06 1.63 18.02 14.62 1.36 17.91 coo 89.69 13.60 54.86 87.60 14.67 54.46 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 F 217 SER B 77 SER^? 10.03 OXT ACT B 134 F 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 85.78 13.19 64.96 85.47 13.47 58.63 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 87.43 17.13 57.15 85.84 15.39 56.76 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 89.69 13.60 54.86 87.60 14.67 54.46 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 105 LYS^? 12.80 O ACT A 134 G 217 SER A 77 SER^? 10.05 O ACT A 134 G 241 SER A 78 SER^? 12.19 O ACT A 134 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 8.54 2.73 14.15 9.40 -2.89 16.14 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 17.06 1.63 18.02 14.62 1.36 17.91 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 G 217 SER B 77 SER^? 10.03 OXT ACT B 134 G 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 105 LYS^? 12.80 O ACT A 134 H 217 SER A 77 SER^? 10.05 O ACT A 134 H 241 SER A 78 SER^? 12.19 O ACT A 134 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 8.54 2.73 14.15 9.40 -2.89 16.14 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 17.06 1.63 18.02 14.62 1.36 17.91 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 H 217 SER B 77 SER^? 10.03 OXT ACT B 134 H 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 105 LYS^? 12.80 O ACT A 134 I 217 SER A 77 SER^? 10.05 O ACT A 134 I 241 SER A 78 SER^? 12.19 O ACT A 134 coo -5.05 91.11 27.04 -1.24 87.39 30.21 8.54 2.73 14.15 9.40 -2.89 16.14 coo 2.83 88.63 29.54 1.30 86.82 30.03 17.06 1.63 18.02 14.62 1.36 17.91 coo 2.37 88.32 34.25 2.82 86.58 32.61 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 I 217 SER B 77 SER^? 10.03 OXT ACT B 134 I 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo -5.05 91.11 27.04 -1.24 87.39 30.21 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 2.83 88.63 29.54 1.30 86.82 30.03 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 2.37 88.32 34.25 2.82 86.58 32.61 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 105 LYS^? 12.80 O ACT A 134 J 217 SER A 77 SER^? 10.05 O ACT A 134 J 241 SER A 78 SER^? 12.19 O ACT A 134 coo -16.11 59.78 61.53 -15.92 58.68 55.43 8.54 2.73 14.15 9.40 -2.89 16.14 coo -17.65 54.92 54.17 -15.81 56.46 53.79 17.06 1.63 18.02 14.62 1.36 17.91 coo -19.92 58.10 51.57 -17.75 57.08 51.34 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 J 217 SER B 77 SER^? 10.03 OXT ACT B 134 J 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo -16.11 59.78 61.53 -15.92 58.68 55.43 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -17.65 54.92 54.17 -15.81 56.46 53.79 17.02 14.81 -13.13 14.60 15.11 -12.99 coo -19.92 58.10 51.57 -17.75 57.08 51.34 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 105 LYS^? 12.80 O ACT A 134 K 217 SER A 77 SER^? 10.05 O ACT A 134 K 241 SER A 78 SER^? 12.19 O ACT A 134 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 8.54 2.73 14.15 9.40 -2.89 16.14 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 17.06 1.63 18.02 14.62 1.36 17.91 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 K 217 SER B 77 SER^? 10.03 OXT ACT B 134 K 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 17.02 14.81 -13.13 14.60 15.11 -12.99 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 105 LYS^? 12.80 O ACT A 134 L 217 SER A 77 SER^? 10.05 O ACT A 134 L 241 SER A 78 SER^? 12.19 O ACT A 134 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 8.54 2.73 14.15 9.40 -2.89 16.14 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 17.06 1.63 18.02 14.62 1.36 17.91 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 L 217 SER B 77 SER^? 10.03 OXT ACT B 134 L 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 105 LYS^? 12.80 O ACT A 134 M 217 SER A 77 SER^? 10.05 O ACT A 134 M 241 SER A 78 SER^? 12.19 O ACT A 134 coo 57.83 99.61 24.25 54.90 95.14 20.60 8.54 2.73 14.15 9.40 -2.89 16.14 coo 51.07 94.66 21.52 53.18 93.49 22.20 17.06 1.63 18.02 14.62 1.36 17.91 coo 51.67 94.23 16.93 51.60 92.47 18.57 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 M 217 SER B 77 SER^? 10.03 OXT ACT B 134 M 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 57.83 99.61 24.25 54.90 95.14 20.60 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 51.07 94.66 21.52 53.18 93.49 22.20 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 51.67 94.23 16.93 51.60 92.47 18.57 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 105 LYS^? 12.80 O ACT A 134 N 217 SER A 77 SER^? 10.05 O ACT A 134 N 241 SER A 78 SER^? 12.19 O ACT A 134 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 8.54 2.73 14.15 9.40 -2.89 16.14 coo 81.67 67.31 -0.58 79.53 68.28 0.00 17.06 1.63 18.02 14.62 1.36 17.91 coo 82.47 71.15 2.07 80.82 69.44 2.28 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 N 217 SER B 77 SER^? 10.03 OXT ACT B 134 N 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 81.67 67.31 -0.58 79.53 68.28 0.00 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 82.47 71.15 2.07 80.82 69.44 2.28 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 105 LYS^? 12.80 O ACT A 134 O 217 SER A 77 SER^? 10.05 O ACT A 134 O 241 SER A 78 SER^? 12.19 O ACT A 134 coo 81.67 70.12 58.71 78.82 64.87 57.22 8.54 2.73 14.15 9.40 -2.89 16.14 coo 81.62 62.23 55.05 79.32 62.93 55.20 17.06 1.63 18.02 14.62 1.36 17.91 coo 79.39 59.54 58.42 78.72 60.00 56.11 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 O 217 SER B 77 SER^? 10.03 OXT ACT B 134 O 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 81.67 70.12 58.71 78.82 64.87 57.22 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 81.62 62.23 55.05 79.32 62.93 55.20 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 79.39 59.54 58.42 78.72 60.00 56.11 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 105 LYS^? 12.80 O ACT A 134 P 217 SER A 77 SER^? 10.05 O ACT A 134 P 241 SER A 78 SER^? 12.19 O ACT A 134 coo 37.29 55.72 69.54 38.73 59.85 65.07 8.54 2.73 14.15 9.40 -2.89 16.14 coo 35.55 61.40 62.96 37.72 60.41 62.66 17.06 1.63 18.02 14.62 1.36 17.91 coo 38.60 64.77 64.10 38.63 63.28 62.26 20.05 1.17 15.74 19.11 -0.15 13.92 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS B 105 LYS^? 12.81 OXT ACT B 134 P 217 SER B 77 SER^? 10.03 OXT ACT B 134 P 241 SER B 78 SER^? 12.20 OXT ACT B 134 coo 37.29 55.72 69.54 38.73 59.85 65.07 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 35.55 61.40 62.96 37.72 60.41 62.66 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 38.60 64.77 64.10 38.63 63.28 62.26 20.02 15.26 -10.83 19.07 16.62 -8.98 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c15 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU B 86 GLU.? 27.22 CH3 ACT A 134 B 128 HIS A 4 HIS.? -31.85 CH3 ACT A 134s C 263 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 6.12 5.94 82.00 7.16 6.32 83.81 35.82 0.62 5.15 36.84 -0.64 6.51 coo 12.51 16.35 80.99 13.16 14.90 82.37 43.87 10.57 9.16 45.61 11.32 10.07 coo 11.58 14.94 93.26 12.25 14.03 91.50 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU B 86 GLU.? 27.22 CH3 ACT A 134 B 128 HIS B 4 HIS.? -31.93 CH3 ACT B 134s C 263 HIS A 4 HIS.? -31.85 CH3 ACT A 134s coo 6.12 5.94 82.00 7.16 6.32 83.81 35.82 0.62 5.15 36.84 -0.64 6.51 coo 12.51 16.35 80.99 13.16 14.90 82.37 43.77 5.80 -4.34 45.50 5.09 -5.28 coo 11.58 14.94 93.26 12.25 14.03 91.50 43.87 10.57 9.16 45.61 11.32 10.07 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 2 hits 1ni4_c00 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 81 ARG^? 17.75 O ACT A 134 B 101 ASP A 80 ASP^? 13.33 O ACT A 134 B 132 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 11.48 3.09 18.25 9.01 4.07 16.77 23.88 0.36 5.26 23.01 -2.52 5.93 coo 11.83 0.33 13.01 10.88 1.04 14.81 21.99 0.20 10.14 20.59 -0.43 11.58 coo 6.85 7.33 14.07 7.10 5.88 15.60 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 101 ASP A 80 ASP^? 13.33 O ACT A 134 B 132 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 11.48 3.09 18.25 9.01 4.07 16.77 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 11.83 0.33 13.01 10.88 1.04 14.81 21.99 0.20 10.14 20.59 -0.43 11.58 coo 6.85 7.33 14.07 7.10 5.88 15.60 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 101 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 132 ASP A 80 ASP^? 13.33 O ACT A 134 coo 11.48 3.09 18.25 9.01 4.07 16.77 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 11.83 0.33 13.01 10.88 1.04 14.81 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.85 7.33 14.07 7.10 5.88 15.60 21.99 0.20 10.14 20.59 -0.43 11.58 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 3 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 128 SER.? 10.42 O ACT A 134 A 154 ASP A 80 ASP^? 13.33 O ACT A 134 A 261 ARG A 107 ARG^? 13.51 O ACT A 134 coo 16.10 74.10 3.11 17.18 73.52 5.20 9.47 2.37 6.00 8.93 0.44 7.47 coo 16.07 84.71 8.14 15.20 82.81 8.14 21.99 0.20 10.14 20.59 -0.43 11.58 coo 10.59 77.85 4.81 13.09 76.36 5.76 14.42 -0.01 7.43 16.47 -2.30 7.52 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 128 SER.? 10.42 O ACT A 134 A 154 ASP A 95 ASP^? -2.87 O ACT A 134s A 261 ARG A 107 ARG^? 13.51 O ACT A 134 coo 16.10 74.10 3.11 17.18 73.52 5.20 9.47 2.37 6.00 8.93 0.44 7.47 coo 16.07 84.71 8.14 15.20 82.81 8.14 13.92 6.03 15.16 12.65 6.91 13.72 coo 10.59 77.85 4.81 13.09 76.36 5.76 14.42 -0.01 7.43 16.47 -2.30 7.52 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER A 132 SER.? 12.20 O ACT A 134 A 154 ASP A 95 ASP^? -2.87 O ACT A 134s A 261 ARG A 107 ARG^? 13.51 O ACT A 134 coo 16.10 74.10 3.11 17.18 73.52 5.20 7.72 -1.19 11.22 7.31 -1.68 8.88 coo 16.07 84.71 8.14 15.20 82.81 8.14 13.92 6.03 15.16 12.65 6.91 13.72 coo 10.59 77.85 4.81 13.09 76.36 5.76 14.42 -0.01 7.43 16.47 -2.30 7.52 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 128 SER.? 10.40 OXT ACT B 134 A 154 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 261 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo 16.10 74.10 3.11 17.18 73.52 5.20 9.49 14.01 -1.20 8.95 15.98 -2.61 coo 16.07 84.71 8.14 15.20 82.81 8.14 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 10.59 77.85 4.81 13.09 76.36 5.76 14.41 16.45 -2.54 16.63 18.58 -2.64 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER B 128 SER.? 10.40 OXT ACT B 134 A 154 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 261 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo 16.10 74.10 3.11 17.18 73.52 5.20 9.49 14.01 -1.20 8.95 15.98 -2.61 coo 16.07 84.71 8.14 15.20 82.81 8.14 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 10.59 77.85 4.81 13.09 76.36 5.76 14.41 16.45 -2.54 16.63 18.58 -2.64 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER B 132 SER.? 12.23 OXT ACT B 134 A 154 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 261 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo 16.10 74.10 3.11 17.18 73.52 5.20 7.68 17.54 -6.39 7.22 18.14 -4.05 coo 16.07 84.71 8.14 15.20 82.81 8.14 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 10.59 77.85 4.81 13.09 76.36 5.76 14.41 16.45 -2.54 16.63 18.58 -2.64 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 6 hits 1o98_c00 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 129 ASP.? 12.18 O ACT A 134 A 146 TYR A 104 TYR^? -4.47 O ACT A 134s A 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -3.50 124.89 25.05 -2.25 124.77 23.26 4.86 1.75 6.36 4.91 0.13 7.65 coo 1.87 119.38 16.45 1.41 122.11 16.84 6.73 6.71 14.57 8.42 7.72 12.53 coo -2.59 124.07 12.67 -0.91 126.17 18.42 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s A 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -3.50 124.89 25.05 -2.25 124.77 23.26 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 1.87 119.38 16.45 1.41 122.11 16.84 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -2.59 124.07 12.67 -0.91 126.17 18.42 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 129 ASP.? 12.18 O ACT A 134 B 146 TYR A 104 TYR^? -4.47 O ACT A 134s B 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -7.43 109.06 51.23 -5.84 110.54 50.86 4.86 1.75 6.36 4.91 0.13 7.65 coo 0.22 114.56 44.62 -0.76 115.18 47.18 6.73 6.71 14.57 8.42 7.72 12.53 coo -4.18 120.17 46.85 -4.02 115.31 51.00 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 B 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s B 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -7.43 109.06 51.23 -5.84 110.54 50.86 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 0.22 114.56 44.62 -0.76 115.18 47.18 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -4.18 120.17 46.85 -4.02 115.31 51.00 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 129 ASP.? 12.18 O ACT A 134 C 146 TYR A 104 TYR^? -4.47 O ACT A 134s C 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -13.49 79.65 43.90 -12.13 80.29 45.45 4.86 1.75 6.36 4.91 0.13 7.65 coo -5.65 86.78 48.49 -7.16 84.72 49.65 6.73 6.71 14.57 8.42 7.72 12.53 coo -11.22 87.18 53.49 -10.94 81.64 50.31 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 C 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s C 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -13.49 79.65 43.90 -12.13 80.29 45.45 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -5.65 86.78 48.49 -7.16 84.72 49.65 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -11.22 87.18 53.49 -10.94 81.64 50.31 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 129 ASP.? 12.18 O ACT A 134 D 146 TYR A 104 TYR^? -4.47 O ACT A 134s D 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -13.44 77.36 13.12 -12.53 75.97 14.48 4.86 1.75 6.36 4.91 0.13 7.65 coo -7.85 74.44 22.75 -9.22 72.86 20.89 6.73 6.71 14.57 8.42 7.72 12.53 coo -14.24 70.61 23.48 -12.55 71.73 17.42 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 D 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s D 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -13.44 77.36 13.12 -12.53 75.97 14.48 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -7.85 74.44 22.75 -9.22 72.86 20.89 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -14.24 70.61 23.48 -12.55 71.73 17.42 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 129 ASP.? 12.18 O ACT A 134 E 146 TYR A 104 TYR^? -4.47 O ACT A 134s E 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -7.12 105.25 1.43 -6.30 103.34 0.77 4.86 1.75 6.36 4.91 0.13 7.65 coo -3.11 94.55 3.01 -3.83 95.92 0.66 6.73 6.71 14.57 8.42 7.72 12.53 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 E 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s E 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -7.12 105.25 1.43 -6.30 103.34 0.77 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -3.11 94.55 3.01 -3.83 95.92 0.66 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 129 ASP.? 12.18 O ACT A 134 F 146 TYR A 104 TYR^? -4.47 O ACT A 134s F 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -44.75 128.15 10.28 -45.68 129.67 11.55 4.86 1.75 6.36 4.91 0.13 7.65 coo -50.43 131.90 19.60 -49.04 133.31 17.60 6.73 6.71 14.57 8.42 7.72 12.53 coo -44.10 135.86 19.99 -45.67 134.21 14.07 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 F 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s F 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -44.75 128.15 10.28 -45.68 129.67 11.55 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -50.43 131.90 19.60 -49.04 133.31 17.60 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -44.10 135.86 19.99 -45.67 134.21 14.07 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 129 ASP.? 12.18 O ACT A 134 G 146 TYR A 104 TYR^? -4.47 O ACT A 134s G 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -44.97 128.78 41.20 -46.32 128.26 42.83 4.86 1.75 6.36 4.91 0.13 7.65 coo -52.83 122.13 46.42 -51.31 124.30 47.39 6.73 6.71 14.57 8.42 7.72 12.53 coo -47.30 122.24 51.49 -47.46 127.44 47.81 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 G 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s G 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -44.97 128.78 41.20 -46.32 128.26 42.83 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -52.83 122.13 46.42 -51.31 124.30 47.39 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -47.30 122.24 51.49 -47.46 127.44 47.81 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 129 ASP.? 12.18 O ACT A 134 H 146 TYR A 104 TYR^? -4.47 O ACT A 134s H 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -51.11 100.30 51.41 -52.67 98.82 51.12 4.86 1.75 6.36 4.91 0.13 7.65 coo -58.70 94.17 45.32 -57.76 93.82 47.92 6.73 6.71 14.57 8.42 7.72 12.53 coo -54.32 88.79 48.13 -54.61 94.04 51.74 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 H 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s H 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -51.11 100.30 51.41 -52.67 98.82 51.12 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -58.70 94.17 45.32 -57.76 93.82 47.92 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -54.32 88.79 48.13 -54.61 94.04 51.74 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 129 ASP.? 12.18 O ACT A 134 I 146 TYR A 104 TYR^? -4.47 O ACT A 134s I 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -54.65 81.97 26.87 -55.88 81.89 25.07 4.86 1.75 6.36 4.91 0.13 7.65 coo -59.92 86.62 17.74 -59.42 83.94 18.40 6.73 6.71 14.57 8.42 7.72 12.53 coo -55.38 81.61 14.50 -57.11 80.05 20.41 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 I 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s I 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -54.65 81.97 26.87 -55.88 81.89 25.07 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -59.92 86.62 17.74 -59.42 83.94 18.40 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -55.38 81.61 14.50 -57.11 80.05 20.41 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 129 ASP.? 12.18 O ACT A 134 J 146 TYR A 104 TYR^? -4.47 O ACT A 134s J 177 LYS A 102 LYS^? 18.24 O ACT A 134 coo -50.64 99.08 1.52 -51.52 100.83 0.67 4.86 1.75 6.36 4.91 0.13 7.65 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 6.73 6.71 14.57 8.42 7.72 12.53 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 129 ASP.? 12.08 OXT ACT B 134 J 146 TYR B 104 TYR^? -4.53 OXT ACT B 134s J 177 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo -50.64 99.08 1.52 -51.52 100.83 0.67 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 6.66 9.79 -9.77 8.33 8.75 -7.73 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 0.61 11.65 -14.75 -4.59 9.81 -15.68 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 80 ASP^? 13.33 O ACT A 134 A 96 GLU A 96 GLU^? 11.35 O ACT A 134 A 132 LYS A 105 LYS^? 12.80 O ACT A 134 coo 31.23 12.29 16.44 30.82 11.56 18.39 21.99 0.20 10.14 20.59 -0.43 11.58 coo 26.82 3.20 24.36 27.99 4.86 24.98 11.55 2.34 19.02 11.24 0.31 19.55 coo 29.99 0.62 22.18 30.38 6.69 20.81 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 96 GLU B 96 GLU^? 11.19 OXT ACT B 134 A 132 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 31.23 12.29 16.44 30.82 11.56 18.39 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 26.82 3.20 24.36 27.99 4.86 24.98 11.63 14.13 -14.15 11.77 16.24 -14.29 coo 29.99 0.62 22.18 30.38 6.69 20.81 8.51 13.68 -9.31 9.43 19.36 -11.32 1onr_c00 source 1onr TRANSALDOLASE B : 2 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 80 ASP^? 13.33 O ACT A 134 B 96 GLU A 96 GLU^? 11.35 O ACT A 134 B 132 LYS A 105 LYS^? 12.80 O ACT A 134 coo 31.16 57.31 -0.94 30.73 56.64 1.01 21.99 0.20 10.14 20.59 -0.43 11.58 coo 26.69 48.45 7.18 27.85 50.13 7.74 11.55 2.34 19.02 11.24 0.31 19.55 coo 29.82 45.80 5.07 30.26 51.81 3.56 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP B 80 ASP^? 13.20 OXT ACT B 134 B 96 GLU B 96 GLU^? 11.19 OXT ACT B 134 B 132 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 31.16 57.31 -0.94 30.73 56.64 1.01 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 26.69 48.45 7.18 27.85 50.13 7.74 11.63 14.13 -14.15 11.77 16.24 -14.29 coo 29.82 45.80 5.07 30.26 51.81 3.56 8.51 13.68 -9.31 9.43 19.36 -11.32 1onr_c01 source 1onr TRANSALDOLASE B : 2 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 84 SER^? 20.86 CH3 ACT A 134 A 239 VAL A 82 VAL^? 15.47 CH3 ACT A 134 A 413 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 30.40 10.24 3.82 32.46 10.17 5.21 coo 75.67 35.37 52.30 76.00 35.96 50.23 27.14 5.94 8.11 27.56 6.98 9.97 coo 81.75 35.21 52.13 80.92 37.12 51.69 31.66 3.78 4.83 30.09 2.36 4.90 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 84 SER^? 20.86 CH3 ACT A 134 A 239 VAL B 82 VAL^? 15.62 CH3 ACT B 134 A 413 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 30.40 10.24 3.82 32.46 10.17 5.21 coo 75.67 35.37 52.30 76.00 35.96 50.23 27.10 10.36 -3.30 27.56 9.27 -5.13 coo 81.75 35.21 52.13 80.92 37.12 51.69 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER A 84 SER^? 20.86 CH3 ACT A 134 A 239 VAL B 89 VAL^? 16.40 CH3 ACT B 134 A 413 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 30.40 10.24 3.82 32.46 10.17 5.21 coo 75.67 35.37 52.30 76.00 35.96 50.23 27.34 3.88 -1.00 28.63 4.08 -2.77 coo 81.75 35.21 52.13 80.92 37.12 51.69 31.66 3.78 4.83 30.09 2.36 4.90 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER A 128 SER.? 10.42 O ACT A 134 A 239 VAL A 108 VAL^? 5.16 O ACT A 134 A 413 ASN A 106 ASN^? 5.57 O ACT A 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 9.47 2.37 6.00 8.93 0.44 7.47 coo 75.67 35.37 52.30 76.00 35.96 50.23 15.18 6.85 8.22 14.31 8.41 9.52 coo 81.75 35.21 52.13 80.92 37.12 51.69 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER B 84 SER^? 21.05 CH3 ACT B 134 A 239 VAL A 82 VAL^? 15.47 CH3 ACT A 134 A 413 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 30.37 6.08 1.00 32.42 6.12 -0.34 coo 75.67 35.37 52.30 76.00 35.96 50.23 27.14 5.94 8.11 27.56 6.98 9.97 coo 81.75 35.21 52.13 80.92 37.12 51.69 31.66 3.78 4.83 30.09 2.36 4.90 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER B 84 SER^? 21.05 CH3 ACT B 134 A 239 VAL A 89 VAL^? 16.19 CH3 ACT A 134 A 413 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 30.37 6.08 1.00 32.42 6.12 -0.34 coo 75.67 35.37 52.30 76.00 35.96 50.23 27.38 12.47 5.89 28.64 12.25 7.64 coo 81.75 35.21 52.13 80.92 37.12 51.69 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 7 3 # 7 A 170 SER B 84 SER^? 21.05 CH3 ACT B 134 A 239 VAL B 82 VAL^? 15.62 CH3 ACT B 134 A 413 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 30.37 6.08 1.00 32.42 6.12 -0.34 coo 75.67 35.37 52.30 76.00 35.96 50.23 27.10 10.36 -3.30 27.56 9.27 -5.13 coo 81.75 35.21 52.13 80.92 37.12 51.69 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 8 3 # 8 A 170 SER B 128 SER.? 10.40 OXT ACT B 134 A 239 VAL B 108 VAL^? 5.16 OXT ACT B 134 A 413 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 80.14 40.76 52.28 77.73 40.59 51.94 9.49 14.01 -1.20 8.95 15.98 -2.61 coo 75.67 35.37 52.30 76.00 35.96 50.23 15.16 9.57 -3.41 14.28 8.01 -4.72 coo 81.75 35.21 52.13 80.92 37.12 51.69 10.24 11.30 -5.95 9.38 10.89 -4.04 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 8 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 84 SER^? 20.86 CH3 ACT A 134 B 239 VAL A 82 VAL^? 15.47 CH3 ACT A 134 B 413 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 30.40 10.24 3.82 32.46 10.17 5.21 coo 29.71 1.00 2.66 29.43 1.57 4.74 27.14 5.94 8.11 27.56 6.98 9.97 coo 23.72 0.88 2.95 24.56 2.79 3.34 31.66 3.78 4.83 30.09 2.36 4.90 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER A 84 SER^? 20.86 CH3 ACT A 134 B 239 VAL B 82 VAL^? 15.62 CH3 ACT B 134 B 413 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 30.40 10.24 3.82 32.46 10.17 5.21 coo 29.71 1.00 2.66 29.43 1.57 4.74 27.10 10.36 -3.30 27.56 9.27 -5.13 coo 23.72 0.88 2.95 24.56 2.79 3.34 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER A 84 SER^? 20.86 CH3 ACT A 134 B 239 VAL B 89 VAL^? 16.40 CH3 ACT B 134 B 413 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 30.40 10.24 3.82 32.46 10.17 5.21 coo 29.71 1.00 2.66 29.43 1.57 4.74 27.34 3.88 -1.00 28.63 4.08 -2.77 coo 23.72 0.88 2.95 24.56 2.79 3.34 31.66 3.78 4.83 30.09 2.36 4.90 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER A 128 SER.? 10.42 O ACT A 134 B 239 VAL A 108 VAL^? 5.16 O ACT A 134 B 413 ASN A 106 ASN^? 5.57 O ACT A 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 9.47 2.37 6.00 8.93 0.44 7.47 coo 29.71 1.00 2.66 29.43 1.57 4.74 15.18 6.85 8.22 14.31 8.41 9.52 coo 23.72 0.88 2.95 24.56 2.79 3.34 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER B 84 SER^? 21.05 CH3 ACT B 134 B 239 VAL A 82 VAL^? 15.47 CH3 ACT A 134 B 413 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 30.37 6.08 1.00 32.42 6.12 -0.34 coo 29.71 1.00 2.66 29.43 1.57 4.74 27.14 5.94 8.11 27.56 6.98 9.97 coo 23.72 0.88 2.95 24.56 2.79 3.34 31.66 3.78 4.83 30.09 2.36 4.90 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER B 84 SER^? 21.05 CH3 ACT B 134 B 239 VAL A 89 VAL^? 16.19 CH3 ACT A 134 B 413 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 30.37 6.08 1.00 32.42 6.12 -0.34 coo 29.71 1.00 2.66 29.43 1.57 4.74 27.38 12.47 5.89 28.64 12.25 7.64 coo 23.72 0.88 2.95 24.56 2.79 3.34 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 7 3 # 7 B 170 SER B 84 SER^? 21.05 CH3 ACT B 134 B 239 VAL B 82 VAL^? 15.62 CH3 ACT B 134 B 413 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 30.37 6.08 1.00 32.42 6.12 -0.34 coo 29.71 1.00 2.66 29.43 1.57 4.74 27.10 10.36 -3.30 27.56 9.27 -5.13 coo 23.72 0.88 2.95 24.56 2.79 3.34 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 8 3 # 8 B 170 SER B 128 SER.? 10.40 OXT ACT B 134 B 239 VAL B 108 VAL^? 5.16 OXT ACT B 134 B 413 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 25.22 6.41 2.90 27.67 6.33 3.11 9.49 14.01 -1.20 8.95 15.98 -2.61 coo 29.71 1.00 2.66 29.43 1.57 4.74 15.16 9.57 -3.41 14.28 8.01 -4.72 coo 23.72 0.88 2.95 24.56 2.79 3.34 10.24 11.30 -5.95 9.38 10.89 -4.04 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 8 hits 1oqz_c01 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 270 LYS A 118 LYS^? 23.86 CH3 ACT A 134 A 382 MET B 1 MET?? 27.03 CH3 ACT A 134 coo -27.63 121.99 45.48 -26.66 123.86 45.68 26.00 19.90 3.85 25.60 19.04 1.99 coo -32.20 115.91 49.56 -31.37 121.03 53.12 28.94 23.42 11.82 28.39 29.21 14.30 coo -23.75 127.89 58.42 -26.02 128.79 55.12 36.56 11.95 3.28 38.45 15.46 4.70 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 129 ASP.? 12.18 O ACT A 134 A 270 LYS A 105 LYS^? 12.80 O ACT A 134 A 382 MET A 46 MET?? 9.75 OXT ACT A 134 coo -27.63 121.99 45.48 -26.66 123.86 45.68 4.86 1.75 6.36 4.91 0.13 7.65 coo -32.20 115.91 49.56 -31.37 121.03 53.12 8.54 2.73 14.15 9.40 -2.89 16.14 coo -23.75 127.89 58.42 -26.02 128.79 55.12 5.64 15.94 3.58 3.91 12.20 4.93 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 270 LYS B 118 LYS^? 22.69 CH3 ACT B 134 A 382 MET A 1 MET?? 27.20 CH3 ACT B 134 coo -27.63 121.99 45.48 -26.66 123.86 45.68 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -32.20 115.91 49.56 -31.37 121.03 53.12 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo -23.75 127.89 58.42 -26.02 128.79 55.12 36.56 4.35 1.53 38.43 0.91 0.08 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 270 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 382 MET B 46 MET?? 9.61 O ACT B 134 coo -27.63 121.99 45.48 -26.66 123.86 45.68 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -32.20 115.91 49.56 -31.37 121.03 53.12 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -23.75 127.89 58.42 -26.02 128.79 55.12 5.61 0.48 1.25 3.91 4.19 -0.22 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 4 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 270 LYS A 118 LYS^? 23.86 CH3 ACT A 134 B 382 MET B 1 MET?? 27.03 CH3 ACT A 134 coo -11.82 154.51 43.38 -12.86 152.74 43.79 26.00 19.90 3.85 25.60 19.04 1.99 coo -5.09 158.39 43.41 -0.74 158.80 47.15 28.94 23.42 11.82 28.39 29.21 14.30 coo -2.79 145.52 50.38 -5.75 148.14 51.66 36.56 11.95 3.28 38.45 15.46 4.70 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 270 LYS B 118 LYS^? 22.69 CH3 ACT B 134 B 382 MET A 1 MET?? 27.20 CH3 ACT B 134 coo -11.82 154.51 43.38 -12.86 152.74 43.79 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -5.09 158.39 43.41 -0.74 158.80 47.15 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo -2.79 145.52 50.38 -5.75 148.14 51.66 36.56 4.35 1.53 38.43 0.91 0.08 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c03 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 58 ARG~? 15.97 OXT ACT A 134 A 479 PHE A 49 PHE.? 12.05 OXT ACT A 134 A 483 GLU A 48 GLU.? 14.70 OXT ACT A 134 coo 17.33 52.29 2.24 18.71 54.03 0.18 9.78 27.17 8.97 7.03 26.14 8.06 coo 20.06 57.44 1.28 18.39 56.19 3.12 7.92 21.75 8.87 7.38 23.30 11.14 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 3.89 23.33 8.60 3.75 23.77 10.68 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 58 ARG~? 15.94 O ACT B 134 A 479 PHE B 49 PHE.? 12.01 O ACT B 134 A 483 GLU B 48 GLU.? 15.07 O ACT B 134 coo 17.33 52.29 2.24 18.71 54.03 0.18 9.78 -10.54 -4.22 7.03 -9.65 -3.15 coo 20.06 57.44 1.28 18.39 56.19 3.12 7.96 -5.25 -4.07 7.44 -6.88 -6.27 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 3.87 -7.04 -3.75 3.32 -7.55 -5.74 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 58 ARG~? 15.97 OXT ACT A 134 B 479 PHE A 49 PHE.? 12.05 OXT ACT A 134 B 483 GLU A 48 GLU.? 14.70 OXT ACT A 134 coo -26.72 93.28 20.13 -28.02 93.55 17.39 9.78 27.17 8.97 7.03 26.14 8.06 coo -29.34 90.48 15.69 -27.62 89.95 17.80 7.92 21.75 8.87 7.38 23.30 11.14 coo -26.63 95.49 14.65 -25.77 93.77 13.77 3.89 23.33 8.60 3.75 23.77 10.68 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 58 ARG~? 15.94 O ACT B 134 B 479 PHE B 49 PHE.? 12.01 O ACT B 134 B 483 GLU B 48 GLU.? 15.07 O ACT B 134 coo -26.72 93.28 20.13 -28.02 93.55 17.39 9.78 -10.54 -4.22 7.03 -9.65 -3.15 coo -29.34 90.48 15.69 -27.62 89.95 17.80 7.96 -5.25 -4.07 7.44 -6.88 -6.27 coo -26.63 95.49 14.65 -25.77 93.77 13.77 3.87 -7.04 -3.75 3.32 -7.55 -5.74 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 53 ASN^? 13.62 OXT ACT A 134 A 192 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 195 HIS A 50 HIS.? 14.57 OXT ACT B 134 coo -4.84 51.77 30.37 -3.89 50.12 29.46 12.53 24.41 5.81 10.72 23.33 5.51 coo 2.03 47.14 19.75 1.72 46.26 21.64 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 1.41 44.84 24.92 -0.49 45.70 25.19 6.53 19.16 0.69 7.13 18.70 -1.26 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 53 ASN^? 13.51 O ACT B 134 A 192 ASP A 129 ASP.? 12.18 O ACT A 134 A 195 HIS B 50 HIS.? 14.60 O ACT A 134 coo -4.84 51.77 30.37 -3.89 50.12 29.46 12.53 -7.97 -0.98 10.78 -6.78 -0.73 coo 2.03 47.14 19.75 1.72 46.26 21.64 4.86 1.75 6.36 4.91 0.13 7.65 coo 1.41 44.84 24.92 -0.49 45.70 25.19 6.58 -2.80 4.18 7.21 -2.33 6.13 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 53 ASN^? 13.62 OXT ACT A 134 B 192 ASP B 129 ASP.? 12.08 OXT ACT B 134 B 195 HIS A 50 HIS.? 14.57 OXT ACT B 134 coo -1.08 51.41 10.34 0.65 52.62 10.17 12.53 24.41 5.81 10.72 23.33 5.51 coo 11.36 52.33 5.59 10.18 53.87 6.47 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 7.99 56.74 7.55 6.88 55.39 8.70 6.53 19.16 0.69 7.13 18.70 -1.26 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 53 ASN^? 13.51 O ACT B 134 B 192 ASP A 129 ASP.? 12.18 O ACT A 134 B 195 HIS B 50 HIS.? 14.60 O ACT A 134 coo -1.08 51.41 10.34 0.65 52.62 10.17 12.53 -7.97 -0.98 10.78 -6.78 -0.73 coo 11.36 52.33 5.59 10.18 53.87 6.47 4.86 1.75 6.36 4.91 0.13 7.65 coo 7.99 56.74 7.55 6.88 55.39 8.70 6.58 -2.80 4.18 7.21 -2.33 6.13 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 33 LEU~? 15.46 CH3 ACT A 134 A 58 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 120 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 34.02 69.29 75.26 34.82 67.82 76.74 19.33 24.92 17.48 17.22 24.79 17.00 coo 34.46 72.45 78.57 32.82 72.75 77.28 24.17 25.65 19.58 23.03 26.79 20.97 coo 28.96 77.64 81.19 29.05 74.53 77.51 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU B 33 LEU~? 15.42 CH3 ACT B 134 A 58 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 120 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 34.02 69.29 75.26 34.82 67.82 76.74 19.26 -8.50 -12.67 17.08 -8.37 -12.30 coo 34.46 72.45 78.57 32.82 72.75 77.28 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 28.96 77.64 81.19 29.05 74.53 77.51 28.80 -7.02 -7.08 28.66 -10.73 -10.74 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 33 LEU~? 15.46 CH3 ACT A 134 B 58 ASP A 34 ASP~? 20.39 CH3 ACT A 134 B 120 LYS A 118 LYS^? 23.86 CH3 ACT A 134 coo 54.50 104.32 58.69 55.83 105.69 59.81 19.33 24.92 17.48 17.22 24.79 17.00 coo 57.63 101.19 59.83 56.60 100.89 57.99 24.17 25.65 19.58 23.03 26.79 20.97 coo 61.58 95.88 55.22 58.18 99.30 54.71 28.94 23.42 11.82 28.39 29.21 14.30 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 33 LEU~? 15.42 CH3 ACT B 134 B 58 ASP B 34 ASP~? 20.32 CH3 ACT B 134 B 120 LYS B 118 LYS^? 22.69 CH3 ACT B 134 coo 54.50 104.32 58.69 55.83 105.69 59.81 19.26 -8.50 -12.67 17.08 -8.37 -12.30 coo 57.63 101.19 59.83 56.60 100.89 57.99 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 61.58 95.88 55.22 58.18 99.30 54.71 28.80 -7.02 -7.08 28.66 -10.73 -10.74 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 A 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 55.45 46.76 42.08 57.34 46.16 42.75 6.53 19.16 0.69 7.13 18.70 -1.26 coo 48.87 29.19 44.63 49.10 27.34 43.63 26.00 19.90 3.85 25.60 19.04 1.99 coo 47.58 17.35 41.83 51.40 20.85 40.83 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 50 HIS.? 14.60 O ACT A 134 A 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 55.45 46.76 42.08 57.34 46.16 42.75 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 47.58 17.35 41.83 51.40 20.85 40.83 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 14 HIS~? 17.04 CH3 ACT A 134 B 236 ASP A 95 ASP^? -2.87 O ACT A 134s B 261 LYS A 102 LYS^? 18.24 O ACT A 134 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 30.04 10.42 13.88 29.99 8.58 12.87 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 13.92 6.03 15.16 12.65 6.91 13.72 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 0.63 4.90 19.56 -4.81 6.46 20.35 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 B 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 6.53 19.16 0.69 7.13 18.70 -1.26 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 26.00 19.90 3.85 25.60 19.04 1.99 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS B 14 HIS~? 17.16 CH3 ACT B 134 B 236 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 261 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS B 50 HIS.? 14.60 O ACT A 134 B 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 C 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 C 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 55.11 47.10 12.61 53.44 47.85 11.58 6.53 19.16 0.69 7.13 18.70 -1.26 coo 45.78 31.11 9.51 44.25 30.06 10.53 26.00 19.90 3.85 25.60 19.04 1.99 coo 37.54 22.37 12.10 37.83 27.55 13.24 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 14 HIS~? 17.16 CH3 ACT B 134 C 236 ASP B 95 ASP^? -2.82 OXT ACT B 134s C 261 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo 55.11 47.10 12.61 53.44 47.85 11.58 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 37.54 22.37 12.10 37.83 27.55 13.24 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS B 50 HIS.? 14.60 O ACT A 134 C 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 C 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 55.11 47.10 12.61 53.44 47.85 11.58 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 37.54 22.37 12.10 37.83 27.55 13.24 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 D 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 D 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 6.53 19.16 0.69 7.13 18.70 -1.26 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 26.00 19.90 3.85 25.60 19.04 1.99 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 50 HIS.? 14.60 O ACT A 134 D 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 D 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 E 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 E 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 6.53 19.16 0.69 7.13 18.70 -1.26 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 26.00 19.90 3.85 25.60 19.04 1.99 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 50 HIS.? 14.60 O ACT A 134 E 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 E 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 F 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 F 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 6.53 19.16 0.69 7.13 18.70 -1.26 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 26.00 19.90 3.85 25.60 19.04 1.99 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 14 HIS~? 17.16 CH3 ACT B 134 F 236 ASP B 95 ASP^? -2.82 OXT ACT B 134s F 261 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS B 50 HIS.? 14.60 O ACT A 134 F 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 F 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 G 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 G 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 6.53 19.16 0.69 7.13 18.70 -1.26 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 26.00 19.90 3.85 25.60 19.04 1.99 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 14 HIS~? 17.16 CH3 ACT B 134 G 236 ASP B 95 ASP^? -2.82 OXT ACT B 134s G 261 LYS B 102 LYS^? 18.05 OXT ACT B 134 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 0.61 11.65 -14.75 -4.59 9.81 -15.68 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS B 50 HIS.? 14.60 O ACT A 134 G 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 G 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 50 HIS.? 14.57 OXT ACT B 134 H 236 ASP A 113 ASP^? 18.42 CH3 ACT A 134 H 261 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 6.53 19.16 0.69 7.13 18.70 -1.26 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 26.00 19.90 3.85 25.60 19.04 1.99 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 50 HIS.? 14.60 O ACT A 134 H 236 ASP B 113 ASP^? 18.51 CH3 ACT B 134 H 261 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c07 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 147 THR A 9 THR~? 21.47 CH3 ACT A 134 A 294 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 37.70 12.40 8.53 36.14 12.23 7.15 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 33.26 16.17 8.09 32.71 16.27 5.99 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 147 THR A 37 THR^? 20.64 CH3 ACT A 134 A 294 ASP A 34 ASP~? 20.39 CH3 ACT A 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 22.90 30.21 5.13 24.67 29.05 5.02 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 24.88 27.66 10.30 25.68 26.74 8.52 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 24.17 25.65 19.58 23.03 26.79 20.97 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 147 THR A 37 THR^? 20.64 CH3 ACT A 134 A 294 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 22.90 30.21 5.13 24.67 29.05 5.02 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 24.88 27.66 10.30 25.68 26.74 8.52 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 147 THR A 87 THR.? 22.88 CH3 ACT A 134 A 294 ASP A 7 ASP~? 23.80 CH3 ACT A 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 26.00 19.90 3.85 25.60 19.04 1.99 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 31.21 17.48 2.82 31.09 18.74 1.05 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 37.70 12.40 8.53 36.14 12.23 7.15 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 147 THR A 87 THR.? 22.88 CH3 ACT A 134 A 294 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 26.00 19.90 3.85 25.60 19.04 1.99 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 31.21 17.48 2.82 31.09 18.74 1.05 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 147 THR A 88 THR^? 17.94 CH3 ACT A 134 A 294 ASP A 7 ASP~? 23.80 CH3 ACT A 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 26.00 19.90 3.85 25.60 19.04 1.99 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 28.18 15.22 3.40 26.60 15.27 1.86 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 37.70 12.40 8.53 36.14 12.23 7.15 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 147 THR B 9 THR~? 21.72 CH3 ACT B 134 A 294 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 33.24 0.14 -3.28 32.74 0.01 -1.15 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 147 THR B 37 THR^? 20.68 CH3 ACT B 134 A 294 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 24.74 -11.26 -5.58 25.50 -10.43 -3.73 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 147 THR B 87 THR.? 23.05 CH3 ACT B 134 A 294 ASP B 7 ASP~? 23.98 CH3 ACT B 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 31.16 -1.20 2.01 31.03 -2.27 3.89 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 37.67 3.93 -3.68 36.11 4.07 -2.28 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 10 3 # 10 A 49 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 147 THR B 87 THR.? 23.05 CH3 ACT B 134 A 294 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 31.16 -1.20 2.01 31.03 -2.27 3.89 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 11 3 # 11 A 49 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 147 THR B 88 THR^? 18.11 CH3 ACT B 134 A 294 ASP B 7 ASP~? 23.98 CH3 ACT B 134 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 28.17 1.09 1.44 26.55 0.98 2.93 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 37.67 3.93 -3.68 36.11 4.07 -2.28 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 11 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 80 ASP^? 13.33 O ACT A 134 A 261 ASP A 129 ASP.? 12.18 O ACT A 134 A 329 ASP A 95 ASP^? -2.87 O ACT A 134s coo 28.46 69.88 26.74 30.40 70.70 26.53 21.99 0.20 10.14 20.59 -0.43 11.58 coo 34.02 79.89 42.60 34.73 78.01 41.86 4.86 1.75 6.36 4.91 0.13 7.65 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 80 ASP^? 13.33 O ACT A 134 A 261 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 329 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 21.99 0.20 10.14 20.59 -0.43 11.58 coo 34.02 79.89 42.60 34.73 78.01 41.86 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 261 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 329 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 34.02 79.89 42.60 34.73 78.01 41.86 37.70 12.40 8.53 36.14 12.23 7.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.00 19.90 3.85 25.60 19.04 1.99 1qho_c05 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 260 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 329 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.17 25.65 19.58 23.03 26.79 20.97 coo 30.73 81.29 37.61 31.23 82.07 35.69 22.90 30.21 5.13 24.67 29.05 5.02 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 260 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 329 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.17 25.65 19.58 23.03 26.79 20.97 coo 30.73 81.29 37.61 31.23 82.07 35.69 26.00 19.90 3.85 25.60 19.04 1.99 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 260 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 329 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.90 30.21 5.13 24.67 29.05 5.02 coo 30.73 81.29 37.61 31.23 82.07 35.69 33.24 23.97 14.06 32.62 25.96 14.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 80 ASP^? 13.33 O ACT A 134 A 260 ASP A 129 ASP.? 12.18 O ACT A 134 A 329 ASP A 95 ASP^? -2.87 O ACT A 134s coo 28.46 69.88 26.74 30.40 70.70 26.53 21.99 0.20 10.14 20.59 -0.43 11.58 coo 30.73 81.29 37.61 31.23 82.07 35.69 4.86 1.75 6.36 4.91 0.13 7.65 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 260 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 329 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 26.00 19.90 3.85 25.60 19.04 1.99 coo 30.73 81.29 37.61 31.23 82.07 35.69 24.17 25.65 19.58 23.03 26.79 20.97 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 260 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 329 ASP A 34 ASP~? 20.39 CH3 ACT A 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 33.24 23.97 14.06 32.62 25.96 14.31 coo 30.73 81.29 37.61 31.23 82.07 35.69 22.90 30.21 5.13 24.67 29.05 5.02 coo 37.87 70.12 31.80 36.61 69.74 30.15 24.17 25.65 19.58 23.03 26.79 20.97 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 260 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 329 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 30.73 81.29 37.61 31.23 82.07 35.69 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 260 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 329 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 30.73 81.29 37.61 31.23 82.07 35.69 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 260 ASP B 117 ASP.? 24.72 CH3 ACT B 134 A 329 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 30.73 81.29 37.61 31.23 82.07 35.69 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 260 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 329 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 28.46 69.88 26.74 30.40 70.70 26.53 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 30.73 81.29 37.61 31.23 82.07 35.69 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 260 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 329 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 30.73 81.29 37.61 31.23 82.07 35.69 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.87 -13.88 -0.47 24.63 -12.69 -0.32 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP B 117 ASP.? 24.72 CH3 ACT B 134 A 260 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 329 ASP B 34 ASP~? 20.32 CH3 ACT B 134 coo 28.46 69.88 26.74 30.40 70.70 26.53 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo 30.73 81.29 37.61 31.23 82.07 35.69 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 37.87 70.12 31.80 36.61 69.74 30.15 24.12 -9.16 -14.81 22.98 -10.29 -16.20 1qho_c07 source 1qho ALPHA-AMYLASE : 12 hits 1qho_c07 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 19 PHE~? 16.57 CH3 ACT A 134 A 201 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 227 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 23.39 49.81 32.16 21.33 51.68 32.26 24.41 18.01 20.14 26.66 18.57 21.69 coo 25.52 45.12 37.98 23.98 46.65 37.85 24.17 25.65 19.58 23.03 26.79 20.97 coo 12.68 46.83 36.69 18.26 48.67 34.51 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 93 PHE^? 5.64 CH3 ACT A 134 A 201 ASP A 80 ASP^? 13.33 O ACT A 134 A 227 LYS A 105 LYS^? 12.80 O ACT A 134 coo 23.39 49.81 32.16 21.33 51.68 32.26 18.45 6.69 12.19 16.89 8.99 12.05 coo 25.52 45.12 37.98 23.98 46.65 37.85 21.99 0.20 10.14 20.59 -0.43 11.58 coo 12.68 46.83 36.69 18.26 48.67 34.51 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 112 PHE^? 11.25 CH3 ACT A 134 A 201 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 227 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 23.39 49.81 32.16 21.33 51.68 32.26 23.79 16.00 9.29 22.27 15.23 11.49 coo 25.52 45.12 37.98 23.98 46.65 37.85 26.00 19.90 3.85 25.60 19.04 1.99 coo 12.68 46.83 36.69 18.26 48.67 34.51 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 19 PHE~? 16.60 CH3 ACT B 134 A 201 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 227 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 23.39 49.81 32.16 21.33 51.68 32.26 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 12.68 46.83 36.69 18.26 48.67 34.51 13.39 -8.84 -10.92 12.04 -11.20 -15.77 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 93 PHE^? 5.85 CH3 ACT B 134 A 201 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 227 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 23.39 49.81 32.16 21.33 51.68 32.26 18.48 9.68 -7.33 16.94 7.39 -7.19 coo 25.52 45.12 37.98 23.98 46.65 37.85 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 12.68 46.83 36.69 18.26 48.67 34.51 8.51 13.68 -9.31 9.43 19.36 -11.32 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 112 PHE^? 11.41 CH3 ACT B 134 A 201 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 227 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 23.39 49.81 32.16 21.33 51.68 32.26 23.76 0.41 -4.47 22.23 1.06 -6.71 coo 25.52 45.12 37.98 23.98 46.65 37.85 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 12.68 46.83 36.69 18.26 48.67 34.51 33.61 2.06 -8.46 36.00 -1.11 -11.84 1qz9_c02 source 1qz9 KYNURENINASE : 6 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 129 ASP.? 12.18 O ACT A 134 A 186 ASN A 106 ASN^? 5.57 O ACT A 134 A 260 ALA A 109 ALA^? 9.97 CH3 ACT A 134 coo 11.81 33.10 11.71 13.07 31.45 11.40 4.86 1.75 6.36 4.91 0.13 7.65 coo 11.43 26.53 7.41 13.01 27.56 8.43 10.24 5.16 10.78 9.42 5.53 8.84 coo 21.53 26.33 6.96 20.26 25.69 7.52 18.06 8.37 6.41 18.44 7.98 4.99 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 129 ASP.? 12.18 O ACT A 134 A 186 ASN A 133 ASN.? 9.96 O ACT A 134 A 260 ALA A 109 ALA^? 9.97 CH3 ACT A 134 coo 11.81 33.10 11.71 13.07 31.45 11.40 4.86 1.75 6.36 4.91 0.13 7.65 coo 11.43 26.53 7.41 13.01 27.56 8.43 12.00 -0.05 11.64 12.23 -0.65 13.67 coo 21.53 26.33 6.96 20.26 25.69 7.52 18.06 8.37 6.41 18.44 7.98 4.99 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 186 ASN B 106 ASN^? 5.54 OXT ACT B 134 A 260 ALA B 109 ALA^? 10.21 CH3 ACT B 134 coo 11.81 33.10 11.71 13.07 31.45 11.40 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 11.43 26.53 7.41 13.01 27.56 8.43 10.24 11.30 -5.95 9.38 10.89 -4.04 coo 21.53 26.33 6.96 20.26 25.69 7.52 18.06 8.00 -1.55 18.47 8.38 -0.11 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 186 ASN B 133 ASN.? 9.91 OXT ACT B 134 A 260 ALA B 109 ALA^? 10.21 CH3 ACT B 134 coo 11.81 33.10 11.71 13.07 31.45 11.40 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 11.43 26.53 7.41 13.01 27.56 8.43 12.00 16.42 -6.80 12.35 17.03 -8.83 coo 21.53 26.33 6.96 20.26 25.69 7.52 18.06 8.00 -1.55 18.47 8.38 -0.11 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 4 hits 1r4f_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 610 HIS B 4 HIS.? -31.93 CH3 ACT B 134s A 661 HIS B 14 HIS~? 17.16 CH3 ACT B 134 coo 75.99 81.56 1.86 73.91 81.34 2.28 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 71.04 78.84 0.46 71.54 76.90 1.02 43.77 5.80 -4.34 45.50 5.09 -5.28 coo 75.40 81.38 12.06 74.88 79.42 12.63 30.01 5.88 -9.10 29.93 7.73 -8.13 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 1 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP B 7 ASP~? 23.98 CH3 ACT B 134 C 610 HIS B 4 HIS.? -31.93 CH3 ACT B 134s C 661 HIS B 14 HIS~? 17.16 CH3 ACT B 134 coo -17.65 80.52 58.00 -16.23 80.79 56.41 37.67 3.93 -3.68 36.11 4.07 -2.28 coo -16.56 83.18 53.03 -16.33 85.18 53.60 43.77 5.80 -4.34 45.50 5.09 -5.28 coo -8.38 80.78 62.24 -7.53 82.67 62.02 30.01 5.88 -9.10 29.93 7.73 -8.13 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 1 hits 1req_c11 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 18 GLU~? 15.74 CH3 ACT A 134 A 288 HIS A 71 HIS.? 15.91 O ACT A 134 A 329 LYS A 102 LYS^? 18.24 O ACT A 134 coo 29.27 18.78 14.99 27.16 18.62 14.76 26.95 12.09 19.56 26.58 10.45 20.84 coo 49.52 10.06 10.36 50.99 9.65 8.92 3.14 13.34 25.08 1.48 14.35 24.29 coo 57.80 12.92 13.83 53.77 8.42 12.15 0.63 4.90 19.56 -4.81 6.46 20.35 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 129 ASP.? 12.18 O ACT A 134 64 HIS B 50 HIS.? 14.60 O ACT A 134 155 ASN B 53 ASN^? 13.51 O ACT B 134 coo 80.16 73.25 62.48 80.01 71.25 61.82 4.86 1.75 6.36 4.91 0.13 7.65 coo 78.27 67.69 61.83 79.58 67.76 60.19 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 80.34 61.88 52.75 81.25 63.19 54.35 12.53 -7.97 -0.98 10.78 -6.78 -0.73 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 129 ASP.? 12.08 OXT ACT B 134 64 HIS A 50 HIS.? 14.57 OXT ACT B 134 155 ASN A 53 ASN^? 13.62 OXT ACT A 134 coo 80.16 73.25 62.48 80.01 71.25 61.82 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 6.53 19.16 0.69 7.13 18.70 -1.26 coo 80.34 61.88 52.75 81.25 63.19 54.35 12.53 24.41 5.81 10.72 23.33 5.51 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 2 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 129 ASP.? 12.18 O ACT A 134 595 GLU B 124 GLU^? -3.39 O ACT B 134s 713 TYR B 125 TYR^? 11.31 O ACT A 134 coo 5.64 2.82 38.49 4.59 4.19 37.25 4.86 1.75 6.36 4.91 0.13 7.65 coo 4.35 13.73 37.63 3.39 12.18 36.55 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 3.76 10.25 31.38 3.16 9.87 34.10 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 129 ASP.? 12.08 OXT ACT B 134 595 GLU A 124 GLU^? -3.29 OXT ACT A 134s 713 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 5.64 2.82 38.49 4.59 4.19 37.25 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 4.35 13.73 37.63 3.39 12.18 36.55 13.89 12.66 7.54 12.94 12.92 9.40 coo 3.76 10.25 31.38 3.16 9.87 34.10 16.00 10.76 2.04 17.57 12.50 0.46 1sll_c00 source 1sll SIALIDASE L : 2 hits 1sll_c00 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 107 ARG^? 13.51 O ACT A 134 A 89 HIS B 50 HIS.? 14.60 O ACT A 134 A 119 ASN B 53 ASN^? 13.51 O ACT B 134 coo 28.44 23.52 73.95 30.13 24.84 76.11 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 21.34 20.13 69.47 22.14 19.11 71.12 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 19.69 29.00 71.61 19.80 26.98 72.20 12.53 -7.97 -0.98 10.78 -6.78 -0.73 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 107 ARG^? 13.48 OXT ACT B 134 A 89 HIS A 50 HIS.? 14.57 OXT ACT B 134 A 119 ASN A 53 ASN^? 13.62 OXT ACT A 134 coo 28.44 23.52 73.95 30.13 24.84 76.11 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 21.34 20.13 69.47 22.14 19.11 71.12 6.53 19.16 0.69 7.13 18.70 -1.26 coo 19.69 29.00 71.61 19.80 26.98 72.20 12.53 24.41 5.81 10.72 23.33 5.51 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 2 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 107 ARG^? 13.51 O ACT A 134 B 89 HIS B 50 HIS.? 14.60 O ACT A 134 B 119 ASN B 53 ASN^? 13.51 O ACT B 134 coo -30.08 23.20 29.48 -31.80 24.60 27.35 14.42 -0.01 7.43 16.47 -2.30 7.52 coo -22.85 19.92 33.92 -23.63 18.94 32.24 6.58 -2.80 4.18 7.21 -2.33 6.13 coo -21.28 28.91 31.84 -21.35 26.90 31.17 12.53 -7.97 -0.98 10.78 -6.78 -0.73 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG B 107 ARG^? 13.48 OXT ACT B 134 B 89 HIS A 50 HIS.? 14.57 OXT ACT B 134 B 119 ASN A 53 ASN^? 13.62 OXT ACT A 134 coo -30.08 23.20 29.48 -31.80 24.60 27.35 14.41 16.45 -2.54 16.63 18.58 -2.64 coo -22.85 19.92 33.92 -23.63 18.94 32.24 6.53 19.16 0.69 7.13 18.70 -1.26 coo -21.28 28.91 31.84 -21.35 26.90 31.17 12.53 24.41 5.81 10.72 23.33 5.51 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 2 hits 1smn_c01 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 39 ASP^? 22.84 CH3 ACT A 134 E 168 LYS A 56 LYS~? 20.00 CH3 ACT A 134 E 201 THR A 41 THR^? 18.02 CH3 ACT A 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 22.90 30.21 5.13 24.67 29.05 5.02 coo 5.06 22.32 18.11 1.02 22.08 22.74 17.29 28.50 12.14 22.41 28.51 15.17 coo -1.79 18.29 19.05 -1.19 20.28 19.71 18.34 24.70 5.20 19.06 25.00 3.19 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 113 ASP^? 18.42 CH3 ACT A 134 E 168 LYS A 118 LYS^? 23.86 CH3 ACT A 134 E 201 THR A 9 THR~? 21.47 CH3 ACT A 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 26.00 19.90 3.85 25.60 19.04 1.99 coo 5.06 22.32 18.11 1.02 22.08 22.74 28.94 23.42 11.82 28.39 29.21 14.30 coo -1.79 18.29 19.05 -1.19 20.28 19.71 33.26 16.17 8.09 32.71 16.27 5.99 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 34 ASP~? 20.32 CH3 ACT B 134 E 168 LYS B 118 LYS^? 22.69 CH3 ACT B 134 E 201 THR B 37 THR^? 20.68 CH3 ACT B 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 5.06 22.32 18.11 1.02 22.08 22.74 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo -1.79 18.29 19.05 -1.19 20.28 19.71 24.74 -11.26 -5.58 25.50 -10.43 -3.73 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 39 ASP^? 22.90 CH3 ACT B 134 E 168 LYS B 56 LYS~? 20.04 CH3 ACT B 134 E 201 THR B 41 THR^? 18.20 CH3 ACT B 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 5.06 22.32 18.11 1.02 22.08 22.74 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo -1.79 18.29 19.05 -1.19 20.28 19.71 18.35 -8.32 -0.39 19.10 -8.72 1.61 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP B 113 ASP^? 18.51 CH3 ACT B 134 E 168 LYS B 118 LYS^? 22.69 CH3 ACT B 134 E 201 THR B 9 THR~? 21.72 CH3 ACT B 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 5.06 22.32 18.11 1.02 22.08 22.74 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo -1.79 18.29 19.05 -1.19 20.28 19.71 33.24 0.14 -3.28 32.74 0.01 -1.15 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 5 hits 1stc_c02 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 7 ASP~? 23.80 CH3 ACT A 134 E 168 LYS A 11 LYS~? 24.23 CH3 ACT A 134 E 171 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 37.70 12.40 8.53 36.14 12.23 7.15 coo 5.06 22.32 18.11 1.02 22.08 22.74 33.70 14.32 13.26 36.02 17.43 17.06 coo 6.68 21.78 22.39 5.28 20.74 23.60 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 95 ASP^? -2.87 O ACT A 134s E 168 LYS A 105 LYS^? 12.80 O ACT A 134 E 171 ASN A 106 ASN^? 5.57 O ACT A 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 13.92 6.03 15.16 12.65 6.91 13.72 coo 5.06 22.32 18.11 1.02 22.08 22.74 8.54 2.73 14.15 9.40 -2.89 16.14 coo 6.68 21.78 22.39 5.28 20.74 23.60 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP A 95 ASP^? -2.87 O ACT A 134s E 168 LYS A 105 LYS^? 12.80 O ACT A 134 E 171 ASN A 133 ASN.? 9.96 O ACT A 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 13.92 6.03 15.16 12.65 6.91 13.72 coo 5.06 22.32 18.11 1.02 22.08 22.74 8.54 2.73 14.15 9.40 -2.89 16.14 coo 6.68 21.78 22.39 5.28 20.74 23.60 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 7 ASP~? 23.98 CH3 ACT B 134 E 168 LYS B 11 LYS~? 24.30 CH3 ACT B 134 E 171 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 5.06 22.32 18.11 1.02 22.08 22.74 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo 6.68 21.78 22.39 5.28 20.74 23.60 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP B 95 ASP^? -2.82 OXT ACT B 134s E 168 LYS B 105 LYS^? 12.81 OXT ACT B 134 E 171 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 5.06 22.32 18.11 1.02 22.08 22.74 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 6.68 21.78 22.39 5.28 20.74 23.60 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP B 95 ASP^? -2.82 OXT ACT B 134s E 168 LYS B 105 LYS^? 12.81 OXT ACT B 134 E 171 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 5.06 22.32 18.11 1.02 22.08 22.74 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 6.68 21.78 22.39 5.28 20.74 23.60 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 7 3 # 7 E 166 ASP B 129 ASP.? 12.08 OXT ACT B 134 E 168 LYS B 105 LYS^? 12.81 OXT ACT B 134 E 171 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 5.36 16.20 22.10 3.88 17.00 23.31 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 5.06 22.32 18.11 1.02 22.08 22.74 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 6.68 21.78 22.39 5.28 20.74 23.60 10.24 11.30 -5.95 9.38 10.89 -4.04 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 7 hits 1stc_c03 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 16 GLY~? 13.90 CH3 ACT A 134 B 17 GLN A 22 GLN~? 15.94 CH3 ACT A 134 B 140 GLU A 18 GLU~? 15.74 CH3 ACT A 134 coo 61.49 19.86 5.96 61.52 19.46 5.16 25.51 16.68 15.22 25.71 15.94 15.51 coo 63.76 11.90 7.93 65.18 13.07 6.77 20.14 15.38 24.13 21.73 16.51 24.99 coo 66.44 19.00 7.38 67.69 17.67 8.37 26.95 12.09 19.56 26.58 10.45 20.84 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY A 27 GLY~? 12.00 CH3 ACT A 134 B 17 GLN A 22 GLN~? 15.94 CH3 ACT A 134 B 140 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 61.49 19.86 5.96 61.52 19.46 5.16 12.79 17.21 23.07 13.53 17.29 23.44 coo 63.76 11.90 7.93 65.18 13.07 6.77 20.14 15.38 24.13 21.73 16.51 24.99 coo 66.44 19.00 7.38 67.69 17.67 8.37 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY B 16 GLY~? 14.00 CH3 ACT B 134 B 17 GLN B 22 GLN~? 15.85 CH3 ACT B 134 B 140 GLU B 18 GLU~? 15.73 CH3 ACT B 134 coo 61.49 19.86 5.96 61.52 19.46 5.16 25.48 -0.27 -10.44 25.65 0.46 -10.73 coo 63.76 11.90 7.93 65.18 13.07 6.77 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 66.44 19.00 7.38 67.69 17.67 8.37 26.90 4.34 -14.80 26.44 5.99 -16.02 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY B 27 GLY~? 11.93 CH3 ACT B 134 B 17 GLN B 22 GLN~? 15.85 CH3 ACT B 134 B 140 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 61.49 19.86 5.96 61.52 19.46 5.16 12.59 -0.72 -18.35 13.34 -0.79 -18.69 coo 63.76 11.90 7.93 65.18 13.07 6.77 20.08 1.10 -19.32 21.69 -0.02 -20.11 coo 66.44 19.00 7.38 67.69 17.67 8.37 15.52 -2.78 -21.66 14.62 -4.61 -22.18 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 4 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 78 SER^? 12.19 O ACT A 134 A 90 SER A 77 SER^? 10.05 O ACT A 134 A 145 LYS A 105 LYS^? 12.80 O ACT A 134 coo -3.31 40.95 15.56 -0.94 40.79 14.97 20.05 1.17 15.74 19.11 -0.15 13.92 coo 1.47 40.03 18.48 2.45 41.37 16.68 17.06 1.63 18.02 14.62 1.36 17.91 coo 7.35 44.71 16.29 4.71 40.98 14.52 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER B 78 SER^? 12.20 OXT ACT B 134 A 90 SER B 77 SER^? 10.03 OXT ACT B 134 A 145 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo -3.31 40.95 15.56 -0.94 40.79 14.97 20.02 15.26 -10.83 19.07 16.62 -8.98 coo 1.47 40.03 18.48 2.45 41.37 16.68 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 7.35 44.71 16.29 4.71 40.98 14.52 8.51 13.68 -9.31 9.43 19.36 -11.32 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 2 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER B 78 SER^? 12.20 OXT ACT B 134 B 90 SER B 77 SER^? 10.03 OXT ACT B 134 B 145 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 61.01 10.03 12.97 58.78 10.97 12.69 20.02 15.26 -10.83 19.07 16.62 -8.98 coo 56.85 12.22 16.37 55.62 11.34 14.45 17.02 14.81 -13.13 14.60 15.11 -12.99 coo 49.80 9.51 14.88 53.14 11.99 12.77 8.51 13.68 -9.31 9.43 19.36 -11.32 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 1 hits 1t7d_c01 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 118 LYS^? 23.86 CH3 ACT A 134 138 ASN A 8 ASN~? 24.32 CH3 ACT A 134 183 HIS A 14 HIS~? 17.04 CH3 ACT A 134 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 28.94 23.42 11.82 28.39 29.21 14.30 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 36.73 18.38 9.71 35.57 19.92 10.59 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 30.04 10.42 13.88 29.99 8.58 12.87 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 11 LYS~? 24.30 CH3 ACT B 134 138 ASN B 8 ASN~? 24.46 CH3 ACT B 134 183 HIS B 4 HIS.? -31.93 CH3 ACT B 134s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 36.75 -2.07 -4.95 35.51 -3.62 -5.82 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 43.77 5.80 -4.34 45.50 5.09 -5.28 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS B 118 LYS^? 22.69 CH3 ACT B 134 138 ASN B 8 ASN~? 24.46 CH3 ACT B 134 183 HIS B 14 HIS~? 17.16 CH3 ACT B 134 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 36.75 -2.07 -4.95 35.51 -3.62 -5.82 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 30.01 5.88 -9.10 29.93 7.73 -8.13 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 3 hits 1uag_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 14 HIS~? 17.04 CH3 ACT A 134 89 GLU A 18 GLU~? 15.74 CH3 ACT A 134 243 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 5.83 15.74 17.38 6.41 17.70 17.86 30.04 10.42 13.88 29.99 8.58 12.87 coo 3.11 16.19 13.44 4.96 17.09 13.42 26.95 12.09 19.56 26.58 10.45 20.84 coo 0.53 21.81 31.33 1.05 20.47 29.70 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS B 14 HIS~? 17.16 CH3 ACT B 134 89 GLU B 18 GLU~? 15.73 CH3 ACT B 134 243 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 5.83 15.74 17.38 6.41 17.70 17.86 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 3.11 16.19 13.44 4.96 17.09 13.42 26.90 4.34 -14.80 26.44 5.99 -16.02 coo 0.53 21.81 31.33 1.05 20.47 29.70 31.66 3.78 4.83 30.09 2.36 4.90 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 2 hits 1ula_c00 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 39 ASP^? 22.84 CH3 ACT A 134 218 GLU A 96 GLU^? 11.35 O ACT A 134 329 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.90 30.21 5.13 24.67 29.05 5.02 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.55 2.34 19.02 11.24 0.31 19.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 80 ASP^? 13.33 O ACT A 134 218 GLU A 38 GLU^? 23.44 CH3 ACT A 134 329 ASP A 95 ASP^? -2.87 O ACT A 134s coo 49.16 35.16 15.19 51.08 34.43 15.65 21.99 0.20 10.14 20.59 -0.43 11.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 24.16 32.64 11.25 23.00 32.22 12.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 95 ASP^? -2.87 O ACT A 134s 218 GLU B 68 GLU~? 13.57 O ACT B 134 329 ASP A 80 ASP^? 13.33 O ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.92 6.03 15.16 12.65 6.91 13.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 3.61 -1.81 -13.67 2.55 -3.32 -12.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 95 ASP^? -2.87 O ACT A 134s 218 GLU B 96 GLU^? 11.19 OXT ACT B 134 329 ASP A 80 ASP^? 13.33 O ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.92 6.03 15.16 12.65 6.91 13.72 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.63 14.13 -14.15 11.77 16.24 -14.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 39 ASP^? 22.90 CH3 ACT B 134 218 GLU B 96 GLU^? 11.19 OXT ACT B 134 329 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.63 14.13 -14.15 11.77 16.24 -14.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 80 ASP^? 13.20 OXT ACT B 134 218 GLU B 38 GLU^? 23.46 CH3 ACT B 134 329 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 49.16 35.16 15.19 51.08 34.43 15.65 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 24.12 -16.18 -6.62 22.89 -15.85 -8.32 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 95 ASP^? -2.82 OXT ACT B 134s 218 GLU A 68 GLU~? 13.77 OXT ACT A 134 329 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 70.09 11.71 8.46 70.56 12.89 6.77 3.88 18.36 18.49 2.57 19.83 17.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 95 ASP^? -2.82 OXT ACT B 134s 218 GLU A 96 GLU^? 11.35 O ACT A 134 329 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.55 2.34 19.02 11.24 0.31 19.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.98 16.13 -5.41 20.58 16.67 -6.85 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 8 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 34 ASP~? 20.39 CH3 ACT A 134 242 GLU A 48 GLU.? 14.70 OXT ACT A 134 329 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.17 25.65 19.58 23.03 26.79 20.97 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.89 23.33 8.60 3.75 23.77 10.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 34 ASP~? 20.39 CH3 ACT A 134 242 GLU A 68 GLU~? 13.77 OXT ACT A 134 329 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.17 25.65 19.58 23.03 26.79 20.97 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.88 18.36 18.49 2.57 19.83 17.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 95 ASP^? -2.87 O ACT A 134s 242 GLU A 48 GLU.? 14.70 OXT ACT A 134 329 ASP A 80 ASP^? 13.33 O ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.92 6.03 15.16 12.65 6.91 13.72 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.89 23.33 8.60 3.75 23.77 10.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 95 ASP^? -2.87 O ACT A 134s 242 GLU A 61 GLU~? 18.11 OXT ACT A 134 329 ASP A 80 ASP^? 13.33 O ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.92 6.03 15.16 12.65 6.91 13.72 coo 30.42 34.74 5.00 29.09 35.09 3.38 9.19 27.65 13.99 8.36 28.92 12.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 113 ASP^? 18.42 CH3 ACT A 134 242 GLU B 86 GLU.? 27.22 CH3 ACT A 134 329 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.00 19.90 3.85 25.60 19.04 1.99 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.82 0.62 5.15 36.84 -0.64 6.51 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 113 ASP^? 18.42 CH3 ACT A 134 242 GLU B 124 GLU^? -3.39 O ACT B 134s 329 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.00 19.90 3.85 25.60 19.04 1.99 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 34 ASP~? 20.32 CH3 ACT B 134 242 GLU B 48 GLU.? 15.07 O ACT B 134 329 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.87 -7.04 -3.75 3.32 -7.55 -5.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 34 ASP~? 20.32 CH3 ACT B 134 242 GLU B 68 GLU~? 13.57 O ACT B 134 329 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.61 -1.81 -13.67 2.55 -3.32 -12.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 95 ASP^? -2.82 OXT ACT B 134s 242 GLU B 48 GLU.? 15.07 O ACT B 134 329 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.87 -7.04 -3.75 3.32 -7.55 -5.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 95 ASP^? -2.82 OXT ACT B 134s 242 GLU B 61 GLU~? 17.99 O ACT B 134 329 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 30.42 34.74 5.00 29.09 35.09 3.38 9.01 -11.16 -9.07 8.40 -12.39 -7.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 113 ASP^? 18.51 CH3 ACT B 134 242 GLU A 124 GLU^? -3.29 OXT ACT A 134s 329 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo 49.16 35.16 15.19 51.08 34.43 15.65 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.89 12.66 7.54 12.94 12.92 9.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.87 -13.88 -0.47 24.63 -12.69 -0.32 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 11 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 596 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 647 ARG A 94 ARG^? 12.39 O ACT A 134 coo 69.13 32.20 28.58 68.39 32.96 30.44 21.29 4.79 5.54 21.77 3.26 4.19 coo 70.89 37.31 29.70 69.54 36.29 32.39 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 596 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 647 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo 69.13 32.20 28.58 68.39 32.96 30.44 21.22 11.60 -0.72 21.76 13.12 0.60 coo 70.89 37.31 29.70 69.54 36.29 32.39 19.67 16.84 1.03 22.28 17.57 2.36 coo 66.09 40.54 34.70 66.92 37.69 35.49 16.67 17.44 -7.09 15.78 18.56 -9.82 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 596 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 647 ARG A 94 ARG^? 12.39 O ACT A 134 coo 38.22 57.83 70.36 36.82 56.74 69.18 21.29 4.79 5.54 21.77 3.26 4.19 coo 34.24 60.89 68.08 33.31 57.93 67.63 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 596 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 647 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo 38.22 57.83 70.36 36.82 56.74 69.18 21.22 11.60 -0.72 21.76 13.12 0.60 coo 34.24 60.89 68.08 33.31 57.93 67.63 19.67 16.84 1.03 22.28 17.57 2.36 coo 31.43 57.38 61.97 31.90 55.58 64.41 16.67 17.44 -7.09 15.78 18.56 -9.82 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 596 ARG B 123 ARG^? 15.62 CH3 ACT B 134 C 647 ARG A 94 ARG^? 12.39 O ACT A 134 coo 11.31 31.26 27.00 13.31 30.71 26.58 21.29 4.79 5.54 21.77 3.26 4.19 coo 13.44 32.78 22.07 15.56 30.91 23.37 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU B 92 GLU^? 14.52 OXT ACT B 134 C 596 ARG A 123 ARG^? 15.41 CH3 ACT A 134 C 647 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo 11.31 31.26 27.00 13.31 30.71 26.58 21.22 11.60 -0.72 21.76 13.12 0.60 coo 13.44 32.78 22.07 15.56 30.91 23.37 19.67 16.84 1.03 22.28 17.57 2.36 coo 21.00 33.35 22.82 19.83 30.82 24.09 16.67 17.44 -7.09 15.78 18.56 -9.82 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 92 GLU^? 14.49 CH3 ACT A 134 D 596 ARG B 123 ARG^? 15.62 CH3 ACT B 134 D 647 ARG A 94 ARG^? 12.39 O ACT A 134 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 21.29 4.79 5.54 21.77 3.26 4.19 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU B 92 GLU^? 14.52 OXT ACT B 134 D 596 ARG A 123 ARG^? 15.41 CH3 ACT A 134 D 647 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 21.22 11.60 -0.72 21.76 13.12 0.60 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 19.67 16.84 1.03 22.28 17.57 2.36 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 16.67 17.44 -7.09 15.78 18.56 -9.82 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 92 GLU^? 14.49 CH3 ACT A 134 E 596 ARG B 123 ARG^? 15.62 CH3 ACT B 134 E 647 ARG A 94 ARG^? 12.39 O ACT A 134 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 21.29 4.79 5.54 21.77 3.26 4.19 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU B 92 GLU^? 14.52 OXT ACT B 134 E 596 ARG A 123 ARG^? 15.41 CH3 ACT A 134 E 647 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 21.22 11.60 -0.72 21.76 13.12 0.60 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 19.67 16.84 1.03 22.28 17.57 2.36 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 16.67 17.44 -7.09 15.78 18.56 -9.82 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 92 GLU^? 14.49 CH3 ACT A 134 F 596 ARG B 123 ARG^? 15.62 CH3 ACT B 134 F 647 ARG A 94 ARG^? 12.39 O ACT A 134 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 21.29 4.79 5.54 21.77 3.26 4.19 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU B 92 GLU^? 14.52 OXT ACT B 134 F 596 ARG A 123 ARG^? 15.41 CH3 ACT A 134 F 647 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 21.22 11.60 -0.72 21.76 13.12 0.60 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 19.67 16.84 1.03 22.28 17.57 2.36 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 16.67 17.44 -7.09 15.78 18.56 -9.82 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 106 ASN^? 5.57 O ACT A 134 457 GLY A 97 GLY^? 8.59 O ACT A 134 459 GLU A 96 GLU^? 11.35 O ACT A 134 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 10.24 5.16 10.78 9.42 5.53 8.84 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 8.55 6.05 19.94 8.09 5.69 19.35 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 11.55 2.34 19.02 11.24 0.31 19.55 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 133 ASN.? 9.96 O ACT A 134 457 GLY A 97 GLY^? 8.59 O ACT A 134 459 GLU A 96 GLU^? 11.35 O ACT A 134 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 12.00 -0.05 11.64 12.23 -0.65 13.67 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 8.55 6.05 19.94 8.09 5.69 19.35 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 11.55 2.34 19.02 11.24 0.31 19.55 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 106 ASN^? 5.54 OXT ACT B 134 457 GLY B 97 GLY^? 8.55 OXT ACT B 134 459 GLU B 96 GLU^? 11.19 OXT ACT B 134 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 10.24 11.30 -5.95 9.38 10.89 -4.04 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 8.48 10.40 -15.07 8.02 10.78 -14.50 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 11.63 14.13 -14.15 11.77 16.24 -14.29 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN B 133 ASN.? 9.91 OXT ACT B 134 457 GLY B 97 GLY^? 8.55 OXT ACT B 134 459 GLU B 96 GLU^? 11.19 OXT ACT B 134 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 12.00 16.42 -6.80 12.35 17.03 -8.83 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 8.48 10.40 -15.07 8.02 10.78 -14.50 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 11.63 14.13 -14.15 11.77 16.24 -14.29 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 122 TYR^? 8.33 CH3 ACT A 134 A 317 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 365 ARG A 58 ARG~? 15.97 OXT ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 18.19 17.99 8.45 16.46 16.26 9.80 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.89 12.66 7.54 12.94 12.92 9.40 coo 3.82 17.09 49.56 4.09 14.32 50.84 9.78 27.17 8.97 7.03 26.14 8.06 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 317 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 365 ARG A 81 ARG^? 17.75 O ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.00 10.76 2.04 17.57 12.50 0.46 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.89 12.66 7.54 12.94 12.92 9.40 coo 3.82 17.09 49.56 4.09 14.32 50.84 23.88 0.36 5.26 23.01 -2.52 5.93 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 317 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 365 ARG A 107 ARG^? 13.51 O ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.00 10.76 2.04 17.57 12.50 0.46 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.89 12.66 7.54 12.94 12.92 9.40 coo 3.82 17.09 49.56 4.09 14.32 50.84 14.42 -0.01 7.43 16.47 -2.30 7.52 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 317 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 365 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.00 10.76 2.04 17.57 12.50 0.46 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.89 12.66 7.54 12.94 12.92 9.40 coo 3.82 17.09 49.56 4.09 14.32 50.84 16.67 17.44 -7.09 15.78 18.56 -9.82 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 317 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 365 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.00 10.76 2.04 17.57 12.50 0.46 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.89 12.66 7.54 12.94 12.92 9.40 coo 3.82 17.09 49.56 4.09 14.32 50.84 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 317 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 365 ARG A 81 ARG^? 17.75 O ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.00 10.76 2.04 17.57 12.50 0.46 coo 3.06 2.85 52.79 4.83 3.89 53.24 21.22 11.60 -0.72 21.76 13.12 0.60 coo 3.82 17.09 49.56 4.09 14.32 50.84 23.88 0.36 5.26 23.01 -2.52 5.93 ULMN 3 1vzx_c02 2.04.01.0087 user 7 3 # 7 A 314 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 317 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 365 ARG A 107 ARG^? 13.51 O ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.00 10.76 2.04 17.57 12.50 0.46 coo 3.06 2.85 52.79 4.83 3.89 53.24 21.22 11.60 -0.72 21.76 13.12 0.60 coo 3.82 17.09 49.56 4.09 14.32 50.84 14.42 -0.01 7.43 16.47 -2.30 7.52 ULMN 3 1vzx_c02 2.04.01.0087 user 8 3 # 8 A 314 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 317 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 365 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.00 10.76 2.04 17.57 12.50 0.46 coo 3.06 2.85 52.79 4.83 3.89 53.24 21.22 11.60 -0.72 21.76 13.12 0.60 coo 3.82 17.09 49.56 4.09 14.32 50.84 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1vzx_c02 2.04.01.0087 user 9 3 # 9 A 314 TYR B 122 TYR^? 8.37 CH3 ACT B 134 A 317 GLU B 124 GLU^? -3.39 O ACT B 134s A 365 ARG B 58 ARG~? 15.94 O ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 9.78 -10.54 -4.22 7.03 -9.65 -3.15 ULMN 3 1vzx_c02 2.04.01.0087 user 10 3 # 10 A 314 TYR B 125 TYR^? 11.31 O ACT A 134 A 317 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 365 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.01 5.62 2.81 17.58 3.86 4.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 21.29 4.79 5.54 21.77 3.26 4.19 coo 3.82 17.09 49.56 4.09 14.32 50.84 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1vzx_c02 2.04.01.0087 user 11 3 # 11 A 314 TYR B 125 TYR^? 11.31 O ACT A 134 A 317 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 365 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.01 5.62 2.81 17.58 3.86 4.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 21.29 4.79 5.54 21.77 3.26 4.19 coo 3.82 17.09 49.56 4.09 14.32 50.84 23.90 15.91 -0.43 22.97 18.81 -0.95 ULMN 3 1vzx_c02 2.04.01.0087 user 12 3 # 12 A 314 TYR B 125 TYR^? 11.31 O ACT A 134 A 317 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 365 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.01 5.62 2.81 17.58 3.86 4.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 21.29 4.79 5.54 21.77 3.26 4.19 coo 3.82 17.09 49.56 4.09 14.32 50.84 14.41 16.45 -2.54 16.63 18.58 -2.64 ULMN 3 1vzx_c02 2.04.01.0087 user 13 3 # 13 A 314 TYR B 125 TYR^? 11.31 O ACT A 134 A 317 GLU B 124 GLU^? -3.39 O ACT B 134s A 365 ARG A 94 ARG^? 12.39 O ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.01 5.62 2.81 17.58 3.86 4.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1vzx_c02 2.04.01.0087 user 14 3 # 14 A 314 TYR B 125 TYR^? 11.31 O ACT A 134 A 317 GLU B 124 GLU^? -3.39 O ACT B 134s A 365 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.01 5.62 2.81 17.58 3.86 4.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1vzx_c02 2.04.01.0087 user 15 3 # 15 A 314 TYR B 125 TYR^? 11.31 O ACT A 134 A 317 GLU B 124 GLU^? -3.39 O ACT B 134s A 365 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.01 5.62 2.81 17.58 3.86 4.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 23.90 15.91 -0.43 22.97 18.81 -0.95 ULMN 3 1vzx_c02 2.04.01.0087 user 16 3 # 16 A 314 TYR B 125 TYR^? 11.31 O ACT A 134 A 317 GLU B 124 GLU^? -3.39 O ACT B 134s A 365 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo 1.77 6.56 57.05 3.05 7.44 59.37 16.01 5.62 2.81 17.58 3.86 4.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 3.82 17.09 49.56 4.09 14.32 50.84 14.41 16.45 -2.54 16.63 18.58 -2.64 1vzx_c02 source 1vzx 2.04.01.0087 : 16 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 122 TYR^? 8.33 CH3 ACT A 134 B1317 GLU A 124 GLU^? -3.29 OXT ACT A 134s B1365 ARG A 58 ARG~? 15.97 OXT ACT A 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 18.19 17.99 8.45 16.46 16.26 9.80 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.89 12.66 7.54 12.94 12.92 9.40 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 9.78 27.17 8.97 7.03 26.14 8.06 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 125 TYR^? 11.32 OXT ACT B 134 B1317 GLU A 124 GLU^? -3.29 OXT ACT A 134s B1365 ARG A 81 ARG^? 17.75 O ACT A 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.00 10.76 2.04 17.57 12.50 0.46 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.89 12.66 7.54 12.94 12.92 9.40 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 23.88 0.36 5.26 23.01 -2.52 5.93 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR A 125 TYR^? 11.32 OXT ACT B 134 B1317 GLU A 124 GLU^? -3.29 OXT ACT A 134s B1365 ARG B 94 ARG^? 12.34 OXT ACT B 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.00 10.76 2.04 17.57 12.50 0.46 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.89 12.66 7.54 12.94 12.92 9.40 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 16.67 17.44 -7.09 15.78 18.56 -9.82 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR A 125 TYR^? 11.32 OXT ACT B 134 B1317 GLU A 124 GLU^? -3.29 OXT ACT A 134s B1365 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.00 10.76 2.04 17.57 12.50 0.46 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.89 12.66 7.54 12.94 12.92 9.40 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR A 125 TYR^? 11.32 OXT ACT B 134 B1317 GLU B 92 GLU^? 14.52 OXT ACT B 134 B1365 ARG A 81 ARG^? 17.75 O ACT A 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.00 10.76 2.04 17.57 12.50 0.46 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.22 11.60 -0.72 21.76 13.12 0.60 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 23.88 0.36 5.26 23.01 -2.52 5.93 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR A 125 TYR^? 11.32 OXT ACT B 134 B1317 GLU B 92 GLU^? 14.52 OXT ACT B 134 B1365 ARG A 107 ARG^? 13.51 O ACT A 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.00 10.76 2.04 17.57 12.50 0.46 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.22 11.60 -0.72 21.76 13.12 0.60 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 14.42 -0.01 7.43 16.47 -2.30 7.52 ULMN 3 1vzx_c03 2.04.01.0087 user 7 3 # 7 B1314 TYR A 125 TYR^? 11.32 OXT ACT B 134 B1317 GLU B 92 GLU^? 14.52 OXT ACT B 134 B1365 ARG B 123 ARG^? 15.62 CH3 ACT B 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.00 10.76 2.04 17.57 12.50 0.46 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.22 11.60 -0.72 21.76 13.12 0.60 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 19.60 -0.44 3.82 22.23 -1.26 2.52 ULMN 3 1vzx_c03 2.04.01.0087 user 8 3 # 8 B1314 TYR B 122 TYR^? 8.37 CH3 ACT B 134 B1317 GLU B 124 GLU^? -3.39 O ACT B 134s B1365 ARG B 58 ARG~? 15.94 O ACT B 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 9.78 -10.54 -4.22 7.03 -9.65 -3.15 ULMN 3 1vzx_c03 2.04.01.0087 user 9 3 # 9 B1314 TYR B 125 TYR^? 11.31 O ACT A 134 B1317 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B1365 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.01 5.62 2.81 17.58 3.86 4.41 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.29 4.79 5.54 21.77 3.26 4.19 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1vzx_c03 2.04.01.0087 user 10 3 # 10 B1314 TYR B 125 TYR^? 11.31 O ACT A 134 B1317 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B1365 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.01 5.62 2.81 17.58 3.86 4.41 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.29 4.79 5.54 21.77 3.26 4.19 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 23.90 15.91 -0.43 22.97 18.81 -0.95 ULMN 3 1vzx_c03 2.04.01.0087 user 11 3 # 11 B1314 TYR B 125 TYR^? 11.31 O ACT A 134 B1317 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B1365 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.01 5.62 2.81 17.58 3.86 4.41 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.29 4.79 5.54 21.77 3.26 4.19 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 14.41 16.45 -2.54 16.63 18.58 -2.64 ULMN 3 1vzx_c03 2.04.01.0087 user 12 3 # 12 B1314 TYR B 125 TYR^? 11.31 O ACT A 134 B1317 GLU B 124 GLU^? -3.39 O ACT B 134s B1365 ARG A 94 ARG^? 12.39 O ACT A 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.01 5.62 2.81 17.58 3.86 4.41 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 16.69 -1.11 11.91 15.79 -2.18 14.67 ULMN 3 1vzx_c03 2.04.01.0087 user 13 3 # 13 B1314 TYR B 125 TYR^? 11.31 O ACT A 134 B1317 GLU B 124 GLU^? -3.39 O ACT B 134s B1365 ARG A 123 ARG^? 15.41 CH3 ACT A 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.01 5.62 2.81 17.58 3.86 4.41 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 19.67 16.84 1.03 22.28 17.57 2.36 ULMN 3 1vzx_c03 2.04.01.0087 user 14 3 # 14 B1314 TYR B 125 TYR^? 11.31 O ACT A 134 B1317 GLU B 124 GLU^? -3.39 O ACT B 134s B1365 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 16.01 5.62 2.81 17.58 3.86 4.41 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 23.90 15.91 -0.43 22.97 18.81 -0.95 1vzx_c03 source 1vzx 2.04.01.0087 : 14 hits 1vzx_c03 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 27 GLY~? 12.00 CH3 ACT A 134 B 419 GLY A 23 GLY~? 10.10 CH3 ACT A 134 B 420 ALA A 25 ALA~? 11.23 CH3 ACT A 134 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 12.79 17.21 23.07 13.53 17.29 23.44 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 16.75 16.04 20.74 16.75 15.21 20.79 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 14.91 11.38 23.04 16.16 10.69 23.60 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 97 GLY^? 8.59 O ACT A 134 B 419 GLY A 73 GLY.? 10.39 CH3 ACT A 134 B 420 ALA A 25 ALA~? 11.23 CH3 ACT A 134 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 8.55 6.05 19.94 8.09 5.69 19.35 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 10.49 10.94 22.88 9.98 10.36 22.90 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 14.91 11.38 23.04 16.16 10.69 23.60 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY B 27 GLY~? 11.93 CH3 ACT B 134 B 419 GLY B 23 GLY~? 10.01 CH3 ACT B 134 B 420 ALA B 25 ALA~? 11.19 CH3 ACT B 134 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 12.59 -0.72 -18.35 13.34 -0.79 -18.69 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 16.67 0.38 -15.90 16.69 1.21 -15.97 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 14.83 5.06 -18.24 16.09 5.75 -18.80 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY B 97 GLY^? 8.55 OXT ACT B 134 B 419 GLY B 73 GLY.? 10.25 CH3 ACT B 134 B 420 ALA B 25 ALA~? 11.19 CH3 ACT B 134 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 8.48 10.40 -15.07 8.02 10.78 -14.50 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 10.45 5.54 -18.05 9.93 6.10 -18.07 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 14.83 5.06 -18.24 16.09 5.75 -18.80 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 4 hits 1xny_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 B 126 ARG A 81 ARG^? 17.75 O ACT A 134 B 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 23.88 0.36 5.26 23.01 -2.52 5.93 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 B 126 ARG A 81 ARG^? 17.75 O ACT A 134 B 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 23.88 0.36 5.26 23.01 -2.52 5.93 coo 6.10 2.00 25.24 6.12 1.84 23.13 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 B 126 ARG A 107 ARG^? 13.51 O ACT A 134 B 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 6.10 2.00 25.24 6.12 1.84 23.13 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 B 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 B 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 6.10 2.00 25.24 6.12 1.84 23.13 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 B 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.45 5.53 11.28 3.59 7.56 13.29 19.67 16.84 1.03 22.28 17.57 2.36 coo 6.10 2.00 25.24 6.12 1.84 23.13 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 B 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.45 5.53 11.28 3.59 7.56 13.29 19.67 16.84 1.03 22.28 17.57 2.36 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 B 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.45 5.53 11.28 3.59 7.56 13.29 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 B 126 ARG B 107 ARG^? 13.48 OXT ACT B 134 B 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo 2.11 4.00 19.31 3.14 4.86 19.99 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.45 5.53 11.28 3.59 7.56 13.29 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 6.10 2.00 25.24 6.12 1.84 23.13 21.29 4.79 5.54 21.77 3.26 4.19 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 9 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 C 126 ARG A 81 ARG^? 17.75 O ACT A 134 C 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 23.88 0.36 5.26 23.01 -2.52 5.93 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 C 126 ARG A 81 ARG^? 17.75 O ACT A 134 C 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 23.88 0.36 5.26 23.01 -2.52 5.93 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 C 126 ARG A 107 ARG^? 13.51 O ACT A 134 C 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 14.42 -0.01 7.43 16.47 -2.30 7.52 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 C 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 C 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 C 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 C 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 C 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 C 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 19.67 16.84 1.03 22.28 17.57 2.36 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 C 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 C 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 19.67 16.84 1.03 22.28 17.57 2.36 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 C 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 C 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 C 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 C 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 C 126 ARG B 107 ARG^? 13.48 OXT ACT B 134 C 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 14.41 16.45 -2.54 16.63 18.58 -2.64 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.29 4.79 5.54 21.77 3.26 4.19 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 10 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 D 126 ARG A 81 ARG^? 17.75 O ACT A 134 D 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 23.88 0.36 5.26 23.01 -2.52 5.93 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 D 126 ARG A 81 ARG^? 17.75 O ACT A 134 D 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 23.88 0.36 5.26 23.01 -2.52 5.93 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 D 126 ARG A 107 ARG^? 13.51 O ACT A 134 D 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 D 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 D 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 D 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 D 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.37 6.41 18.44 7.98 4.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 D 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 D 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 19.67 16.84 1.03 22.28 17.57 2.36 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 D 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 D 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 19.67 16.84 1.03 22.28 17.57 2.36 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 D 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 D 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 D 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 D 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 D 126 ARG B 107 ARG^? 13.48 OXT ACT B 134 D 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 18.06 8.00 -1.55 18.47 8.38 -0.11 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.29 4.79 5.54 21.77 3.26 4.19 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 10 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 E 126 ARG A 81 ARG^? 17.75 O ACT A 134 E 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 23.88 0.36 5.26 23.01 -2.52 5.93 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 E 126 ARG A 81 ARG^? 17.75 O ACT A 134 E 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 23.88 0.36 5.26 23.01 -2.52 5.93 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 E 126 ARG A 107 ARG^? 13.51 O ACT A 134 E 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 14.42 -0.01 7.43 16.47 -2.30 7.52 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 E 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 E 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 E 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 E 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.37 6.41 18.44 7.98 4.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 E 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 E 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.02 12.00 70.07 -1.94 13.84 67.82 19.67 16.84 1.03 22.28 17.57 2.36 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 E 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 E 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.02 12.00 70.07 -1.94 13.84 67.82 19.67 16.84 1.03 22.28 17.57 2.36 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 E 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 E 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.02 12.00 70.07 -1.94 13.84 67.82 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 E 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 E 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.02 12.00 70.07 -1.94 13.84 67.82 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 E 126 ARG B 107 ARG^? 13.48 OXT ACT B 134 E 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -4.56 10.03 62.36 -4.38 11.31 61.55 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -3.02 12.00 70.07 -1.94 13.84 67.82 14.41 16.45 -2.54 16.63 18.58 -2.64 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.29 4.79 5.54 21.77 3.26 4.19 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 10 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 F 126 ARG A 81 ARG^? 17.75 O ACT A 134 F 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.37 6.41 18.44 7.98 4.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 23.88 0.36 5.26 23.01 -2.52 5.93 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 F 126 ARG A 81 ARG^? 17.75 O ACT A 134 F 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.37 6.41 18.44 7.98 4.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 23.88 0.36 5.26 23.01 -2.52 5.93 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 F 126 ARG A 107 ARG^? 13.51 O ACT A 134 F 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.37 6.41 18.44 7.98 4.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 14.42 -0.01 7.43 16.47 -2.30 7.52 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 F 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 F 138 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.37 6.41 18.44 7.98 4.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA A 109 ALA^? 9.97 CH3 ACT A 134 F 126 ARG B 123 ARG^? 15.62 CH3 ACT B 134 F 138 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.37 6.41 18.44 7.98 4.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 F 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 F 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 19.67 16.84 1.03 22.28 17.57 2.36 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 F 126 ARG A 123 ARG^? 15.41 CH3 ACT A 134 F 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 19.67 16.84 1.03 22.28 17.57 2.36 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 F 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 F 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 F 126 ARG B 81 ARG^? 17.71 OXT ACT B 134 F 138 GLU B 124 GLU^? -3.39 O ACT B 134s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.91 3.81 -2.65 12.88 3.52 -4.44 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA B 109 ALA^? 10.21 CH3 ACT B 134 F 126 ARG B 107 ARG^? 13.48 OXT ACT B 134 F 138 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 18.06 8.00 -1.55 18.47 8.38 -0.11 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 14.41 16.45 -2.54 16.63 18.58 -2.64 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.29 4.79 5.54 21.77 3.26 4.19 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 10 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 51 GLY^? 14.42 OXT ACT A 134 B 175 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 242 TYR A 122 TYR^? 8.33 CH3 ACT A 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 10.22 20.76 0.78 10.34 20.77 1.56 coo 106.37 63.53 0.89 108.02 63.40 -1.62 19.67 16.84 1.03 22.28 17.57 2.36 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.19 17.99 8.45 16.46 16.26 9.80 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 51 GLY^? 14.42 OXT ACT A 134 B 175 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 242 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 10.22 20.76 0.78 10.34 20.77 1.56 coo 106.37 63.53 0.89 108.02 63.40 -1.62 19.67 16.84 1.03 22.28 17.57 2.36 coo 100.93 69.04 4.38 99.52 68.48 2.09 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 127 GLY.? 9.53 O ACT A 134 B 175 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 242 TYR B 122 TYR^? 8.37 CH3 ACT B 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 12.52 4.09 4.54 11.86 4.20 4.96 coo 106.37 63.53 0.89 108.02 63.40 -1.62 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.14 -1.53 -3.61 16.39 0.20 -4.99 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY A 130 GLY.? 7.72 O ACT A 134 B 175 ARG A 107 ARG^? 13.51 O ACT A 134 B 242 TYR B 125 TYR^? 11.31 O ACT A 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 5.91 4.26 10.34 5.79 3.49 10.19 coo 106.37 63.53 0.89 108.02 63.40 -1.62 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 100.93 69.04 4.38 99.52 68.48 2.09 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 51 GLY^? 14.43 O ACT B 134 B 175 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 242 TYR B 122 TYR^? 8.37 CH3 ACT B 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 10.20 -4.27 4.11 10.27 -4.29 3.32 coo 106.37 63.53 0.89 108.02 63.40 -1.62 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.14 -1.53 -3.61 16.39 0.20 -4.99 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 51 GLY^? 14.43 O ACT B 134 B 175 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 242 TYR B 125 TYR^? 11.31 O ACT A 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 10.20 -4.27 4.11 10.27 -4.29 3.32 coo 106.37 63.53 0.89 108.02 63.40 -1.62 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 100.93 69.04 4.38 99.52 68.48 2.09 16.01 5.62 2.81 17.58 3.86 4.41 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY B 127 GLY.? 9.55 OXT ACT B 134 B 175 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 242 TYR A 122 TYR^? 8.33 CH3 ACT A 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 12.50 12.31 0.32 11.86 12.20 -0.12 coo 106.37 63.53 0.89 108.02 63.40 -1.62 19.67 16.84 1.03 22.28 17.57 2.36 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.19 17.99 8.45 16.46 16.26 9.80 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY B 130 GLY.? 7.66 OXT ACT B 134 B 175 ARG B 107 ARG^? 13.48 OXT ACT B 134 B 242 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 99.45 58.28 3.33 99.57 58.61 4.10 5.91 12.14 -5.55 5.78 12.90 -5.37 coo 106.37 63.53 0.89 108.02 63.40 -1.62 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 100.93 69.04 4.38 99.52 68.48 2.09 16.00 10.76 2.04 17.57 12.50 0.46 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 8 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 A 165 GLU A 28 GLU.? 17.43 CH3 ACT A 134 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.29 28.50 12.14 22.41 28.51 15.17 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.42 25.37 15.69 13.26 28.28 21.22 coo 22.22 16.06 48.76 23.94 15.33 49.78 15.61 19.30 26.46 14.70 21.14 26.89 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 A 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 18.28 7.83 36.39 22.82 8.75 39.52 17.29 28.50 12.14 22.41 28.51 15.17 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.42 25.37 15.69 13.26 28.28 21.22 coo 22.22 16.06 48.76 23.94 15.33 49.78 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 A 165 GLU B 28 GLU.? 17.35 CH3 ACT B 134 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 15.52 -2.78 -21.66 14.62 -4.61 -22.18 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 A 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo 18.28 7.83 36.39 22.82 8.75 39.52 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 13.91 3.81 -2.65 12.88 3.52 -4.44 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 56 LYS~? 20.00 CH3 ACT A 134 B 74 LYS A 60 LYS~? 19.22 CH3 ACT A 134 B 165 GLU A 124 GLU^? -3.29 OXT ACT A 134s coo 13.51 0.92 76.10 12.98 6.13 74.68 17.29 28.50 12.14 22.41 28.51 15.17 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.42 25.37 15.69 13.26 28.28 21.22 coo 21.39 11.56 68.52 20.24 13.13 67.73 13.89 12.66 7.54 12.94 12.92 9.40 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS B 56 LYS~? 20.04 CH3 ACT B 134 B 74 LYS B 60 LYS~? 18.28 CH3 ACT B 134 B 165 GLU B 124 GLU^? -3.39 O ACT B 134s coo 13.51 0.92 76.10 12.98 6.13 74.68 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.39 -8.84 -10.92 12.04 -11.20 -15.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 13.91 3.81 -2.65 12.88 3.52 -4.44 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 371 LYS A 11 LYS~? 24.23 CH3 ACT A 134 A 407 THR A 9 THR~? 21.47 CH3 ACT A 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 37.70 12.40 8.53 36.14 12.23 7.15 coo -4.43 30.92 22.89 -6.61 31.91 19.71 33.70 14.32 13.26 36.02 17.43 17.06 coo -8.38 36.02 19.06 -8.83 34.10 19.89 33.26 16.17 8.09 32.71 16.27 5.99 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 371 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 407 THR A 37 THR^? 20.64 CH3 ACT A 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 22.90 30.21 5.13 24.67 29.05 5.02 coo -4.43 30.92 22.89 -6.61 31.91 19.71 17.29 28.50 12.14 22.41 28.51 15.17 coo -8.38 36.02 19.06 -8.83 34.10 19.89 24.88 27.66 10.30 25.68 26.74 8.52 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 371 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 407 THR A 41 THR^? 18.02 CH3 ACT A 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 22.90 30.21 5.13 24.67 29.05 5.02 coo -4.43 30.92 22.89 -6.61 31.91 19.71 17.29 28.50 12.14 22.41 28.51 15.17 coo -8.38 36.02 19.06 -8.83 34.10 19.89 18.34 24.70 5.20 19.06 25.00 3.19 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 371 LYS B 11 LYS~? 24.30 CH3 ACT B 134 A 407 THR B 9 THR~? 21.72 CH3 ACT B 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 37.67 3.93 -3.68 36.11 4.07 -2.28 coo -4.43 30.92 22.89 -6.61 31.91 19.71 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo -8.38 36.02 19.06 -8.83 34.10 19.89 33.24 0.14 -3.28 32.74 0.01 -1.15 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 371 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 407 THR B 37 THR^? 20.68 CH3 ACT B 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo -4.43 30.92 22.89 -6.61 31.91 19.71 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo -8.38 36.02 19.06 -8.83 34.10 19.89 24.74 -11.26 -5.58 25.50 -10.43 -3.73 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 371 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 407 THR B 41 THR^? 18.20 CH3 ACT B 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo -4.43 30.92 22.89 -6.61 31.91 19.71 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo -8.38 36.02 19.06 -8.83 34.10 19.89 18.35 -8.32 -0.39 19.10 -8.72 1.61 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 6 hits 1zrz_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 371 LYS A 11 LYS~? 24.23 CH3 ACT A 134 A 374 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 37.70 12.40 8.53 36.14 12.23 7.15 coo -4.43 30.92 22.89 -6.61 31.91 19.71 33.70 14.32 13.26 36.02 17.43 17.06 coo -4.84 27.04 20.49 -6.40 27.76 19.26 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 95 ASP^? -2.87 O ACT A 134s A 371 LYS A 105 LYS^? 12.80 O ACT A 134 A 374 ASN A 106 ASN^? 5.57 O ACT A 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 13.92 6.03 15.16 12.65 6.91 13.72 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.54 2.73 14.15 9.40 -2.89 16.14 coo -4.84 27.04 20.49 -6.40 27.76 19.26 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP A 95 ASP^? -2.87 O ACT A 134s A 371 LYS A 105 LYS^? 12.80 O ACT A 134 A 374 ASN A 133 ASN.? 9.96 O ACT A 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 13.92 6.03 15.16 12.65 6.91 13.72 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.54 2.73 14.15 9.40 -2.89 16.14 coo -4.84 27.04 20.49 -6.40 27.76 19.26 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP A 129 ASP.? 12.18 O ACT A 134 A 371 LYS A 105 LYS^? 12.80 O ACT A 134 A 374 ASN A 106 ASN^? 5.57 O ACT A 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 4.86 1.75 6.36 4.91 0.13 7.65 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.54 2.73 14.15 9.40 -2.89 16.14 coo -4.84 27.04 20.49 -6.40 27.76 19.26 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 371 LYS B 11 LYS~? 24.30 CH3 ACT B 134 A 374 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 37.67 3.93 -3.68 36.11 4.07 -2.28 coo -4.43 30.92 22.89 -6.61 31.91 19.71 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo -4.84 27.04 20.49 -6.40 27.76 19.26 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 371 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 374 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 13.83 10.37 -10.37 12.59 9.49 -8.86 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -4.84 27.04 20.49 -6.40 27.76 19.26 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 371 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 374 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 13.83 10.37 -10.37 12.59 9.49 -8.86 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -4.84 27.04 20.49 -6.40 27.76 19.26 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 8 3 # 8 A 369 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 371 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 374 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo -5.17 31.09 15.73 -7.07 31.12 16.73 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -4.43 30.92 22.89 -6.61 31.91 19.71 8.51 13.68 -9.31 9.43 19.36 -11.32 coo -4.84 27.04 20.49 -6.40 27.76 19.26 10.24 11.30 -5.95 9.38 10.89 -4.04 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 8 hits 1zrz_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 43 TRP^? 14.25 OXT ACT B 134 223 ASP B 80 ASP^? 13.20 OXT ACT B 134 258 ALA A 109 ALA^? 9.97 CH3 ACT A 134 coo 128.40 33.01 26.67 128.12 36.28 28.81 15.04 20.31 0.01 11.76 18.61 -1.33 coo 127.91 41.73 23.55 129.18 40.35 24.44 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 141.00 37.49 25.74 139.80 37.53 24.78 18.06 8.37 6.41 18.44 7.98 4.99 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP B 43 TRP^? 14.30 O ACT A 134 223 ASP A 80 ASP^? 13.33 O ACT A 134 258 ALA B 109 ALA^? 10.21 CH3 ACT B 134 coo 128.40 33.01 26.67 128.12 36.28 28.81 15.09 -3.95 4.83 11.80 -2.25 6.20 coo 127.91 41.73 23.55 129.18 40.35 24.44 21.99 0.20 10.14 20.59 -0.43 11.58 coo 141.00 37.49 25.74 139.80 37.53 24.78 18.06 8.00 -1.55 18.47 8.38 -0.11 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 2 hits 2aat_c01 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 34 ASP~? 20.39 CH3 ACT A 134 231 ASP A 95 ASP^? -2.87 O ACT A 134s 294 ASP A 117 ASP.? 24.68 CH3 ACT A 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 24.17 25.65 19.58 23.03 26.79 20.97 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.92 6.03 15.16 12.65 6.91 13.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 33.24 23.97 14.06 32.62 25.96 14.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 80 ASP^? 13.33 O ACT A 134 231 ASP A 113 ASP^? 18.42 CH3 ACT A 134 294 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 21.99 0.20 10.14 20.59 -0.43 11.58 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.00 19.90 3.85 25.60 19.04 1.99 coo 33.16 106.80 7.72 33.34 104.87 6.92 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 80 ASP^? 13.33 O ACT A 134 231 ASP B 80 ASP^? 13.20 OXT ACT B 134 294 ASP A 95 ASP^? -2.87 O ACT A 134s coo 27.89 102.52 14.98 29.35 101.92 13.57 21.99 0.20 10.14 20.59 -0.43 11.58 coo 14.74 93.05 -1.00 14.30 94.22 0.73 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 80 ASP^? 13.33 O ACT A 134 231 ASP B 95 ASP^? -2.82 OXT ACT B 134s 294 ASP A 95 ASP^? -2.87 O ACT A 134s coo 27.89 102.52 14.98 29.35 101.92 13.57 21.99 0.20 10.14 20.59 -0.43 11.58 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 13.92 6.03 15.16 12.65 6.91 13.72 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 95 ASP^? -2.87 O ACT A 134s 231 ASP B 129 ASP.? 12.08 OXT ACT B 134 294 ASP A 80 ASP^? 13.33 O ACT A 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 13.92 6.03 15.16 12.65 6.91 13.72 coo 14.74 93.05 -1.00 14.30 94.22 0.73 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 21.99 0.20 10.14 20.59 -0.43 11.58 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP A 113 ASP^? 18.42 CH3 ACT A 134 231 ASP A 95 ASP^? -2.87 O ACT A 134s 294 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.00 19.90 3.85 25.60 19.04 1.99 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.92 6.03 15.16 12.65 6.91 13.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP A 113 ASP^? 18.42 CH3 ACT A 134 231 ASP B 129 ASP.? 12.08 OXT ACT B 134 294 ASP A 39 ASP^? 22.84 CH3 ACT A 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.00 19.90 3.85 25.60 19.04 1.99 coo 14.74 93.05 -1.00 14.30 94.22 0.73 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.90 30.21 5.13 24.67 29.05 5.02 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 34 ASP~? 20.32 CH3 ACT B 134 231 ASP B 95 ASP^? -2.82 OXT ACT B 134s 294 ASP B 117 ASP.? 24.72 CH3 ACT B 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 33.19 -7.58 -9.17 32.54 -9.56 -9.43 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP B 80 ASP^? 13.20 OXT ACT B 134 231 ASP A 80 ASP^? 13.33 O ACT A 134 294 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 27.89 102.52 14.98 29.35 101.92 13.57 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 21.99 0.20 10.14 20.59 -0.43 11.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP B 80 ASP^? 13.20 OXT ACT B 134 231 ASP A 95 ASP^? -2.87 O ACT A 134s 294 ASP B 95 ASP^? -2.82 OXT ACT B 134s coo 27.89 102.52 14.98 29.35 101.92 13.57 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.92 6.03 15.16 12.65 6.91 13.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 13.83 10.37 -10.37 12.59 9.49 -8.86 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP B 80 ASP^? 13.20 OXT ACT B 134 231 ASP B 113 ASP^? 18.51 CH3 ACT B 134 294 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP B 95 ASP^? -2.82 OXT ACT B 134s 231 ASP A 129 ASP.? 12.18 O ACT A 134 294 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 14.74 93.05 -1.00 14.30 94.22 0.73 4.86 1.75 6.36 4.91 0.13 7.65 coo 33.16 106.80 7.72 33.34 104.87 6.92 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP B 113 ASP^? 18.51 CH3 ACT B 134 231 ASP A 129 ASP.? 12.18 O ACT A 134 294 ASP B 39 ASP^? 22.90 CH3 ACT B 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 14.74 93.05 -1.00 14.30 94.22 0.73 4.86 1.75 6.36 4.91 0.13 7.65 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.87 -13.88 -0.47 24.63 -12.69 -0.32 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP B 113 ASP^? 18.51 CH3 ACT B 134 231 ASP B 95 ASP^? -2.82 OXT ACT B 134s 294 ASP A 80 ASP^? 13.33 O ACT A 134 coo 27.89 102.52 14.98 29.35 101.92 13.57 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 14.74 93.05 -1.00 14.30 94.22 0.73 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 21.99 0.20 10.14 20.59 -0.43 11.58 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 14 hits 2amg_c06 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 21.29 4.79 5.54 21.77 3.26 4.19 coo 67.47 20.07 1.34 65.99 20.06 2.88 13.89 12.66 7.54 12.94 12.92 9.40 coo 67.44 25.26 13.91 67.54 23.65 15.28 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 156 GLU B 124 GLU^? -3.39 O ACT B 134s A 194 ASN A 106 ASN^? 5.57 O ACT A 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 21.29 4.79 5.54 21.77 3.26 4.19 coo 67.47 20.07 1.34 65.99 20.06 2.88 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 67.44 25.26 13.91 67.54 23.65 15.28 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 156 GLU B 124 GLU^? -3.39 O ACT B 134s A 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 21.29 4.79 5.54 21.77 3.26 4.19 coo 67.47 20.07 1.34 65.99 20.06 2.88 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 67.44 25.26 13.91 67.54 23.65 15.28 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 156 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 13.89 12.66 7.54 12.94 12.92 9.40 coo 67.47 20.07 1.34 65.99 20.06 2.88 21.29 4.79 5.54 21.77 3.26 4.19 coo 67.44 25.26 13.91 67.54 23.65 15.28 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 156 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 194 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 13.89 12.66 7.54 12.94 12.92 9.40 coo 67.47 20.07 1.34 65.99 20.06 2.88 21.22 11.60 -0.72 21.76 13.12 0.60 coo 67.44 25.26 13.91 67.54 23.65 15.28 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 194 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 21.22 11.60 -0.72 21.76 13.12 0.60 coo 67.47 20.07 1.34 65.99 20.06 2.88 13.89 12.66 7.54 12.94 12.92 9.40 coo 67.44 25.26 13.91 67.54 23.65 15.28 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s A 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 21.22 11.60 -0.72 21.76 13.12 0.60 coo 67.47 20.07 1.34 65.99 20.06 2.88 13.89 12.66 7.54 12.94 12.92 9.40 coo 67.44 25.26 13.91 67.54 23.65 15.28 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 156 GLU B 124 GLU^? -3.39 O ACT B 134s A 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 21.22 11.60 -0.72 21.76 13.12 0.60 coo 67.47 20.07 1.34 65.99 20.06 2.88 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 67.44 25.26 13.91 67.54 23.65 15.28 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU B 124 GLU^? -3.39 O ACT B 134s A 156 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 194 ASN A 106 ASN^? 5.57 O ACT A 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 67.47 20.07 1.34 65.99 20.06 2.88 21.29 4.79 5.54 21.77 3.26 4.19 coo 67.44 25.26 13.91 67.54 23.65 15.28 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU B 124 GLU^? -3.39 O ACT B 134s A 156 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 74.14 15.91 8.55 72.08 15.36 8.63 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 67.47 20.07 1.34 65.99 20.06 2.88 21.22 11.60 -0.72 21.76 13.12 0.60 coo 67.44 25.26 13.91 67.54 23.65 15.28 12.00 16.42 -6.80 12.35 17.03 -8.83 2dbt_c00 source 2dbt CHITINASE C : 10 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 21.29 4.79 5.54 21.77 3.26 4.19 coo 54.43 67.89 19.82 55.62 67.90 18.07 13.89 12.66 7.54 12.94 12.92 9.40 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 156 GLU B 124 GLU^? -3.39 O ACT B 134s B 194 ASN A 106 ASN^? 5.57 O ACT A 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 21.29 4.79 5.54 21.77 3.26 4.19 coo 54.43 67.89 19.82 55.62 67.90 18.07 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 49.79 70.75 7.78 50.10 68.90 6.86 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 156 GLU B 124 GLU^? -3.39 O ACT B 134s B 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 21.29 4.79 5.54 21.77 3.26 4.19 coo 54.43 67.89 19.82 55.62 67.90 18.07 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 156 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 13.89 12.66 7.54 12.94 12.92 9.40 coo 54.43 67.89 19.82 55.62 67.90 18.07 21.29 4.79 5.54 21.77 3.26 4.19 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 156 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 194 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 13.89 12.66 7.54 12.94 12.92 9.40 coo 54.43 67.89 19.82 55.62 67.90 18.07 21.22 11.60 -0.72 21.76 13.12 0.60 coo 49.79 70.75 7.78 50.10 68.90 6.86 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 194 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 21.22 11.60 -0.72 21.76 13.12 0.60 coo 54.43 67.89 19.82 55.62 67.90 18.07 13.89 12.66 7.54 12.94 12.92 9.40 coo 49.79 70.75 7.78 50.10 68.90 6.86 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s B 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 21.22 11.60 -0.72 21.76 13.12 0.60 coo 54.43 67.89 19.82 55.62 67.90 18.07 13.89 12.66 7.54 12.94 12.92 9.40 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 156 GLU B 124 GLU^? -3.39 O ACT B 134s B 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 21.22 11.60 -0.72 21.76 13.12 0.60 coo 54.43 67.89 19.82 55.62 67.90 18.07 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU B 124 GLU^? -3.39 O ACT B 134s B 156 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 194 ASN A 106 ASN^? 5.57 O ACT A 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 54.43 67.89 19.82 55.62 67.90 18.07 21.29 4.79 5.54 21.77 3.26 4.19 coo 49.79 70.75 7.78 50.10 68.90 6.86 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU B 124 GLU^? -3.39 O ACT B 134s B 156 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 45.64 63.11 17.20 47.48 62.43 16.45 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 54.43 67.89 19.82 55.62 67.90 18.07 21.22 11.60 -0.72 21.76 13.12 0.60 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.00 16.42 -6.80 12.35 17.03 -8.83 2dbt_c01 source 2dbt CHITINASE C : 10 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s C 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 21.29 4.79 5.54 21.77 3.26 4.19 coo 44.75 23.09 5.51 46.77 22.91 6.12 13.89 12.66 7.54 12.94 12.92 9.40 coo 49.75 21.00 18.12 50.45 23.02 18.26 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 156 GLU B 124 GLU^? -3.39 O ACT B 134s C 194 ASN A 106 ASN^? 5.57 O ACT A 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 21.29 4.79 5.54 21.77 3.26 4.19 coo 44.75 23.09 5.51 46.77 22.91 6.12 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 49.75 21.00 18.12 50.45 23.02 18.26 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 156 GLU B 124 GLU^? -3.39 O ACT B 134s C 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 21.29 4.79 5.54 21.77 3.26 4.19 coo 44.75 23.09 5.51 46.77 22.91 6.12 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 49.75 21.00 18.12 50.45 23.02 18.26 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 124 GLU^? -3.29 OXT ACT A 134s C 156 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 194 ASN A 133 ASN.? 9.96 O ACT A 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 13.89 12.66 7.54 12.94 12.92 9.40 coo 44.75 23.09 5.51 46.77 22.91 6.12 21.29 4.79 5.54 21.77 3.26 4.19 coo 49.75 21.00 18.12 50.45 23.02 18.26 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 124 GLU^? -3.29 OXT ACT A 134s C 156 GLU B 92 GLU^? 14.52 OXT ACT B 134 C 194 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 13.89 12.66 7.54 12.94 12.92 9.40 coo 44.75 23.09 5.51 46.77 22.91 6.12 21.22 11.60 -0.72 21.76 13.12 0.60 coo 49.75 21.00 18.12 50.45 23.02 18.26 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 C 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s C 194 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 21.22 11.60 -0.72 21.76 13.12 0.60 coo 44.75 23.09 5.51 46.77 22.91 6.12 13.89 12.66 7.54 12.94 12.92 9.40 coo 49.75 21.00 18.12 50.45 23.02 18.26 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 C 156 GLU A 124 GLU^? -3.29 OXT ACT A 134s C 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 21.22 11.60 -0.72 21.76 13.12 0.60 coo 44.75 23.09 5.51 46.77 22.91 6.12 13.89 12.66 7.54 12.94 12.92 9.40 coo 49.75 21.00 18.12 50.45 23.02 18.26 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU B 92 GLU^? 14.52 OXT ACT B 134 C 156 GLU B 124 GLU^? -3.39 O ACT B 134s C 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 21.22 11.60 -0.72 21.76 13.12 0.60 coo 44.75 23.09 5.51 46.77 22.91 6.12 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 49.75 21.00 18.12 50.45 23.02 18.26 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU B 124 GLU^? -3.39 O ACT B 134s C 156 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 194 ASN A 106 ASN^? 5.57 O ACT A 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 44.75 23.09 5.51 46.77 22.91 6.12 21.29 4.79 5.54 21.77 3.26 4.19 coo 49.75 21.00 18.12 50.45 23.02 18.26 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU B 124 GLU^? -3.39 O ACT B 134s C 156 GLU B 92 GLU^? 14.52 OXT ACT B 134 C 194 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 41.23 29.31 13.28 43.03 29.85 12.29 13.91 3.81 -2.65 12.88 3.52 -4.44 coo 44.75 23.09 5.51 46.77 22.91 6.12 21.22 11.60 -0.72 21.76 13.12 0.60 coo 49.75 21.00 18.12 50.45 23.02 18.26 12.00 16.42 -6.80 12.35 17.03 -8.83 2dbt_c02 source 2dbt CHITINASE C : 10 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 40 PHE^? 14.40 CH3 ACT A 134 A 245 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 273 LYS A 11 LYS~? 24.23 CH3 ACT A 134 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 20.14 24.61 9.13 19.21 21.98 9.50 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.00 19.90 3.85 25.60 19.04 1.99 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 33.70 14.32 13.26 36.02 17.43 17.06 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 40 PHE^? 14.44 CH3 ACT B 134 A 245 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 273 LYS B 11 LYS~? 24.30 CH3 ACT B 134 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 33.61 2.06 -8.46 36.00 -1.11 -11.84 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 19 PHE~? 16.57 CH3 ACT A 134 A 263 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 292 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 51.51 50.32 16.39 52.13 49.68 13.75 24.41 18.01 20.14 26.66 18.57 21.69 coo 54.43 44.82 23.74 55.21 45.06 21.80 24.17 25.65 19.58 23.03 26.79 20.97 coo 63.95 45.30 16.71 59.11 49.15 16.05 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 19 PHE~? 16.57 CH3 ACT A 134 A 263 ASP A 34 ASP~? 20.39 CH3 ACT A 134 A 292 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 51.51 50.32 16.39 52.13 49.68 13.75 24.41 18.01 20.14 26.66 18.57 21.69 coo 54.43 44.82 23.74 55.21 45.06 21.80 24.17 25.65 19.58 23.03 26.79 20.97 coo 63.95 45.30 16.71 59.11 49.15 16.05 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 19 PHE~? 16.60 CH3 ACT B 134 A 263 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 292 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 51.51 50.32 16.39 52.13 49.68 13.75 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 63.95 45.30 16.71 59.11 49.15 16.05 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 19 PHE~? 16.60 CH3 ACT B 134 A 263 ASP B 34 ASP~? 20.32 CH3 ACT B 134 A 292 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 51.51 50.32 16.39 52.13 49.68 13.75 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 63.95 45.30 16.71 59.11 49.15 16.05 13.39 -8.84 -10.92 12.04 -11.20 -15.77 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 4 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 19 PHE~? 16.57 CH3 ACT A 134 B 263 ASP A 34 ASP~? 20.39 CH3 ACT A 134 B 292 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 49.99 26.05 6.28 51.46 26.87 8.49 24.41 18.01 20.14 26.66 18.57 21.69 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 24.17 25.65 19.58 23.03 26.79 20.97 coo 60.53 31.67 0.97 57.79 27.51 3.63 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 19 PHE~? 16.57 CH3 ACT A 134 B 263 ASP A 34 ASP~? 20.39 CH3 ACT A 134 B 292 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 49.99 26.05 6.28 51.46 26.87 8.49 24.41 18.01 20.14 26.66 18.57 21.69 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 24.17 25.65 19.58 23.03 26.79 20.97 coo 60.53 31.67 0.97 57.79 27.51 3.63 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 19 PHE~? 16.60 CH3 ACT B 134 B 263 ASP B 34 ASP~? 20.32 CH3 ACT B 134 B 292 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 49.99 26.05 6.28 51.46 26.87 8.49 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 19 PHE~? 16.60 CH3 ACT B 134 B 263 ASP B 34 ASP~? 20.32 CH3 ACT B 134 B 292 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 49.99 26.05 6.28 51.46 26.87 8.49 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 13.39 -8.84 -10.92 12.04 -11.20 -15.77 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 4 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 19 PHE~? 16.57 CH3 ACT A 134 C 263 ASP A 34 ASP~? 20.39 CH3 ACT A 134 C 292 LYS A 56 LYS~? 20.00 CH3 ACT A 134 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 24.41 18.01 20.14 26.66 18.57 21.69 coo 19.84 12.02 9.33 18.68 11.23 7.75 24.17 25.65 19.58 23.03 26.79 20.97 coo 12.82 3.49 4.98 17.80 5.59 1.90 17.29 28.50 12.14 22.41 28.51 15.17 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 19 PHE~? 16.57 CH3 ACT A 134 C 263 ASP A 34 ASP~? 20.39 CH3 ACT A 134 C 292 LYS A 60 LYS~? 19.22 CH3 ACT A 134 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 24.41 18.01 20.14 26.66 18.57 21.69 coo 19.84 12.02 9.33 18.68 11.23 7.75 24.17 25.65 19.58 23.03 26.79 20.97 coo 12.82 3.49 4.98 17.80 5.59 1.90 13.42 25.37 15.69 13.26 28.28 21.22 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 19 PHE~? 16.60 CH3 ACT B 134 C 263 ASP B 34 ASP~? 20.32 CH3 ACT B 134 C 292 LYS B 56 LYS~? 20.04 CH3 ACT B 134 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 12.82 3.49 4.98 17.80 5.59 1.90 17.26 -12.01 -7.36 22.35 -12.14 -10.46 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 19 PHE~? 16.60 CH3 ACT B 134 C 263 ASP B 34 ASP~? 20.32 CH3 ACT B 134 C 292 LYS B 60 LYS~? 18.28 CH3 ACT B 134 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 24.33 -1.57 -15.38 26.55 -2.24 -16.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 24.12 -9.16 -14.81 22.98 -10.29 -16.20 coo 12.82 3.49 4.98 17.80 5.59 1.90 13.39 -8.84 -10.92 12.04 -11.20 -15.77 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 4 hits 2oat_c05 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 151 LYS A 11 LYS~? 24.23 CH3 ACT A 134 A 154 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 37.70 12.40 8.53 36.14 12.23 7.15 coo 45.75 16.58 39.61 47.43 18.26 45.54 33.70 14.32 13.26 36.02 17.43 17.06 coo 44.77 13.10 43.25 45.01 14.21 45.03 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 95 ASP^? -2.87 O ACT A 134s A 151 LYS A 105 LYS^? 12.80 O ACT A 134 A 154 ASN A 106 ASN^? 5.57 O ACT A 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 13.92 6.03 15.16 12.65 6.91 13.72 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.54 2.73 14.15 9.40 -2.89 16.14 coo 44.77 13.10 43.25 45.01 14.21 45.03 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP A 95 ASP^? -2.87 O ACT A 134s A 151 LYS A 105 LYS^? 12.80 O ACT A 134 A 154 ASN A 133 ASN.? 9.96 O ACT A 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 13.92 6.03 15.16 12.65 6.91 13.72 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.54 2.73 14.15 9.40 -2.89 16.14 coo 44.77 13.10 43.25 45.01 14.21 45.03 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP A 129 ASP.? 12.18 O ACT A 134 A 151 LYS A 105 LYS^? 12.80 O ACT A 134 A 154 ASN A 106 ASN^? 5.57 O ACT A 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 4.86 1.75 6.36 4.91 0.13 7.65 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.54 2.73 14.15 9.40 -2.89 16.14 coo 44.77 13.10 43.25 45.01 14.21 45.03 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2phk_c03 MC-PEPTIDE user 5 3 # 5 A 149 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 151 LYS B 11 LYS~? 24.30 CH3 ACT B 134 A 154 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 37.67 3.93 -3.68 36.11 4.07 -2.28 coo 45.75 16.58 39.61 47.43 18.26 45.54 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo 44.77 13.10 43.25 45.01 14.21 45.03 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 3 2phk_c03 MC-PEPTIDE user 6 3 # 6 A 149 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 151 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 154 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 44.77 13.10 43.25 45.01 14.21 45.03 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2phk_c03 MC-PEPTIDE user 7 3 # 7 A 149 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 151 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 154 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 44.77 13.10 43.25 45.01 14.21 45.03 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2phk_c03 MC-PEPTIDE user 8 3 # 8 A 149 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 151 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 154 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 41.42 17.90 44.98 43.39 18.36 45.61 4.87 14.63 -1.58 4.99 16.28 -2.86 coo 45.75 16.58 39.61 47.43 18.26 45.54 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 44.77 13.10 43.25 45.01 14.21 45.03 10.24 11.30 -5.95 9.38 10.89 -4.04 2phk_c03 source 2phk MC-PEPTIDE : 8 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 80 ASP^? 13.33 O ACT A 134 166 GLY A 0 GLY.? 23.91 CH3 ACT B 134 169 GLU A 86 GLU.? 27.53 CH3 ACT B 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.99 0.20 10.14 20.59 -0.43 11.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.16 7.61 0.26 34.64 7.43 0.87 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.97 15.66 -0.32 36.99 16.96 -1.64 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 80 ASP^? 13.33 O ACT A 134 166 GLY B 0 GLY.? 23.71 CH3 ACT A 134 169 GLU A 86 GLU.? 27.53 CH3 ACT B 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.99 0.20 10.14 20.59 -0.43 11.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.16 8.68 4.55 34.62 8.93 3.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.97 15.66 -0.32 36.99 16.96 -1.64 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 80 ASP^? 13.33 O ACT A 134 166 GLY B 55 GLY~? 19.19 CH3 ACT B 134 169 GLU B 38 GLU^? 23.46 CH3 ACT B 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.99 0.20 10.14 20.59 -0.43 11.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.83 -12.90 -3.70 16.52 -12.17 -3.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.12 -16.18 -6.62 22.89 -15.85 -8.32 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 80 ASP^? 13.33 O ACT A 134 166 GLY B 55 GLY~? 19.19 CH3 ACT B 134 169 GLU B 61 GLU~? 17.99 O ACT B 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.99 0.20 10.14 20.59 -0.43 11.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.83 -12.90 -3.70 16.52 -12.17 -3.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 9.01 -11.16 -9.07 8.40 -12.39 -7.45 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 117 ASP.? 24.68 CH3 ACT A 134 166 GLY A 55 GLY~? 19.21 CH3 ACT A 134 169 GLU A 61 GLU~? 18.11 OXT ACT A 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 33.24 23.97 14.06 32.62 25.96 14.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.89 29.31 8.45 16.59 28.62 8.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 9.19 27.65 13.99 8.36 28.92 12.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 117 ASP.? 24.68 CH3 ACT A 134 166 GLY B 0 GLY.? 23.71 CH3 ACT A 134 169 GLU B 86 GLU.? 27.22 CH3 ACT A 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 33.24 23.97 14.06 32.62 25.96 14.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.16 8.68 4.55 34.62 8.93 3.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.82 0.62 5.15 36.84 -0.64 6.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 80 ASP^? 13.20 OXT ACT B 134 166 GLY A 0 GLY.? 23.91 CH3 ACT B 134 169 GLU B 86 GLU.? 27.22 CH3 ACT A 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.16 7.61 0.26 34.64 7.43 0.87 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.82 0.62 5.15 36.84 -0.64 6.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 80 ASP^? 13.20 OXT ACT B 134 166 GLY A 55 GLY~? 19.21 CH3 ACT A 134 169 GLU A 38 GLU^? 23.44 CH3 ACT A 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.89 29.31 8.45 16.59 28.62 8.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.16 32.64 11.25 23.00 32.22 12.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 80 ASP^? 13.20 OXT ACT B 134 166 GLY A 55 GLY~? 19.21 CH3 ACT A 134 169 GLU A 61 GLU~? 18.11 OXT ACT A 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.89 29.31 8.45 16.59 28.62 8.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 9.19 27.65 13.99 8.36 28.92 12.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 80 ASP^? 13.20 OXT ACT B 134 166 GLY B 0 GLY.? 23.71 CH3 ACT A 134 169 GLU B 86 GLU.? 27.22 CH3 ACT A 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.16 8.68 4.55 34.62 8.93 3.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.82 0.62 5.15 36.84 -0.64 6.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP B 117 ASP.? 24.72 CH3 ACT B 134 166 GLY A 0 GLY.? 23.91 CH3 ACT B 134 169 GLU A 86 GLU.? 27.53 CH3 ACT B 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.16 7.61 0.26 34.64 7.43 0.87 coo -16.67 7.89 2.78 -17.65 6.56 1.49 35.97 15.66 -0.32 36.99 16.96 -1.64 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 117 ASP.? 24.72 CH3 ACT B 134 166 GLY B 55 GLY~? 19.19 CH3 ACT B 134 169 GLU B 61 GLU~? 17.99 O ACT B 134 coo 8.28 6.87 1.62 10.08 5.77 1.34 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.83 -12.90 -3.70 16.52 -12.17 -3.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 9.01 -11.16 -9.07 8.40 -12.39 -7.45 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 12 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 107 ARG^? 13.51 O ACT A 134 A 130 SER A 78 SER^? 12.19 O ACT A 134 A 159 LYS A 105 LYS^? 12.80 O ACT A 134 coo 18.35 45.84 20.99 16.20 47.83 21.89 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 15.14 43.67 10.77 15.61 44.43 13.04 20.05 1.17 15.74 19.11 -0.15 13.92 coo 11.57 48.49 22.18 13.51 49.99 17.21 8.54 2.73 14.15 9.40 -2.89 16.14 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 107 ARG^? 13.48 OXT ACT B 134 A 130 SER B 78 SER^? 12.20 OXT ACT B 134 A 159 LYS B 105 LYS^? 12.81 OXT ACT B 134 coo 18.35 45.84 20.99 16.20 47.83 21.89 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 15.14 43.67 10.77 15.61 44.43 13.04 20.02 15.26 -10.83 19.07 16.62 -8.98 coo 11.57 48.49 22.18 13.51 49.99 17.21 8.51 13.68 -9.31 9.43 19.36 -11.32 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 81 ARG^? 17.75 O ACT A 134 127 ARG B 123 ARG^? 15.62 CH3 ACT B 134 270 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -1.14 25.72 1.64 0.76 28.10 1.50 23.88 0.36 5.26 23.01 -2.52 5.93 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 19.60 -0.44 3.82 22.23 -1.26 2.52 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.22 11.60 -0.72 21.76 13.12 0.60 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 123 ARG^? 15.41 CH3 ACT A 134 127 ARG B 81 ARG^? 17.71 OXT ACT B 134 270 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -1.14 25.72 1.64 0.76 28.10 1.50 19.67 16.84 1.03 22.28 17.57 2.36 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG B 81 ARG^? 17.71 OXT ACT B 134 127 ARG A 123 ARG^? 15.41 CH3 ACT A 134 270 GLU A 92 GLU^? 14.49 CH3 ACT A 134 coo -1.14 25.72 1.64 0.76 28.10 1.50 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 19.67 16.84 1.03 22.28 17.57 2.36 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.29 4.79 5.54 21.77 3.26 4.19 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG B 123 ARG^? 15.62 CH3 ACT B 134 127 ARG A 81 ARG^? 17.75 O ACT A 134 270 GLU B 92 GLU^? 14.52 OXT ACT B 134 coo -1.14 25.72 1.64 0.76 28.10 1.50 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 23.88 0.36 5.26 23.01 -2.52 5.93 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.22 11.60 -0.72 21.76 13.12 0.60 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 4 hits 5cpa_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 117 ASP.? 24.68 CH3 ACT A 134 A 99 GLY A 116 GLY.? 24.65 CH3 ACT A 134 A 125 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 33.24 23.97 14.06 32.62 25.96 14.31 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 33.67 24.05 9.33 33.05 23.47 9.34 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP A 129 ASP.? 12.18 O ACT A 134 A 99 GLY A 130 GLY.? 7.72 O ACT A 134 A 125 ASN A 106 ASN^? 5.57 O ACT A 134 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 4.86 1.75 6.36 4.91 0.13 7.65 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 5.91 4.26 10.34 5.79 3.49 10.19 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP B 117 ASP.? 24.72 CH3 ACT B 134 A 99 GLY B 116 GLY.? 24.79 CH3 ACT B 134 A 125 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 33.19 -7.58 -9.17 32.54 -9.56 -9.43 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 33.65 -7.66 -4.45 32.99 -7.13 -4.49 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 4 3 # 4 A 81 ASP B 129 ASP.? 12.08 OXT ACT B 134 A 99 GLY B 130 GLY.? 7.66 OXT ACT B 134 A 125 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 4.87 14.63 -1.58 4.99 16.28 -2.86 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 5.91 12.14 -5.55 5.78 12.90 -5.37 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 10.24 11.30 -5.95 9.38 10.89 -4.04 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 4 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 53 ASN^? 13.62 OXT ACT A 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.53 24.41 5.81 10.72 23.33 5.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 85 ASN.? 20.84 CH3 ACT B 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 31.62 12.53 -0.05 30.06 14.00 -0.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 106 ASN^? 5.57 O ACT A 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 133 ASN.? 9.96 O ACT A 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 53 ASN^? 13.51 O ACT B 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.53 -7.97 -0.98 10.78 -6.78 -0.73 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 85 ASN.? 20.67 CH3 ACT A 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 31.66 3.78 4.83 30.09 2.36 4.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.00 16.42 -6.80 12.35 17.03 -8.83 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 10 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 122 TYR^? 8.33 CH3 ACT A 134 A 112 PHE A 62 PHE~? 8.11 OXT ACT A 134 A 140 ASN A 53 ASN^? 13.62 OXT ACT A 134 coo -6.29 44.15 17.65 -9.00 44.92 17.68 18.19 17.99 8.45 16.46 16.26 9.80 coo -7.38 52.77 16.75 -5.54 52.71 18.82 11.42 20.47 11.27 11.65 17.82 10.47 coo -4.46 50.64 12.29 -5.69 49.89 13.85 12.53 24.41 5.81 10.72 23.33 5.51 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 112 PHE B 126 PHE^? 5.73 O ACT B 134 A 140 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo -6.29 44.15 17.65 -9.00 44.92 17.68 16.00 10.76 2.04 17.57 12.50 0.46 coo -7.38 52.77 16.75 -5.54 52.71 18.82 9.55 7.10 -0.62 8.51 4.83 -1.87 coo -4.46 50.64 12.29 -5.69 49.89 13.85 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR B 122 TYR^? 8.37 CH3 ACT B 134 A 112 PHE B 62 PHE~? 8.01 O ACT B 134 A 140 ASN B 53 ASN^? 13.51 O ACT B 134 coo -6.29 44.15 17.65 -9.00 44.92 17.68 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo -7.38 52.77 16.75 -5.54 52.71 18.82 11.39 -3.91 -6.44 11.73 -1.26 -5.68 coo -4.46 50.64 12.29 -5.69 49.89 13.85 12.53 -7.97 -0.98 10.78 -6.78 -0.73 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 4 3 # 4 A 56 TYR B 125 TYR^? 11.31 O ACT A 134 A 112 PHE A 126 PHE^? 5.77 OXT ACT A 134 A 140 ASN A 106 ASN^? 5.57 O ACT A 134 coo -6.29 44.15 17.65 -9.00 44.92 17.68 16.01 5.62 2.81 17.58 3.86 4.41 coo -7.38 52.77 16.75 -5.54 52.71 18.82 9.56 9.33 5.49 8.55 11.71 6.60 coo -4.46 50.64 12.29 -5.69 49.89 13.85 10.24 5.16 10.78 9.42 5.53 8.84 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 4 hits 1o8s_p00 naa= 3 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 1 4 # 1 A 87 ASP A 80 ASP^? 13.33 O ACT A 134 A 184 TYR B 122 TYR^? 8.37 CH3 ACT B 134 A 400 ARG A 81 ARG^? 17.75 O ACT A 134 A 416 ASP B 113 ASP^? 18.51 CH3 ACT B 134 coo -0.32 21.89 76.95 -2.29 21.43 77.55 21.99 0.20 10.14 20.59 -0.43 11.58 coo -13.84 24.02 81.30 -13.39 23.42 78.61 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo -2.45 25.99 82.19 -2.93 24.57 79.52 23.88 0.36 5.26 23.01 -2.52 5.93 coo -5.39 20.15 83.91 -5.94 21.73 82.59 25.97 -3.50 0.94 25.56 -2.60 2.79 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 2 4 # 2 A 87 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 184 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 400 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 416 ASP B 80 ASP^? 13.20 OXT ACT B 134 coo -0.32 21.89 76.95 -2.29 21.43 77.55 26.00 19.90 3.85 25.60 19.04 1.99 coo -13.84 24.02 81.30 -13.39 23.42 78.61 16.00 10.76 2.04 17.57 12.50 0.46 coo -2.45 25.99 82.19 -2.93 24.57 79.52 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -5.39 20.15 83.91 -5.94 21.73 82.59 21.98 16.13 -5.41 20.58 16.67 -6.85 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 3 4 # 3 A 87 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 184 TYR A 122 TYR^? 8.33 CH3 ACT A 134 A 400 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 416 ASP A 113 ASP^? 18.42 CH3 ACT A 134 coo -0.32 21.89 76.95 -2.29 21.43 77.55 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -13.84 24.02 81.30 -13.39 23.42 78.61 18.19 17.99 8.45 16.46 16.26 9.80 coo -2.45 25.99 82.19 -2.93 24.57 79.52 23.90 15.91 -0.43 22.97 18.81 -0.95 coo -5.39 20.15 83.91 -5.94 21.73 82.59 26.00 19.90 3.85 25.60 19.04 1.99 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 4 4 # 4 A 87 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 184 TYR B 125 TYR^? 11.31 O ACT A 134 A 400 ARG A 81 ARG^? 17.75 O ACT A 134 A 416 ASP A 80 ASP^? 13.33 O ACT A 134 coo -0.32 21.89 76.95 -2.29 21.43 77.55 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -13.84 24.02 81.30 -13.39 23.42 78.61 16.01 5.62 2.81 17.58 3.86 4.41 coo -2.45 25.99 82.19 -2.93 24.57 79.52 23.88 0.36 5.26 23.01 -2.52 5.93 coo -5.39 20.15 83.91 -5.94 21.73 82.59 21.99 0.20 10.14 20.59 -0.43 11.58 2g3n_p00 source 2g3n ALPHA-GLUCOSIDASE : 4 hits 2g3n_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 81 ARG^? 17.75 O ACT A 134 A 188 TYR B 122 TYR^? 8.37 CH3 ACT B 134 A 190 SER B 111 SER^? 14.22 CH3 ACT B 134 coo 37.69 7.64 13.51 38.82 8.84 16.11 23.88 0.36 5.26 23.01 -2.52 5.93 coo 47.14 12.10 13.73 48.75 12.33 16.01 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 43.77 6.93 15.46 45.49 7.21 17.11 21.84 2.81 -0.55 22.81 2.45 1.66 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG A 81 ARG^? 17.75 O ACT A 134 A 188 TYR B 125 TYR^? 11.31 O ACT A 134 A 190 SER B 111 SER^? 14.22 CH3 ACT B 134 coo 37.69 7.64 13.51 38.82 8.84 16.11 23.88 0.36 5.26 23.01 -2.52 5.93 coo 47.14 12.10 13.73 48.75 12.33 16.01 16.01 5.62 2.81 17.58 3.86 4.41 coo 43.77 6.93 15.46 45.49 7.21 17.11 21.84 2.81 -0.55 22.81 2.45 1.66 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 188 TYR A 122 TYR^? 8.33 CH3 ACT A 134 A 190 SER A 111 SER^? 14.00 CH3 ACT A 134 coo 37.69 7.64 13.51 38.82 8.84 16.11 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 47.14 12.10 13.73 48.75 12.33 16.01 18.19 17.99 8.45 16.46 16.26 9.80 coo 43.77 6.93 15.46 45.49 7.21 17.11 21.88 13.56 5.40 22.76 13.90 3.16 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 188 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 190 SER A 111 SER^? 14.00 CH3 ACT A 134 coo 37.69 7.64 13.51 38.82 8.84 16.11 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 47.14 12.10 13.73 48.75 12.33 16.01 16.00 10.76 2.04 17.57 12.50 0.46 coo 43.77 6.93 15.46 45.49 7.21 17.11 21.88 13.56 5.40 22.76 13.90 3.16 2p3i_p00 source 2p3i VP4 : 4 hits 2p3i_p00 naa= 3 ULMN 4 2v73_p00 PUTATIVE EXO-ALPHA-SIALIDASE user 1 4 # 1 A 79 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 81 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 151 ARG A 94 ARG^? 12.39 O ACT A 134 A 156 ASN A 133 ASN.? 9.96 O ACT A 134 coo 25.74 5.61 48.63 24.52 5.15 50.30 21.29 4.79 5.54 21.77 3.26 4.19 coo 27.07 3.11 52.61 25.23 3.35 55.08 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 21.76 -2.20 51.78 21.90 0.24 53.63 16.69 -1.11 11.91 15.79 -2.18 14.67 coo 16.67 0.72 52.58 15.80 1.51 50.78 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 4 2v73_p00 PUTATIVE EXO-ALPHA-SIALIDASE user 2 4 # 2 A 79 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 81 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 151 ARG A 107 ARG^? 13.51 O ACT A 134 A 156 ASN A 133 ASN.? 9.96 O ACT A 134 coo 25.74 5.61 48.63 24.52 5.15 50.30 21.29 4.79 5.54 21.77 3.26 4.19 coo 27.07 3.11 52.61 25.23 3.35 55.08 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 21.76 -2.20 51.78 21.90 0.24 53.63 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 16.67 0.72 52.58 15.80 1.51 50.78 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 4 2v73_p00 PUTATIVE EXO-ALPHA-SIALIDASE user 3 4 # 3 A 79 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 81 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 151 ARG B 94 ARG^? 12.34 OXT ACT B 134 A 156 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 25.74 5.61 48.63 24.52 5.15 50.30 21.22 11.60 -0.72 21.76 13.12 0.60 coo 27.07 3.11 52.61 25.23 3.35 55.08 19.67 16.84 1.03 22.28 17.57 2.36 coo 21.76 -2.20 51.78 21.90 0.24 53.63 16.67 17.44 -7.09 15.78 18.56 -9.82 coo 16.67 0.72 52.58 15.80 1.51 50.78 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 4 2v73_p00 PUTATIVE EXO-ALPHA-SIALIDASE user 4 4 # 4 A 79 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 81 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 151 ARG B 107 ARG^? 13.48 OXT ACT B 134 A 156 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 25.74 5.61 48.63 24.52 5.15 50.30 21.22 11.60 -0.72 21.76 13.12 0.60 coo 27.07 3.11 52.61 25.23 3.35 55.08 19.67 16.84 1.03 22.28 17.57 2.36 coo 21.76 -2.20 51.78 21.90 0.24 53.63 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 16.67 0.72 52.58 15.80 1.51 50.78 12.00 16.42 -6.80 12.35 17.03 -8.83 2v73_p00 source 2v73 PUTATIVE EXO-ALPHA-SIALIDASE : 4 hits 2v73_p00 naa= 4 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 58 ARG~? 15.97 OXT ACT A 134 B 6 THR A 41 THR^? 18.02 CH3 ACT A 134 B 8 THR A 37 THR^? 20.64 CH3 ACT A 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 9.78 27.17 8.97 7.03 26.14 8.06 coo 36.11 13.64 95.03 34.54 14.86 95.91 18.34 24.70 5.20 19.06 25.00 3.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.88 27.66 10.30 25.68 26.74 8.52 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 81 ARG^? 17.75 O ACT A 134 B 6 THR A 83 THR^? 17.54 CH3 ACT A 134 B 8 THR A 88 THR^? 17.94 CH3 ACT A 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.88 0.36 5.26 23.01 -2.52 5.93 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.55 7.09 4.80 27.08 6.14 3.47 coo 32.72 8.05 92.39 31.25 9.11 91.35 28.18 15.22 3.40 26.60 15.27 1.86 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG A 81 ARG^? 17.75 O ACT A 134 B 6 THR B 87 THR.? 23.05 CH3 ACT B 134 B 8 THR B 9 THR~? 21.72 CH3 ACT B 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.88 0.36 5.26 23.01 -2.52 5.93 coo 36.11 13.64 95.03 34.54 14.86 95.91 31.16 -1.20 2.01 31.03 -2.27 3.89 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.24 0.14 -3.28 32.74 0.01 -1.15 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG A 81 ARG^? 17.75 O ACT A 134 B 6 THR B 88 THR^? 18.11 CH3 ACT B 134 B 8 THR B 9 THR~? 21.72 CH3 ACT B 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.88 0.36 5.26 23.01 -2.52 5.93 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.17 1.09 1.44 26.55 0.98 2.93 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.24 0.14 -3.28 32.74 0.01 -1.15 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 6 THR A 41 THR^? 18.02 CH3 ACT A 134 B 8 THR A 37 THR^? 20.64 CH3 ACT A 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 19.67 16.84 1.03 22.28 17.57 2.36 coo 36.11 13.64 95.03 34.54 14.86 95.91 18.34 24.70 5.20 19.06 25.00 3.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.88 27.66 10.30 25.68 26.74 8.52 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 6 THR A 88 THR^? 17.94 CH3 ACT A 134 B 8 THR A 9 THR~? 21.47 CH3 ACT A 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 19.67 16.84 1.03 22.28 17.57 2.36 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.18 15.22 3.40 26.60 15.27 1.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.26 16.17 8.09 32.71 16.27 5.99 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG A 123 ARG^? 15.41 CH3 ACT A 134 B 6 THR A 88 THR^? 17.94 CH3 ACT A 134 B 8 THR A 83 THR^? 17.54 CH3 ACT A 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 19.67 16.84 1.03 22.28 17.57 2.36 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.18 15.22 3.40 26.60 15.27 1.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 28.55 7.09 4.80 27.08 6.14 3.47 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG B 58 ARG~? 15.94 O ACT B 134 B 6 THR B 41 THR^? 18.20 CH3 ACT B 134 B 8 THR B 37 THR^? 20.68 CH3 ACT B 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 9.78 -10.54 -4.22 7.03 -9.65 -3.15 coo 36.11 13.64 95.03 34.54 14.86 95.91 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.74 -11.26 -5.58 25.50 -10.43 -3.73 ULMN 3 1b01_d00 GENE REGULATION/DNA user 9 3 # 9 B 4 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 6 THR A 87 THR.? 22.88 CH3 ACT A 134 B 8 THR A 9 THR~? 21.47 CH3 ACT A 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 36.11 13.64 95.03 34.54 14.86 95.91 31.21 17.48 2.82 31.09 18.74 1.05 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.26 16.17 8.09 32.71 16.27 5.99 ULMN 3 1b01_d00 GENE REGULATION/DNA user 10 3 # 10 B 4 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 6 THR A 88 THR^? 17.94 CH3 ACT A 134 B 8 THR A 9 THR~? 21.47 CH3 ACT A 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.18 15.22 3.40 26.60 15.27 1.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.26 16.17 8.09 32.71 16.27 5.99 ULMN 3 1b01_d00 GENE REGULATION/DNA user 11 3 # 11 B 4 ARG B 81 ARG^? 17.71 OXT ACT B 134 B 6 THR B 83 THR^? 17.78 CH3 ACT B 134 B 8 THR B 88 THR^? 18.11 CH3 ACT B 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.55 9.24 0.02 27.11 10.23 1.39 coo 32.72 8.05 92.39 31.25 9.11 91.35 28.17 1.09 1.44 26.55 0.98 2.93 ULMN 3 1b01_d00 GENE REGULATION/DNA user 12 3 # 12 B 4 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 6 THR B 41 THR^? 18.20 CH3 ACT B 134 B 8 THR B 37 THR^? 20.68 CH3 ACT B 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 36.11 13.64 95.03 34.54 14.86 95.91 18.35 -8.32 -0.39 19.10 -8.72 1.61 coo 32.72 8.05 92.39 31.25 9.11 91.35 24.74 -11.26 -5.58 25.50 -10.43 -3.73 ULMN 3 1b01_d00 GENE REGULATION/DNA user 13 3 # 13 B 4 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 6 THR B 88 THR^? 18.11 CH3 ACT B 134 B 8 THR B 9 THR~? 21.72 CH3 ACT B 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.17 1.09 1.44 26.55 0.98 2.93 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.24 0.14 -3.28 32.74 0.01 -1.15 ULMN 3 1b01_d00 GENE REGULATION/DNA user 14 3 # 14 B 4 ARG B 123 ARG^? 15.62 CH3 ACT B 134 B 6 THR B 88 THR^? 18.11 CH3 ACT B 134 B 8 THR B 83 THR^? 17.78 CH3 ACT B 134 coo 40.52 16.08 100.90 37.97 16.41 102.60 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.17 1.09 1.44 26.55 0.98 2.93 coo 32.72 8.05 92.39 31.25 9.11 91.35 28.55 9.24 0.02 27.11 10.23 1.39 1b01_d00 source 1b01 GENE REGULATION/DNA : 14 hits 1b01_d00 naa= 3 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 1 4 # 1 A 15 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 19 VAL A 108 VAL^? 5.16 O ACT A 134 A 37 PHE A 17 PHE~? 9.37 CH3 ACT A 134 A 41 SER A 111 SER^? 14.00 CH3 ACT A 134 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 16.00 10.76 2.04 17.57 12.50 0.46 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 15.18 6.85 8.22 14.31 8.41 9.52 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 23.39 11.02 14.17 21.27 9.32 13.60 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 21.88 13.56 5.40 22.76 13.90 3.16 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 2 4 # 2 A 15 TYR A 125 TYR^? 11.32 OXT ACT B 134 A 19 VAL B 108 VAL^? 5.16 OXT ACT B 134 A 37 PHE B 17 PHE~? 9.52 CH3 ACT B 134 A 41 SER B 111 SER^? 14.22 CH3 ACT B 134 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 16.00 10.76 2.04 17.57 12.50 0.46 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 15.16 9.57 -3.41 14.28 8.01 -4.72 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 23.32 5.37 -9.36 21.26 7.18 -8.91 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 21.84 2.81 -0.55 22.81 2.45 1.66 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 3 4 # 3 A 15 TYR B 125 TYR^? 11.31 O ACT A 134 A 19 VAL A 108 VAL^? 5.16 O ACT A 134 A 37 PHE A 17 PHE~? 9.37 CH3 ACT A 134 A 41 SER A 111 SER^? 14.00 CH3 ACT A 134 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 16.01 5.62 2.81 17.58 3.86 4.41 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 15.18 6.85 8.22 14.31 8.41 9.52 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 23.39 11.02 14.17 21.27 9.32 13.60 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 21.88 13.56 5.40 22.76 13.90 3.16 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 4 4 # 4 A 15 TYR B 125 TYR^? 11.31 O ACT A 134 A 19 VAL B 108 VAL^? 5.16 OXT ACT B 134 A 37 PHE B 17 PHE~? 9.52 CH3 ACT B 134 A 41 SER B 111 SER^? 14.22 CH3 ACT B 134 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 16.01 5.62 2.81 17.58 3.86 4.41 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 15.16 9.57 -3.41 14.28 8.01 -4.72 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 23.32 5.37 -9.36 21.26 7.18 -8.91 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 21.84 2.81 -0.55 22.81 2.45 1.66 1ckt_d00 source 1ckt GENE REGULATION/DNA : 4 hits 1ckt_d00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 122 TYR^? 8.33 CH3 ACT A 134 I 306 VAL A 110 VAL^? 7.57 CH3 ACT A 134 I 308 VAL A 89 VAL^? 16.19 CH3 ACT A 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.19 17.99 8.45 16.46 16.26 9.80 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.31 11.75 7.52 18.94 12.80 9.43 coo 16.43 30.18 9.35 15.05 30.67 11.01 27.38 12.47 5.89 28.64 12.25 7.64 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 122 TYR^? 8.33 CH3 ACT A 134 I 306 VAL A 110 VAL^? 7.57 CH3 ACT A 134 I 308 VAL A 90 VAL^? 13.41 CH3 ACT A 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.19 17.99 8.45 16.46 16.26 9.80 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.31 11.75 7.52 18.94 12.80 9.43 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.36 10.18 5.78 23.20 9.70 3.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 122 TYR^? 8.33 CH3 ACT A 134 I 306 VAL A 110 VAL^? 7.57 CH3 ACT A 134 I 308 VAL A 108 VAL^? 5.16 O ACT A 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.19 17.99 8.45 16.46 16.26 9.80 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.31 11.75 7.52 18.94 12.80 9.43 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.18 6.85 8.22 14.31 8.41 9.52 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 125 TYR^? 11.32 OXT ACT B 134 I 306 VAL A 110 VAL^? 7.57 CH3 ACT A 134 I 308 VAL A 89 VAL^? 16.19 CH3 ACT A 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.00 10.76 2.04 17.57 12.50 0.46 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.31 11.75 7.52 18.94 12.80 9.43 coo 16.43 30.18 9.35 15.05 30.67 11.01 27.38 12.47 5.89 28.64 12.25 7.64 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 125 TYR^? 11.32 OXT ACT B 134 I 306 VAL B 110 VAL^? 7.71 CH3 ACT B 134 I 308 VAL B 90 VAL^? 13.62 CH3 ACT B 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.00 10.76 2.04 17.57 12.50 0.46 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.24 4.57 -2.66 18.70 3.49 -4.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.36 6.22 -0.91 23.18 6.63 0.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 122 TYR^? 8.37 CH3 ACT B 134 I 306 VAL B 110 VAL^? 7.71 CH3 ACT B 134 I 308 VAL B 89 VAL^? 16.40 CH3 ACT B 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.24 4.57 -2.66 18.70 3.49 -4.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 27.34 3.88 -1.00 28.63 4.08 -2.77 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 122 TYR^? 8.37 CH3 ACT B 134 I 306 VAL B 110 VAL^? 7.71 CH3 ACT B 134 I 308 VAL B 90 VAL^? 13.62 CH3 ACT B 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.24 4.57 -2.66 18.70 3.49 -4.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.36 6.22 -0.91 23.18 6.63 0.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 122 TYR^? 8.37 CH3 ACT B 134 I 306 VAL B 110 VAL^? 7.71 CH3 ACT B 134 I 308 VAL B 108 VAL^? 5.16 OXT ACT B 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.14 -1.53 -3.61 16.39 0.20 -4.99 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.24 4.57 -2.66 18.70 3.49 -4.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.16 9.57 -3.41 14.28 8.01 -4.72 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 125 TYR^? 11.31 O ACT A 134 I 306 VAL A 110 VAL^? 7.57 CH3 ACT A 134 I 308 VAL A 90 VAL^? 13.41 CH3 ACT A 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.01 5.62 2.81 17.58 3.86 4.41 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.31 11.75 7.52 18.94 12.80 9.43 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.36 10.18 5.78 23.20 9.70 3.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 125 TYR^? 11.31 O ACT A 134 I 306 VAL B 110 VAL^? 7.71 CH3 ACT B 134 I 308 VAL B 89 VAL^? 16.40 CH3 ACT B 134 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.01 5.62 2.81 17.58 3.86 4.41 coo 23.55 29.53 9.81 23.15 27.39 10.24 19.24 4.57 -2.66 18.70 3.49 -4.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 27.34 3.88 -1.00 28.63 4.08 -2.77 1cqt_d00 source 1cqt GENE REGULATION/DNA : 10 hits 1cqt_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 115 ARG^? 23.19 CH3 ACT A 134 C 71 LYS A 118 LYS^? 23.86 CH3 ACT A 134 C 72 VAL A 114 VAL^? 19.42 CH3 ACT A 134 coo 23.89 33.54 29.21 26.59 34.86 28.68 29.95 27.15 5.66 27.05 27.70 4.87 coo 25.82 26.89 29.68 23.33 22.98 25.84 28.94 23.42 11.82 28.39 29.21 14.30 coo 28.86 29.08 30.37 28.04 31.02 29.93 29.19 20.15 7.05 30.30 18.96 8.53 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 115 ARG^? 23.47 CH3 ACT B 134 C 71 LYS B 118 LYS^? 22.69 CH3 ACT B 134 C 72 VAL B 114 VAL^? 19.55 CH3 ACT B 134 coo 23.89 33.54 29.21 26.59 34.86 28.68 29.96 -10.90 -1.02 27.10 -11.56 -0.24 coo 25.82 26.89 29.68 23.33 22.98 25.84 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo 28.86 29.08 30.37 28.04 31.02 29.93 29.10 -3.84 -2.24 30.22 -2.64 -3.70 1hwt_d00 source 1hwt GENE REGULATION/DNA : 2 hits 1hwt_d00 naa= 3 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 1 4 # 1 B 242 GLU A 96 GLU^? 11.35 O ACT A 134 B 245 LYS A 105 LYS^? 12.80 O ACT A 134 B 249 ARG A 94 ARG^? 12.39 O ACT A 134 B 250 ARG A 107 ARG^? 13.51 O ACT A 134 coo -0.89 32.39 60.42 -0.92 32.12 58.30 11.55 2.34 19.02 11.24 0.31 19.55 coo -4.54 26.92 60.10 0.40 29.01 56.76 8.54 2.73 14.15 9.40 -2.89 16.14 coo 0.78 21.41 59.82 1.77 24.31 59.87 16.69 -1.11 11.91 15.79 -2.18 14.67 coo 0.56 22.39 66.71 0.61 25.40 66.07 14.42 -0.01 7.43 16.47 -2.30 7.52 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 2 4 # 2 B 242 GLU B 96 GLU^? 11.19 OXT ACT B 134 B 245 LYS B 105 LYS^? 12.81 OXT ACT B 134 B 249 ARG B 94 ARG^? 12.34 OXT ACT B 134 B 250 ARG B 107 ARG^? 13.48 OXT ACT B 134 coo -0.89 32.39 60.42 -0.92 32.12 58.30 11.63 14.13 -14.15 11.77 16.24 -14.29 coo -4.54 26.92 60.10 0.40 29.01 56.76 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 0.78 21.41 59.82 1.77 24.31 59.87 16.67 17.44 -7.09 15.78 18.56 -9.82 coo 0.56 22.39 66.71 0.61 25.40 66.07 14.41 16.45 -2.54 16.63 18.58 -2.64 1kb6_d00 source 1kb6 TRANSCRIPTION/DNA : 2 hits 1kb6_d00 naa= 4 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 118 LYS^? 23.86 CH3 ACT A 134 A 564 VAL A 114 VAL^? 19.42 CH3 ACT A 134 A 568 ARG A 115 ARG^? 23.19 CH3 ACT A 134 coo -6.60 80.79 55.64 -8.55 79.48 61.01 28.94 23.42 11.82 28.39 29.21 14.30 coo -9.25 78.14 55.31 -11.11 77.94 56.39 29.19 20.15 7.05 30.30 18.96 8.53 coo -12.31 74.86 52.32 -13.99 74.91 54.92 29.95 27.15 5.66 27.05 27.70 4.87 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS B 118 LYS^? 22.69 CH3 ACT B 134 A 564 VAL B 114 VAL^? 19.55 CH3 ACT B 134 A 568 ARG B 115 ARG^? 23.47 CH3 ACT B 134 coo -6.60 80.79 55.64 -8.55 79.48 61.01 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo -9.25 78.14 55.31 -11.11 77.94 56.39 29.10 -3.84 -2.24 30.22 -2.64 -3.70 coo -12.31 74.86 52.32 -13.99 74.91 54.92 29.96 -10.90 -1.02 27.10 -11.56 -0.24 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 2 hits 1r4i_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 84 SER^? 20.86 CH3 ACT A 134 E 5 VAL A 82 VAL^? 15.47 CH3 ACT A 134 E 7 ARG A 81 ARG^? 17.75 O ACT A 134 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 30.40 10.24 3.82 32.46 10.17 5.21 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 27.14 5.94 8.11 27.56 6.98 9.97 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 23.88 0.36 5.26 23.01 -2.52 5.93 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 84 SER^? 21.05 CH3 ACT B 134 E 5 VAL B 82 VAL^? 15.62 CH3 ACT B 134 E 7 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 30.37 6.08 1.00 32.42 6.12 -0.34 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 27.10 10.36 -3.30 27.56 9.27 -5.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 23.90 15.91 -0.43 22.97 18.81 -0.95 2bsq_d00 source 2bsq TRANSCRIPTION : 2 hits 2bsq_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 81 ARG^? 17.75 O ACT A 134 A 50 LYS A 105 LYS^? 12.80 O ACT A 134 A 51 ASN A 133 ASN.? 9.96 O ACT A 134 coo 28.68 23.77 42.74 27.76 26.72 42.93 23.88 0.36 5.26 23.01 -2.52 5.93 coo 14.40 30.33 40.28 14.25 28.31 45.36 8.54 2.73 14.15 9.40 -2.89 16.14 coo 19.09 30.55 41.51 19.09 28.89 42.82 12.00 -0.05 11.64 12.23 -0.65 13.67 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG A 115 ARG^? 23.19 CH3 ACT A 134 A 50 LYS A 11 LYS~? 24.23 CH3 ACT A 134 A 51 ASN A 8 ASN~? 24.32 CH3 ACT A 134 coo 28.68 23.77 42.74 27.76 26.72 42.93 29.95 27.15 5.66 27.05 27.70 4.87 coo 14.40 30.33 40.28 14.25 28.31 45.36 33.70 14.32 13.26 36.02 17.43 17.06 coo 19.09 30.55 41.51 19.09 28.89 42.82 36.73 18.38 9.71 35.57 19.92 10.59 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 50 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 51 ASN B 106 ASN^? 5.54 OXT ACT B 134 coo 28.68 23.77 42.74 27.76 26.72 42.93 19.67 16.84 1.03 22.28 17.57 2.36 coo 14.40 30.33 40.28 14.25 28.31 45.36 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 19.09 30.55 41.51 19.09 28.89 42.82 10.24 11.30 -5.95 9.38 10.89 -4.04 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 5 ARG A 123 ARG^? 15.41 CH3 ACT A 134 A 50 LYS B 105 LYS^? 12.81 OXT ACT B 134 A 51 ASN B 133 ASN.? 9.91 OXT ACT B 134 coo 28.68 23.77 42.74 27.76 26.72 42.93 19.67 16.84 1.03 22.28 17.57 2.36 coo 14.40 30.33 40.28 14.25 28.31 45.36 8.51 13.68 -9.31 9.43 19.36 -11.32 coo 19.09 30.55 41.51 19.09 28.89 42.82 12.00 16.42 -6.80 12.35 17.03 -8.83 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 5 ARG B 115 ARG^? 23.47 CH3 ACT B 134 A 50 LYS B 11 LYS~? 24.30 CH3 ACT B 134 A 51 ASN B 8 ASN~? 24.46 CH3 ACT B 134 coo 28.68 23.77 42.74 27.76 26.72 42.93 29.96 -10.90 -1.02 27.10 -11.56 -0.24 coo 14.40 30.33 40.28 14.25 28.31 45.36 33.61 2.06 -8.46 36.00 -1.11 -11.84 coo 19.09 30.55 41.51 19.09 28.89 42.82 36.75 -2.07 -4.95 35.51 -3.62 -5.82 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 5 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 50 LYS A 105 LYS^? 12.80 O ACT A 134 A 51 ASN A 106 ASN^? 5.57 O ACT A 134 coo 28.68 23.77 42.74 27.76 26.72 42.93 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 14.40 30.33 40.28 14.25 28.31 45.36 8.54 2.73 14.15 9.40 -2.89 16.14 coo 19.09 30.55 41.51 19.09 28.89 42.82 10.24 5.16 10.78 9.42 5.53 8.84 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 5 ARG B 123 ARG^? 15.62 CH3 ACT B 134 A 50 LYS A 105 LYS^? 12.80 O ACT A 134 A 51 ASN A 133 ASN.? 9.96 O ACT A 134 coo 28.68 23.77 42.74 27.76 26.72 42.93 19.60 -0.44 3.82 22.23 -1.26 2.52 coo 14.40 30.33 40.28 14.25 28.31 45.36 8.54 2.73 14.15 9.40 -2.89 16.14 coo 19.09 30.55 41.51 19.09 28.89 42.82 12.00 -0.05 11.64 12.23 -0.65 13.67 2hos_d00 source 2hos TRANSCRIPTION/DNA : 7 hits 2hos_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 115 ARG^? 23.19 CH3 ACT A 134 A 32 LYS A 118 LYS^? 23.86 CH3 ACT A 134 A 46 ARG B 81 ARG^? 17.71 OXT ACT B 134 coo -8.00 4.27 27.74 -7.09 2.66 30.09 29.95 27.15 5.66 27.05 27.70 4.87 coo -5.15 8.65 26.69 -4.26 5.48 32.02 28.94 23.42 11.82 28.39 29.21 14.30 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 23.90 15.91 -0.43 22.97 18.81 -0.95 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG B 115 ARG^? 23.47 CH3 ACT B 134 A 32 LYS B 118 LYS^? 22.69 CH3 ACT B 134 A 46 ARG A 81 ARG^? 17.75 O ACT A 134 coo -8.00 4.27 27.74 -7.09 2.66 30.09 29.96 -10.90 -1.02 27.10 -11.56 -0.24 coo -5.15 8.65 26.69 -4.26 5.48 32.02 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 23.88 0.36 5.26 23.01 -2.52 5.93 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 2 hits 2ky8_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 6 SER.? 30.38 CH3 ACT A 134 B 37 ASN A 8 ASN~? 24.32 CH3 ACT A 134 B 45 THR A 83 THR^? 17.54 CH3 ACT A 134 coo -19.49 41.97 71.08 -17.37 40.80 71.17 41.59 14.69 10.23 42.94 14.02 8.31 coo -23.05 39.62 69.74 -22.86 39.59 67.61 36.73 18.38 9.71 35.57 19.92 10.59 coo -30.87 34.84 80.57 -28.94 34.51 81.49 28.55 7.09 4.80 27.08 6.14 3.47 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 6 SER.? 30.38 CH3 ACT A 134 B 37 ASN A 8 ASN~? 24.32 CH3 ACT A 134 B 45 THR B 83 THR^? 17.78 CH3 ACT B 134 coo -19.49 41.97 71.08 -17.37 40.80 71.17 41.59 14.69 10.23 42.94 14.02 8.31 coo -23.05 39.62 69.74 -22.86 39.59 67.61 36.73 18.38 9.71 35.57 19.92 10.59 coo -30.87 34.84 80.57 -28.94 34.51 81.49 28.55 9.24 0.02 27.11 10.23 1.39 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 132 SER.? 12.20 O ACT A 134 B 37 ASN A 133 ASN.? 9.96 O ACT A 134 B 45 THR B 41 THR^? 18.20 CH3 ACT B 134 coo -19.49 41.97 71.08 -17.37 40.80 71.17 7.72 -1.19 11.22 7.31 -1.68 8.88 coo -23.05 39.62 69.74 -22.86 39.59 67.61 12.00 -0.05 11.64 12.23 -0.65 13.67 coo -30.87 34.84 80.57 -28.94 34.51 81.49 18.35 -8.32 -0.39 19.10 -8.72 1.61 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 6 SER.? 30.50 CH3 ACT B 134 B 37 ASN B 8 ASN~? 24.46 CH3 ACT B 134 B 45 THR A 83 THR^? 17.54 CH3 ACT A 134 coo -19.49 41.97 71.08 -17.37 40.80 71.17 41.52 1.70 -5.49 42.88 2.30 -3.57 coo -23.05 39.62 69.74 -22.86 39.59 67.61 36.75 -2.07 -4.95 35.51 -3.62 -5.82 coo -30.87 34.84 80.57 -28.94 34.51 81.49 28.55 7.09 4.80 27.08 6.14 3.47 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 6 SER.? 30.50 CH3 ACT B 134 B 37 ASN B 8 ASN~? 24.46 CH3 ACT B 134 B 45 THR B 83 THR^? 17.78 CH3 ACT B 134 coo -19.49 41.97 71.08 -17.37 40.80 71.17 41.52 1.70 -5.49 42.88 2.30 -3.57 coo -23.05 39.62 69.74 -22.86 39.59 67.61 36.75 -2.07 -4.95 35.51 -3.62 -5.82 coo -30.87 34.84 80.57 -28.94 34.51 81.49 28.55 9.24 0.02 27.11 10.23 1.39 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 132 SER.? 12.23 OXT ACT B 134 B 37 ASN B 133 ASN.? 9.91 OXT ACT B 134 B 45 THR A 41 THR^? 18.02 CH3 ACT A 134 coo -19.49 41.97 71.08 -17.37 40.80 71.17 7.68 17.54 -6.39 7.22 18.14 -4.05 coo -23.05 39.62 69.74 -22.86 39.59 67.61 12.00 16.42 -6.80 12.35 17.03 -8.83 coo -30.87 34.84 80.57 -28.94 34.51 81.49 18.34 24.70 5.20 19.06 25.00 3.19 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 6 hits 2z3x_d00 naa= 3 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG A 107 ARG^? 13.51 O ACT A 134 G 387 HIS B 50 HIS.? 14.60 O ACT A 134 G 390 SER A 132 SER.? 12.20 O ACT A 134 coo 93.17 52.97 31.81 95.66 54.71 32.14 14.42 -0.01 7.43 16.47 -2.30 7.52 coo 95.60 53.07 40.31 97.10 52.52 41.67 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 93.25 46.91 38.79 94.12 47.43 36.62 7.72 -1.19 11.22 7.31 -1.68 8.88 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 G 386 ARG B 107 ARG^? 13.48 OXT ACT B 134 G 387 HIS A 50 HIS.? 14.57 OXT ACT B 134 G 390 SER B 132 SER.? 12.23 OXT ACT B 134 coo 93.17 52.97 31.81 95.66 54.71 32.14 14.41 16.45 -2.54 16.63 18.58 -2.64 coo 95.60 53.07 40.31 97.10 52.52 41.67 6.53 19.16 0.69 7.13 18.70 -1.26 coo 93.25 46.91 38.79 94.12 47.43 36.62 7.68 17.54 -6.39 7.22 18.14 -4.05 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 2 hits 3qrf_d00 naa= 3 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 89 VAL^? 16.19 CH3 ACT A 134 A 102 PHE A 91 PHE^? 12.26 CH3 ACT A 134 A 169 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo -0.48 2.03 12.21 0.64 0.32 12.97 27.38 12.47 5.89 28.64 12.25 7.64 coo 0.51 5.20 15.97 0.26 4.09 18.50 24.03 9.83 10.49 26.27 11.25 11.31 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL A 90 VAL^? 13.41 CH3 ACT A 134 A 102 PHE A 91 PHE^? 12.26 CH3 ACT A 134 A 169 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo -0.48 2.03 12.21 0.64 0.32 12.97 24.36 10.18 5.78 23.20 9.70 3.91 coo 0.51 5.20 15.97 0.26 4.09 18.50 24.03 9.83 10.49 26.27 11.25 11.31 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 3 3 # 3 A 101 VAL A 110 VAL^? 7.57 CH3 ACT A 134 A 102 PHE A 91 PHE^? 12.26 CH3 ACT A 134 A 169 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo -0.48 2.03 12.21 0.64 0.32 12.97 19.31 11.75 7.52 18.94 12.80 9.43 coo 0.51 5.20 15.97 0.26 4.09 18.50 24.03 9.83 10.49 26.27 11.25 11.31 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 4 3 # 4 A 101 VAL B 89 VAL^? 16.40 CH3 ACT B 134 A 102 PHE B 91 PHE^? 12.41 CH3 ACT B 134 A 169 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo -0.48 2.03 12.21 0.64 0.32 12.97 27.34 3.88 -1.00 28.63 4.08 -2.77 coo 0.51 5.20 15.97 0.26 4.09 18.50 24.01 6.53 -5.66 26.22 5.03 -6.49 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 24.60 -7.54 -2.15 26.44 -7.04 -0.09 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 5 3 # 5 A 101 VAL B 90 VAL^? 13.62 CH3 ACT B 134 A 102 PHE B 91 PHE^? 12.41 CH3 ACT B 134 A 169 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo -0.48 2.03 12.21 0.64 0.32 12.97 24.36 6.22 -0.91 23.18 6.63 0.92 coo 0.51 5.20 15.97 0.26 4.09 18.50 24.01 6.53 -5.66 26.22 5.03 -6.49 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 24.60 -7.54 -2.15 26.44 -7.04 -0.09 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 6 3 # 6 A 101 VAL B 110 VAL^? 7.71 CH3 ACT B 134 A 102 PHE B 91 PHE^? 12.41 CH3 ACT B 134 A 169 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo -0.48 2.03 12.21 0.64 0.32 12.97 19.24 4.57 -2.66 18.70 3.49 -4.48 coo 0.51 5.20 15.97 0.26 4.09 18.50 24.01 6.53 -5.66 26.22 5.03 -6.49 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 6 hits 3s57_d00 naa= 3 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS A 118 LYS^? 23.86 CH3 ACT A 134 B 443 VAL A 114 VAL^? 19.42 CH3 ACT A 134 B 447 ARG A 115 ARG^? 23.19 CH3 ACT A 134 coo -11.49 8.72 29.13 -11.20 3.78 25.16 28.94 23.42 11.82 28.39 29.21 14.30 coo -11.96 6.22 31.96 -10.74 4.61 32.81 29.19 20.15 7.05 30.30 18.96 8.53 coo -14.58 4.58 36.41 -12.11 2.82 36.84 29.95 27.15 5.66 27.05 27.70 4.87 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 2 3 # 2 B 442 LYS B 118 LYS^? 22.69 CH3 ACT B 134 B 443 VAL B 114 VAL^? 19.55 CH3 ACT B 134 B 447 ARG B 115 ARG^? 23.47 CH3 ACT B 134 coo -11.49 8.72 29.13 -11.20 3.78 25.16 28.80 -7.02 -7.08 28.66 -10.73 -10.74 coo -11.96 6.22 31.96 -10.74 4.61 32.81 29.10 -3.84 -2.24 30.22 -2.64 -3.70 coo -14.58 4.58 36.41 -12.11 2.82 36.84 29.96 -10.90 -1.02 27.10 -11.56 -0.24 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 2 hits 4hn5_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 A 208 ASP A 80 ASP^? 13.33 O ACT A 134 A 296 SER A 67 SER~? 9.22 CH3 ACT A 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.04 10.42 13.88 29.99 8.58 12.87 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.99 0.20 10.14 20.59 -0.43 11.58 coo 6.89 17.22 46.63 5.08 16.21 47.91 8.90 16.37 19.47 11.28 16.56 19.94 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 A 208 ASP A 80 ASP^? 13.33 O ACT A 134 A 296 SER B 6 SER.? 30.50 CH3 ACT B 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.04 10.42 13.88 29.99 8.58 12.87 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.99 0.20 10.14 20.59 -0.43 11.58 coo 6.89 17.22 46.63 5.08 16.21 47.91 41.52 1.70 -5.49 42.88 2.30 -3.57 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 A 208 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 296 SER A 67 SER~? 9.22 CH3 ACT A 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.04 10.42 13.88 29.99 8.58 12.87 coo 18.47 29.19 29.68 19.30 29.17 27.75 26.00 19.90 3.85 25.60 19.04 1.99 coo 6.89 17.22 46.63 5.08 16.21 47.91 8.90 16.37 19.47 11.28 16.56 19.94 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 A 208 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 296 SER A 128 SER.? 10.42 O ACT A 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.04 10.42 13.88 29.99 8.58 12.87 coo 18.47 29.19 29.68 19.30 29.17 27.75 26.00 19.90 3.85 25.60 19.04 1.99 coo 6.89 17.22 46.63 5.08 16.21 47.91 9.47 2.37 6.00 8.93 0.44 7.47 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 A 208 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 296 SER B 6 SER.? 30.50 CH3 ACT B 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.04 10.42 13.88 29.99 8.58 12.87 coo 18.47 29.19 29.68 19.30 29.17 27.75 26.00 19.90 3.85 25.60 19.04 1.99 coo 6.89 17.22 46.63 5.08 16.21 47.91 41.52 1.70 -5.49 42.88 2.30 -3.57 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS A 50 HIS.? 14.57 OXT ACT B 134 A 208 ASP B 95 ASP^? -2.82 OXT ACT B 134s A 296 SER A 132 SER.? 12.20 O ACT A 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 6.53 19.16 0.69 7.13 18.70 -1.26 coo 18.47 29.19 29.68 19.30 29.17 27.75 13.83 10.37 -10.37 12.59 9.49 -8.86 coo 6.89 17.22 46.63 5.08 16.21 47.91 7.72 -1.19 11.22 7.31 -1.68 8.88 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 A 208 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 296 SER A 6 SER.? 30.38 CH3 ACT A 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 6.89 17.22 46.63 5.08 16.21 47.91 41.59 14.69 10.23 42.94 14.02 8.31 ULMN 3 2odj_o00 PORIN D user 8 3 # 8 A 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 A 208 ASP B 80 ASP^? 13.20 OXT ACT B 134 A 296 SER B 67 SER~? 9.18 CH3 ACT B 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.98 16.13 -5.41 20.58 16.67 -6.85 coo 6.89 17.22 46.63 5.08 16.21 47.91 8.81 0.10 -14.70 11.16 -0.29 -15.12 ULMN 3 2odj_o00 PORIN D user 9 3 # 9 A 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 A 208 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 296 SER A 6 SER.? 30.38 CH3 ACT A 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.89 17.22 46.63 5.08 16.21 47.91 41.59 14.69 10.23 42.94 14.02 8.31 ULMN 3 2odj_o00 PORIN D user 10 3 # 10 A 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 A 208 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 296 SER B 67 SER~? 9.18 CH3 ACT B 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.89 17.22 46.63 5.08 16.21 47.91 8.81 0.10 -14.70 11.16 -0.29 -15.12 ULMN 3 2odj_o00 PORIN D user 11 3 # 11 A 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 A 208 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 296 SER B 128 SER.? 10.40 OXT ACT B 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 30.01 5.88 -9.10 29.93 7.73 -8.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 6.89 17.22 46.63 5.08 16.21 47.91 9.49 14.01 -1.20 8.95 15.98 -2.61 ULMN 3 2odj_o00 PORIN D user 12 3 # 12 A 156 HIS B 50 HIS.? 14.60 O ACT A 134 A 208 ASP A 95 ASP^? -2.87 O ACT A 134s A 296 SER B 132 SER.? 12.23 OXT ACT B 134 coo 12.72 17.48 24.71 12.80 19.37 23.81 6.58 -2.80 4.18 7.21 -2.33 6.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 13.92 6.03 15.16 12.65 6.91 13.72 coo 6.89 17.22 46.63 5.08 16.21 47.91 7.68 17.54 -6.39 7.22 18.14 -4.05 2odj_o00 source 2ODJ PORIN D : 12 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 B 208 ASP A 80 ASP^? 13.33 O ACT A 134 B 296 SER A 67 SER~? 9.22 CH3 ACT A 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.04 10.42 13.88 29.99 8.58 12.87 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 21.99 0.20 10.14 20.59 -0.43 11.58 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 8.90 16.37 19.47 11.28 16.56 19.94 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 B 208 ASP A 80 ASP^? 13.33 O ACT A 134 B 296 SER B 6 SER.? 30.50 CH3 ACT B 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.04 10.42 13.88 29.99 8.58 12.87 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 21.99 0.20 10.14 20.59 -0.43 11.58 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 41.52 1.70 -5.49 42.88 2.30 -3.57 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 B 208 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 296 SER A 67 SER~? 9.22 CH3 ACT A 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.04 10.42 13.88 29.99 8.58 12.87 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 26.00 19.90 3.85 25.60 19.04 1.99 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 8.90 16.37 19.47 11.28 16.56 19.94 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS A 14 HIS~? 17.04 CH3 ACT A 134 B 208 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 296 SER A 128 SER.? 10.42 O ACT A 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.04 10.42 13.88 29.99 8.58 12.87 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 26.00 19.90 3.85 25.60 19.04 1.99 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 9.47 2.37 6.00 8.93 0.44 7.47 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS A 50 HIS.? 14.57 OXT ACT B 134 B 208 ASP B 95 ASP^? -2.82 OXT ACT B 134s B 296 SER A 132 SER.? 12.20 O ACT A 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 6.53 19.16 0.69 7.13 18.70 -1.26 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 13.83 10.37 -10.37 12.59 9.49 -8.86 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.72 -1.19 11.22 7.31 -1.68 8.88 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 B 208 ASP B 80 ASP^? 13.20 OXT ACT B 134 B 296 SER A 6 SER.? 30.38 CH3 ACT A 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.01 5.88 -9.10 29.93 7.73 -8.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 41.59 14.69 10.23 42.94 14.02 8.31 ULMN 3 2odj_o01 PORIN D user 7 3 # 7 B 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 B 208 ASP B 80 ASP^? 13.20 OXT ACT B 134 B 296 SER B 67 SER~? 9.18 CH3 ACT B 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.01 5.88 -9.10 29.93 7.73 -8.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 21.98 16.13 -5.41 20.58 16.67 -6.85 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 8.81 0.10 -14.70 11.16 -0.29 -15.12 ULMN 3 2odj_o01 PORIN D user 8 3 # 8 B 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 B 208 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 296 SER B 67 SER~? 9.18 CH3 ACT B 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.01 5.88 -9.10 29.93 7.73 -8.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 8.81 0.10 -14.70 11.16 -0.29 -15.12 ULMN 3 2odj_o01 PORIN D user 9 3 # 9 B 156 HIS B 14 HIS~? 17.16 CH3 ACT B 134 B 208 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 296 SER B 128 SER.? 10.40 OXT ACT B 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 30.01 5.88 -9.10 29.93 7.73 -8.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 9.49 14.01 -1.20 8.95 15.98 -2.61 ULMN 3 2odj_o01 PORIN D user 10 3 # 10 B 156 HIS B 50 HIS.? 14.60 O ACT A 134 B 208 ASP A 95 ASP^? -2.87 O ACT A 134s B 296 SER B 132 SER.? 12.23 OXT ACT B 134 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 6.58 -2.80 4.18 7.21 -2.33 6.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 13.92 6.03 15.16 12.65 6.91 13.72 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.68 17.54 -6.39 7.22 18.14 -4.05 2odj_o01 source 2ODJ PORIN D : 10 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 67 SER~? 9.22 CH3 ACT A 134 A 166 PHE A 49 PHE.? 12.05 OXT ACT A 134 A 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 8.90 16.37 19.47 11.28 16.56 19.94 coo -36.62 39.62 84.60 -38.76 41.24 85.25 7.92 21.75 8.87 7.38 23.30 11.14 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 78 SER^? 12.19 O ACT A 134 A 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 A 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 20.05 1.17 15.74 19.11 -0.15 13.92 coo -36.62 39.62 84.60 -38.76 41.24 85.25 24.03 9.83 10.49 26.27 11.25 11.31 coo -36.55 45.66 79.22 -38.34 43.94 80.53 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 84 SER^? 20.86 CH3 ACT A 134 A 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 A 182 PHE A 93 PHE^? 5.64 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 30.40 10.24 3.82 32.46 10.17 5.21 coo -36.62 39.62 84.60 -38.76 41.24 85.25 24.03 9.83 10.49 26.27 11.25 11.31 coo -36.55 45.66 79.22 -38.34 43.94 80.53 18.45 6.69 12.19 16.89 8.99 12.05 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 84 SER^? 20.86 CH3 ACT A 134 A 166 PHE A 112 PHE^? 11.25 CH3 ACT A 134 A 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 30.40 10.24 3.82 32.46 10.17 5.21 coo -36.62 39.62 84.60 -38.76 41.24 85.25 23.79 16.00 9.29 22.27 15.23 11.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 84 SER^? 20.86 CH3 ACT A 134 A 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 A 182 PHE B 112 PHE^? 11.41 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 30.40 10.24 3.82 32.46 10.17 5.21 coo -36.62 39.62 84.60 -38.76 41.24 85.25 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 23.76 0.41 -4.47 22.23 1.06 -6.71 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 17 PHE~? 9.37 CH3 ACT A 134 A 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 23.39 11.02 14.17 21.27 9.32 13.60 coo -36.55 45.66 79.22 -38.34 43.94 80.53 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 19.15 14.12 14.90 17.05 13.12 13.34 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 A 182 PHE A 40 PHE^? 14.40 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.55 19.39 16.02 20.64 18.71 13.32 coo -36.55 45.66 79.22 -38.34 43.94 80.53 20.14 24.61 9.13 19.21 21.98 9.50 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 A 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.14 24.61 9.13 19.21 21.98 9.50 coo -36.55 45.66 79.22 -38.34 43.94 80.53 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 A 182 PHE A 62 PHE~? 8.11 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.14 24.61 9.13 19.21 21.98 9.50 coo -36.55 45.66 79.22 -38.34 43.94 80.53 11.42 20.47 11.27 11.65 17.82 10.47 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 A 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.14 24.61 9.13 19.21 21.98 9.50 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 A 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.89 21.94 7.67 12.75 23.35 8.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 A 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.89 21.94 7.67 12.75 23.35 8.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 A 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 10.18 16.78 6.78 8.76 15.01 8.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 15 3 # 15 A 130 SER A 111 SER^? 14.00 CH3 ACT A 134 A 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 A 182 PHE A 126 PHE^? 5.77 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.88 13.56 5.40 22.76 13.90 3.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 10.18 16.78 6.78 8.76 15.01 8.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 9.56 9.33 5.49 8.55 11.71 6.60 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 16 3 # 16 A 130 SER A 121 SER^? 16.65 CH3 ACT A 134 A 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 182 PHE A 19 PHE~? 16.57 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.93 21.60 5.62 22.92 20.74 3.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 19.15 14.12 14.90 17.05 13.12 13.34 coo -36.55 45.66 79.22 -38.34 43.94 80.53 24.41 18.01 20.14 26.66 18.57 21.69 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 17 3 # 17 A 130 SER A 121 SER^? 16.65 CH3 ACT A 134 A 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.93 21.60 5.62 22.92 20.74 3.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 19.15 14.12 14.90 17.05 13.12 13.34 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 18 3 # 18 A 130 SER A 121 SER^? 16.65 CH3 ACT A 134 A 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 A 182 PHE A 91 PHE^? 12.26 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.93 21.60 5.62 22.92 20.74 3.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 19.15 14.12 14.90 17.05 13.12 13.34 coo -36.55 45.66 79.22 -38.34 43.94 80.53 24.03 9.83 10.49 26.27 11.25 11.31 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 19 3 # 19 A 130 SER A 121 SER^? 16.65 CH3 ACT A 134 A 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 A 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.93 21.60 5.62 22.92 20.74 3.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.55 19.39 16.02 20.64 18.71 13.32 coo -36.55 45.66 79.22 -38.34 43.94 80.53 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 20 3 # 20 A 130 SER A 121 SER^? 16.65 CH3 ACT A 134 A 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 A 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.93 21.60 5.62 22.92 20.74 3.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.60 20.08 14.87 16.25 19.26 12.77 coo -36.55 45.66 79.22 -38.34 43.94 80.53 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 21 3 # 21 A 130 SER A 121 SER^? 16.65 CH3 ACT A 134 A 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 A 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.93 21.60 5.62 22.92 20.74 3.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.60 20.08 14.87 16.25 19.26 12.77 coo -36.55 45.66 79.22 -38.34 43.94 80.53 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 22 3 # 22 A 130 SER A 121 SER^? 16.65 CH3 ACT A 134 A 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 A 182 PHE A 49 PHE.? 12.05 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.93 21.60 5.62 22.92 20.74 3.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.60 20.08 14.87 16.25 19.26 12.77 coo -36.55 45.66 79.22 -38.34 43.94 80.53 7.92 21.75 8.87 7.38 23.30 11.14 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 23 3 # 23 A 130 SER A 128 SER.? 10.42 O ACT A 134 A 166 PHE B 44 PHE^? 6.37 O ACT B 134 A 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 9.47 2.37 6.00 8.93 0.44 7.47 coo -36.62 39.62 84.60 -38.76 41.24 85.25 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 24 3 # 24 A 130 SER A 132 SER.? 12.20 O ACT A 134 A 166 PHE A 126 PHE^? 5.77 OXT ACT A 134 A 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 7.72 -1.19 11.22 7.31 -1.68 8.88 coo -36.62 39.62 84.60 -38.76 41.24 85.25 9.56 9.33 5.49 8.55 11.71 6.60 coo -36.55 45.66 79.22 -38.34 43.94 80.53 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 25 3 # 25 A 130 SER B 67 SER~? 9.18 CH3 ACT B 134 A 166 PHE B 49 PHE.? 12.01 O ACT B 134 A 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 7.96 -5.25 -4.07 7.44 -6.88 -6.27 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 26 3 # 26 A 130 SER B 78 SER^? 12.20 OXT ACT B 134 A 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 A 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 20.02 15.26 -10.83 19.07 16.62 -8.98 coo -36.62 39.62 84.60 -38.76 41.24 85.25 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 27 3 # 27 A 130 SER B 84 SER^? 21.05 CH3 ACT B 134 A 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 A 182 PHE A 112 PHE^? 11.25 CH3 ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 30.37 6.08 1.00 32.42 6.12 -0.34 coo -36.62 39.62 84.60 -38.76 41.24 85.25 24.03 9.83 10.49 26.27 11.25 11.31 coo -36.55 45.66 79.22 -38.34 43.94 80.53 23.79 16.00 9.29 22.27 15.23 11.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 28 3 # 28 A 130 SER B 84 SER^? 21.05 CH3 ACT B 134 A 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 A 182 PHE B 93 PHE^? 5.85 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 30.37 6.08 1.00 32.42 6.12 -0.34 coo -36.62 39.62 84.60 -38.76 41.24 85.25 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 18.48 9.68 -7.33 16.94 7.39 -7.19 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 29 3 # 29 A 130 SER B 84 SER^? 21.05 CH3 ACT B 134 A 166 PHE B 112 PHE^? 11.41 CH3 ACT B 134 A 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 30.37 6.08 1.00 32.42 6.12 -0.34 coo -36.62 39.62 84.60 -38.76 41.24 85.25 23.76 0.41 -4.47 22.23 1.06 -6.71 coo -36.55 45.66 79.22 -38.34 43.94 80.53 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 30 3 # 30 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 17 PHE~? 9.52 CH3 ACT B 134 A 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 23.32 5.37 -9.36 21.26 7.18 -8.91 coo -36.55 45.66 79.22 -38.34 43.94 80.53 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 31 3 # 31 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 20 PHE~? 5.94 CH3 ACT B 134 A 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 32 3 # 32 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 A 182 PHE B 40 PHE^? 14.44 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -36.55 45.66 79.22 -38.34 43.94 80.53 20.07 -8.19 -4.31 19.11 -5.62 -4.70 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 33 3 # 33 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 A 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 34 3 # 34 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 A 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -36.55 45.66 79.22 -38.34 43.94 80.53 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 35 3 # 35 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 A 182 PHE B 62 PHE~? 8.01 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -36.55 45.66 79.22 -38.34 43.94 80.53 11.39 -3.91 -6.44 11.73 -1.26 -5.68 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 36 3 # 36 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 A 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 37 3 # 37 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 42 PHE^? 12.28 O ACT B 134 A 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -36.55 45.66 79.22 -38.34 43.94 80.53 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 38 3 # 38 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 42 PHE^? 12.28 O ACT B 134 A 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 39 3 # 39 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 44 PHE^? 6.37 O ACT B 134 A 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 40 3 # 40 A 130 SER B 111 SER^? 14.22 CH3 ACT B 134 A 166 PHE B 44 PHE^? 6.37 O ACT B 134 A 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.84 2.81 -0.55 22.81 2.45 1.66 coo -36.62 39.62 84.60 -38.76 41.24 85.25 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -36.55 45.66 79.22 -38.34 43.94 80.53 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 41 3 # 41 A 130 SER B 121 SER^? 16.88 CH3 ACT B 134 A 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 A 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -36.55 45.66 79.22 -38.34 43.94 80.53 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 42 3 # 42 A 130 SER B 121 SER^? 16.88 CH3 ACT B 134 A 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 A 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 43 3 # 43 A 130 SER B 121 SER^? 16.88 CH3 ACT B 134 A 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 A 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 44 3 # 44 A 130 SER B 121 SER^? 16.88 CH3 ACT B 134 A 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 A 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 45 3 # 45 A 130 SER B 121 SER^? 16.88 CH3 ACT B 134 A 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 A 182 PHE B 49 PHE.? 12.01 O ACT B 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 7.96 -5.25 -4.07 7.44 -6.88 -6.27 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 46 3 # 46 A 130 SER B 128 SER.? 10.40 OXT ACT B 134 A 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 A 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 9.49 14.01 -1.20 8.95 15.98 -2.61 coo -36.62 39.62 84.60 -38.76 41.24 85.25 10.18 16.78 6.78 8.76 15.01 8.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 47 3 # 47 A 130 SER B 132 SER.? 12.23 OXT ACT B 134 A 166 PHE B 126 PHE^? 5.73 O ACT B 134 A 182 PHE A 126 PHE^? 5.77 OXT ACT A 134 coo -46.28 37.24 81.97 -44.96 39.32 82.40 7.68 17.54 -6.39 7.22 18.14 -4.05 coo -36.62 39.62 84.60 -38.76 41.24 85.25 9.55 7.10 -0.62 8.51 4.83 -1.87 coo -36.55 45.66 79.22 -38.34 43.94 80.53 9.56 9.33 5.49 8.55 11.71 6.60 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 47 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 67 SER~? 9.22 CH3 ACT A 134 B 166 PHE A 49 PHE.? 12.05 OXT ACT A 134 B 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 8.90 16.37 19.47 11.28 16.56 19.94 coo -29.59 43.40 95.66 -28.22 45.54 94.50 7.92 21.75 8.87 7.38 23.30 11.14 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 78 SER^? 12.19 O ACT A 134 B 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 B 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 20.05 1.17 15.74 19.11 -0.15 13.92 coo -29.59 43.40 95.66 -28.22 45.54 94.50 24.03 9.83 10.49 26.27 11.25 11.31 coo -32.72 50.15 98.46 -30.32 48.85 97.77 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 84 SER^? 20.86 CH3 ACT A 134 B 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 B 182 PHE A 93 PHE^? 5.64 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 30.40 10.24 3.82 32.46 10.17 5.21 coo -29.59 43.40 95.66 -28.22 45.54 94.50 24.03 9.83 10.49 26.27 11.25 11.31 coo -32.72 50.15 98.46 -30.32 48.85 97.77 18.45 6.69 12.19 16.89 8.99 12.05 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 84 SER^? 20.86 CH3 ACT A 134 B 166 PHE A 112 PHE^? 11.25 CH3 ACT A 134 B 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 30.40 10.24 3.82 32.46 10.17 5.21 coo -29.59 43.40 95.66 -28.22 45.54 94.50 23.79 16.00 9.29 22.27 15.23 11.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 84 SER^? 20.86 CH3 ACT A 134 B 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 B 182 PHE B 112 PHE^? 11.41 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 30.40 10.24 3.82 32.46 10.17 5.21 coo -29.59 43.40 95.66 -28.22 45.54 94.50 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 23.76 0.41 -4.47 22.23 1.06 -6.71 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 17 PHE~? 9.37 CH3 ACT A 134 B 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 23.39 11.02 14.17 21.27 9.32 13.60 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 B 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 19.15 14.12 14.90 17.05 13.12 13.34 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 B 182 PHE A 40 PHE^? 14.40 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.55 19.39 16.02 20.64 18.71 13.32 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.14 24.61 9.13 19.21 21.98 9.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 B 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.55 19.39 16.02 20.64 18.71 13.32 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 B 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.14 24.61 9.13 19.21 21.98 9.50 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 B 182 PHE A 62 PHE~? 8.11 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.14 24.61 9.13 19.21 21.98 9.50 coo -32.72 50.15 98.46 -30.32 48.85 97.77 11.42 20.47 11.27 11.65 17.82 10.47 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 B 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.14 24.61 9.13 19.21 21.98 9.50 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 B 182 PHE A 40 PHE^? 14.40 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.89 21.94 7.67 12.75 23.35 8.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.14 24.61 9.13 19.21 21.98 9.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 14 3 # 14 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 B 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.89 21.94 7.67 12.75 23.35 8.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 15 3 # 15 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 B 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.89 21.94 7.67 12.75 23.35 8.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 16 3 # 16 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 B 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 10.18 16.78 6.78 8.76 15.01 8.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 17 3 # 17 B 130 SER A 111 SER^? 14.00 CH3 ACT A 134 B 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 B 182 PHE A 126 PHE^? 5.77 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 10.18 16.78 6.78 8.76 15.01 8.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 9.56 9.33 5.49 8.55 11.71 6.60 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 18 3 # 18 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 B 182 PHE A 19 PHE~? 16.57 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 19.15 14.12 14.90 17.05 13.12 13.34 coo -32.72 50.15 98.46 -30.32 48.85 97.77 24.41 18.01 20.14 26.66 18.57 21.69 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 19 3 # 19 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 B 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 19.15 14.12 14.90 17.05 13.12 13.34 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 20 3 # 20 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 B 182 PHE A 91 PHE^? 12.26 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 19.15 14.12 14.90 17.05 13.12 13.34 coo -32.72 50.15 98.46 -30.32 48.85 97.77 24.03 9.83 10.49 26.27 11.25 11.31 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 21 3 # 21 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 B 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.55 19.39 16.02 20.64 18.71 13.32 coo -32.72 50.15 98.46 -30.32 48.85 97.77 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 22 3 # 22 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 B 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.55 19.39 16.02 20.64 18.71 13.32 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 23 3 # 23 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 B 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.60 20.08 14.87 16.25 19.26 12.77 coo -32.72 50.15 98.46 -30.32 48.85 97.77 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 24 3 # 24 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 B 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.60 20.08 14.87 16.25 19.26 12.77 coo -32.72 50.15 98.46 -30.32 48.85 97.77 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 25 3 # 25 B 130 SER A 121 SER^? 16.65 CH3 ACT A 134 B 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 B 182 PHE A 49 PHE.? 12.05 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.60 20.08 14.87 16.25 19.26 12.77 coo -32.72 50.15 98.46 -30.32 48.85 97.77 7.92 21.75 8.87 7.38 23.30 11.14 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 26 3 # 26 B 130 SER A 128 SER.? 10.42 O ACT A 134 B 166 PHE B 44 PHE^? 6.37 O ACT B 134 B 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 9.47 2.37 6.00 8.93 0.44 7.47 coo -29.59 43.40 95.66 -28.22 45.54 94.50 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 27 3 # 27 B 130 SER A 132 SER.? 12.20 O ACT A 134 B 166 PHE A 126 PHE^? 5.77 OXT ACT A 134 B 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 7.72 -1.19 11.22 7.31 -1.68 8.88 coo -29.59 43.40 95.66 -28.22 45.54 94.50 9.56 9.33 5.49 8.55 11.71 6.60 coo -32.72 50.15 98.46 -30.32 48.85 97.77 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 28 3 # 28 B 130 SER B 67 SER~? 9.18 CH3 ACT B 134 B 166 PHE B 49 PHE.? 12.01 O ACT B 134 B 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 7.96 -5.25 -4.07 7.44 -6.88 -6.27 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 29 3 # 29 B 130 SER B 78 SER^? 12.20 OXT ACT B 134 B 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 B 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 20.02 15.26 -10.83 19.07 16.62 -8.98 coo -29.59 43.40 95.66 -28.22 45.54 94.50 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 30 3 # 30 B 130 SER B 84 SER^? 21.05 CH3 ACT B 134 B 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 B 182 PHE A 112 PHE^? 11.25 CH3 ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 30.37 6.08 1.00 32.42 6.12 -0.34 coo -29.59 43.40 95.66 -28.22 45.54 94.50 24.03 9.83 10.49 26.27 11.25 11.31 coo -32.72 50.15 98.46 -30.32 48.85 97.77 23.79 16.00 9.29 22.27 15.23 11.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 31 3 # 31 B 130 SER B 84 SER^? 21.05 CH3 ACT B 134 B 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 B 182 PHE B 93 PHE^? 5.85 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 30.37 6.08 1.00 32.42 6.12 -0.34 coo -29.59 43.40 95.66 -28.22 45.54 94.50 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 18.48 9.68 -7.33 16.94 7.39 -7.19 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 32 3 # 32 B 130 SER B 84 SER^? 21.05 CH3 ACT B 134 B 166 PHE B 112 PHE^? 11.41 CH3 ACT B 134 B 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 30.37 6.08 1.00 32.42 6.12 -0.34 coo -29.59 43.40 95.66 -28.22 45.54 94.50 23.76 0.41 -4.47 22.23 1.06 -6.71 coo -32.72 50.15 98.46 -30.32 48.85 97.77 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 33 3 # 33 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 17 PHE~? 9.52 CH3 ACT B 134 B 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 23.32 5.37 -9.36 21.26 7.18 -8.91 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 34 3 # 34 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 20 PHE~? 5.94 CH3 ACT B 134 B 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 35 3 # 35 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 B 182 PHE B 40 PHE^? 14.44 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.07 -8.19 -4.31 19.11 -5.62 -4.70 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 36 3 # 36 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 B 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 37 3 # 37 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 B 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 38 3 # 38 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 B 182 PHE B 62 PHE~? 8.01 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -32.72 50.15 98.46 -30.32 48.85 97.77 11.39 -3.91 -6.44 11.73 -1.26 -5.68 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 39 3 # 39 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 B 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 40 3 # 40 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 42 PHE^? 12.28 O ACT B 134 B 182 PHE B 40 PHE^? 14.44 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -32.72 50.15 98.46 -30.32 48.85 97.77 20.07 -8.19 -4.31 19.11 -5.62 -4.70 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 41 3 # 41 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 42 PHE^? 12.28 O ACT B 134 B 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -32.72 50.15 98.46 -30.32 48.85 97.77 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 42 3 # 42 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 42 PHE^? 12.28 O ACT B 134 B 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 43 3 # 43 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 44 PHE^? 6.37 O ACT B 134 B 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 44 3 # 44 B 130 SER B 111 SER^? 14.22 CH3 ACT B 134 B 166 PHE B 44 PHE^? 6.37 O ACT B 134 B 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -29.59 43.40 95.66 -28.22 45.54 94.50 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -32.72 50.15 98.46 -30.32 48.85 97.77 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 45 3 # 45 B 130 SER B 121 SER^? 16.88 CH3 ACT B 134 B 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 B 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -32.72 50.15 98.46 -30.32 48.85 97.77 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 46 3 # 46 B 130 SER B 121 SER^? 16.88 CH3 ACT B 134 B 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 B 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 47 3 # 47 B 130 SER B 121 SER^? 16.88 CH3 ACT B 134 B 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 B 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 48 3 # 48 B 130 SER B 121 SER^? 16.88 CH3 ACT B 134 B 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 B 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 49 3 # 49 B 130 SER B 121 SER^? 16.88 CH3 ACT B 134 B 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 B 182 PHE B 49 PHE.? 12.01 O ACT B 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 7.96 -5.25 -4.07 7.44 -6.88 -6.27 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 50 3 # 50 B 130 SER B 128 SER.? 10.40 OXT ACT B 134 B 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 B 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 9.49 14.01 -1.20 8.95 15.98 -2.61 coo -29.59 43.40 95.66 -28.22 45.54 94.50 10.18 16.78 6.78 8.76 15.01 8.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 51 3 # 51 B 130 SER B 132 SER.? 12.23 OXT ACT B 134 B 166 PHE B 126 PHE^? 5.73 O ACT B 134 B 182 PHE A 126 PHE^? 5.77 OXT ACT A 134 coo -19.94 46.29 97.83 -22.38 46.56 97.60 7.68 17.54 -6.39 7.22 18.14 -4.05 coo -29.59 43.40 95.66 -28.22 45.54 94.50 9.55 7.10 -0.62 8.51 4.83 -1.87 coo -32.72 50.15 98.46 -30.32 48.85 97.77 9.56 9.33 5.49 8.55 11.71 6.60 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 51 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 67 SER~? 9.22 CH3 ACT A 134 C 166 PHE A 49 PHE.? 12.05 OXT ACT A 134 C 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.90 16.37 19.47 11.28 16.56 19.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 7.92 21.75 8.87 7.38 23.30 11.14 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 67 SER~? 9.22 CH3 ACT A 134 C 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 C 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.90 16.37 19.47 11.28 16.56 19.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.60 20.08 14.87 16.25 19.26 12.77 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 67 SER~? 9.22 CH3 ACT A 134 C 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 C 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.90 16.37 19.47 11.28 16.56 19.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.60 20.08 14.87 16.25 19.26 12.77 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 67 SER~? 9.22 CH3 ACT A 134 C 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 C 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.90 16.37 19.47 11.28 16.56 19.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.60 20.08 14.87 16.25 19.26 12.77 coo -7.71 55.92 42.70 -7.18 57.60 44.85 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 67 SER~? 9.22 CH3 ACT A 134 C 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 C 182 PHE A 49 PHE.? 12.05 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.90 16.37 19.47 11.28 16.56 19.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.60 20.08 14.87 16.25 19.26 12.77 coo -7.71 55.92 42.70 -7.18 57.60 44.85 7.92 21.75 8.87 7.38 23.30 11.14 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER A 78 SER^? 12.19 O ACT A 134 C 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 C 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 20.05 1.17 15.74 19.11 -0.15 13.92 coo -11.14 61.91 46.89 -9.88 60.30 48.76 24.03 9.83 10.49 26.27 11.25 11.31 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER A 84 SER^? 20.86 CH3 ACT A 134 C 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 C 182 PHE A 93 PHE^? 5.64 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 30.40 10.24 3.82 32.46 10.17 5.21 coo -11.14 61.91 46.89 -9.88 60.30 48.76 24.03 9.83 10.49 26.27 11.25 11.31 coo -7.71 55.92 42.70 -7.18 57.60 44.85 18.45 6.69 12.19 16.89 8.99 12.05 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER A 84 SER^? 20.86 CH3 ACT A 134 C 166 PHE A 112 PHE^? 11.25 CH3 ACT A 134 C 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 30.40 10.24 3.82 32.46 10.17 5.21 coo -11.14 61.91 46.89 -9.88 60.30 48.76 23.79 16.00 9.29 22.27 15.23 11.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER A 84 SER^? 20.86 CH3 ACT A 134 C 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 C 182 PHE B 112 PHE^? 11.41 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 30.40 10.24 3.82 32.46 10.17 5.21 coo -11.14 61.91 46.89 -9.88 60.30 48.76 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 23.76 0.41 -4.47 22.23 1.06 -6.71 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 17 PHE~? 9.37 CH3 ACT A 134 C 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 23.39 11.02 14.17 21.27 9.32 13.60 coo -7.71 55.92 42.70 -7.18 57.60 44.85 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 C 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 19.15 14.12 14.90 17.05 13.12 13.34 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 C 182 PHE A 40 PHE^? 14.40 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.55 19.39 16.02 20.64 18.71 13.32 coo -7.71 55.92 42.70 -7.18 57.60 44.85 20.14 24.61 9.13 19.21 21.98 9.50 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 13 3 # 13 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 C 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.14 24.61 9.13 19.21 21.98 9.50 coo -7.71 55.92 42.70 -7.18 57.60 44.85 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 14 3 # 14 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 C 182 PHE A 62 PHE~? 8.11 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.14 24.61 9.13 19.21 21.98 9.50 coo -7.71 55.92 42.70 -7.18 57.60 44.85 11.42 20.47 11.27 11.65 17.82 10.47 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 15 3 # 15 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 C 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.14 24.61 9.13 19.21 21.98 9.50 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 16 3 # 16 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 C 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.89 21.94 7.67 12.75 23.35 8.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 17 3 # 17 C 130 SER A 111 SER^? 14.00 CH3 ACT A 134 C 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 C 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.88 13.56 5.40 22.76 13.90 3.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.89 21.94 7.67 12.75 23.35 8.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 18 3 # 18 C 130 SER A 121 SER^? 16.65 CH3 ACT A 134 C 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 C 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.55 19.39 16.02 20.64 18.71 13.32 coo -7.71 55.92 42.70 -7.18 57.60 44.85 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 19 3 # 19 C 130 SER A 121 SER^? 16.65 CH3 ACT A 134 C 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 C 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.60 20.08 14.87 16.25 19.26 12.77 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 20 3 # 20 C 130 SER A 121 SER^? 16.65 CH3 ACT A 134 C 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 C 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.60 20.08 14.87 16.25 19.26 12.77 coo -7.71 55.92 42.70 -7.18 57.60 44.85 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 21 3 # 21 C 130 SER A 121 SER^? 16.65 CH3 ACT A 134 C 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 C 182 PHE A 49 PHE.? 12.05 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.93 21.60 5.62 22.92 20.74 3.60 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.60 20.08 14.87 16.25 19.26 12.77 coo -7.71 55.92 42.70 -7.18 57.60 44.85 7.92 21.75 8.87 7.38 23.30 11.14 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 22 3 # 22 C 130 SER A 128 SER.? 10.42 O ACT A 134 C 166 PHE B 44 PHE^? 6.37 O ACT B 134 C 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 9.47 2.37 6.00 8.93 0.44 7.47 coo -11.14 61.91 46.89 -9.88 60.30 48.76 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 23 3 # 23 C 130 SER A 132 SER.? 12.20 O ACT A 134 C 166 PHE A 126 PHE^? 5.77 OXT ACT A 134 C 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 7.72 -1.19 11.22 7.31 -1.68 8.88 coo -11.14 61.91 46.89 -9.88 60.30 48.76 9.56 9.33 5.49 8.55 11.71 6.60 coo -7.71 55.92 42.70 -7.18 57.60 44.85 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 24 3 # 24 C 130 SER B 67 SER~? 9.18 CH3 ACT B 134 C 166 PHE B 49 PHE.? 12.01 O ACT B 134 C 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 7.96 -5.25 -4.07 7.44 -6.88 -6.27 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 25 3 # 25 C 130 SER B 67 SER~? 9.18 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 26 3 # 26 C 130 SER B 67 SER~? 9.18 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 27 3 # 27 C 130 SER B 67 SER~? 9.18 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 28 3 # 28 C 130 SER B 67 SER~? 9.18 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 29 3 # 29 C 130 SER B 67 SER~? 9.18 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 49 PHE.? 12.01 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 7.96 -5.25 -4.07 7.44 -6.88 -6.27 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 30 3 # 30 C 130 SER B 78 SER^? 12.20 OXT ACT B 134 C 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 C 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 20.02 15.26 -10.83 19.07 16.62 -8.98 coo -11.14 61.91 46.89 -9.88 60.30 48.76 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 31 3 # 31 C 130 SER B 84 SER^? 21.05 CH3 ACT B 134 C 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 C 182 PHE A 112 PHE^? 11.25 CH3 ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 30.37 6.08 1.00 32.42 6.12 -0.34 coo -11.14 61.91 46.89 -9.88 60.30 48.76 24.03 9.83 10.49 26.27 11.25 11.31 coo -7.71 55.92 42.70 -7.18 57.60 44.85 23.79 16.00 9.29 22.27 15.23 11.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 32 3 # 32 C 130 SER B 84 SER^? 21.05 CH3 ACT B 134 C 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 C 182 PHE B 93 PHE^? 5.85 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 30.37 6.08 1.00 32.42 6.12 -0.34 coo -11.14 61.91 46.89 -9.88 60.30 48.76 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 18.48 9.68 -7.33 16.94 7.39 -7.19 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 33 3 # 33 C 130 SER B 84 SER^? 21.05 CH3 ACT B 134 C 166 PHE B 112 PHE^? 11.41 CH3 ACT B 134 C 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 30.37 6.08 1.00 32.42 6.12 -0.34 coo -11.14 61.91 46.89 -9.88 60.30 48.76 23.76 0.41 -4.47 22.23 1.06 -6.71 coo -7.71 55.92 42.70 -7.18 57.60 44.85 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 34 3 # 34 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 17 PHE~? 9.52 CH3 ACT B 134 C 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 23.32 5.37 -9.36 21.26 7.18 -8.91 coo -7.71 55.92 42.70 -7.18 57.60 44.85 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 35 3 # 35 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 20 PHE~? 5.94 CH3 ACT B 134 C 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 36 3 # 36 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 C 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -7.71 55.92 42.70 -7.18 57.60 44.85 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 37 3 # 37 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 C 182 PHE B 62 PHE~? 8.01 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -7.71 55.92 42.70 -7.18 57.60 44.85 11.39 -3.91 -6.44 11.73 -1.26 -5.68 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 38 3 # 38 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 C 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 39 3 # 39 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 42 PHE^? 12.28 O ACT B 134 C 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -7.71 55.92 42.70 -7.18 57.60 44.85 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 40 3 # 40 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 42 PHE^? 12.28 O ACT B 134 C 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 41 3 # 41 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 44 PHE^? 6.37 O ACT B 134 C 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 42 3 # 42 C 130 SER B 111 SER^? 14.22 CH3 ACT B 134 C 166 PHE B 44 PHE^? 6.37 O ACT B 134 C 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.84 2.81 -0.55 22.81 2.45 1.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -7.71 55.92 42.70 -7.18 57.60 44.85 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 43 3 # 43 C 130 SER B 121 SER^? 16.88 CH3 ACT B 134 C 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 C 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -7.71 55.92 42.70 -7.18 57.60 44.85 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 44 3 # 44 C 130 SER B 121 SER^? 16.88 CH3 ACT B 134 C 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 C 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 45 3 # 45 C 130 SER B 121 SER^? 16.88 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 46 3 # 46 C 130 SER B 121 SER^? 16.88 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 47 3 # 47 C 130 SER B 121 SER^? 16.88 CH3 ACT B 134 C 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 C 182 PHE B 49 PHE.? 12.01 O ACT B 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 7.96 -5.25 -4.07 7.44 -6.88 -6.27 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 48 3 # 48 C 130 SER B 128 SER.? 10.40 OXT ACT B 134 C 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 C 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 9.49 14.01 -1.20 8.95 15.98 -2.61 coo -11.14 61.91 46.89 -9.88 60.30 48.76 10.18 16.78 6.78 8.76 15.01 8.39 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 49 3 # 49 C 130 SER B 132 SER.? 12.23 OXT ACT B 134 C 166 PHE B 126 PHE^? 5.73 O ACT B 134 C 182 PHE A 126 PHE^? 5.77 OXT ACT A 134 coo -2.19 64.27 51.12 -3.34 62.10 50.60 7.68 17.54 -6.39 7.22 18.14 -4.05 coo -11.14 61.91 46.89 -9.88 60.30 48.76 9.55 7.10 -0.62 8.51 4.83 -1.87 coo -7.71 55.92 42.70 -7.18 57.60 44.85 9.56 9.33 5.49 8.55 11.71 6.60 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 49 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 67 SER~? 9.22 CH3 ACT A 134 D 166 PHE A 49 PHE.? 12.05 OXT ACT A 134 D 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 8.90 16.37 19.47 11.28 16.56 19.94 coo -23.62 58.20 50.84 -23.76 56.14 48.96 7.92 21.75 8.87 7.38 23.30 11.14 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 67 SER~? 9.22 CH3 ACT A 134 D 166 PHE A 62 PHE~? 8.11 OXT ACT A 134 D 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 8.90 16.37 19.47 11.28 16.56 19.94 coo -23.62 58.20 50.84 -23.76 56.14 48.96 11.42 20.47 11.27 11.65 17.82 10.47 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 78 SER^? 12.19 O ACT A 134 D 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 D 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 20.05 1.17 15.74 19.11 -0.15 13.92 coo -23.62 58.20 50.84 -23.76 56.14 48.96 24.03 9.83 10.49 26.27 11.25 11.31 coo -23.08 51.44 54.96 -24.43 52.71 52.88 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 84 SER^? 20.86 CH3 ACT A 134 D 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 D 182 PHE A 93 PHE^? 5.64 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 30.40 10.24 3.82 32.46 10.17 5.21 coo -23.62 58.20 50.84 -23.76 56.14 48.96 24.03 9.83 10.49 26.27 11.25 11.31 coo -23.08 51.44 54.96 -24.43 52.71 52.88 18.45 6.69 12.19 16.89 8.99 12.05 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 84 SER^? 20.86 CH3 ACT A 134 D 166 PHE A 112 PHE^? 11.25 CH3 ACT A 134 D 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 30.40 10.24 3.82 32.46 10.17 5.21 coo -23.62 58.20 50.84 -23.76 56.14 48.96 23.79 16.00 9.29 22.27 15.23 11.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 84 SER^? 20.86 CH3 ACT A 134 D 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 D 182 PHE B 112 PHE^? 11.41 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 30.40 10.24 3.82 32.46 10.17 5.21 coo -23.62 58.20 50.84 -23.76 56.14 48.96 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 23.76 0.41 -4.47 22.23 1.06 -6.71 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 17 PHE~? 9.37 CH3 ACT A 134 D 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 23.39 11.02 14.17 21.27 9.32 13.60 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 D 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.15 14.12 14.90 17.05 13.12 13.34 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 D 182 PHE A 40 PHE^? 14.40 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.55 19.39 16.02 20.64 18.71 13.32 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.14 24.61 9.13 19.21 21.98 9.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 D 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.55 19.39 16.02 20.64 18.71 13.32 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 D 182 PHE A 32 PHE~? 11.19 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.14 24.61 9.13 19.21 21.98 9.50 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.55 19.39 16.02 20.64 18.71 13.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 D 182 PHE A 62 PHE~? 8.11 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.14 24.61 9.13 19.21 21.98 9.50 coo -23.08 51.44 54.96 -24.43 52.71 52.88 11.42 20.47 11.27 11.65 17.82 10.47 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 40 PHE^? 14.40 CH3 ACT A 134 D 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.14 24.61 9.13 19.21 21.98 9.50 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 D 182 PHE A 40 PHE^? 14.40 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.89 21.94 7.67 12.75 23.35 8.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.14 24.61 9.13 19.21 21.98 9.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 D 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.89 21.94 7.67 12.75 23.35 8.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 16 3 # 16 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 42 PHE^? 12.32 OXT ACT A 134 D 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.89 21.94 7.67 12.75 23.35 8.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 17 3 # 17 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 D 182 PHE A 62 PHE~? 8.11 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.18 16.78 6.78 8.76 15.01 8.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 11.42 20.47 11.27 11.65 17.82 10.47 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 18 3 # 18 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 D 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.18 16.78 6.78 8.76 15.01 8.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 19 3 # 19 D 130 SER A 111 SER^? 14.00 CH3 ACT A 134 D 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 D 182 PHE A 126 PHE^? 5.77 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.88 13.56 5.40 22.76 13.90 3.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.18 16.78 6.78 8.76 15.01 8.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 9.56 9.33 5.49 8.55 11.71 6.60 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 20 3 # 20 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 D 182 PHE A 19 PHE~? 16.57 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.15 14.12 14.90 17.05 13.12 13.34 coo -23.08 51.44 54.96 -24.43 52.71 52.88 24.41 18.01 20.14 26.66 18.57 21.69 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 21 3 # 21 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 D 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.15 14.12 14.90 17.05 13.12 13.34 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 22 3 # 22 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 20 PHE~? 5.83 CH3 ACT A 134 D 182 PHE A 91 PHE^? 12.26 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.15 14.12 14.90 17.05 13.12 13.34 coo -23.08 51.44 54.96 -24.43 52.71 52.88 24.03 9.83 10.49 26.27 11.25 11.31 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 23 3 # 23 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 D 182 PHE A 17 PHE~? 9.37 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.55 19.39 16.02 20.64 18.71 13.32 coo -23.08 51.44 54.96 -24.43 52.71 52.88 23.39 11.02 14.17 21.27 9.32 13.60 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 24 3 # 24 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 32 PHE~? 11.19 CH3 ACT A 134 D 182 PHE A 63 PHE~? 9.05 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.55 19.39 16.02 20.64 18.71 13.32 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.60 20.08 14.87 16.25 19.26 12.77 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 25 3 # 25 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 62 PHE~? 8.11 OXT ACT A 134 D 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 11.42 20.47 11.27 11.65 17.82 10.47 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 26 3 # 26 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 D 182 PHE A 20 PHE~? 5.83 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.60 20.08 14.87 16.25 19.26 12.77 coo -23.08 51.44 54.96 -24.43 52.71 52.88 19.15 14.12 14.90 17.05 13.12 13.34 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 27 3 # 27 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 D 182 PHE A 44 PHE^? 6.38 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.60 20.08 14.87 16.25 19.26 12.77 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.18 16.78 6.78 8.76 15.01 8.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 28 3 # 28 D 130 SER A 121 SER^? 16.65 CH3 ACT A 134 D 166 PHE A 63 PHE~? 9.05 CH3 ACT A 134 D 182 PHE A 49 PHE.? 12.05 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.93 21.60 5.62 22.92 20.74 3.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.60 20.08 14.87 16.25 19.26 12.77 coo -23.08 51.44 54.96 -24.43 52.71 52.88 7.92 21.75 8.87 7.38 23.30 11.14 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 29 3 # 29 D 130 SER A 128 SER.? 10.42 O ACT A 134 D 166 PHE B 44 PHE^? 6.37 O ACT B 134 D 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 9.47 2.37 6.00 8.93 0.44 7.47 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 30 3 # 30 D 130 SER A 132 SER.? 12.20 O ACT A 134 D 166 PHE A 126 PHE^? 5.77 OXT ACT A 134 D 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 7.72 -1.19 11.22 7.31 -1.68 8.88 coo -23.62 58.20 50.84 -23.76 56.14 48.96 9.56 9.33 5.49 8.55 11.71 6.60 coo -23.08 51.44 54.96 -24.43 52.71 52.88 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 31 3 # 31 D 130 SER B 67 SER~? 9.18 CH3 ACT B 134 D 166 PHE B 49 PHE.? 12.01 O ACT B 134 D 182 PHE B 42 PHE^? 12.28 O ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 8.81 0.10 -14.70 11.16 -0.29 -15.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 7.96 -5.25 -4.07 7.44 -6.88 -6.27 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.88 -5.47 -2.80 12.77 -6.80 -4.00 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 32 3 # 32 D 130 SER B 78 SER^? 12.20 OXT ACT B 134 D 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 D 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 20.02 15.26 -10.83 19.07 16.62 -8.98 coo -23.62 58.20 50.84 -23.76 56.14 48.96 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 33 3 # 33 D 130 SER B 84 SER^? 21.05 CH3 ACT B 134 D 166 PHE A 91 PHE^? 12.26 CH3 ACT A 134 D 182 PHE A 112 PHE^? 11.25 CH3 ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 30.37 6.08 1.00 32.42 6.12 -0.34 coo -23.62 58.20 50.84 -23.76 56.14 48.96 24.03 9.83 10.49 26.27 11.25 11.31 coo -23.08 51.44 54.96 -24.43 52.71 52.88 23.79 16.00 9.29 22.27 15.23 11.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 34 3 # 34 D 130 SER B 84 SER^? 21.05 CH3 ACT B 134 D 166 PHE B 91 PHE^? 12.41 CH3 ACT B 134 D 182 PHE B 93 PHE^? 5.85 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 30.37 6.08 1.00 32.42 6.12 -0.34 coo -23.62 58.20 50.84 -23.76 56.14 48.96 24.01 6.53 -5.66 26.22 5.03 -6.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 18.48 9.68 -7.33 16.94 7.39 -7.19 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 35 3 # 35 D 130 SER B 84 SER^? 21.05 CH3 ACT B 134 D 166 PHE B 112 PHE^? 11.41 CH3 ACT B 134 D 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 30.37 6.08 1.00 32.42 6.12 -0.34 coo -23.62 58.20 50.84 -23.76 56.14 48.96 23.76 0.41 -4.47 22.23 1.06 -6.71 coo -23.08 51.44 54.96 -24.43 52.71 52.88 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 36 3 # 36 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 17 PHE~? 9.52 CH3 ACT B 134 D 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 23.32 5.37 -9.36 21.26 7.18 -8.91 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 37 3 # 37 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 20 PHE~? 5.94 CH3 ACT B 134 D 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 38 3 # 38 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 D 182 PHE B 40 PHE^? 14.44 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.07 -8.19 -4.31 19.11 -5.62 -4.70 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 39 3 # 39 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 D 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 40 3 # 40 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 D 182 PHE B 32 PHE~? 11.23 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.49 -2.98 -11.25 20.62 -2.27 -8.52 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 41 3 # 41 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 40 PHE^? 14.44 CH3 ACT B 134 D 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.07 -8.19 -4.31 19.11 -5.62 -4.70 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 42 3 # 42 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 42 PHE^? 12.28 O ACT B 134 D 182 PHE B 40 PHE^? 14.44 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -23.08 51.44 54.96 -24.43 52.71 52.88 20.07 -8.19 -4.31 19.11 -5.62 -4.70 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 43 3 # 43 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 42 PHE^? 12.28 O ACT B 134 D 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 44 3 # 44 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 42 PHE^? 12.28 O ACT B 134 D 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.88 -5.47 -2.80 12.77 -6.80 -4.00 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 45 3 # 45 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 44 PHE^? 6.37 O ACT B 134 D 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 46 3 # 46 D 130 SER B 111 SER^? 14.22 CH3 ACT B 134 D 166 PHE B 44 PHE^? 6.37 O ACT B 134 D 182 PHE B 126 PHE^? 5.73 O ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.84 2.81 -0.55 22.81 2.45 1.66 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.16 -0.39 -1.93 8.83 1.48 -3.54 coo -23.08 51.44 54.96 -24.43 52.71 52.88 9.55 7.10 -0.62 8.51 4.83 -1.87 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 47 3 # 47 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 20 PHE~? 5.94 CH3 ACT B 134 D 182 PHE B 19 PHE~? 16.60 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -23.08 51.44 54.96 -24.43 52.71 52.88 24.33 -1.57 -15.38 26.55 -2.24 -16.92 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 48 3 # 48 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 20 PHE~? 5.94 CH3 ACT B 134 D 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 49 3 # 49 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 20 PHE~? 5.94 CH3 ACT B 134 D 182 PHE B 91 PHE^? 12.41 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.13 2.31 -10.10 17.00 3.15 -8.48 coo -23.08 51.44 54.96 -24.43 52.71 52.88 24.01 6.53 -5.66 26.22 5.03 -6.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 50 3 # 50 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 D 182 PHE B 17 PHE~? 9.52 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -23.08 51.44 54.96 -24.43 52.71 52.88 23.32 5.37 -9.36 21.26 7.18 -8.91 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 51 3 # 51 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 32 PHE~? 11.23 CH3 ACT B 134 D 182 PHE B 63 PHE~? 8.97 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 20.49 -2.98 -11.25 20.62 -2.27 -8.52 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.54 -3.61 -10.05 16.20 -2.79 -7.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 52 3 # 52 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 D 182 PHE B 20 PHE~? 5.94 CH3 ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 19.13 2.31 -10.10 17.00 3.15 -8.48 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 53 3 # 53 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 D 182 PHE B 44 PHE^? 6.37 O ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.16 -0.39 -1.93 8.83 1.48 -3.54 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 54 3 # 54 D 130 SER B 121 SER^? 16.88 CH3 ACT B 134 D 166 PHE B 63 PHE~? 8.97 CH3 ACT B 134 D 182 PHE B 49 PHE.? 12.01 O ACT B 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.94 -5.22 -0.75 23.02 -4.36 1.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 14.54 -3.61 -10.05 16.20 -2.79 -7.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 7.96 -5.25 -4.07 7.44 -6.88 -6.27 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 55 3 # 55 D 130 SER B 128 SER.? 10.40 OXT ACT B 134 D 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 D 182 PHE A 42 PHE^? 12.32 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 9.49 14.01 -1.20 8.95 15.98 -2.61 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.18 16.78 6.78 8.76 15.01 8.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.89 21.94 7.67 12.75 23.35 8.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 56 3 # 56 D 130 SER B 128 SER.? 10.40 OXT ACT B 134 D 166 PHE A 44 PHE^? 6.38 OXT ACT A 134 D 182 PHE A 62 PHE~? 8.11 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 9.49 14.01 -1.20 8.95 15.98 -2.61 coo -23.62 58.20 50.84 -23.76 56.14 48.96 10.18 16.78 6.78 8.76 15.01 8.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 11.42 20.47 11.27 11.65 17.82 10.47 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 57 3 # 57 D 130 SER B 132 SER.? 12.23 OXT ACT B 134 D 166 PHE B 126 PHE^? 5.73 O ACT B 134 D 182 PHE A 126 PHE^? 5.77 OXT ACT A 134 coo -32.42 55.27 46.18 -30.51 54.94 47.67 7.68 17.54 -6.39 7.22 18.14 -4.05 coo -23.62 58.20 50.84 -23.76 56.14 48.96 9.55 7.10 -0.62 8.51 4.83 -1.87 coo -23.08 51.44 54.96 -24.43 52.71 52.88 9.56 9.33 5.49 8.55 11.71 6.60 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 57 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 86 GLU.? 27.53 CH3 ACT B 134 A 44 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 50 THR A 3 THR.? 25.34 CH3 ACT A 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.97 15.66 -0.32 36.99 16.96 -1.64 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 37.70 12.40 8.53 36.14 12.23 7.15 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 39.15 8.12 6.79 37.84 7.92 8.51 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 86 GLU.? 27.53 CH3 ACT B 134 A 44 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 50 THR A 9 THR~? 21.47 CH3 ACT A 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.97 15.66 -0.32 36.99 16.96 -1.64 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 37.70 12.40 8.53 36.14 12.23 7.15 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 33.26 16.17 8.09 32.71 16.27 5.99 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU A 86 GLU.? 27.53 CH3 ACT B 134 A 44 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 50 THR A 88 THR^? 17.94 CH3 ACT A 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.97 15.66 -0.32 36.99 16.96 -1.64 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 26.00 19.90 3.85 25.60 19.04 1.99 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 28.18 15.22 3.40 26.60 15.27 1.86 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU A 86 GLU.? 27.53 CH3 ACT B 134 A 44 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 50 THR B 3 THR.? 25.35 CH3 ACT B 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.97 15.66 -0.32 36.99 16.96 -1.64 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 37.67 3.93 -3.68 36.11 4.07 -2.28 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 39.05 8.24 -2.00 37.67 8.32 -3.71 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU A 92 GLU^? 14.49 CH3 ACT A 134 A 44 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 50 THR B 88 THR^? 18.11 CH3 ACT B 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 21.29 4.79 5.54 21.77 3.26 4.19 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 28.17 1.09 1.44 26.55 0.98 2.93 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU B 86 GLU.? 27.22 CH3 ACT A 134 A 44 ASP A 7 ASP~? 23.80 CH3 ACT A 134 A 50 THR A 3 THR.? 25.34 CH3 ACT A 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.82 0.62 5.15 36.84 -0.64 6.51 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 37.70 12.40 8.53 36.14 12.23 7.15 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 39.15 8.12 6.79 37.84 7.92 8.51 ULMN 3 3hde_o00 LYSOZYME user 7 3 # 7 A 35 GLU B 86 GLU.? 27.22 CH3 ACT A 134 A 44 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 50 THR B 3 THR.? 25.35 CH3 ACT B 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.82 0.62 5.15 36.84 -0.64 6.51 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 37.67 3.93 -3.68 36.11 4.07 -2.28 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 39.05 8.24 -2.00 37.67 8.32 -3.71 ULMN 3 3hde_o00 LYSOZYME user 8 3 # 8 A 35 GLU B 86 GLU.? 27.22 CH3 ACT A 134 A 44 ASP B 7 ASP~? 23.98 CH3 ACT B 134 A 50 THR B 9 THR~? 21.72 CH3 ACT B 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.82 0.62 5.15 36.84 -0.64 6.51 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 37.67 3.93 -3.68 36.11 4.07 -2.28 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 33.24 0.14 -3.28 32.74 0.01 -1.15 ULMN 3 3hde_o00 LYSOZYME user 9 3 # 9 A 35 GLU B 86 GLU.? 27.22 CH3 ACT A 134 A 44 ASP B 113 ASP^? 18.51 CH3 ACT B 134 A 50 THR B 88 THR^? 18.11 CH3 ACT B 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 35.82 0.62 5.15 36.84 -0.64 6.51 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 28.17 1.09 1.44 26.55 0.98 2.93 ULMN 3 3hde_o00 LYSOZYME user 10 3 # 10 A 35 GLU B 92 GLU^? 14.52 OXT ACT B 134 A 44 ASP A 113 ASP^? 18.42 CH3 ACT A 134 A 50 THR A 88 THR^? 17.94 CH3 ACT A 134 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 21.22 11.60 -0.72 21.76 13.12 0.60 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 26.00 19.90 3.85 25.60 19.04 1.99 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 28.18 15.22 3.40 26.60 15.27 1.86 3hde_o00 source 3HDE LYSOZYME : 10 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 92 GLU^? 14.49 CH3 ACT A 134 B 44 ASP B 113 ASP^? 18.51 CH3 ACT B 134 B 50 THR B 87 THR.? 23.05 CH3 ACT B 134 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 21.29 4.79 5.54 21.77 3.26 4.19 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 25.97 -3.50 0.94 25.56 -2.60 2.79 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 31.16 -1.20 2.01 31.03 -2.27 3.89 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU B 92 GLU^? 14.52 OXT ACT B 134 B 44 ASP A 113 ASP^? 18.42 CH3 ACT A 134 B 50 THR A 87 THR.? 22.88 CH3 ACT A 134 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 21.22 11.60 -0.72 21.76 13.12 0.60 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 26.00 19.90 3.85 25.60 19.04 1.99 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 31.21 17.48 2.82 31.09 18.74 1.05 3hde_o01 source 3HDE LYSOZYME : 2 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 92 GLU^? 14.49 CH3 ACT A 134 C 44 ASP B 113 ASP^? 18.51 CH3 ACT B 134 C 50 THR B 87 THR.? 23.05 CH3 ACT B 134 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 21.29 4.79 5.54 21.77 3.26 4.19 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 25.97 -3.50 0.94 25.56 -2.60 2.79 coo 25.48 4.87 1.60 23.90 4.95 0.15 31.16 -1.20 2.01 31.03 -2.27 3.89 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 92 GLU^? 14.52 OXT ACT B 134 C 44 ASP A 113 ASP^? 18.42 CH3 ACT A 134 C 50 THR A 87 THR.? 22.88 CH3 ACT A 134 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 21.22 11.60 -0.72 21.76 13.12 0.60 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 26.00 19.90 3.85 25.60 19.04 1.99 coo 25.48 4.87 1.60 23.90 4.95 0.15 31.21 17.48 2.82 31.09 18.74 1.05 3hde_o02 source 3HDE LYSOZYME : 2 hits 3hde_o02 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 A 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 A 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 37.97 47.82 5.46 38.65 48.02 7.40 22.90 30.21 5.13 24.67 29.05 5.02 coo 41.02 51.33 13.36 40.18 47.06 9.99 17.29 28.50 12.14 22.41 28.51 15.17 coo 39.17 42.30 8.54 40.94 44.26 7.78 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 A 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 A 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 37.97 47.82 5.46 38.65 48.02 7.40 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 41.02 51.33 13.36 40.18 47.06 9.99 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 39.17 42.30 8.54 40.94 44.26 7.78 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 1 3 # 1 B 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 B 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 B 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 33.94 43.16 45.29 35.02 43.05 43.47 22.90 30.21 5.13 24.67 29.05 5.02 coo 38.53 39.60 38.22 36.76 43.89 41.37 17.29 28.50 12.14 22.41 28.51 15.17 coo 35.77 48.61 42.57 37.40 46.62 43.48 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 2 3 # 2 B 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 B 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 B 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 33.94 43.16 45.29 35.02 43.05 43.47 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 38.53 39.60 38.22 36.76 43.89 41.37 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 35.77 48.61 42.57 37.40 46.62 43.48 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o01 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o01 naa= 3 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 1 3 # 1 C 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 C 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 C 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 22.90 30.21 5.13 24.67 29.05 5.02 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 17.29 28.50 12.14 22.41 28.51 15.17 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 2 3 # 2 C 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 C 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 C 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o02 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o02 naa= 3 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 1 3 # 1 D 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 D 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 D 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 25.05 13.27 54.10 26.66 12.10 53.60 22.90 30.21 5.13 24.67 29.05 5.02 coo 33.45 10.03 51.76 28.31 9.37 53.37 17.29 28.50 12.14 22.41 28.51 15.17 coo 24.32 7.20 55.59 24.80 8.07 53.08 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 2 3 # 2 D 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 D 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 D 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 25.05 13.27 54.10 26.66 12.10 53.60 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 33.45 10.03 51.76 28.31 9.37 53.37 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 24.32 7.20 55.59 24.80 8.07 53.08 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o03 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o03 naa= 3 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 1 3 # 1 E 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 E 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 E 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 54.17 11.77 49.20 52.64 11.40 50.63 22.90 30.21 5.13 24.67 29.05 5.02 coo 45.83 11.66 53.42 50.97 10.25 52.77 17.29 28.50 12.14 22.41 28.51 15.17 coo 55.28 7.50 53.67 54.71 10.14 54.01 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 2 3 # 2 E 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 E 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 E 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 54.17 11.77 49.20 52.64 11.40 50.63 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 45.83 11.66 53.42 50.97 10.25 52.77 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 55.28 7.50 53.67 54.71 10.14 54.01 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o04 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o04 naa= 3 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 1 3 # 1 F 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 F 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 F 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 41.67 65.37 28.64 40.76 63.70 27.74 22.90 30.21 5.13 24.67 29.05 5.02 coo 38.34 58.97 23.05 39.26 61.42 28.02 17.29 28.50 12.14 22.41 28.51 15.17 coo 39.64 61.25 32.92 38.08 62.62 31.22 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 2 3 # 2 F 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 F 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 F 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 41.67 65.37 28.64 40.76 63.70 27.74 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 38.34 58.97 23.05 39.26 61.42 28.02 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 39.64 61.25 32.92 38.08 62.62 31.22 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o05 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o05 naa= 3 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 1 3 # 1 G 29 ASP A 39 ASP^? 22.84 CH3 ACT A 134 G 117 LYS A 56 LYS~? 20.00 CH3 ACT A 134 G 150 CYH A 120 CYH^? 19.90 CH3 ACT A 134 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 22.90 30.21 5.13 24.67 29.05 5.02 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 17.29 28.50 12.14 22.41 28.51 15.17 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 24.68 23.88 6.89 26.52 23.27 4.81 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 2 3 # 2 G 29 ASP B 39 ASP^? 22.90 CH3 ACT B 134 G 117 LYS B 56 LYS~? 20.04 CH3 ACT B 134 G 150 CYH B 120 CYH^? 20.05 CH3 ACT B 134 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 22.87 -13.88 -0.47 24.63 -12.69 -0.32 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 17.26 -12.01 -7.36 22.35 -12.14 -10.46 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 24.60 -7.54 -2.15 26.44 -7.04 -0.09 3uao_o06 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o06 naa= 3 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 1 3 # 1 A 966 SER A 111 SER^? 14.00 CH3 ACT A 134 A 967 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 975 TYR A 122 TYR^? 8.33 CH3 ACT A 134 coo 82.02 40.88 31.11 79.88 41.56 30.18 21.88 13.56 5.40 22.76 13.90 3.16 coo 78.94 44.79 33.75 77.86 47.56 32.82 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 83.57 40.86 25.45 83.15 43.18 26.91 18.19 17.99 8.45 16.46 16.26 9.80 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 2 3 # 2 A 966 SER A 111 SER^? 14.00 CH3 ACT A 134 A 967 ARG B 81 ARG^? 17.71 OXT ACT B 134 A 975 TYR A 125 TYR^? 11.32 OXT ACT B 134 coo 82.02 40.88 31.11 79.88 41.56 30.18 21.88 13.56 5.40 22.76 13.90 3.16 coo 78.94 44.79 33.75 77.86 47.56 32.82 23.90 15.91 -0.43 22.97 18.81 -0.95 coo 83.57 40.86 25.45 83.15 43.18 26.91 16.00 10.76 2.04 17.57 12.50 0.46 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 3 3 # 3 A 966 SER B 111 SER^? 14.22 CH3 ACT B 134 A 967 ARG A 81 ARG^? 17.75 O ACT A 134 A 975 TYR B 122 TYR^? 8.37 CH3 ACT B 134 coo 82.02 40.88 31.11 79.88 41.56 30.18 21.84 2.81 -0.55 22.81 2.45 1.66 coo 78.94 44.79 33.75 77.86 47.56 32.82 23.88 0.36 5.26 23.01 -2.52 5.93 coo 83.57 40.86 25.45 83.15 43.18 26.91 18.14 -1.53 -3.61 16.39 0.20 -4.99 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 4 3 # 4 A 966 SER B 111 SER^? 14.22 CH3 ACT B 134 A 967 ARG A 81 ARG^? 17.75 O ACT A 134 A 975 TYR B 125 TYR^? 11.31 O ACT A 134 coo 82.02 40.88 31.11 79.88 41.56 30.18 21.84 2.81 -0.55 22.81 2.45 1.66 coo 78.94 44.79 33.75 77.86 47.56 32.82 23.88 0.36 5.26 23.01 -2.52 5.93 coo 83.57 40.86 25.45 83.15 43.18 26.91 16.01 5.62 2.81 17.58 3.86 4.41 4dqk_o00 source 4DQK BIFUNCTIONAL P-450/NADPH-P450 REDUCTASE : 4 hits 4dqk_o00 naa= 3